
<html lang="en"     class="pb-page"  data-request-id="f15e4a68-dab8-417c-b66f-31e5ac7dd90b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2016.59.issue-20;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.6b00948;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections" /></meta><meta name="dc.Creator" content="Laurel  Mydock-McGrane" /></meta><meta name="dc.Creator" content="Zachary  Cusumano" /></meta><meta name="dc.Creator" content="Zhenfu  Han" /></meta><meta name="dc.Creator" content="Jana  Binkley" /></meta><meta name="dc.Creator" content="Maria  Kostakioti" /></meta><meta name="dc.Creator" content="Thomas  Hannan" /></meta><meta name="dc.Creator" content="Jerome S.  Pinkner" /></meta><meta name="dc.Creator" content="Roger  Klein" /></meta><meta name="dc.Creator" content="Vasilios  Kalas" /></meta><meta name="dc.Creator" content="Jan  Crowley" /></meta><meta name="dc.Creator" content="Nigam P.  Rath" /></meta><meta name="dc.Creator" content="Scott J.  Hultgren" /></meta><meta name="dc.Creator" content="James W.  Janetka" /></meta><meta name="dc.Description" content="Gram-negative uropathogenic Escherichia coli (UPEC) bacteria are a causative pathogen of urinary tract infections (UTIs). Previously developed antivirulence inhibitors of the type 1 pilus adhesin, ..." /></meta><meta name="Description" content="Gram-negative uropathogenic Escherichia coli (UPEC) bacteria are a causative pathogen of urinary tract infections (UTIs). Previously developed antivirulence inhibitors of the type 1 pilus adhesin, ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 14, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00948" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00948" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00948" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00948" /></link>
        
    
    

<title>Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00948" /></meta><meta property="og:title" content="Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0016.jpeg" /></meta><meta property="og:description" content="Gram-negative uropathogenic Escherichia coli (UPEC) bacteria are a causative pathogen of urinary tract infections (UTIs). Previously developed antivirulence inhibitors of the type 1 pilus adhesin, FimH, demonstrated oral activity in animal models of UTI but were found to have limited compound exposure due to the metabolic instability of the O-glycosidic bond (O-mannosides). Herein, we disclose that compounds having the O-glycosidic bond replaced with carbon linkages had improved stability and inhibitory activity against FimH. We report on the design, synthesis, and in vivo evaluation of this promising new class of carbon-linked C-mannosides that show improved pharmacokinetic (PK) properties relative to O-mannosides. Interestingly, we found that FimH binding is stereospecifically modulated by hydroxyl substitution on the methylene linker, where the R-hydroxy isomer has a 60-fold increase in potency. This new class of C-mannoside antagonists have significantly increased compound exposure and, as a result, enhanced efficacy in mouse models of acute and chronic UTI." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00948"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00948">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00948&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00948&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00948&amp;href=/doi/10.1021/acs.jmedchem.6b00948" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 9390-9408</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b00938" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b00967" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Antivirulence <i>C</i>-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurel++Mydock-McGrane">Laurel Mydock-McGrane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zachary++Cusumano">Zachary Cusumano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhenfu++Han">Zhenfu Han</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jana++Binkley">Jana Binkley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Kostakioti">Maria Kostakioti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Hannan">Thomas Hannan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerome+S.++Pinkner">Jerome S. Pinkner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger++Klein">Roger Klein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vasilios++Kalas">Vasilios Kalas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Crowley">Jan Crowley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigam+P.++Rath">Nigam P. Rath</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott+J.++Hultgren">Scott J. Hultgren</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+W.++Janetka">James W. Janetka</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Fimbrion Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>‡</sup>Departments of Biochemistry and Molecular Biophysics, and Chemistry, <sup>§</sup>Department of Molecular Microbiology, <sup>∥</sup>Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Chemistry and Biochemistry, University of Missouri, Saint Louis, Missouri 63121 United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 314-362-0509. Fax: 314-362-7183. E-mail: <a href="/cdn-cgi/l/email-protection#e78d868982938c868da7858e88848f828ac9909294938bc9828392"><span class="__cf_email__" data-cfemail="f09a919e95849b919ab092999f9398959dde878583849cde959485">[email protected]</span></a>. Address: 660 South Euclid Avenue, Box 8231, St. Louis, Missouri 63110, United States.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00948&amp;href=/doi/10.1021%2Facs.jmedchem.6b00948" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 9390–9408</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 30, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>28 June 2016</li><li><span class="item_label"><b>Published</b> online</span>14 October 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 October 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00948" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00948</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00948"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3372</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00948" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Antivirulence C-Mannosides as Antibiotic-Sparing, Oral Therapeutics for Urinary Tract Infections&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Laurel&quot;,&quot;last_name&quot;:&quot;Mydock-McGrane&quot;},{&quot;first_name&quot;:&quot;Zachary&quot;,&quot;last_name&quot;:&quot;Cusumano&quot;},{&quot;first_name&quot;:&quot;Zhenfu&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Jana&quot;,&quot;last_name&quot;:&quot;Binkley&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Kostakioti&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Hannan&quot;},{&quot;first_name&quot;:&quot;Jerome&quot;,&quot;last_name&quot;:&quot;S. Pinkner&quot;},{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;Klein&quot;},{&quot;first_name&quot;:&quot;Vasilios&quot;,&quot;last_name&quot;:&quot;Kalas&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Crowley&quot;},{&quot;first_name&quot;:&quot;Nigam&quot;,&quot;last_name&quot;:&quot;P. Rath&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;J. Hultgren&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;W. Janetka&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;9390-9408&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00948&quot;},&quot;abstract&quot;:&quot;Gram-negative uropathogenic Escherichia coli (UPEC) bacteria are a causative pathogen of urinary tract infections (UTIs). Previously developed antivirulence inhibitors of the type 1 pilus adhesin, FimH, demonstrated oral activity in animal models of UTI but were found to have limited compound exposure due to the metabolic instability of the O-glycosidic bond (O-mannosides). Herein, we disclose that compounds having the O-glycosidic bond replaced with carbon linkages had improved stability and inhibitory activity against FimH. We report on the design, synthesis, and in vivo evaluation of this promising new class of carbon-linked C-mannosides that show improved pharmacokinetic (PK) properties relative to O-mannosides. Interestingly, we found that FimH binding is stereospecifically modulated by hydroxyl substitution on the methylene linker, where the R-hydroxy isomer has a 60-fold increase in potency. This new class of C-mannoside antagonists have significantly increased compound exposure and, as a result, enhan&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00948&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00948" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00948&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00948" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00948&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00948" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00948&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00948&amp;href=/doi/10.1021/acs.jmedchem.6b00948" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00948" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00948" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00948%26sid%3Dliteratum%253Aachs%26pmid%3D27689912%26genre%3Darticle%26aulast%3DMydock-McGrane%26date%3D2016%26atitle%3DAntivirulence%2BC-Mannosides%2Bas%2BAntibiotic-Sparing%252C%2BOral%2BTherapeutics%2Bfor%2BUrinary%2BTract%2BInfections%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D20%26spage%3D9390%26epage%3D9408%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292016" title="Therapeutics">Therapeutics</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/jmcmar.2016.59.issue-20/20161027/jmcmar.2016.59.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Gram-negative uropathogenic <i>Escherichia coli</i> (UPEC) bacteria are a causative pathogen of urinary tract infections (UTIs). Previously developed antivirulence inhibitors of the type 1 pilus adhesin, FimH, demonstrated oral activity in animal models of UTI but were found to have limited compound exposure due to the metabolic instability of the <i>O</i>-glycosidic bond (<i>O</i>-mannosides). Herein, we disclose that compounds having the <i>O</i>-glycosidic bond replaced with carbon linkages had improved stability and inhibitory activity against FimH. We report on the design, synthesis, and in vivo evaluation of this promising new class of carbon-linked <i>C</i>-mannosides that show improved pharmacokinetic (PK) properties relative to <i>O</i>-mannosides. Interestingly, we found that FimH binding is stereospecifically modulated by hydroxyl substitution on the methylene linker, where the <i>R</i>-hydroxy isomer has a 60-fold increase in potency. This new class of <i>C</i>-mannoside antagonists have significantly increased compound exposure and, as a result, enhanced efficacy in mouse models of acute and chronic UTI.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82351" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82351" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since the 1970s, antibiotic resistance has been steadily increasing and now multidrug resistant pathogens are an imminent threat. Antibiotics target processes essential for bacterial replication and thus induce strong pressure to evolve resistance to these drugs. An alternate therapeutic strategy is to disarm the pathogen by inhibiting critical host–pathogen interactions necessary for persistence in a host. Herein, we describe a promising antibiotic-sparing strategy using small molecule <i>C</i>-mannosides that specifically block the ability of uropathogenic <i>Escherichia coli</i> (UPEC) to colonize the lower urinary tract by neutralizing the FimH adhesin. In mouse models, we show that <i>C</i>-mannosides are oral drugs that are effective in both preventing and treating urinary tract infections (UTIs). These compounds represent advanced preclinical candidates for UTI therapy.</div><div class="NLM_p">Microbial adherence to host cells is a critical initial step in most infectious diseases.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The ability of bacteria to bind and invade epithelial tissues allows them to establish a niche within the host and evade host immune responses.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> While antimicrobial therapy has traditionally been effective in treating bacterial infections, resistance to the most commonly used antimicrobials is on the rise,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> highlighting the need for new therapeutic strategies.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The study of critical host–pathogen interactions during bacterial infection has revealed promising novel targets for therapeutic intervention.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Monoclonal antibodies, vaccines, glycoconjugates, and small molecules have all been developed to disrupt bacterial adherence by competitively blocking the bacterial protein(s) involved in the recognition of various host receptors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This process and molecular mechanism has been most thoroughly studied in urinary tract infection (UTI) pathogenesis.</div><div class="NLM_p">A key step in UTI pathogenesis is the initial colonization of the bladder epithelium by uropathogenic <i>E. coli</i> (UPEC). This binding is mediated by hair-like fibers, termed type 1 pili, that are tipped with the virulence factor FimH adhesin.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The lectin domain of FimH binds mannosylated glycoproteins expressed on the luminal surface of human and murine bladder cells. The terminal FimH residue is a prototypical two-domain adhesin, which is joined to the distal end of the linear tip fibrillum of type 1 pili by a donor strand exchange reaction with subunit FimG.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> FimG then undergoes its own donor strand exchange reaction with subunit FimF, which adapts the fibrillum tip to the long pilus rod, which consists of a homopolymer of ∼1000 FimA subunits coiled into a rigid right-handed helical structure that is capable of unwinding into a linear fiber.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The FimH lectin domain contains a deep acidic pocket that recognizes α-<span class="smallcaps smallerCapital">d</span>-mannose with stereochemical specificity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> FimH-mediated binding to mannosylated uroplakins<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> or α1,β3 integrins<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> facilitates bacterial colonization and invasion of bladder epithelial cells.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">UTIs present a significant burden for women, with nearly 20 million cases reported annually.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Despite antibiotic treatment, 20–40% of these women will have at least one recurrence within 6 months of their initial diagnosis.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This results in a significant economic impact, approximately two billion dollars in the U.S. alone,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> associated with these common and painful infections. The majority of UTIs (85–95%) are caused by members of the <i>Enterobacteriaceae</i> family; UPEC are isolated in approximately 80–85% of community-acquired UTI, and other <i>Enterobacteriaceae</i> account for 5–10% of infections.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Because of the increasing prevalence of recurrent infections, as well as the increasing emergence of antibiotic resistant strains,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> including multidrug resistant UPEC such as the ESBL (extended spectrum β-lactamase) strain ST131,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> the desire for new UTI therapeutics has escalated rapidly in recent years. The requirement for FimH to cause disease has led to its classification as a promising and validated therapeutic target<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> for UTI and, more recently, for Crohn’s disease.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Inhibition of FimH function and activity circumvents bacterial bladder cell adhesion, invasion, and subsequent intracellular biofilm formation, making the bacteria unable to cause or propagate an existing infection.</div><div class="NLM_p">We have previously developed<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> small molecule glycosides based on α-<span class="smallcaps smallerCapital">d</span>-mannose (<i>O</i>-mannosides), such as <b>1</b> and <b>4</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), as tight-binding ligands and potent antagonists of FimH both in vitro and in animal models of UTI. Although, phenyl α-<span class="smallcaps smallerCapital">d</span>-mannosides were first reported by Firon and Sharon in the 1980s as inhibitors of yeast agglutination by mannose-specific enterobacteria,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> the true viability of synthetic mannosides as oral therapeutics for treatment of UTI was not validated in vivo until 2010,<a onclick="showRef(event, 'cit20a ref22'); return false;" href="javascript:void(0);" class="ref cit20a ref22">(20a, 22)</a> where the oral activity of several biphenyl α-<span class="smallcaps smallerCapital">d</span>-mannosides in animal models of acute and chronic UTI was demonstrated. Since then, other related mannosides have also been reported<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and glycodendrimer<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> FimH antagonists. X-ray crystallographic data of mannosides binding to the FimH lectin domain has aided in the rational design of higher affinity ligands, with improvement gained through interactions to the “tyrosine gate” at the periphery of the deep mannose binding pocket<a onclick="showRef(event, 'cit6c ref8 cit20c'); return false;" href="javascript:void(0);" class="ref cit6c ref8 cit20c">(6c, 8, 20c)</a> and to a small hydrophobic pocket<a onclick="showRef(event, 'cit20b cit23a ref25'); return false;" href="javascript:void(0);" class="ref cit20b cit23a ref25">(20b, 23a, 25)</a> near the mannoside glycosidic bond. While <i>O</i>-mannosides have good efficacy in animal models of UTI, they have low bioavailability and half-life, which can possibly be attributed to the metabolic instability of the <i>O</i>-glycosidic bond<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> to either hydrolysis in the stomach or intestinal tract or, alternately, from the enzymatic action of mannosidases.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of simple glycosidic bond replacement of early lead <i>O</i>-mannosides <b>1</b> and <b>4</b>, with alternate linkers to the biphenyl aglycone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In this article, we specifically address and eliminate this potential metabolic liability of <i>O</i>-mannosides with new <i>C</i>-mannosides, which have the labile <i>O</i>-glycosidic bond replaced with stable carbon-based linkers to the aglycone portion of the mannoside. Herein, we report on a novel, stereoselective, synthetic route to construct this new class of biaryl, <i>C</i>-glycoside FimH antagonists, which encompass a unique <i>R</i>-hydroxy methylene bond to the aglycone. We have employed X-ray crystallography and computational docking studies of mannosides to develop a pharmacophore model of stereospecific <i>C</i>-mannoside binding to FimH. Furthermore, we show that relative to <i>O</i>-mannosides, these new <i>C</i>-mannosides have greatly increased compound exposure, which we postulate to result from an increase in metabolic stability of the glycosidic bond. Exactingly, C-mannosides also have significantly improved in vitro FimH activity and in vivo efficacy in animal models of UTI.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> <i>N</i>-, <i>S</i>-Linked Mannosides</h3><div class="NLM_p">At the onset of this work, we synthesized two compounds, one containing a nitrogen (<b>2</b>) and the other a sulfur atom (<b>3</b>) in place of the oxygen glycosidic bond (<b>1</b>) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). As shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>A, these <i>S</i>- and <i>N</i>-mannosides were prepared using a traditional glycosylation methodology with slight modification, first coupling α-<span class="smallcaps smallerCapital">d</span>-mannose with methyl 4′-aminobiphenyl-3-carboxylate to give N-linked mannoside <b>2</b>, then glycosylating mannose-pentaacetate with 4-bromobenzenethiol to give <b>3a</b>, followed by a Suzuki reaction with 3-methoxycarbonylphenyl boronic acid and deprotection to give S-linked mannoside <b>3</b>. We found that both analogues had slightly lower activity (HAI = 4 μM) to that of <i>O</i>-mannoside <b>1</b> when tested in a hemagglutination (HA) inhibition assay using the clinical <i>E. coli</i> strain UTI89. To help guide our SAR, we also tested <b>2</b> and <b>3</b> in an isothermal shift melting point assay and found that they had equivalent binding affinity to FimH, relative to <b>1</b>. Next, we synthesized an N-linked heterocycle, triazolomannoside, via “click” chemistry methodology. Shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>B, the reaction of azido mannoside <b>7</b><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> with phenylacetylene and copper sulfate, followed by sodium methoxide deacetylation, gave phenyl triazole mannoside <b>8</b> in good yield. However, mannoside <b>8</b> lost substantial potency relative to <b>1</b>, only exhibiting an HAI of 32 μM.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> On the other hand, it was shown by another group that <b>8</b> still retains good FimH binding affinity (IC<sub>50</sub> = 0.25 μM) as determined in a competitive binding assay.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Hoping to build from these initial results with <i>N</i>- and <i>S</i>-mannosides, we aimed to construct potentially more metabolically stable, carbon-based linkers, or <i>C</i>-mannosides.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-, <i>S</i>-, and Triazole-Linked Biphenyl Mannosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 4′-aminobiphenyl-3-carboxylate, EtOH, 55 °C; (b) 4-bromobenzenethiol, BF<sub>3</sub>–OEt<sub>2</sub>, DCM, 0 °C to rt; (c) 3-methoxycarbonylphenyl boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/water (5/1), 80 °C; (d) NaOMe/MeOH, 0 °C to rt; (e) phenylacetylene, CuSO<sub>4</sub>, Na ascorbate, EtOH/H<sub>2</sub>O (4/1), rt.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> <i>C</i>-Linked Amide Mannosides</h3><div class="NLM_p">Because of ease of synthesis, we first targeted a series of simple <i>C</i>-linked amide mannosides. Shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, cyano mannoside <b>9</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was obtained by reaction of mannose pentaacetate with trimethylsilyl cyanide and boron trifluoride diethyl etherate to give <b>9</b> as a 2:1 mixture of α and β isomers. Compound <b>9</b> was then hydrolyzed to carboxyl mannoside <b>10</b> by heating in 25% aq HCl for 2 days. 1-[Bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate (HATU) mediated coupling of <b>10</b> with methyl 4′-aminobiphenyl-3-carboxylate yielded the target <i>C</i>-linked amide mannoside <b>11</b>. In parallel, we pursued methylene spaced amides in order to investigate the effect of length and flexibility of the linker. Thus, starting from cyano mannoside <b>9</b>, we synthesized aminomethyl mannoside intermediate <b>12</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Acylation with 4-bromo-benzoyl chloride gave amide mannoside <b>13</b>, which was coupled to methoxycarbonylphenylboronic acid via Suzuki reaction, to give methylene-spaced amide <b>14</b> as a matched pair of <b>1</b>. Testing of <b>11</b>, <b>13</b>, and <b>14</b> in the HA assay revealed that all analogues had reduced potency, relative to <b>1</b>, with HAIs of 16 μM. We rationalized that these, and the triazole linker <b>8</b>, do not allow sufficient flexibility to mimic the conformation, or key FimH binding interactions, observed for <i>O</i>-mannoside <b>1</b>. Hence, we next pursued direct methylene (CH<sub>2</sub>) spaced <i>C</i>-mannosides, which provide a closer structural match to <i>O</i>-, <i>N</i>-, and <i>S</i>-mannosides <b>1</b>–<b>3</b>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>C</i>-Linked Amide Mannosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 25% HCl aq, 50 °C; (b) HATU, DIPEA, 0 °C to rt, DMF; (c) 4-bromobenzoyl chloride, pyridine, rt; (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/water(5/1), 80 °C.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Direct Methylene <i>C</i>-Linked Mannosides</h3><div class="NLM_p">Methylene-spaced, <i>C</i>-mannoside analogues of <i>O</i>-mannoside <b>4</b> and <i>ortho</i>-methylated <i>O</i>-mannoside <b>23</b> were obtained using a newly developed, multistep synthetic procedure, starting from nitrile <b>15</b> (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The non-<i>ortho</i> substituted analogues were synthesized first. Bromide intermediates <b>17R</b> and <b>17S</b> were constructed in a one-pot, two-step sequence, first reducing nitrile <b>15</b> to aldehyde <b>16</b> with DIBAL, followed by the addition of an organolithium reagent (formed by lithiation of 1,4-dibromobenzene (R = H, step b). The organolithium addition yielded a mixture of alcohol isomers (<b>17R</b> and <b>17S</b>), which were separable by silica gel chromatography. Following a palladium-mediated cross-coupling of <b>17R</b> and <b>17S</b> with 3-(<i>N</i>-methylaminocarbonyl)phenyl boronate, <b>18R</b> and <b>18S</b> were obtained in good yield, respectively. Subsequent benzyl deprotection produced methylene-linked <i>C</i>-mannosides <b>5</b>, <b>6R</b> and <b>6S</b>. Following testing in the HA assay, we discovered that methylene-spaced analogue <b>5</b> (HAI = 1 μM) was equipotent to its matched pair <i>O</i>-mannoside <b>4</b> (HAI = 0.5 μM) (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). Surprisingly, we found the secondary alcohol isomers <b>6S</b> and <b>6R</b> showed differential potency, with a pronounced stereochemical preference for the <i>R</i>-hydroxyl group for FimH binding affinity. The isomer <b>6S</b> had 25-fold less potency in the HA assay (HAI = 24 μM) than <b>5</b>, whereas isomer <b>6R</b> gained 4-fold activity (HAI = 0.25 μM).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>C</i>-Linked Methylene and Hydroxy-Methylene Mannosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIBAL, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; (b) diethyl ether, −78 °C to −20 °C; (c) Dess–Martin periodinane, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) Li(<sup>t</sup>OBu)<sub>3</sub>AlH, THF, −40 to 0 °C; (e) 3-(<i>N</i>-methyaminocarbonyl)phenylboronic acid pinacol ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/water (5/1), 80 °C; (f) 10% Pd/C, H<sub>2</sub>, MeOH, rt.</p></p></figure><div class="NLM_p">On the basis of these key results, we synthesized the <i>ortho</i>-methyl analogues <b>22</b> and <b>21</b> based on our lead <i>O</i>-glycoside <b>23</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> Shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, <i>C</i>-mannosides <b>21</b> and <b>22</b> were constructed in a similar fashion as for <b>5</b> and <b>6</b>, only differing in the organolithium reagent (4-bromo-2-methyl-iodobenzene [R = Me, step b]) used for the addition to aldehyde <b>16</b>. We discovered that methylene <i>C</i>-mannoside <b>22</b> (HAI = 2 μM) had a 30-fold decrease in activity relative to <b>23</b>, which is in contrast to the results obtained from <b>5</b>, which retained activity relative to its matched pair, <b>4</b>. However, we did discover the same <i>R</i>-stereospecificity of the benzylic alcohols observed with <b>6R</b> and <b>6S</b> also exists in the more potent <i>ortho</i>-methyl series, with <i>C</i>-mannoside <b>21R</b> having an HAI of 30 nM (relative to 62 nM for <b>23</b>) and S-isomer <b>21S</b> having an HAI of only 24 μM. This striking increase in the FimH activity of <i>R</i>-isomers <b>6R</b> and <b>21R</b> was attributed exclusively to a change in their relative FimH binding affinities when compared to <b>6S</b> and <b>4</b> and <b>21S</b> and <b>23</b>, respectively (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). It should be noted that although the <i>R</i> and <i>S</i> stereochemical assignment of the hydroxymethylene linker in <b>6</b> and <b>21</b> were only speculation at this time, we later confirmed the stereochemistry through small molecule X-ray crystal structure of a derivative of a key precursor, <b>19R</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). From the vast potency difference seen between <b>21R</b> and <b>21S</b>, we can also presuppose that our potency-based assignments are correct for the less effective <b>6R</b> and <b>6S</b> compounds.</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Direct comparison of the potencies of <i>C</i>-linked methylene mannosides <b>21R</b>, <b>21S</b>, and <b>22</b> to those of similar <i>O</i>-mannoside analogues <b>23</b>, <b>24</b>, and <b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro analysis of mannoside potency. The difference in the conformational stability of the FimH lectin domain in the presence of mannoside compared to that in the absence of mannoside, as determined by differential scanning fluorimetry, is presented on the left axis. Measurement of the melting temperature is described in the methods. The hemagglutination inhibition data is presented relative to <span class="smallcaps smallerCapital">d</span>-mannose on the right axis and is described in the methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Stereoselective Methodology for Recycling the Undesired <b>19S</b>-Isomer into the <b>19R</b>-Isomer</h3><div class="NLM_p last">To improve upon our yield of <i>R</i>-hydroxybenzyl <i>C</i>-mannosides, we explored alternate synthetic strategies. In this study, we sought to maximize the yield of <b>19R</b> in step d, depicted in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, which generates a mixture of diastereomers, yielding <b>19R</b> in only 16%, and the <b>19S</b> isomer in 20%. We first investigated modified reaction conditions, including a systematic evaluation of solvents. However, these changes resulted in a lower reaction yield and also gave rise to an inseparable 4-iodo-3-methyl byproduct. Variation of other reaction parameters, such as temperature, concentration, additives, and order of addition, were also attempted, but these unproductively increased the <b>19S</b> isomer ratio. As a possible solution, we envisioned a transformation to convert <b>19S</b> into the desired <b>19R</b> isomer. Therefore, we implemented a two-step oxidation and selective reduction protocol, allowing us to efficiently recycle the undesired <b>19S</b> isomer into <b>19R</b>. This stereoselective recycling method improved the <i>R</i>:<i>S</i> ratios from 1:1.2 (steps c,d) to 28:1 (steps c–f), also increasing the overall yield of <b>19R</b> from 16% to 28% (calculated from compound <b>15</b>). The oxidation of <b>19S</b> (or unresolved mixtures of <b>19S</b> and <b>19R</b>) was carried out using Dess–Martin periodinane in pyridine to give the aryl ketone intermediate <b>19a</b> (not shown) in 74%. Stereoselective reduction using the bulky lithium tri-<i>tert</i>-butoxyaluminum hydride reagent in THF gives <b>19R</b> with a respectable 17:1 (<i>R</i>:<i>S</i>) diastereoselectivity and an excellent yield of 84%. Upon further investigation, we elucidated that the corresponding bulky potassium tri-<i>sec</i>-butylborohydride (K-selectride), the unhindered lithium aluminum hydride (LAH), and sodium borohydride (NaBH<sub>4</sub>) reagents all favored stereoselectivity for the undesired <b>19S</b> isomer. This strongly suggests that the stereoselectivity for the hydride delivery, and reduction comes from a combination of both steric and electronic interactions between the chirality of the α-<span class="smallcaps smallerCapital">d</span>-mannoside and the chosen reducing agent. A careful review of the literature reveals that this particular use of mannose, or any other sugar, as a chiral director for the stereoselective reduction of ketones has not been reported to date and could be precedent for further investigation. We surmise that this methodology could be applied to other glycoside systems to effect a large array of diastereoselective or possibly even enantioselective ketone reductions.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Prodrugs of Mannosides</h3><div class="NLM_p">In a parallel strategy to improve the oral bioavailability and half-life (compound exposure) of <i>O</i>-mannosides, we designed and synthesized various prodrugs<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> of lead <i>O</i>-mannoside <b>23</b>. The prodrugs include tetraacetate <b>23a</b>, the 6-position phosphate <b>23b</b>, and dimethylglycine acetate <b>23c</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Although <b>23a</b> is the precursor in the synthesis of <b>23</b>,<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> it was synthesized by reacetylating mannoside <b>23</b>. To selectively phosphorylate the 6-position, as in prodrug <b>23b</b>, mannoside <b>23</b> was reacted with phosphoryl chloride (POCl<sub>3</sub>) in water and trimethyl phosphate. Finally, prodrug <b>23c</b> was constructed via silylation of <b>23</b>, followed by selective deprotection of the primary trimethylsilyl group. Next, coupling of the free 6-hydroxy group with <i>N</i>,<i>N</i>-dimethylaminoglycine was achieved using <i>N</i>,<i>N</i>-diisopropylcarbodiimide (DIC) to give prodrug <b>23c</b> upon protecting group removal with TFA.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Structures and Synthesis of Prodrug Analogues of <i>O</i>-Mannoside <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, pyridine, rt; (b) POCl<sub>3</sub> trimethylphosphate, H<sub>2</sub>O, 0 °C; (c) TMSCl, Et<sub>3</sub>N, DMF, 0 °C; (d) AcOH, acetone/MeOH, 0 °C to rt; (e) <i>N</i>,<i>N</i>-dimethylglycine hydrochloride, DMAP, DIC, CH<sub>2</sub>Cl<sub>2</sub>/DIPEA, rt; (f) TFA, CH<sub>3</sub>CN, 0 °C.</p></p></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> X-ray Crystallography and Computational Modeling</h3><div class="NLM_p">To better understand the molecular interactions of <i>O</i>-mannosides <b>23</b> and its matched disubstituted analogue <b>24</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>)<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> with FimH, and to help us design improved mannosides based on <i>C</i>-mannoside <b>21R</b>, we obtained co-crystal structures of <b>23</b> and <b>24</b> bound to FimH. A high-resolution 1.67 Å X-ray crystal structure of <b>24</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F2F">5F2F</a>)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and a 1.75 Å structure of <b>23</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F3F">5F3F</a>) bound to the FimH lectin domain were obtained (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A) and used to develop a pharmacophore model for mannoside FimH ligands. The <i>O</i>-linked aglycone projects toward the “lid” of the binding pocket, which engages in favorable hydrophobic and H-bonding interactions. The <i>ortho</i>-methyl substituent on the biphenyl A-ring makes hydrophobic interactions in a small pocket formed by I52, Y137, and N138. The biphenyl B-ring forms favorable π–π stacking interactions with Y48, and the <i>meta</i>-substituted amide also makes polar contacts with FimH. For example, the carbonyl of the amide forms a predicted electrostatic or H-bonding interaction with the neighboring salt bridge, R98, and/or Y137 residues. In <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B, comparison of mannosides <b>23</b> and <b>24</b> to non-<i>ortho</i>-substituted <b>1</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MCY">3MCY</a>),<a onclick="showRef(event, 'cit20c'); return false;" href="javascript:void(0);" class="ref cit20c">(20c)</a> highlights a marked difference in the biphenyl group B-ring conformation upon installation of the <i>ortho</i>-methyl group. On the basis of this new X-ray structure of <b>23</b> and previously reported structures,<a onclick="showRef(event, 'cit23a ref25 ref32'); return false;" href="javascript:void(0);" class="ref cit23a ref25 ref32">(23a, 25, 32)</a> it is apparent that the hydrophobic contacts of the <i>ortho</i>-substituents within the small pocket, and the resultant twisted B-ring conformation, improves π–π stacking in the “tyrosine gate” with Y48 and Y137.</div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) X-ray structure of <b>23</b> bound to FimH (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F3F">5F3F</a>). Water-mediated H-bond of amide carbonyl to Y48. (B) Overlay of <b>23</b> with <b>24</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F2F">5F2F</a>) and <b>1</b> (PBD <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MCY">3MCY</a>). Altered biphenyl ring conformation and amide carbonyl orientation of ortho-substituted mannosides <b>23</b> and <b>24</b> compared to <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Computational Docking of <i>C</i>-Mannosides to FimH</h3><div class="NLM_p">Because we have not been able to obtain a co-crystal structure of <i>C</i>-mannoside <b>21R</b>, we have formulated a computational binding model, shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. As seen in the structure of <b>23</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A), there is a crystallized water molecule between the glycoside anomeric oxygen and the D140 and N135 FimH side chains. The location of the water suggests it is involved in a H-bonding interaction between the anomeric oxygen and FimH. Our computational docking model of the diastereomers <b>21S</b> and <b>21R</b> indicates that the <i>R</i>-isomer (<b>21R</b>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B) is favored energetically over the <i>S</i>-isomer (<b>21S</b>, <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A) due to a productive water-mediated H-bond in the former. This same water molecule, positioned between the hydroxyl group of the <i>R</i>-isomer and residue(s) D140 and N135, is not accessible to the <i>S</i>-isomer. This preference is also predicted from thermodynamic calculations, as the calculated Δ<i>G</i> of binding for the <i>R</i>-isomer is favored by 2.8 kcal/mol over that of the <i>S</i>-isomer. These observations can explain the strong stereospecific preference for FimH binding the <i>R</i>-isomer, relative to the <i>S</i>-isomer, and why methylene spaced mannoside <b>22</b> loses activity<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> compared to <i>O</i>-mannoside <b>23</b>, as the CH<sub>2</sub> is not able to participate in H-bonding to this water molecule. In the absence of X-ray crystallography data of FimH binding, we determined the stereochemistry of the <b>21R</b> benzylic hydroxyl by obtaining a small molecule X-ray crystal structure of crystalline <i>C</i>-mannoside aryl bromide intermediate, <b>27</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). The high resolution X-ray of <b>27</b> unequivocally confirms that the benzylic hydroxyl group of intermediate <b>19R</b>. By logical deduction, <b>19R</b> and its final product <b>21R</b>, both have the <i>R</i>-stereochemistry, reinforcing our computational docking model invoking a stereospecific water-mediated H-bond to FimH.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Computational docking models of isomeric <i>C</i>-mannosides: (A) <i>S</i>-hydroxy (<b>21S</b>) and (B) <i>R</i>-hydroxy (<b>21R</b>) bound to the FimH mannose-binding pocket. The accepted model of <b>21R</b> is bound to FimH through water-mediated H-bond to D140 and N135.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Derivatization of key building block <b>19R</b> (precursor to <b>21R</b>). (B) Small molecule X-ray structure of acetylated intermediate <b>27</b>, confirming the <i>R</i>-stereochemistry of the <b>21R</b> benzylic hydroxyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetics (PK) of Mannosides</h3><div class="NLM_p">To further examine the therapeutic potential of the new <i>C</i>-mannosides and <i>O</i>-mannoside prodrugs, we evaluated their pharmacokinetic (PK) behavior in vivo. Mannosides were delivered orally in a suspension of 10% cyclodextrin. Previous administration utilized DMSO as a vehicle. Our decision to administer in cyclodextrin was 2-fold: (1) cyclodextrin is commonly used for increasing the aqueous solubility and bioavailability of drugs<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and (2) DMSO has been demonstrated to modulate the host immune response, obfuscating any observed results.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The concentration of mannoside detected in the urine of mice was monitored at multiple time points following oral delivery over a period of 8 h and quantitatively measured by HPLC and mass spectrometry. As previously published, <i>O</i>-linked mannosides, including both <b>23</b> and <b>24</b>, were found to accumulate at high concentrations in the urine as early as 1 h post dosing,<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> followed by a steady almost linear decrease throughout the collection time frame (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A). Despite this continual decrease in concentration, the relative concentration of each mannoside remained well above the HAI EC<sub>90</sub> (0.062 μM) and biofilm IC<sub>50</sub> (0.15 μM) of <b>23</b> throughout this period. In contrast to <b>23</b> and <b>24</b>, the concentrations of <b>21R</b> and <b>23a</b> (the acetate prodrug of <b>23</b>) remained substantially higher throughout the period measured, resulting in a significantly increased AUC. Shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A, the concentration of both <b>21R</b> and <b>23a</b> in the urine 8 h following oral delivery was significantly higher than <b>23</b>. Compound levels of <b>21R</b> reached 50 μM at 8 h, which is <i>1600 times higher than its HAI potency</i>. Acetate prodrug <b>23a</b> also showed enhanced concentration, presumably from higher gut permeability, resulting in a 20-fold higher concentration (20 μM) of <b>23</b> relative to direct oral dosing of <b>23</b> (1 μM) at 8 h.</div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Mannoside levels were quantified in the urines of mice over a period of 8 h following oral gavage of drug as described in the methods. Data is presented as the mean and standard deviation from at least three independent experiments. Differences in concentration at the 8 h time point were tested for significance using Mann–Whitney U test. (* <i>P</i> < 0.05). (B) Measurement of mannoside in the plasma of rats following either a 10 mg/kg oral dose (dashed lines) or a 3 mg/kg intravenous dose (solid lines). Details regarding the measurement of mannoside are described in the methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To further expand on this result, we conducted a more thorough examination of the PK properties of <b>23</b> and <b>21R</b> as well as the analogous ring-constrained isoquinolone <i>O</i>-mannoside <b>25</b><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>) in rats (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). Recent examination of the PK behavior and efficacy of <b>25</b> in mice identified it as a leading therapeutic candidate in the <i>O</i>-mannosides series.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> In contrast to the previous study (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>A), here we monitored the concentration of mannoside in the plasma of rats following either a 10 mg/kg oral dose (dashed lines) or a 3 mg/kg intravenous dose (solid lines) (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>B). Analysis of the rat PK data revealed that, while <i>C</i>-mannoside <b>21R</b> encompassed the highest level of compound exposure (as assessed by <i>C</i><sub>max</sub> and AUC<sub>all</sub>) and the lowest clearance rate, at 34.9 mL/min/kg (<b>23</b> clearance rate = 98.4 mL/min/kg) <i>O</i>-mannoside <b>25</b> shows the highest clearance rate (408 mL/min/kg) and volume of distribution (<i>V</i><sub>dss</sub> = 6.7 L) but the highest bioavailability (7%) of all compounds tested. This suggests that the biaryl B-ring isoquinolone aglycone of <b>25</b> significantly enhances permeability in the gut, while on the other hand, <i>C</i>-mannoside <b>21R</b> and the <i>O</i>-mannoside prodrug <b>23a</b> have a longer half-life and extended compound exposure, presumably from a combination of increased bioavailability from the prodrugs and metabolic stability of the <i>C</i>-mannoside. Because <i>O</i>-mannosides <b>24</b> and <b>25</b> were stable (<i>t</i><sub>1/2</sub> > 2h) in plasma, simulated gut fluid (pH 1.2), simulated intestinal fluid (pH 6.8), and liver microsomes, we hypothesize that the increased exposure of C-mannoside <b>21R</b> is likely due to evading the enzymatic action of mannosidases. This combined data constitutes key structure–property relationships (SPR) and was useful for guiding further optimization of the <i>C</i>-mannosides described below.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthesis of Optimized <i>C</i>-Linked Isoquinolone Mannosides</h3><div class="NLM_p">Inspired by the enhanced potency and increased compound exposure of <i>C</i>-mannoside <b>21R</b>, coupled with the improved oral bioavailability of <b>25</b>, we synthesized its <i>C</i>-mannoside matched pair analogue, <b>28R</b>. Suzuki cross-coupling between <b>27</b> and 1-hydroxyisoquinoline-7-boronate ester, followed by acetyl deprotection, generated biaryl isoquinolone <i>C</i>-mannoside <b>28R</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In an alternate synthesis, <b>19R</b> was used in place of <b>27</b> in the Suzuki reaction, but attempts to remove the benzyl protecting groups via hydrogenation resulted in formation of the saturated dihydroisoquinolone analogue <b>29R</b>. For direct comparison, we repeated this hydrogenation on <i>O</i>-glycoside <b>25</b> to give corresponding analogue <b>30</b>. We found that both isoquinolone <b>28R</b> and dihydroisoquinolone <b>29R</b> have excellent potency, with HAI titers of 8 and 6 nM, respectively. This equates to a ∼4.5-fold increase in potency over the <i>O</i>-mannoside matched pairs, <b>25</b> and <b>30</b> (HAI = 31 and 32 nM, respectively). Following these exciting results, we evaluated fused ring systems like <b>25</b> that would still retain their H-bonding and FimH binding attributes. Using similar procedures as described above, we synthesized aminoisoquinoline <b>31R</b> and isoquinoline <b>32R</b>, both possessing a nitrogen atom that occupies a position equivalent to the carbonyl oxygen on the isoquinolone ring of <b>25</b>. Isoquinoline <b>32R</b> has a different ring fusion, being attached to the aglycone A-ring at the 5-position (versus the 7-position in <b>31R</b>, <b>28R</b>, and <b>29R</b>). As expected, the <i>C</i>-mannoside <b>31R</b> was 3-fold more potent than its matched <i>O</i>-mannoside pair <b>33</b>, with an HAI of 6 nM. However, the 5-position isoquinoline <i>C</i>-mannoside <b>32R</b> had lower potency relative to its <i>O</i>-mannoside pair <b>34</b><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (HAI = 62 nM), with an HAI of 125 nM (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). This unexpected result can be rationalized from docking studies (not shown), wherein we found that due to a dramatic shift in ring conformation of the <i>C</i>-mannosides relative to the <i>O</i>-mannosides (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>), a steric clash exists between FimH and this 5-position ring substitution of <b>32R</b> in the <i>C</i>-mannoside series, which does not exist in <b>34</b> of the <i>O</i>-mannoside series. When comparing the matched pair <i>C</i>- and <i>O</i>-mannosides shown in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, it is apparent that the cLogP values are approximately 1 Log unit lower in the <i>C</i>-mannoside series. For example, comparing <b>33</b> to <b>31R</b>, we see a drop in cLogP from 2.28 to 1.2, respectively, suggesting that <b>31R</b> has respectable oral drug-like physical properties like <b>25</b> (cLogP 1.4) but with enhanced glycosidic bond stability.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Compound Structures and Comparison of Biological Activity and Physical Properties Between <i>O</i>- and <i>C</i>-Mannoside Matched Pairs (ND = not determined)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0015.gif" alt="" id="fx1" /></img><div></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> In Vivo Efficacy of Mannosides in Acute and Chronic Cystitis</h3><div class="NLM_p">Given the improved in vivo PK behavior of both the <i>C</i>-mannoside <b>21R</b> and the prodrug <b>23a</b>, we next investigated whether these enhancements improved their potency in animal models of UTI.<a onclick="showRef(event, 'cit20a ref36'); return false;" href="javascript:void(0);" class="ref cit20a ref36">(20a, 36)</a> The distinct pathophysiology of UTI that has been identified in these murine models has also been observed in humans, demonstrating their relevance.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> To measure efficacy in these models, we examined the ability of mannosides to <i>prevent</i> the initial pathogenic steps of UPEC infection in our prophylactic model of acute UTI as well as their ability to <i>treat</i> an established infection in our model of chronic UTI. Despite the disparity in potency and PK behavior, the efficacy of all the compounds, in either model, were nearly identical (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). When tested as a prophylaxis therapy (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>A), where the mannoside is dosed 30 min prior to UPEC infection and bacterial titers enumerated 6 h postinfection, tetraacetate prodrug <b>23a</b> and phosphate prodrug <b>23b</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_001.pdf" class="ext-link">Supporting Information</a> data) each showed improved efficacy compared to <b>23</b>. In contrast, the glycine acetate prodrug <b>23c</b> (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_001.pdf" class="ext-link">Supporting Information</a> data) did not show enhanced efficacy, perhaps due to its increased stability in conversion to drug or decreased oral absorption in the gut relative to <b>23a</b> and <b>23b</b>.</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Prophylactic treatment of an acute UTI. Mannoside was dosed orally at 25 mg/kg in 10% cyclodextrin, 30 min prior to infection with 10<sup>7</sup> CFUs UPEC. Bladders were harvested 6 h postinfection and bacterial burdens enumerated. (B) Mannoside treatment of chronic UTI. Mice were treated orally with 50 mg/kg of mannoside in 10% cyclodextrin, after 14 days of chronic UPEC infection. Bladders were harvested 6 h following oral dosing and bacterial burdens enumerated. Data from at least two independent experiments are presented in each panel; bars indicate geometric means. Differences between treated groups and vehicle were tested for significance using Mann–Whitney U test (*** <i>P</i> = 0.0001, **** <i>P</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Both the <i>O</i>-linked and <i>C</i>-linked mannosides accumulated in the urine at concentrations over 10-fold higher than their HAI EC<sub>90</sub> and biofilm IC<sub>50</sub> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>) up to 8 h following oral dosing. Thus, we hypothesized that 6 h post-treatment was too early to discriminate relative mannoside potency in the chronic UTI model (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>B). To investigate this possibility, we first monitored the pharmacodynamics (PD) of <i>O</i>-linked mannoside <b>24</b> in our treatment model of chronic UTI to evaluate its therapeutic window. Diamide mannoside <b>24</b> has similar PK to monoamide mannoside <b>23</b> but was found to be 4-fold more potent in our HA assay (HAI = 16 nM), identifying it as one of our most effective <i>O</i>-linked mannosides in vitro. Following oral delivery of <b>24</b> in the chronic UTI model, we found a significant decrease in bladder burden from 10<sup>7</sup> CFUs to approximately 10<sup>5</sup> CFUs 2 h postdosing (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Bladder burdens continued to decrease to 10<sup>4</sup> CFUs at 6 h but leveled off at 12 hours, when the geometric mean of the bacterial burden increased to 10<sup>5</sup>. Interestingly, the 12-hour time point appears to be comprised of a bimodal distribution, consisting of mice that have either high or low bacterial burdens in the bladder (<a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a>). Taken together, this data demonstrates a rapid reduction of bladder burdens following oral delivery of <i>O</i>-linked mannoside <b>24</b> and an increase of burdens in a subpopulation of mice 12 hours after treatment that may represent bladder repopulation once mannoside levels fall below the HAI.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Pharmacodynamics of <i>O</i>-linked mannoside. Chronically infected mice were treated orally with 50 mg/kg of mannoside <b>24</b>. Bladders were harvested at the designated time points following oral dosing and bacterial burden enumerated. Bars indicate geometric means. Differences between the designated time point and the 0 h time point were tested for significance using Mann–Whitney U test (* <i>P</i> < 0.05, ** <i>P</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>C</i>-Mannosides Displays Significantly Improved and Prolonged Efficacy in Vivo</h3><div class="NLM_p">Given the observed bimodal distribution of bladder burdens 12 hours after treatment with mannoside <b>24</b>, we next decided to investigate the influence of the improved pharmacokinetic behavior of <i>C</i>-mannoside <b>21R</b> on its ability to treat chronic cystitis at this time point following oral delivery of the mannoside (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>A). Additionally, to accentuate any differences in efficacy at this time point, we reduced the mannoside dosages by half, treating only with a 25 mg/kg dose. At 12 h post treatment, the <i>O</i>-linked mannoside <b>24</b> resulted in a noticeable, but not significant, decrease in bladder burdens compared to vehicle. Treatment with prodrug <b>23a</b> resulted in a similar, but statistically significant, decrease in bladder burdens. In contrast, it was found that treatment with <i>C</i>-mannoside <b>21R</b> at 25 mg/kg resulted in a dramatic and significant decrease in CFUs as compared to both vehicle and <i>O</i>-linked mannosides <b>24</b> and <b>23a</b>. Indeed, bladder burdens of mice treated with <b>21R</b> were uniformly three logs lower than untreated mice, clearly demonstrating the improved efficacy of the <i>C</i>-linked mannoside.</div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Improved efficacy of <i>C</i>-linked mannosides. (A) Chronically infected mice were treated orally with 25 mg/kg of mannoside. Bladders were harvested 12 hours following oral dosing and bacterial burdens enumerated. (B) Mice were treated orally with 25 mg/kg of mannoside 30 min prior to infection. Bladders were harvested 6 h following infection and bacterial burdens enumerated. Data from at least two independent experiments are presented; bars indicate geometric means. Differences between treated groups and vehicle were tested for significance using Mann–Whitney U test (**<i>P</i> < 0.01, *** <i>P</i> = 0.0001, **** <i>P</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Furthermore, using the newly optimized heterocyclic <i>C</i>-mannosides, <b>28R</b>, <b>29R</b> and <b>31R</b>, we found significantly augmented activity relative to <i>O</i>-mannoside <b>25</b> when tested in the prophylactic model of UTI (<a class="ref internalNav" href="#fig10" aria-label="Figure 10">Figure 10</a>B), described above, where compound was dosed orally (25 mg/kg) 30 min before infection. The in vivo activity seen with <b>28R</b>, <b>29R</b>, and <b>31R</b> is similar to <b>21R</b>, but it can be argued that <b>29R</b> and <b>31R</b> perform slightly better in preventing an infection in this model of acute UTI. However, there is a clear difference in efficacy displayed between the <i>C</i>-mannosides and <i>O</i>-mannoside <b>25</b>. This is nicely illustrated by direct comparison of <i>O</i>-mannoside <b>25</b> and its matched <i>C</i>-mannoside <b>28R</b>, which decreases bacterial titers 2 Logs lower (100-fold). Taken together with the fact that <i>O</i>-mannoside <b>25</b> and <i>C</i>-mannoside <b>21R</b> are equivalent in both FimH binding (DSF = 75.4 °C) and target inhibition (HAI = 31 nM), this result suggests that the <i>C</i>-mannosides have superior metabolic stability.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Carbohydrates, and in particular small glycosides, are typically unstable in vivo due to their inherent susceptibility to hydrolysis in the stomach or intestine and to enzymatic hydrolysis by various glycosidases present in the gut, plasma, and some tissues. This instability can critically limit the oral bioavailability, half-life. and overall therapeutic potential of glycoside-based drugs<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> like FimH mannoside antagonists. The replacement of <i>O</i>-glycosidic bonds with sulfur, carbon, or nitrogen-based linkers is one strategy that can be utilized to increase the metabolic stability of glycosides while also theoretically helping to increase their bioavailability. However, the synthesis of unnatural glycoside linkers is challenging and the influence of these changes on activity are not always predictable or straightforward. In the current manuscript, we implemented a rational strategy to improve mannoside PK and efficacy by replacing the glycosidic bond of the <i>O</i>-mannosides with a number of unique carbon-based linkers that are likely stable to metabolism. To access these novel <i>C</i>-mannosides, we have designed a new stereoselective synthetic route for the assembly of hydroxymethyl <i>C</i>-mannosides. While increased stability to mannosidases is the most reasonable explanation for the improved efficacy in vivo, other properties may be contributing to this behavior. Current investigations are confirming this hypothesis through both in vitro and in vivo studies which are beyond the scope of this initial communication.</div><div class="NLM_p last">In summary, mannoside FimH antagonists represent a first-in-class antivirulence drug in the treatment of chronic UTI and the prevention of recurrent cystitis. Herein, we have rationally designed a novel <i>C</i>-mannoside FimH antagonist <b>21R</b>, which we subsequently modified, based on <i>O</i>-mannoside SAR and isoquinolone derivative <b>25</b>,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> to generate several optimized analogues, <b>28R</b>, <b>29R</b>, and <b>31R</b>. These <i>C</i>-mannosides have become preclinical candidates for use as novel antivirulence drugs in UTI therapy.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Along with other lead compounds, they are currently being profiled in advanced in vivo PK, efficacy, and toxicologuey studies in preparation for selecting a lead candidate drug for clinical trials. Upon successful clinical development, a mannoside would not only represent the first small molecule FimH antagonist drug for UTI but also the first antibiotic-sparing therapeutic for the treatment of Gram-negative infections. This could also pave the way for the new development of other antibiotic-sparing drugs targeting other lectins or virulence factors, which are desperately needed for other infectious diseases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Synthesis, Purification, and Chemistry Procedures</h3><div class="NLM_p last">Starting materials, reagents, and solvents were purchased from commercial vendors unless otherwise noted. In general, anhydrous solvents are used for carrying out all reactions. <sup>1</sup>H NMR spectra were measured on a Varian 300 MHz NMR instrument or Varian 400 MHz NMR instrument equipped with an auto sampler. The chemical shifts were reported as δ ppm relative to TMS using residual solvent peak as the reference unless otherwise noted. The following abbreviations were used to express the peak multiplicities: s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet; br = broad. Melting points were determined on a Kofler micro hot stage and were uncorrected. High-performance liquid chromatography (HPLC) was carried out on GILSON GX-281 using Waters C18 5 μM 4.6 mm × 50 mm and Waters Prep C18 5 μM 19 mm × 150 mm reverse phase columns, eluted with a gradient system of 5:95 to 95:5 acetonitrile:water with a buffer consisting of 0.05–0.1% TFA. Mass spectroscopy (MS) was performed on HPLC/MSD using a gradient system of 5:95 to 95:5 acetonitrile:water with a buffer consisting of 0.05–0.1% TFA on a C18 or C8 reversed phased column and electrospray ionization (ESI) for detection. All reactions were monitored by thin layer chromatography (TLC) carried out on either Merck silica gel plates (0.25 mm thick, 60F254) or Millipore Silica gel aluminum sheets (60F254) and visualized by using UV (254 nm) or dyes such as KMnO<sub>4</sub>, <i>p</i>-anisaldehyde, and CAM (Hannesian’s Stain). Silica gel chromatography was carried out on a Teledyne ISCO CombiFlash purification system using prepacked silica gel columns (12–330 g sizes). All compounds used for biological assays are greater than 95% purity based on NMR and HPLC by absorbance at 220 and 254 nm wavelengths.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure for the Suzuki Coupling Reactions (Amounts and Volumes Are Specified within Individual Procedures)</h3><div class="NLM_p last">Cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>) was activated by adding it to a round-bottom flask, which was then heated to 250 °C under vacuum for 2 min and then allowed to cool to rt under vacuum for an additional 10 min, after which time a nitrogen atmosphere was continuously maintained. Next, the desired mannosyl bromide (or mannosyl boronate ester) derivative was dissolved into dioxane and the solution was added dropwise, followed by the addition of the desired boronate-aglycone (or bromide-aglycon if mannosyl boronate was used) and, finally a small amount of water. After allowing the reaction contents to stir for 5 min at rt, a catalytic amount of tetrakis(triphenylphosphine)palladium(0) [Pd(Ph<sub>3</sub>)<sub>4</sub>] was added and the reaction flask was evacuated under high vacuum and backfilled with N<sub>2</sub> three times and then placed in an oil bath preheated to 80 °C and allowed to stir for the time specified (typically 1.5 h). Upon completion, the reaction was cooled to rt and solvents were evaporated under reduced pressure. The crude reaction residue was then purified and deprotected as specified.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Detailed Procedures for the Synthesis of Final Mannosides and Intermediates</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4′-(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosylamino)-[1,1′biphenyl]-3-carboxylic Acid Methyl Ester (<b>2</b>)</h4><div class="NLM_p last">α-<span class="smallcaps smallerCapital">d</span>-Mannose (0.360 g, 2 mmol) and methyl 4′-aminobiphenyl-3-carboxylate (0.454 g, 2 mmol) were dissolved into ethanol (5 mL), and the reaction was heated to 55 °C for 17 h. After cooling down to rt, the white precipitate that formed was collected by filtration. The precipitate was washed with ethanol (2 × 3 mL) and then dried in vacuo to afford pure <b>2</b> in 77% yield. Analytical data for <b>2</b>: <sup>1</sup>H NMR (300 MHz, acetonitrile-<i>d</i><sub>3</sub> and D<sub>2</sub>O) δ ppm 3.28–3.38 (m, 1H), 3.54–3.59 (m, 2H), 3.64–3.71 (m, 2H), 3.86 (s, 3H), 3.88–3.92 (m, 1H), 4.89 (d, <i>J</i> = 1.1 Hz, 1H), 6.80–6.91 (m, 2H), 7.44–7.58 (m, 3H), 7.75–7.90 (m, 2H), 8.11–8.20 (m, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>/dimethyl sulfoxide-<i>d</i><sub>6</sub>; 10/1) δ ppm 52.8, 62.8, 68.6, 72.9, 76.2, 78.9, 83.3, 115.6 (×2), 127.8, 128.1, 128.7 (×2), 130.2, 130.8, 131.7, 131.9, 142.8, 147.5, 168.4. ESI-MS found: [M + H]<sup>+</sup>, 390.1.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 4′-(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosylthio)-[1,1′biphenyl]-3-carboxylic Acid Methyl Ester (<b>3</b>)</h4><div class="NLM_p">Step 1: Under nitrogen atmosphere at 0 °C, boron trifluoride diethyl etherate (0.427 g, 3.0 mmol) was added dropwise into a solution of α-<span class="smallcaps smallerCapital">d</span>-mannose pentaacetate (0.390 g, 1.0 mmol) and 4-bromobenzenethiol (0.378 g, 2.0 mmol) in 6 mL of CH<sub>2</sub>Cl<sub>2</sub>. After 5 min, the mixture was warmed to rt and allowed to stir for 48 h. The reaction was then quenched with water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The CH<sub>2</sub>Cl<sub>2</sub> layer was collected, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was purified by silica gel chromatography (ethyl acetate–hexanes gradient elution), giving rise to the intermediate 4-bromophenyl 2,3,4,6-tetra-<i>O</i>-acetyl-1-thio-α-<span class="smallcaps smallerCapital">d</span>-mannopyranoside (<b>3a</b>) (0.40 g) in 77% yield. Analytical data for <b>3a</b>: <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 2.01–2.10 (m, 9H), 2.16 (s, 3H), 4.10 (dd, <i>J</i> = 12.1, 2.5 Hz, 1H), 4.30 (dd, <i>J</i> = 12.1, 6.0 Hz, 1H), 4.43–4.61 (m, 1H), 5.24–5.40 (m, 2H), 5.43–5.52 (m, 2H), 7.32–7.39 (m, 2H), 7.42–7.49 (m, 2H). ESI-MS found: [2 M + H<sup>+</sup>] 1039.1.</div><div class="NLM_p last">Step 2: Following the general Suzuki-coupling procedure, mannosyl bromide <b>3a</b> (0.20 g, 0.39 mmol) from step 1, commercially available 3-methoxycarbonylphenylboronic acid (0.106 g, 0.59 mmol), cesium carbonate (0.381 g, 1.17 mmol), and tetrakis(triphenylphosphine)palladium (0.045 g, 0.04 mmol) in dioxane/water (5 mL/1 mL) were reacted under N<sub>2</sub> at 80 °C for 1 h. Upon completion, the reaction was cooled to rt, and the mixture was filtered through a silica gel column (ethyl acetate–hexanes, 2/1 isocratic elution) to remove the metal catalyst and salts. The filtrate was concentrated then dried in vacuo. To the crude residue was added MeOH (6 mL) and a catalytic amount of sodium methoxide (0.02 M), and the mixture was stirred at rt overnight. H<sup>+</sup> exchange resin (DOWEX 50WX4-100) was added to neutralize the mixture, the resin was filtered off, and the filtrate concentrated. The resulting residue was purified by HPLC [C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.1% TFA)] to give <b>3</b> (0.095 g) in 63% yield. Analytical data for <b>3</b>: <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 3.66–3.91 (m, 4H), 3.94 (s, 3H), 4.01–4.16 (m, 2H), 5.51 (d, <i>J</i> = 1.4 Hz, 1H), 7.51–7.69 (m, 5H), 7.81–7.93 (m, 1H), 8.00 (dt, <i>J</i> = 7.8, 1.4 Hz, 1H), 8.24 (t, <i>J</i> = 1.7 Hz, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub> /dimethyl sulfoxide-<i>d</i><sub>6</sub>; 20/1) δ ppm 52.8, 62.6, 68.7, 73.2, 73.6, 76.0, 90.2, 128.6 (×2), 128.6, 129.5, 130.4, 132.0, 132.5, 133.2 (×2), 135.9, 140.0, 141.8, 168.1. ESI-MS found: [M + H<sup>+</sup>] 407.1.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4′-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)methyl]-<i>N</i>-methyl-[1,1′biphenyl]-3-carboxamide (<b>5</b>)</h4><div class="NLM_p last">The title compound was obtained from the preparation of <b>6S</b> as a side product in 35% yield (0.005 g, 0.013 mmol). Analytical data for <b>5</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.93–3.00 (m, 4H), 3.04–3.13 (m, 1H), 3.62–3.88 (m, 6H), 4.09–4.17 (m, 1H), 7.39 (d, <i>J</i> = 8.2 Hz, 2H), 7.48–7.57 (m, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 2H), 7.74–7.79 (m, 2H), 8.06 (br s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 26.9, 36.1, 63.1, 69.4, 72.0, 72.7, 76.4, 80.4, 126.6, 126.9, 128.1 (×2), 130.1, 130.9 (×2), 131.0, 136.2, 139.6, 139.7, 142.6, 170.7. ESI-MS found: [M + H<sup>+</sup>] 388.2.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4′-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)-(<i>R</i>)-hydroxymethyl]-<i>N</i>-methyl-[1,1′biphenyl]-3-carboxamide (<b>6R</b>)</h4><div class="NLM_p last">A mixture of <b>18R</b> (0.039 g, 0.051 mmol) and 10% wt Pd/C (0.044 g, 0.02 mmol) in MeOH (10 mL) was stirred under 1 atm of H<sub>2</sub> for 16 h. The Pd/C was filtered off, and the filtrate was concentrated and dried in vacuo to give title compound <b>6R</b> (0.020 g, 0.050 mmol) in 99% yield. Analytical data for <b>6R</b>: <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.95 (s, 3H), 3.54–3.81 (m, 4H), 3.86–4.05 (m, 2H), 4.25 (t, <i>J</i> = 3.0 Hz, 1H), 5.01 (d, <i>J</i> = 8.0 Hz, 1H), 7.46–7.61 (m, 3H), 7.67 (d, <i>J</i> = 8.2 Hz, 2H), 7.74–7.88 (m, 2H), 8.08 (t, <i>J</i> = 1.7 Hz, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 27.0, 62.8, 69.0, 69.9, 72.6, 72.9, 77.8, 82.4, 126.7, 127.0, 127.8 (×2), 128.7 (×2), 130.1, 131.0, 136.2, 140.8, 142.6, 143.5, 170.7. ESI-MS found: [M + Na<sup>+</sup>] 426.2.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4′-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)-(<i>S</i>)-hydroxymethyl]-<i>N</i>-methyl-[1,1′biphenyl]-3-carboxamide (<b>6S</b>)</h4><div class="NLM_p last">A mixture of <b>18S</b> (0.028 g, 0.037 mmol) and 10% wt Pd/C (0.032 g, 0.015 mmol) in MeOH (10 mL) was stirred under 1 atm of H<sub>2</sub> for 16 h. The Pd/C was filtered off, and the filtrate was concentrated and dried in vacuo. The resulting residue was purified by HPLC [C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)], to give <b>6S</b> (0.010 g, 0.025 mmol) in 67% yield [compound <b>5</b> was also isolated as a product in 35% yield (0.005 g, 0.013 mmol)]. Analytical data for <b>6S</b>: <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.95 (s, 3H), 3.49–3.58 (m, 1H), 3.59–3.84 (m, 4H), 3.86–4.02 (m, 2H), 5.04 (d, <i>J</i> = 9.0 Hz, 1H), 7.48–7.60 (m, 3H), 7.71 (d, <i>J</i> = 8.2 Hz, 2H), 7.76–7.84 (m, 2H), 8.08 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 27.0, 63.4, 69.1, 69.9, 71.2, 72.9, 77.1, 84.0, 126.8, 127.1, 128.3 (×2), 128.7 (×2), 130.2, 131.0, 136.2, 141.4, 142.3, 142.3, 170.6. ESI-MS found: [M + Na<sup>+</sup>] 426.2.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl-4-phenyl-<i>1H</i>-1,2,3-triazole (<b>8</b>)<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a></h4><div class="NLM_p">Step 1: Under a nitrogen atmosphere, ethanol/water (4 mL/1 mL) was added into the RB flask containing 2,3,4,6-tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl azide (<b>7</b>) (0.075 g, 0.20 mmol) (obtained from <span class="smallcaps smallerCapital">d</span>-mannose pentaacetate<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a>), phenyl acetylene (0.026 g, 0.24 mmol), copper(II) sulfate pentahydrate (0.01 g, 0.04 mmol), and sodium ascorbate (0.016 g, 0.08 mmol). The mixture was stirred at room temperature overnight. The solvent was removed and the residue was purified by silica gel chromatography (ethyl acetate–hexanes gradient elution), giving rise to the tetraacetate protected intermediate 1-(2,3,4,6-tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-4-phenyl-1<i>H</i>-1,2,3-triazole (<b>8a</b>) (0.030 g, 0.062 mmol) in 31% yield. Analytical data for <b>8a</b>: <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 2.05–2.12 (m, 9H), 2.20 (s, 3H), 3.89–3.99 (m, 1H), 4.08 (dd, <i>J</i> = 12.50, 2.61 Hz, 1H), 4.40 (dd, <i>J</i> = 12.50, 5.36 Hz, 1H), 5.40 (t, <i>J</i> = 8.79 Hz, 1H), 5.95–6.04 (m, 2H), 6.07 (d, <i>J</i> = 2.75 Hz, 1H), 7.34–7.53 (m, 3H), 7.79–7.92 (m, 2H), 7.96 (s, 1H). ESI-MS found: [M + Na<sup>+</sup>] 498.1.</div><div class="NLM_p last">Step 2: Tetraacetate <b>8a</b> (0.028 g, 0.059 mmol) from step 1 was stirred in 6 mL of MeOH with a catalytic amount of sodium methoxide (0.02 M) at room temperature overnight. H<sup>+</sup> exchange resin (DOWEX 50WX4-100) was added to neutralize the mixture pH. The resin was filtered off, and the filtrate was concentrated and then dried in vacuo, giving rise to the title compound (0.015 g, 0.049 mmol) in 83% yield. Analytical data for <b>8</b>: <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 3.34–3.44 (m, 1H), 3.70–3.92 (m, 3H), 4.12 (dd, <i>J</i> = 8.52, 3.57 Hz, 1H), 4.71–4.80 (m, 1H), 6.08 (d, <i>J</i> = 2.75 Hz, 1H), 7.30–7.41 (m, 1H), 7.41–7.51 (m, 2H), 7.77–7.90 (m, 2H), 8.51 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 62.6, 68.7, 70.1, 72.6, 78.7, 88.5, 122.1, 126.8 (×2), 129.5, 130.0 (×2), 131.5, 149.1. MS-ESI found: [M + Na<sup>+</sup>] 330.2.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4′-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosylcarbonyl)amino]-[1,1′-biphenyl]-3-carboxylic Acid Methyl Ester (<b>11</b>)</h4><div class="NLM_p last">The solution of 2,3,4,6-tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannosyl cyanide (<b>9</b>)<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> (0.107g, 0.3 mmol) in 25% hydrochloric acid was heated at 50 °C for 48 h. The solvent was removed. Water (10 mL) and H+ exchange resin (DOWEX 50WX4-100) was added and kept stirring for 5 min. The resin was filtered off, and the filtrate was concentrated and then dried in vacuo to give crude α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl carboxylic acid (<b>10</b>). To the crude product, 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate (HATU) (0.274 g, 0.72 mmol) and anhydrous DMF (6 mL) were added at 0 °C. After stirring for 10 min, methyl 4′-aminobiphenyl-3-carboxylate (0.164 g, 0.72 mmol), and then <i>N</i>,<i>N</i>-diisopropylethylamine (0.233 g, 1.80 mmol) were added. The mixture was stirred overnight while being warmed to rt naturally. The solvent was removed and the residue was purified by silica gel chromatography (methanol–dichloromethane gradient elution) to give the title compound (0.066 g) in 52% yield. Analytical data for <b>11</b>: <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 3.50 (dt, <i>J</i> = 4.67, 2.33 Hz, 1H), 3.58–3.65 (m, 2H), 3.76 (dd, <i>J</i> = 11.81, 7.42 Hz, 1H), 3.86–4.03 (m, 4H), 4.52 (t, <i>J</i> = 2.61 Hz, 1H), 4.57 (d, <i>J</i> = 2.75 Hz, 1H), 7.55 (t, <i>J</i> = 7.69 Hz, 1H), 7.60–7.68 (m, 2H), 7.68–7.76 (m, 2H), 7.82–7.91 (m, 1H), 7.97 (dt, <i>J</i> = 7.69, 1.37 Hz, 1H), 8.21–8.28 (m, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 52.7, 63.3, 68.5, 70.1, 73.2, 79.6, 80.4, 121.9 (×2), 128.4 (×2), 128.6, 129.1, 130.2, 132.0, 132.4, 137.4, 138.9, 142.2, 168.5, 170.1. ESI-MS found: [M + H<sup>+</sup>] 418.1.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 4-Bromo-<i>N</i>-[(α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)methyl]-benzamide (<b>13</b>)</h4><div class="NLM_p last">To a solution of [(α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)methyl]amine (<b>12</b>) (0.58 mmol) (obtained from 2,3,4,6-tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannosyl cyanide <b>9</b><a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a>) in pyridine (10 mL) was added 4-bromo-benzoyl chloride (2.2 g, 10 mmol), and the reaction was stirred at RT overnight. Excess acid chloride was quenched by the addition of MeOH (2 mL). After 30 min, the reaction was concentrated in vacuo and dried. To the crude residue was added 25 mL of [0.5 M] sodium methoxide in MeOH (pH ∼ 10), and the reaction was stirred for 3 h at RT. H<sup>+</sup> exchange resin (DOWEX 50WX4-100) was washed with MeOH and then added while stirring for 15 min. After filtration, the crude product was obtained by concentrating the filtrate and then was purified by silica gel chromatography (methanol–dichloromethane gradient elution). It was found that pyridine-HCl was a large contaminant, so the crude product was redissolved in MeOH (10 mL) and charged with 0.5 mL of 3 M NaOH and stirred for 5 min. The reaction was then neutralized with H<sup>+</sup> exchange resin (DOWEX 50WX4-100). After filtration and concentrating the filtrate, the title product was isolated (120 mg, 0.32 mmol; 55% over 2 steps). Analytical data for <b>13</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 3.63–3.68 (m, 4H), 3.75–3.85 (m, 4H), 4.03–4.07 (m, 1H), 7.63 (d, <i>J</i> = 8.8 Hz, 1H), 7.75 (d, <i>J</i> = 8.4 Hz, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 40.2, 62.6, 70.0, 70.3, 72.7, 76.3, 77.4, 127.1, 130.3 (×2), 132.7 (×2), 134.6. ESI-MS found: [M + H<sup>+</sup>] 376.0 (100%), 378.0 (97.3%).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 4′-[([(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)methyl]amino)carbonyl]-[1,1′biphenyl]-3-carboxylic Acid Methyl Ester (<b>14</b>)</h4><div class="NLM_p last">To a stirred solution of 4-bromo-<i>N</i>-[(α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)methyl]-benzamide (<b>13</b>) (0.38 g, 0.1 mmol), 3-methoxycarbonylphenylboronic acid (0.027 g, 0.15 mmol), and cesium carbonate (0.098 g, 0.3 mmol) in dioxane/water (5 mL/1 mL) under nitrogen atmosphere was added tetrakis(triphenylphosphine)palladium (0.012 g, 0.01 mmol) was heated at 80 °C for 1 h. The reaction was concentrated to dryness and dissolved in DMSO and was purified by HPLC [C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.1% TFA)]. After lyopholiztion of pure fractions, the title compound (24 mg, 0.056 mmol) was obtained in 55% yield. Analytical data for <b>14</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 3.68–3.71 (m, 4H), 3.78–3.83 (m, 3H), 3.87 (t, <i>J</i> = 3.2 Hz, 1H), 3.93 (s, 3H), 4.07–4.15 (m, 1H), 7.57 (t, <i>J</i> = 7.6 Hz, 1H), 7.73 (d, <i>J</i> = 7.6 Hz, 2H), 7.89 (d, <i>J</i> = 8.0 Hz, 1H), 7.94 (d, <i>J</i> = 8.0 Hz, 2H), 8.01 (dd, <i>J</i> = 1.6, 8.0 Hz, 1H), 8.26 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 40.2, 52.8, 62.7, 69.9, 70.4, 72.7, 76.5, 77.5, 128.1 (×2), 129.0, 129.2 (×2), 129.9, 130.4, 132.1, 132.7, 134.8, 141.7, 144.4, 168.3, 170.0. ESI-MS found: [M + H<sup>+</sup>] 432.2.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl Cyanide (<b>15</b>)</h4><div class="NLM_p last">Similar to the synthesis of compound <b>9</b>, acetyl 2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranoside (56.97 g, 97.84 mmol) was dissolved into dry acetonitrile (800 mL) under N<sub>2</sub>, and the reaction was cooled to 0 °C. Trimethylsilyl cyanide (36.86 mL, 293.53 mmol) was added, followed by the dropwise addition of boron trifluoride diethyl etherate (2.46 mL, 19.57 mmol). After 5 min, the reaction was brought to rt and stirred for an additional 30 min. Upon completion, brine (400 mL) and ethyl acetate (400 mL) were added and the reaction was stirred vigorously for 5 min. The layers were then partitioned, and the aqueous layer was extracted with ethyl acetate (3 × 100 mL). The organic portions were then combined and washed with 1 M aq HCl (2 × 200 mL) and brine (200 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude residue contained a 2:1 mixture of α- and β-anomers, which were easily separated by silica gel chromatography (ethyl acetate–hexanes gradient), the more nonpolar product being the desired α-mannoside <b>15</b>, obtained in 51% yield (the β-mannoside byproduct was obtained in 27% yield). Analytical data for <b>15</b>:<a onclick="showRef(event, 'cit31b'); return false;" href="javascript:void(0);" class="ref cit31b">(31b)</a><sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ ppm 3.72–3.76 (m, 1H), 3.80–3.91 (m, 3H), 3.93–3.97 (m, 1H), 4.01–4.08 (m, 1H), 4.51–4.71 (m, 7H), 4.81 (d, <i>J</i> = 2.3 Hz, 1H), 4.88 (d, <i>J</i> = 11.0 Hz, 1H), 7.17–7.22 (m, 2H), 7.27–7.40 (m, 18H). ESI-MS found: [M + Na<sup>+</sup>] 572.2.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl Carbaldehyde (<b>16</b>)</h4><div class="NLM_p last">Similarly to previously reported protocols,<a onclick="showRef(event, 'cit31b ref39'); return false;" href="javascript:void(0);" class="ref cit31b ref39">(31b, 39)</a> at −78 °C, DIBAL/hexane (1.0 M, 11.3 mL) was added dropwise into the solution of 2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl cyanide (<b>15</b>) (4.97 g, 9.04 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (150 mL) under N<sub>2</sub>. The mixture was stirred for 30 min, maintaining a temperature of −78 °C. Then, the reaction was diluted with CH<sub>2</sub>Cl<sub>2</sub> (150 mL) and then acidified with the addition of 0.2 M aq HCl (400 mL), stirring for 10 min at rt, and then filtered through Celite (to help break up emulsion) into a separatory funnel. The distinct layers were separated, and the aqueous layer was then extracted an additional time with CH<sub>2</sub>Cl<sub>2</sub>. The two organic fractions were combined and washed 2× with brine (100 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, which also cleared up any remaining emulsion, and then concentrated to give intermediate carbaldehyde <b>16</b> as the crude product. Because of its instability, this intermediate was used without further purification, after drying 30 min to 1 h under high vacuum. Compound <b>16</b> was confirmed by ESI-MS, found [M + Na<sup>+</sup>] 575.5.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromophenyl)-methan-1(<i><b>R</b></i>/<i><b>S</b></i>)-ol (<b>17R</b>/<b>S</b>)</h4><div class="NLM_p last">Into a flask containing 1,4-dibromobenzene (0.354 g, 1.5 mmol) in ether (5 mL) was added BuLi/hexanes (2.5 M, 0.5 mL) at −78 °C. One hour later, crude aldehyde <b>16</b> (synthesized from 0.56 mmol of carbonitrile <b>15</b>) was added. The mixture was stirred at −78 °C for 1 h and then was warmed slowly to −40 °C over 1 h. Then 0.5 N aq HCl was used to quench the reaction, and ethyl acetate was use for extraction. The organic layer was collected, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated, and the resulting residue was partially purified by silica gel chromatography (ethyl acetate–hexane gradient elution). The diastereomers, (2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromophenyl)-methan-1(<i>R</i>)-ol (<b>17R</b>) and (2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromophenyl)-methan-1(<i>S</i>)-ol (<b>17S</b>) were separated and collected, the more nonpolar fractions containing intermediate <b>17R</b>. After separation, the impure compounds <b>17R</b> (0.075 g, 0.1 mmol) and <b>17S</b> (0.034 g, 0.048 mmol) were used without further purification in the synthesis of <b>18R</b> and <b>18S</b>, respectively. Both compounds <b>17R</b> and <b>17S</b> were separately confirmed by ESI-MS, found [M + Na<sup>+</sup>] 731.1.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4′-[(2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(<i>R</i>)-hydroxymethyl]-<i>N</i>-methyl-[1,1′biphenyl]-3-carboxamide (<b>18R</b>)</h4><div class="NLM_p last">Following the general Suzuki-coupling procedure, the impure mannosyl bromide <b>17R</b> (0.075 g, 0.1 mmol), commercially available <i>N</i>-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (0.039g, 0.15 mmol), cesium carbonate (0.098 g, 0.3 mmol), and tetrakis(triphenylphosphine)palladium (0.012 g, 0.01 mmol) in dioxane/water (5 mL/1 mL) were stirred under N<sub>2</sub>, at 80 °C for 1 h. Upon completion, the solvent was removed, and the resulting residue was purified by silica gel chromatography (methanol–dichloromethane gradient elution) to give 4′-[(2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(<i>R</i>)-hydroxymethyl]-<i>N</i>-methyl-[1,1′biphenyl]-3-carboxamide (<b>18R</b>) in 9% total yield (0.039 g, 0.051 mmol) (3 steps; based on 0.56 mmol carbonitrile <b>15</b>). Analytical data for <b>18R</b>: <sup>1</sup>H NMR (300 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 2.89 (d, <i>J</i> = 4.7 Hz, 3H), 3.49–3.69 (m, 2H), 3.72–3.83 (m, 2H), 3.85–3.96 (m, 1H), 4.06 (dd, <i>J</i> = 8.0, 3.0 Hz, 2H), 4.13–4.22 (m, 1H), 4.27–4.46 (m, 2H), 4.48–4.68 (m, 5H), 4.76 (d, <i>J</i> = 11.3 Hz, 1H), 4.90–5.00 (m, 1H), 7.03–7.15 (m, 1H), 7.18–7.41 (m, 20H), 7.43–7.56 (m, 3H), 7.57–7.65 (m, 2H), 7.69–7.80 (m, 2H), 8.00 (t, <i>J</i> = 1.6 Hz, 1H). ESI-MS found: [M + Na<sup>+</sup>] 786.2.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 4′-[(2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(<i>S</i>)-hydroxymethyl]-<i>N</i>-methyl-[1,1′biphenyl]-3-carboxamide (<b>18S</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>17S</b> (0.034 g, 0.048 mmol) following the same procedure described for <b>18R</b>. <b>18S</b> was obtained in 6.5% (0.028 g, 0.037 mmol) (3 steps, based on 0.56 mmol carbonitrile <b>15</b>). Analytical data for <b>18S</b>: <sup>1</sup>H NMR (300 MHz, acetonitrile-<i>d</i><sub>3</sub>) δ ppm 2.90 (d, <i>J</i> = 4.7 Hz, 3H), 3.48 (d, <i>J</i> = 4.4 Hz, 1H), 3.57–3.62 (m, 1H), 3.62–3.85 (m, 3H), 3.86–3.94 (m, 2H), 3.95–4.03 (m, 1H), 4.33–4.51 (m, 6H), 4.52–4.76 (m, 2H), 4.85–4.99 (m, 1H), 6.98–7.45 (m, 22H), 7.47–7.68 (m, 4H), 7.71–7.84 (m, 2H), 8.03 (t, <i>J</i> = 1.7 Hz, 1H). ESI-MS found: [M + Na<sup>+</sup>] 786.2.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>R</i>/<i>S</i>)-ol (<b>19R</b>/<b>S</b>)</h4><div class="NLM_p last">Into a flask containing 4-bromo-2-methyl-iodobenzene (9.04 mL, 63.29 mmol) in anhydrous Et<sub>2</sub>O (150 mL) under N<sub>2</sub> was added BuLi/hexanes (2.5 M, 21.7 mL) dropwise at −78 °C. After 1 h, the freshly prepared crude <b>16</b> [from starting material <b>15</b> (4.97 g, 9.04 mmol)] was dissolved into Et<sub>2</sub>O (50 mL) and added via cannula over a period of 5 min. The mixture was stirred at −78 °C for 30 min and then slowly warmed to 0 °C over 1.5 h. Saturated aq NH<sub>4</sub>Cl was used to quench the reaction, and the reaction was extracted with ethyl acetate (2 × 100 mL). The organic fractions were then combined and washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The resulting residue was mixture of diastereomers, which were purified and separated by silica gel chromatography (1/9, v/v, ethyl acetate–hexanes, isocratic elution) to give (2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>R</i>)-ol (<b>19R</b>) as a syrup in 16% yield (1.05g, 1.45 mmol) and (2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>S</i>)-ol (<b>19S</b>) as a syrup in 20% yield (1.30 g, 1.80 mmol); the fractions coming out of the column earlier containing isomer <b>19R</b>. Analytical data for <b>19R</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 2.29 (s, 3H); 3.49 (br s, 1H), 3.70–3.83 (m, 2H), 3.89 (t, <i>J</i> = 5.9 Hz, 1H), 3.94–3.99 (m, 1H), 4.10 (t, <i>J</i> = 5.1 Hz, 1H), 4.13–4.18 (m, 1H), 4.21–4.28 (m, 1H), 4.40 (s, 2H), 4.49 (s, 2H), 4.56–4.64 (m, 3H), 4.71 (d, <i>J</i> = 11.7 Hz, 1H), 5.08 (d, <i>J</i> = 5.1 Hz, 1H), 7.13–7.18 (m, 2H), 7.28–7.41 (m, 21H). ESI-MS found: [M + Na<sup>+</sup>] 745.5 (100%), 747.5 (97.3%). Analytical data for <b>19S</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 2.18 (s, 3H), 3.19 (br s, 1H), 3.67–3.73 (m, 2H), 3.76–3.85 (m, 3H), 4.03–4.11 (m, 2H), 4.44–4.62 (m, 7H), 4.67–4.73 (m, 1H), 5.06 (d, <i>J</i> = 5.5 Hz, 1H), 7.16–7.37 (m, 23H). ESI-MS found: [M + Na<sup>+</sup>] 745.5 (100%), 747.5 (97.3%).</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Two-Step Oxidation and Reduction Protocol to Convert <b>19S</b> into <b>19R</b> (Step 1 <b>19S</b> to <b>19a</b>)</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methanone (<b>19a</b>)</h4><div class="NLM_p last">The <b>19S</b> product was converted into the <b>19R</b> isomer via a two-step oxidation reduction procedure. First, oxidation to the ketone intermediate (<b>19a</b>) was achieved by dissolving <b>19S</b> (0.58 g, 0.80 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and dry pyridine (0.16 mL, 2.01 mmol) under N<sub>2</sub> at 0 °C. Dess–Martin periodinane (DMP) (0.68 g, 1.61 mmol) was added portionwise, and the reaction mixture was kept at 0 °C for 1 h and then allowed to warm to 15 °C over an additional 1.5 h. Upon completion, the reaction flask was cooled in an ice bath and a 1:1 mixture of 10% aq Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (6 mL) and saturated aq NaHCO<sub>3</sub> (6 mL) was added, and the reaction was stirred for 5 min at rt. The layers were then separated, and the aqueous layer was extracted an additional time with CH<sub>2</sub>Cl<sub>2</sub> (5 mL). The organic fractions were combined and washed sequentially with saturated aq NaHCO<sub>3</sub> (10 mL) and brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo without heating. The residue was quickly purified by silica gel chromatography (ethyl acetate–hexane gradient elution), and pure compound eluent was again concentrated in vacuo in the absence of heat to afford the desired ketone intermediate (2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methanone (<b>19a</b>) in 74% yield (0.43 g, 0.59 mmol). Analytical data for <b>19a</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 2.40 (s, 3H), 3.50–3.56 (m, 1H), 3.61 (d, <i>J</i> = 10.6 Hz, 1H), 3.67–3.77 (m, 2H), 4.05 (t, <i>J</i> = 9.0 Hz, 1H), 4.43 (d, <i>J</i> = 12.1 Hz, 1H), 4.49–4.61 (m, 3H), 4.64–4.74 (m, 2H), 4.76–4.85 (m, 2H), 4.89 (d, <i>J</i> = 11.0 Hz, 1H), 5.12 (d, <i>J</i> = 2.7 Hz, 1H), 7.19–7.24 (m, 2H), 7.31–7.45 (m, 20H), 7.60 (d, <i>J</i> = 8.6 Hz, 1H). ESI-MS found: [M + Na<sup>+</sup>] 743.5 (100%), 745.5 (97.3%).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Two-Step Oxidation and Reduction Protocol to Convert <b>19S</b> into <b>19R</b> (Step 2 <b>19a</b> to <b>19R</b>)</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>R</i>)-ol (<b>19R</b>)</h4><div class="NLM_p last">Next, selective reduction to the (<i>R</i>)-alcohol was achieved by reacting ketone (<b>19a</b>) (0.31 g, 0.43 mmol) in dry THF (30 mL) under N<sub>2</sub> at −40 °C, with the dropwise addition of lithium tri-<i>tert</i>-butoxyaluminum hydride (1 M in hex; 0.87 mL, 0.87 mmol). The reaction was warmed to 0 °C over 1 h and then stirred an additional 1 h at 0 °C. Upon completion, the reaction was diluted with ethyl acetate (60 mL). Saturated aq potassium sodium tartrate (30 mL) was added, and the reaction was vigorously stirred 1 h at rt. At this time, the layers were separated and the aqueous layer was additionally extracted with ethyl acetate (2 × 15 mL), using 1 M aq HCl to break up any remaining emulsion. The organic fractions were then combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by silica gel chromatography (ethyl acetate–hexane gradient elution) to afford the desired <i>R</i>-isomer <b>19R</b> (0.26 g, 0.36 mmol) in 84% yield (with 16% of the <b>19S</b> (0.050 g, 0.069 mmol) isomer also generated). Analytical data as reported above.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4′-[(2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(<i>R</i>/<i>S</i>)-hydroxymethyl]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (<b>20R</b>/<b>S</b>)</h4><div class="NLM_p last">The title compound was synthesized following the general Suzuki-coupling procedure. Although separable, for this reaction the purified <b>19R</b>/<b>S</b> (0.130 g, 0.18 mmol, generated from the reaction of aldehyde <b>16</b>) was taken as a mixture of isomers and was reacted with commercially available <i>N</i>-methyl-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (0.071g, 0.27 mmol), cesium carbonate (0.176 g, 0.54 mmol), and tetrakis(triphenylphosphine)palladium (0.021 g, 0.018 mmol) in dioxane/water (5 mL/1 mL), and the reaction was stirred under N<sub>2</sub>, at 80 °C for 1 h. Upon completion, the solvent was removed and the resulting products were separated and purified by silica gel chromatography (methanol–dichloromethane gradient elution). <b>20R</b> (0.046 g, 0.059 mmol) was obtained in 33% yield as the more nonpolar compound, and the more polar <b>20S</b> (0.055 g, 0.071 mmol) was obtained in 39% yield. Analytical data for <b>20R</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 2.38 (s, 3H), 2.88–3.17 (m, 4H), 3.65 (dd, <i>J</i> = 10.6, 4.3 Hz, 1H), 3.71–3.84 (m, 2H), 4.02 (d, <i>J</i> = 5.5 Hz, 2H), 4.09–4.21 (m, 2H), 4.30–4.44 (m, 4H), 4.51–4.68 (m, 4H), 5.17 (dd, <i>J</i> = 5.9, 3.1 Hz, 1H), 6.15 (d, <i>J</i> = 4.7 Hz, 1H), 7.08–7.39 (m, 22H), 7.43–7.54 (m, 2H), 7.62–7.67 (m, 1H), 7.68–7.73 (m, 1H), 7.87–7.90 (m, 1H). MS (ESI) found: [M + Na<sup>+</sup>] 800.6. Analytical data for <b>20S</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 2.27 (s, 3H), 3.03 (d, <i>J</i> = 4.8 Hz, 3H), 3.13 (br s, 1H), 3.61–3.89 (m, 5H), 3.98–4.10 (m, 1H), 4.12–4.20 (m, 1H), 4.33–4.61 (m, 7H), 4.69 (d, <i>J</i> = 11.4 Hz, 1H), 5.14 (d, <i>J</i> = 5.1 Hz, 1H), 6.19 (d, <i>J</i> = 4.3 Hz, 1H), 7.04–7.59 (m, 24H), 7.61–7.76 (m, 2H), 7.91–8.01 (m, 1H). ESI-MS found: [M + Na<sup>+</sup>] 800.6.</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4′-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)-(<i>R</i>)-hydroxymethyl]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (<b>21R</b>)</h4><div class="NLM_p last">Compound <b>20R</b> (0.046 g, 0.059 mmol) and 10% wt Pd/C (0.050 g, 0.024 mmol) were stirred in MeOH (5 mL) under 1 atm of H<sub>2</sub> for 16 h. The Pd/C was then filtered off, and the filtrate was concentrated in vacuo. The resulting residue was purified by HPLC [C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)] to give <b>21R</b> (0.020 g, 0.048 mmol) in 81% yield. [Compound <b>22</b> was also isolated as a product in 12% yield (0.003 g, 0.0072 mmol)]. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.51 (s, 3H), 2.95 (s, 3H), 3.57–3.78 (m, 4H), 4.00–4.07 (m, 1H), 4.10 (dd, <i>J</i> = 6.9, 2.4 Hz, 1H), 4.25 (t, <i>J</i> = 2.9 Hz, 1H), 5.24 (d, <i>J</i> = 6.7 Hz, 1H), 7.45–7.57 (m, 3H), 7.62 (d, <i>J</i> = 8.2 Hz, 1H), 7.71–7.83 (m, 2H), 8.07 (t, <i>J</i> = 1.6 Hz, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 19.6, 26.9, 63.0, 69.0, 69.9, 71.0, 73.3, 78.2, 81.6, 125.6, 126.7, 126.9, 128.9, 130.1, 130.1, 130.9, 136.1, 137.7, 140.5, 141.2, 142.6, 170.7. ESI-MS found: [M + Na<sup>+</sup>] 440.3.</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4′-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)-(<i>S</i>)-hydroxymethyl]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (<b>21S</b>)</h4><div class="NLM_p last">The title compound was synthesized from <b>20S</b> (0.055 g, 0.071 mmol), following the same procedure as for <b>21R</b>. Compound <b>21S</b> (0.025 g, 0.062 mmol) was obtained in 88% yield. Analytical data for <b>21S</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.51 (s, 3H), 2.95 (s, 3H), 3.56 (dd, <i>J</i> = 1.0 Hz, 1H), 3.67 (d, <i>J</i> = 8.2 Hz, 1H), 3.70–3.82 (m, 3H), 3.91 (d, <i>J</i> = 9.4 Hz, 1H), 4.10 (dd, <i>J</i> = 9.0, 2.0 Hz, 1H), 5.28 (d, <i>J</i> = 8.6 Hz, 1H), 7.34–7.63 (m, 4H), 7.69–7.90 (m, 2H), 8.07 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 19.9, 27.0, 63.4, 67.5, 69.0, 69.9, 73.6, 77.3, 83.4, 126.0, 126.7, 127.0, 129.2, 130.1, 130.3, 130.9, 136.1, 137.4, 140.2, 140.9, 142.3, 170.6. ESI-MS found: [M + Na<sup>+</sup>] 440.3.</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4′-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)methyl]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (<b>22</b>)</h4><div class="NLM_p last">The title compound was obtained from the preparation of <b>21R</b> as a side-product in 12% yield (0.003 g, 0.0072 mmol). Analytical data for <b>22</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.44 (s, 3H), 2.95 (s, 3H), 3.04 (d, <i>J</i> = 7.4 Hz, 2H), 3.69 (m, 3H), 3.83 (m, 2H), 3.86–3.92 (m, 1H), 4.04–4.21 (m, 1H), 7.31 (d, <i>J</i> = 7.8 Hz, 1H), 7.42–7.47 (m, 1H), 7.50 (m, 2H), 7.75 (m, 2H), 8.05 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 19.8, 26.9, 33.7, 63.1, 69.3, 72.1, 72.7, 76.5, 79.4, 125.6, 126.6, 126.8, 130.0, 130.1, 130.9, 131.7, 136.1, 137.8, 138.1, 139.8, 142.7, 170.7. ESI-MS found: [M + H<sup>+</sup>] 402.3.</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4′-(2,3,4,6-Tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy)-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (<b>23a</b>)</h4><div class="NLM_p last">4′-(-α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyloxy)-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> (0.072 g, 0.178 mmol) was dissolved in anhydrous pyridine (1 mL) and acetic anhydride (1 mL). The solvent was removed in vacuo, and the residue was purified by HPLC [C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.1% TFA)]. Pure fractions were combined and lyophilized to give the title compound as a white powder in 62% yield (0.063 g, 0.11 mmol). Analytical data for <b>23a</b>: <sup>1</sup>H NMR (400 MHz, dimethyl sulfoxide-<i>d</i><sub>6</sub>) δ ppm 1.94 (s, 3H), 2.00 (s, 3H), 2.05 (s, 3H), 2.16 (s, 3H), 2.32 (s, 3H), 2.81 (d, <i>J</i> = 4.30 Hz, 3H), 3.93–4.11 (m, 2H), 4.19 (dd, <i>J</i> = 12.13, 5.09 Hz, 1H), 5.22 (t, <i>J</i> = 9.98 Hz, 1H), 5.33–5.45 (m, 2H), 5.80 (s, 1H), 7.23 (d, <i>J</i> = 8.61 Hz, 1H), 7.46–7.65 (m, 3H), 7.77 (d, <i>J</i> = 7.83 Hz, 2H), 8.07 (s, 1H), 8.54 (d, <i>J</i> = 4.30 Hz, 1H). <sup>13</sup>C NMR (100 MHz, chloroform-<i>d</i>) δ ppm 16.4, 20.8 (×3), 21.0, 27.0, 62.3, 66.0, 69.2, 69.5, 69.6, 96.0, 114.7, 125.3, 125.7, 125.7, 128.1, 129.0, 129.7, 130.0, 135.0, 135.3, 141.1, 153.9, 168.4, 169.9, 170.1, 170.2, 170.7. ESI-MS found: [M + Na<sup>+</sup>] 594.3.</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 4′-(6-Dihydrogen Phosphate-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy)-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (<b>23b</b>)</h4><div class="NLM_p last">4′-(-α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyloxy)-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> (0.20 g, 0.5 mmol) was dissolved in trimethyl phosphate (5 mL) and water (9 uL, 0.5 mmol). The reaction was cooled to 0 °C, and then phosphoryl trichloride (142 μL, 1.5 mmol) was slowly added and then stirred for 3 h at 0 °C. The reaction was neutralized by adding crushed ice and then conc ammonia. The solvent was removed in vacuo, and the residue was purified by HPLC [C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.1% TFA)]. Pure fractions were combined and lyophilized to give the title compound as a white powder in 29% yield (0.070 g, 0.145 mmol). Analytical data for <b>23b</b>: <sup>1</sup>H NMR (400 MHz, dimethyl sulfoxide-<i>d</i><sub>6</sub>) δ ppm 2.26 (s, 3H), 2.81 (d, <i>J</i> = 4.70 Hz, 3H), 3.42–3.68 (m, 3H), 3.75 (dd, <i>J</i> = 9.00, 3.13 Hz, 1H), 3.86–3.97 (m, 2H), 4.03 (dd, <i>J</i> = 9.78, 5.87 Hz, 1H), 5.45 (d, <i>J</i> = 1.96 Hz, 1H), 7.24 (d, <i>J</i> = 8.61 Hz, 1H), 7.43–7.60 (m, 3H), 7.76 (dd, <i>J</i> = 7.43, 1.57 Hz, 2H), 8.06 (s, 1H), 8.56 (d, <i>J</i> = 4.30 Hz, 1H). <sup>13</sup>C NMR (100 MHz, dimethyl sulfoxide-<i>d</i><sub>6</sub>) δ ppm 16.1, 26.3, 66.3, 70.1, 70.6, 73.3, 73.3, 98.7, 115.1, 124.8, 125.4, 125.6, 127.3, 128.8, 128.9, 129.1, 133.0, 135.1, 139.9, 154.3, 166.6. ESI-MS found: [M + H<sup>+</sup>] 484.3</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4′-[6-<i>O</i>-(<i>N</i>,<i>N</i>-Dimethylaminoacetyl)-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (<b>23c</b>)</h4><div class="NLM_p">Step 1: 4′-(-α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyloxy)-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> (0.202 g, 0.50 mmol) was stirred in a flask with triethylamine (0.38 mL, 2.75 mmol) and anhydrous DMF (2 mL) at under N<sub>2</sub> at 0 °C. Trimethylsilyl chloride (0.35 mL, 2.75 mmol) was added dropwise, and the reaction was brought to rt and stirred an additional 3.5 h. The reaction was then quenched with ice water, and the reaction mixture was extracted twice with ethyl acetate. The organic extractions were then combined and concentrated under reduced pressure to give the crude 4′-[2,3,4,6-tetra-<i>O</i>-trimethylsilyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide intermediate, which was then redissolved in acetone/methanol (1/1.5 mL). The reaction was cooled to 0 °C, and acetic acid (0.055 mL, 0.96 mmol) was added. The reaction was allowed to slowly warm to rt and was monitored for progress by TLC (ethyl acetate–hexanes, 1/1). After 9 h, NaHCO<sub>3</sub> (0.16 g, 1.90 mmol) was added and the solvents were removed in vacuo. Purification by silica gel chromatography (ethyl acetate–hexanes gradient elution) gave the corresponding 4′-[2,3,4,-tri-<i>O</i>-trimethylsilyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide in 61% yield (0.19 g, 0.36 mmol). Analytical data: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 0.18 (d, <i>J</i> = 4.3 Hz, 18H), 0.23 (s, 9H), 1.90 (dd, <i>J</i> = 7.0, 5.9 Hz, 1H), 2.30 (s, 3H), 3.05 (d, <i>J</i> = 4.7 Hz, 3H), 3.62–3.68 (m, 1H), 3.69–3.77 (m, 2H), 4.01–4.05 (m, 3H), 5.39 (d, <i>J</i> = 1.6 Hz, 1H), 6.20 (br s, 1H), 7.17 (d, <i>J</i> = 8.6 Hz, 1H), 7.36–7.44 (m, 2H), 7.45–7.50 (m, 1H), 7.67 (dt, <i>J</i> = 7.7, 1.8 Hz, 2H), 7.95 (t, <i>J</i> = 1.8 Hz, 1H). ESI-MS found: [M + H<sup>+</sup>] 489.4;</div><div class="NLM_p last">Step 2: <i>N</i>,<i>N</i>-Dimethylglycine hydrochloride (0.0154 g, 0.11 mmol) was dissolved into CH<sub>2</sub>Cl<sub>2</sub>/diisopropylethylamine (DIPEA) (5/0.2 mL). Dimethylaminopyridine (DMAP) (0.0024 g, 0.02 mmol) was added, followed by the 4′-[2,3,4,-tri-<i>O</i>-trimethylsilyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy]-<i>N</i>,3′-dimethyl-[1,1′biphenyl]-3-carboxamide (0.062 g, 0.10 mmol) from step 1 and finally <i>N</i>,<i>N</i>-diisopropylcarbodiimide (DIC) (0.020 mL, 0.13 mmol). The reaction was stirred for 16 h and then solvent was removed under reduced pressure and the residue was redissolved into acetonitrile (3 mL) and the reaction was cooled to 0 °C. Trifluoroacetic acid (0.08 mL) was added, and the reaction was stirred for 2 h at 0 °C. The solvent was removed in vacuo, and the residue was purified by HPLC [C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.1% TFA)]. Pure fractions were combined and lyophilized to give the title compound as a white powder (0.015 g, 0.031 mmol) in 31% yield. Analytical data for <b>23c</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.32 (s, 3H), 2.89 (s, 6H), 2.95 (s, 3H), 3.71–3.85 (m, 2H), 3.94–4.00 (m, 1H), 4.06 (d, <i>J</i> = 5.48 Hz, 2H), 4.11 (t, <i>J</i> = 2.54 Hz, 1H), 4.42 (m, 1H), 4.61 (dd, <i>J</i> = 11.74, 1.56 Hz, 1H), 5.57 (d, <i>J</i> = 1.57 Hz, 1H), 7.23 (d, <i>J</i> = 8.61 Hz, 1H), 7.47–7.53 (m, 3H), 7.73–7.78 (m, 2H), 8.05 (m, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 16.5, 27.0, 44.4 (×2), 57.9, 66.5, 68.3, 71.9, 72.5, 72.8, 99.9, 115.6, 126.4, 126.5, 126.5, 129.0, 130.1, 130.6, 130.6, 135.3, 136.1, 142.3, 155.5, 166.7, 170.7. ESI-MS found: [M + H<sup>+</sup>] 489.4;</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (2,3,4,6-Tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>R</i>)-ol Acetate (<b>26</b>)</h4><div class="NLM_p last">Dimethylaminopyridine (8.9 mg, 0.07 mmol) and (2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>R</i>)-ol (<b>19R</b>) (1.06 g, 1.47 mmol) were dissolved in dry pyridine (5 mL) under N<sub>2</sub>, and the reaction was cooled to 0 °C. Acetic anhydride (0.21 mL, 2.21 mmol) was added dropwise, and after 5 min the ice bath was removed. After stirring 1 h at rt, the reaction was cooled to 0 °C and quenched with MeOH (0.5 mL) and the pyridine was removed in vacuo. The residue was redissolved in CH<sub>2</sub>Cl<sub>2</sub>, (25 mL) and washed successively with water (10 mL), 1 M aq HCl (2 × 10 mL), and water (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was purified by silica gel chromatography (ethyl acetate–hexane gradient elution) to afford compound <b>26</b> (1.11 g, 1.46 mmol) in 99% yield. Analytical data for <b>26</b>: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 1.91 (s, 3H), 2.38 (s, 3H), 3.60–3.69 (m, 1H), 3.69–3.78 (m, 1H), 3.78–3.87 (m, 2H), 3.91–4.04 (m, 2H), 4.34 (dd, <i>J</i> = 6.7, 3.5 Hz, 1H), 4.39–4.46 (m, 1H), 4.50–4.69 (m, 6H), 4.81 (d, <i>J</i> = 11.3 Hz, 1H), 6.15 (d, <i>J</i> = 6.7 Hz, 1H), 7.07–7.13 (m, 1H), 7.23–7.38 (m, 22H). ESI-MS found: [M + Na<sup>+</sup>] 787.5 (100%), 789.5 (97.3%).</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (2,3,4,6-Tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>R</i>)-ol Acetate (<b>27</b>)</h4><div class="NLM_p last">Following a modified literature protocol for benzyl ether removal,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (2,3,4,6-tetra-<i>O</i>-benzyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(4-bromo-2-methylphenyl)-methan-1(<i>R</i>)-ol acetate (<b>26</b>) (1.0 g, 1.30 mmol) was dissolved in dry CH<sub>2</sub>Cl<sub>2</sub> (50 mL) under N<sub>2</sub>, and the reaction was cooled to −78 °C. Boron trichloride (1 M in CH<sub>2</sub>Cl<sub>2</sub>; 10.4 mL, 10.4 mmol) was added dropwise, and the reaction was stirred for 30 min. Once removal of the benzyl ethers was complete, the excess reagent was quenched by the addition of MeOH (1 mL). At this time, it was observed (via TLC and LCMS) that upon quenching, a minor product corresponding to benzylic acetate cleavage was produced. The reaction mixture containing both the tetraacetate and pentaacetate intermediates was concentrated under reduced pressure and purified by silica gel chromatography (methanol–dichloromethane gradient elution). Both intermediates were collected and combined and then redissolved in dry pyridine (10 mL) under N<sub>2</sub>, and the reaction was cooled to 0 °C. Dimethylaminopyridine (7.0 mg, 0.06 mmol) was added, followed by acetic anhydride (0.77 mL, 8.16 mmol), and the reaction was stirred for 5 min at 0 °C, then brought to rt. After 1 h, the reaction was cooled to 0 °C and quenched with MeOH (0.25 mL). The pyridine was removed in vacuo, and the residue was then redissolved in CH<sub>2</sub>Cl<sub>2</sub>, (25 mL) and washed successively with water (10 mL), 1 M aq HCl (2 × 10 mL), and water (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. Purification by silica gel chromatography (ethyl acetate–hexanes gradient) gave the desired compound <b>27</b> (0.51 g, 0.88 mmol) in 68% yield. Analytical data for <b>27</b>: mp 115–118 °C (diethyl ether–hexanes). <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 1.90 (s, 3H), 1.97 (s, 3H), 2.01 (s, 6H), 2.08 (s, 3H), 2.37 (s, 3H), 3.84–3.90 (m, 1H), 3.94 (dd, <i>J</i> = 12.1, 2.0 Hz, 1H), 4.14–4.23 (m, 2H), 5.10 (t, <i>J</i> = 8.6 Hz, 1H), 5.30 (dd, <i>J</i> = 9.0, 3.1 Hz, 1H), 5.47 (t, <i>J</i> = 2.9 Hz, 1H), 6.12 (d, <i>J</i> = 7.0 Hz, 1H), 7.15–7.20 (m, 1H), 7.23–7.30 (m, 2H). ESI-MS found: [M + Na<sup>+</sup>] 595.2 (100%), 597.2 (97.3%).</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 7-(4-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)-(<i>R</i>)-hydroxymethyl)-3-methylphenyl]-1(2<i>H</i>)-isoquinolinone (<b>28R</b>)</h4><div class="NLM_p last">Following the general Suzuki-coupling procedure, the acetylated mannosyl bromide <b>27</b> (0.10 g, 0.174 mmol), commercially available1-hydroxyisoquinoline-7-boronate ester (0.095 g, 0.35 mmol), cesium carbonate (0.17 g, 0.052 mmol), and tetrakis(triphenylphosphine)palladium (0.03 g, 0.026 mmol) in dioxane/water (5 mL/1 mL) were reacted under N<sub>2</sub> at 80 °C for 1.5 h. Upon completion, the reaction was then cooled to rt, and solvents were evaporated under reduced pressure. The crude reaction residue was then redissolved into CH<sub>2</sub>Cl<sub>2</sub> (typically a colorless solid byproduct remains insoluble) and partially purified by column chromatography to remove metal catalysts and salts to give the impure acetate-protected intermediate. The mannoside intermediate was then redissolved in MeOH (3 mL) and cooled to 0 °C. [1 M] Sodium methoxide in MeOH was added dropwise until a pH of 9–10 was achieved. After 5 min, the ice bath was removed and the reaction was stirred for 2 h. Upon completion, the reaction was neutralized with H<sup>+</sup> exchange resin (DOWEX 50WX4-100). The resin was filtered, and the filtrate was concentrated in vacuo. The resulting residue was purified by HPLC [(C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)] to give compound <b>28R</b> (0.035 g, 0.082 mmol) in 47% yield. Analytical data for <b>28R</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.52 (s, 3H), 3.64–3.75 (m, 4H), 4.05 (br s, 1H), 4.09–4.15 (m, 1H), 4.26 (br s, 1H), 5.25 (d, <i>J</i> = 6.7 Hz, 1H), 6.70 (d, <i>J</i> = 7.0 Hz, 1H), 7.18 (d, <i>J</i> = 7.0 Hz, 1H), 7.52–7.61 (m, 2H), 7.62–7.67 (m, 1H), 7.72 (d, <i>J</i> = 8.2 Hz, 1H), 8.00 (d, <i>J</i> = 8.6 Hz, 1H), 8.54 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 19.6, 63.0, 69.0, 69.9, 71.0, 73.2, 78.3, 81.6, 107.7, 125.5, 125.5, 127.3, 128.2, 128.8, 129.0, 130.0, 132.6, 137.8, 138.8, 140.1, 140.7, 141.3, 165.1. ESI-MS found: [M + H<sup>+</sup>] 428.4, [M – 18 + H<sup>+</sup>] 410.3, [2M + H<sup>+</sup>] 855.6.</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 3,4-Dihydro-7-(4-[(α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyl)-(<i>R</i>)-hydroxymethyl]-3-methylphenyl)-1(2<i>H</i>)-isoquinolinone (<b>29R</b>)</h4><div class="NLM_p last">Following the general Suzuki-coupling procedure, mannosyl bromide <b>19R</b> (0.220 g, 0.304 mmol), commercially available1-hydroxyisoquinoline-7-boronate ester (0.165 g, 0.608 mmol), cesium carbonate (0.297 g, 0.912 mmol), and tetrakis(triphenylphosphine)palladium (0.046 g, 0.053 mmol) in dioxane/water (10 mL/2 mL) were reacted under N<sub>2</sub>, at 80 °C for 1.5 h. Upon completion, the reaction was then cooled to rt and solvents were evaporated under reduced pressure. The crude reaction residue was then redissolved into CH<sub>2</sub>Cl<sub>2</sub> (typically a colorless solid byproduct remains insoluble) and partially purified by column chromatography to remove metal catalysts and salts to give the impure benzyl-protected intermediate. The mannoside intermediate was then redissolved in MeOH (5 mL), and 10% wt Pd/C (0.150 g, 0.14 mmol) was added. The reaction was stirred under 1 atm of H<sub>2</sub> for 16 h. Upon completion, the Pd/C was filtered off and the filtrate was concentrated and dried in vacuo. The resulting residue was purified by HPLC [(C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)] to give compound <b>29R</b> (0.06 mg, 0.140 mmol) in 46% yield. Analytical data for <b>29R</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.49 (s, 3H), 3.01 (t, <i>J</i> = 6.7 Hz, 2H), 3.52 (t, <i>J</i> = 6.7 Hz, 2H), 3.63–3.74 (m, 4H), 4.05 (br s, 1H), 4.10 (dd, <i>J</i> = 6.7, 2.0 Hz, 1H), 4.25 (t, <i>J</i> = 2.5 Hz, 1H), 5.24 (d, <i>J</i> = 7.0 Hz, 1H), 7.37 (d, <i>J</i> = 7.8 Hz, 1H), 7.44–7.53 (m, 2H), 7.61 (d, <i>J</i> = 7.8 Hz, 1H), 7.75 (dd, <i>J</i> = 7.8, 2.0 Hz, 1H), 8.18 (d, <i>J</i> = 1.6 Hz, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 19.6, 28.7, 40.8, 63.0, 69.0, 69.9, 71.0, 73.2, 78.2, 81.6, 125.3, 126.6, 128.9, 129.2, 129.8, 130.2, 131.7, 137.6, 139.7, 140.2, 141.0, 141.1, 168.3. ESI-MS found: [M + H<sup>+</sup>] 430.4, [M – 18 + H<sup>+</sup>] 412.4, [2M + H<sup>+</sup>] 859.6.</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 3,4-Dihydro-7-[4-(α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy)-3-methylphenyl]-1(2<i>H</i>)-isoquinolinone (<b>30</b>)</h4><div class="NLM_p last">The previously reported compound 7-[4-(α-<span class="smallcaps smallerCapital">d</span>-mannopyranosyloxy)-3-methylphenyl]-isoquinolin-1-one<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> (<b>25</b>) (30 mg, 0.073 mmol) was dissolved into MeOH (3 mL), and 10% wt Pd/C (30 mg) was added. The reaction was stirred under 1 atm of H<sub>2</sub> for 16 h, after which the reaction was filtered and the filtrate was concentrated in vacuo. The resulting residue was purified by HPLC [(C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)] to give compound <b>30</b> (0.30 mg, 0.072 mmol) in 99% yield. Analytical data for <b>30</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.30 (s, 3H), 2.96–3.03 (m, 2H), 3.49–3.55 (m, 2H), 3.57–3.65 (m, 1H), 3.72–3.81 (m, 3H), 3.97 (d, <i>J</i> = 9.4 Hz, 1H), 4.08 (br s, 1H), 5.55 (s, 1H), 7.31 (dd, <i>J</i> = 19.4, 8.0 Hz, 2H), 7.40–7.47 (m, 2H), 7.70 (d, <i>J</i> = 7.8 Hz, 1H), 8.14 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 16.6, 28.7, 40.9, 62.7, 68.4, 72.1, 72.7, 75.5, 99.9, 115.9, 126.3, 126.3, 128.9, 129.1, 130.2, 131.5, 135.1, 139.2, 141.0, 155.7, 168.4. ESI-MS found: [M + H<sup>+</sup>] 416.4, [2M + H<sup>+</sup>] 831.6.</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1-amine (<b>31a</b>) and Isoquinolin-1-amine-7 Boronic Acid (<b>31b</b>)</h4><div class="NLM_p last">Potassium acetate (264 mg, 2.69 mmol) was activated by adding it to a round-bottom flask, which was then heated to 250 °C under vacuum for 2 min and then allowed to cool to rt under vacuum for an additional 10 min, after which time a nitrogen atmosphere was continuously maintained. Dry DMSO (2 mL) was added, followed by the addition of commercially available 7-bromoisoquinolin-1-amine (150 mg, 0.67 mmol) and bis(pinacolato)diboron (256 mg, 1.0 mmol). Pd(dppf)Cl<sub>2</sub> (49.2 mg, 0.067 mmol) was added, and the reaction flask was evacuated under high vacuum and then backfilled with N<sub>2</sub> three times. The flask was then placed in an oil bath preheated to 80 °C and allowed to stir for 2.5 h. The reaction was cooled to rt, and solvents were evaporated under reduced pressure. The crude reaction residue was then redissolved into CH<sub>2</sub>Cl<sub>2</sub> and allowed to sit for 5 min to allow for byproducts to precipitate. The precipitate was filtered off. Evaporation of the CH<sub>2</sub>Cl<sub>2</sub> in vacuo resulted in more byproduct precipitation, and so the residue was redissolved in CH<sub>2</sub>Cl<sub>2</sub> and the process was repeated until no further precipitation was observed. The crude brown residue was then diluted with water (1 mL) and lyophilized to removed trace DMSO, resulting in a brown solid, which was comosed of a mix of the boronate ester and the boronic acid (<b>31a</b>/<b>b</b>), as determined by LCMS. This crude mixture was used without further purification. Analytical data for <b>31a</b>: ESI-MS found, [M + H<sup>+</sup>] 271.3. Analytical data for <b>31b</b>: ESI-MS found, [M + H<sup>+</sup>] 189.2</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 7-(4-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)-(<i>R</i>)-hydroxymethyl]-3-methylphenyl)-isoquinolin-1-amine (<b>31R</b>)</h4><div class="NLM_p last">Following the general Suzuki-coupling procedure, mannosyl bromide <b>27</b> (0.092 g, 0.160 mmol), isoquinolin-1-amine-7-boronate ester/acid <b>31a</b>/<b>b</b> (0.086, 0.32 mmol), cesium carbonate (0.16 g, 0.48 mmol), and tetrakis(triphenylphosphine)palladium (0.028 g, 0.024 mmol) in dioxane/water (5 mL/1 mL) were reacted under N<sub>2</sub> at 80 °C for 1.5 h. Upon completion, the solvent was removed under reduced pressure and mixture was filtered through a silica gel column (ethyl acetate–hexanes, 2/1 isocratic elution) to remove the metal catalyst and salts. The filtrate was concentrated then dried in vacuo. The crude compound was then redissolved into MeOH (3 mL) and cooled to 0 °C. Sodium methoxide [1M] in MeOH was added dropwise until a pH of 9–10 was achieved. After 5 min, the ice bath was removed and the reaction was stirred for 30 min. Upon completion, the reaction was neutralized with H<sup>+</sup> exchange resin (DOWEX 50WX4-100). The resin was filtered, and the filtrate was concentrated in vacuo. The resulting residue was purified by HPLC [(C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)] to give compound <b>31R</b> (0.018 g, 0.042 mmol) in 26% yield. Analytical data for <b>31R</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 8.71 (s, 1H), 8.26 (d, <i>J</i> = 8.2 Hz, 1H), 7.97 (d, <i>J</i> = 8.6 Hz, 1H), 7.62–7.72 (m, 3H), 7.54 (d, <i>J</i> = 7.0 Hz, 1H), 7.24 (d, <i>J</i> = 7.0 Hz, 1H), 5.27 (d, <i>J</i> = 7.0 Hz, 1H), 4.27 (t, <i>J</i> = 2.9 Hz, 1H), 4.13 (dd, <i>J</i> = 6.8, 2.2 Hz, 1H), 4.01–4.07 (m, 1H), 3.63–3.73 (m, 4H), 2.55 (s, 3H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 19.7, 63.0, 69.0, 69.9, 70.8, 73.1, 78.4, 81.5, 113.0, 119.6, 123.6, 125.8, 127.8, 129.3, 129.6, 130.3, 135.0, 137.7, 138.1, 138.9, 142.3, 143.0, 156.1. ESI-MS found: [M + H<sup>+</sup>] 427.4.</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 5-(4-[(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyl)-(<i>R</i>)-hydroxymethyl]-3-methylphenyl)-isoquinoline (<b>32R</b>)</h4><div class="NLM_p last">Following the general Suzuki-coupling procedure, mannosyl bromide <b>27</b> (0.092 g, 0.160 mmol), commercially purchased 5-isoquinolinylboronic acid (0.056 g, 0.32 mmol), cesium carbonate (0.16 g, 0.48 mmol), and tetrakis(triphenylphosphine)palladium (0.028 g, 0.024 mmol) in dioxane/water (5 mL/1 mL) were reacted under N<sub>2</sub> at 80 °C for 1.5 h. Upon completion, the solvent was removed under reduced pressure and mixture was filtered through a silica gel column (ethyl acetate–hexanes, 2/1 isocratic elution) to remove the metal catalyst and salts. The filtrate was concentrated then dried in vacuo. The crude compound was then redissolved into MeOH (5 mL) and cooled to 0 °C. Sodium methoxide [1M] in MeOH was added dropwise until a pH of 9–10 was achieved. After 5 min, the ice bath was removed and the reaction was stirred for 30 min. Upon completion, the reaction was neutralized with H<sup>+</sup> exchange resin (DOWEX 50WX4-100). The resin was filtered, and the filtrate was concentrated in vacuo. The resulting residue was purified by HPLC [(C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)] to give compound <b>32R</b> (0.025 g, 0.060 mmol) in 38% yield. Analytical data for <b>32R</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 9.75 (s, 1H), 8.48 (dd, <i>J</i> = 15.8, 7.2 Hz, 2H), 8.28 (d, <i>J</i> = 6.7 Hz, 1H), 8.02–8.13 (m, 2H), 7.74 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (d, <i>J</i> = 8.6 Hz, 1H), 7.34 (s, 1H), 5.30 (d, <i>J</i> = 7.0 Hz, 1H), 4.28 (br s, 1H), 4.14–4.19 (m, 1H), 4.04 (br s, 1H), 3.69 (br s, 4H), 2.54 (s, 3H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 19.6, 63.1, 69.1, 70.1, 70.8, 73.2, 78.4, 81.4, 124.2, 128.5, 129.1, 129.6, 129.6, 130.7, 131.5, 132.9, 134.2, 137.4, 137.6, 138.1, 141.6, 142.3, 149.6. ESI-MS found: [M + H<sup>+</sup>] 412.3.</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 7-[4-(α-<span class="smallcaps smallerCapital">d</span>-Mannopyranosyloxy)-3-methylphenyl]- isoquinolin-1-amine (<b>33</b>)</h4><div class="NLM_p">Step 1: Under nitrogen atmosphere, the mixture of 4-bromo-2-methylphenyl 2,3,4,6-tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranoside<a onclick="showRef(event, 'cit20b'); return false;" href="javascript:void(0);" class="ref cit20b">(20b)</a> (2.869 g, 5.55 mmol), bis(pinacolato)diboron (1.690g, 6.66 mmol), potassium acetate (2.177 g, 22.18 mmol), and (1.1′-bis(diphenylphosohino)ferrocene)dichloropalladium(II) (Pd(dppf)Cl<sub>2</sub>) (0.244 g, 0.33 mmol) in DMSO (50 mL) was heated at 80 °C with stirring for 2 h. The solvent was removed, and the resulting residue was purified by silica gel chromatography (ethyl acetate–dichloromethane gradient elution) to give the intermediate boronate ester, 2-methyl-4-[4,4,5,5-tetramethyl-(1,3,2)dioxaborolan-2-yl]phenyl 2,3,4,6-tetra-<i>O</i>-acetyl-α-<span class="smallcaps smallerCapital">d</span>-mannopyranoside (<b>33a</b>),<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (2.50 g, 4.43 mmol) in 79% yield. Analytical data: <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ ppm 1.34 (s, 12H), 2.05 (d, <i>J</i> = 2.3 Hz, 6H), 2.06 (s, 3H), 2.21 (s, 3H), 2.30 (s, 3H), 4.03–4.09 (m, 2H), 4.27–4.33 (m, 1H), 5.39 (t, <i>J</i> = 12.0 Hz, 1H), 5.48 (dd, <i>J</i> = 3.3, 1.8 Hz, 1H), 5.54–5.60 (m, 2H), 7.09 (d, <i>J</i> = 8.2 Hz, 1H), 7.55–7.67 (m, 2H). ESI-MS found: [M + Na<sup>+</sup>] 587.4.</div><div class="NLM_p last">Step 2: Following the general Suzuki-coupling procedure, <b>33a</b> (0.150, 0.27 mmol) from step 1, 7-bromoisoquinolin-1-amine (0.060, 0.27 mmol), cesium carbonate (0.26 g, 0.80 mmol), and tetrakis(triphenylphosphine)palladium (0.031 g, 0.027 mmol) in dioxane/water (5 mL/1 mL) were reacted under N<sub>2</sub>, at 80 °C for 1.5 h. Upon completion, the solvent was removed under reduced pressure, and mixture was filtered through a silica gel column (ethyl acetate–hexanes, 2/1 isocratic elution) to remove the metal catalyst and salts. The filtrate was concentrated then dried in vacuo. The crude compound was then redissolved into MeOH (3 mL) and cooled to 0 °C. Sodium methoxide [1M] in MeOH was added dropwise until a pH of 9–10 was achieved. After 5 min, the ice bath was removed and the reaction was stirred for 2 h. Upon completion, the reaction was neutralized with H<sup>+</sup> exchange resin (DOWEX 50WX4-100). The resin was filtered, and the filtrate was concentrated in vacuo. The resulting residue was purified by HPLC [(C18, 15 mm × 150 mm column; eluent, acetonitrile/water (0.05% TFA)] to give compound <b>33</b> (0.040 g, 0.097 mmol) in 36% yield. Analytical data for <b>33</b>: <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 2.34 (s, 3H), 3.57–3.64 (m, 1H), 3.72–3.83 (m, 3H), 3.98 (dd, <i>J</i> = 9.4, 3.1 Hz, 1H), 4.10 (br s, 1H), 5.60 (s, 1H), 7.21 (d, <i>J</i> = 6.7 Hz, 1H), 7.36 (d, <i>J</i> = 8.2 Hz, 1H), 7.52 (d, <i>J</i> = 7.0 Hz, 1H), 7.59 (d, <i>J</i> = 8.6 Hz, 1H), 7.64 (s, 1H), 7.93 (d, <i>J</i> = 8.6 Hz, 1H), 8.21 (d, <i>J</i> = 8.6 Hz, 1H), 8.64 (s, 1H). <sup>13</sup>C NMR (100 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 16.6, 62.7, 68.4, 72.1, 72.7, 75.6, 99.8, 113.0, 116.0, 119.6, 123.0, 127.0, 127.6, 129.2, 129.5, 130.6, 133.6, 134.8, 137.3, 142.9, 156.0, 156.4. ESI-MS found: [M + H<sup>+</sup>] 413.4.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Hemagglutination Assay</h3><div class="NLM_p last">The hemagglutination inhibition (HAI) assay was performed with UTI89 bacteria and guinea pig red blood cells, as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Biofilm Assay</h3><div class="NLM_p last">The biofilm assay was performed with UTI89 bacteria as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Differential Scanning Fluorimetry (DSF)</h3><div class="NLM_p last">The DSF assay was performed with FimH<sub>L</sub> (10 μM) in the absence or presence of 100 μM mannoside, as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Computational Molecular Modeling</h3><div class="NLM_p last">Computer-generated docking was performed with AutoDock Vina. Ligand coordinates were generated in eLBOW within the Phenix program suite. Simple optimization of mannosides <b>21R</b> and <b>21S</b>, as described by its SMILES sequence, was manually inspected and modified to ensure the correct chair conformation of the mannose pucker. These pdb coordinates were then converted to pdbqt format using Babel. The X-ray coordinates of FimH from the <b>23</b> co-crystal structure was converted to its topology file using AutoDock Tools. The grid box was centered at the mannose binding pocket of FimH, and its dimensions (40 × 40 × 40 Å<sup>3</sup>) were chosen to accommodate multiple potential binding modes at or near the binding pocket. The exhaustiveness of the search was set to a value of 20. The top binding modes and scores within this grid space were generated by AutoDock Vina and visualized in PyMOL.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Animal Infections</h3><div class="NLM_p last">The bacterial inoculum and infection of mice was performed as previously described.<a onclick="showRef(event, 'cit20a'); return false;" href="javascript:void(0);" class="ref cit20a">(20a)</a> Briefly, the bacterial strain UTI89 with a kanamycin antibiotic cassette inserted in the chromosome (UTI89<sub>KAN</sub>) was grown under type 1-inducing conditions, 2 × 24 static growth in LB at 37 °C. Bacteria were harvested, washed, and resuspended in sterile PBS to the appropriate concentration. Six to eight week C3H/HeN female mice were purchased from Envigo (formerly Harlan Laboratories). Mice were anesthetized by inhalation of isoflurane and infected by transurethral inoculation of 50 μL of bacterial suspension at the appropriate density. At the designated time point, mice were killed by cervical dislocation under anesthesia and bladders harvested and processed by mechanical disruption. Processed bladders were serially diluted and plated on LB with 50 μg/mL of kanamycin to enumerate bacterial burden.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Treatment of Chronic Urinary Tract Infection in Mice</h3><div class="NLM_p last">Mice were infected with 1–2 × 10<sup>8</sup> UTI89<sub>KAN</sub>, and the infection was allowed to continue for 2 weeks. Twelve days post inoculation, the urine from mice was collected and titered to identify chronically infected mice (urine titers ≥10<sup>5</sup>). At 2 weeks post inoculation, chronically infected mice were treated orally with 100 μL of mannoside resuspended in 10% cyclodextrin to the appropriate concentration to generate the designated dosage. Bladders were harvested and titered to determine the bacterial burden at the designated time points following treatment.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Prophylactic Treatment of Acute Urinary Tract Infection in Mice</h3><div class="NLM_p last">Prophylactic treatment of mice involved oral delivery of mannoside at 25 mg/kg 30 min prior to infection with UTI89<sub>KAN</sub>. Mice were infected with 1–2 × 10<sup>7</sup> UTI89<sub>KAN</sub>, and bladders were harvested and titered to determine the bacterial burden 6 h following inoculation.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Mouse Pharmacokinetic (PK) Studies</h3><div class="NLM_p last">For dosing in mice, 100 μL of a solution of mannoside in 10% cyclodextrin [10 mg/mL (50 mg/kg)] was inoculated with a gavage needle into the mouse stomach. Urine was collected at 1, 3, 6, and 8 h after dosing and spiked with an internal standard. Analysis for test article levels by LC–MS/MS was performed using a C18 reversed phase column and an AB Sciex API-4000 QTrap instrument (a gradient of acetonitrile and water in 0.1% formic acid), with ion spray detection (+) ESI. Selected reaction monitoring (SRM) mode quantification was performed for the following MS/MS transitions [precursor mass/charge ratio (<i>m</i>/<i>z</i>)/product <i>m</i>/<i>z</i>]: compound <b>21R</b>, 418.20/238.20 amu; compound <b>23</b>, 404.20/242.20 amu (Levels of <b>23</b> were quantitated after dosing of prodrug, <b>23a</b>); compound <b>24</b>, 461.20/299.20 amu.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00948">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00948" class="ext-link">10.1021/acs.jmedchem.6b00948</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR, HPLC, and MS analytical data for new compounds and the details of the crystallography experiments, including the X-ray crystal determinants for both for the small molecule <b>27</b> and FimH co-crystal structure with <b>23</b>; details of the prophylactic acute UTI mouse model with <b>23</b> and prodrugs <b>23a</b>–<b>c</b>, as well as the rat pharmacokinetic study of <b>21R</b>, <b>23</b>, and <b>25</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_001.pdf">jm6b00948_si_001.pdf (4.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_002.csv">jm6b00948_si_002.csv (3.62 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.6b00948" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James W. Janetka</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d7bdb6b9b2a3bcb6bd97b5beb8b4bfb2baf9a0a2a4a3bbf9b2b3a2"><span class="__cf_email__" data-cfemail="acc6cdc2c9d8c7cdc6eccec5c3cfc4c9c182dbd9dfd8c082c9c8d9">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurel Mydock-McGrane</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zachary Cusumano</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenfu Han</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Departments of Biochemistry
and Molecular Biophysics, and Chemistry, §Department of Molecular
Microbiology, ∥Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jana Binkley</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Departments of Biochemistry
and Molecular Biophysics, and Chemistry, §Department of Molecular
Microbiology, ∥Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Kostakioti</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Departments of Biochemistry
and Molecular Biophysics, and Chemistry, §Department of Molecular
Microbiology, ∥Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Hannan</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerome S. Pinkner</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Departments of Biochemistry
and Molecular Biophysics, and Chemistry, §Department of Molecular
Microbiology, ∥Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger Klein</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Departments of Biochemistry
and Molecular Biophysics, and Chemistry, §Department of Molecular
Microbiology, ∥Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vasilios Kalas</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Departments of Biochemistry
and Molecular Biophysics, and Chemistry, §Department of Molecular
Microbiology, ∥Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Crowley</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span>; 
    <span class="hlFld-Affiliation affiliation">‡Departments of Biochemistry
and Molecular Biophysics, and Chemistry, §Department of Molecular
Microbiology, ∥Center for Women’s Infectious Disease Research, Washington University School of Medicine, Saint Louis, Missouri 63110 United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigam P. Rath</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry and Biochemistry, University
of Missouri, Saint Louis, Missouri 63121 United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott J. Hultgren</span> - <span class="hlFld-Affiliation affiliation">Fimbrion
Therapeutics, Inc., Saint Louis, Missouri 63108 United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>L.M.-M. and Z.C. contributed equally to the work</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Scott Hultgren and James Janetka are co-founders and stockholders in Fimbrion Therapeutics, Inc.<br /></br></div></li></ul></div><div class="ack" id="ACK-d52e5204-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Rick Stegeman (X-ray facility, Biochemistry Department) for help with X-ray crystallography studies and Scott Wildman (Biochemistry Department) for help with molecular modeling and docking of FimH ligands. We also thank Drs. Rasesh Shah and Jay Wendling at Seventh Wave for conducting the rat PK study. This work was funded in part by the NIH grants 1RC1DK086378 (Washington University) from NIDDK, and 5R43AI106112-02 (Fimbrion Therapeutics, Inc.) from NIAID. Support for the Biomedical Mass Spectrometry Resource to do the mouse urine PK bioanalytical studies is provided by the NIH/NIGMS grant no. P41GM103422. For the small molecule X-ray structure of compound <b>27</b>, we acknowledge funding from the NSF (MRI, CHE-0420497) for the purchase of the ApexII diffractometer.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i70" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i70"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i71" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i71"> Abbreviations Used</h2><tr><td class="NLM_term">UTI</td><td class="NLM_def"><p class="first last">urinary tract infection</p></td></tr><tr><td class="NLM_term">UPEC</td><td class="NLM_def"><p class="first last">uropathogenic <i>E. coli</i></p></td></tr><tr><td class="NLM_term">CFUs</td><td class="NLM_def"><p class="first last">colony forming units</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">structure–property relationships</p></td></tr><tr><td class="NLM_term">HA</td><td class="NLM_def"><p class="first last">hemagglutination</p></td></tr><tr><td class="NLM_term">HAI</td><td class="NLM_def"><p class="first last">hemagglutination Inhibition</p></td></tr><tr><td class="NLM_term">IBC</td><td class="NLM_def"><p class="first last">intracellular bacterial community</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">concentration maximum</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60786" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60786" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 40 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Boyle, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, B. B.</span><span> </span><span class="NLM_article-title">Bacterial pathogenesis: exploiting cellular adherence</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1016/S0955-0674(03)00099-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0955-0674%2803%2900099-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=14519399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=633-639&author=E.+C.+Boyleauthor=B.+B.+Finlay&title=Bacterial+pathogenesis%3A+exploiting+cellular+adherence&doi=10.1016%2FS0955-0674%2803%2900099-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial pathogenesis: exploiting cellular adherence</span></div><div class="casAuthors">Boyle, Erin C.; Finlay, B. Brett</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">633-639</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cell adhesion mols., such as integrins, cadherins, the Ig superfamily of cell adhesion mols. and selectins, play important structural roles and are involved in various signal transduction processes.  As an initial step in the infectious process, many bacterial pathogens adhere to cell adhesion mols. as a means of exploiting the underlying signaling pathways, entering into host cells or establishing extracellular persistence.  Often, bacteria are able to bind to cell adhesion mols. by mimicking or acting in place of host cell receptors or their ligands.  Recent studies have contributed to the authors' understanding of bacterial adherence mechanisms and the consequences of receptor engagement; they have also highlighted alternative functions of cell adhesion mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_foAdj7ONorVg90H21EOLACvtfcHk0livCEHo__SsAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSqsbc%253D&md5=2c66a4bf7a0edf039bc1258b164d271a</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2803%2900099-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252803%252900099-1%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DE.%2BC.%26aulast%3DFinlay%26aufirst%3DB.%2BB.%26atitle%3DBacterial%2520pathogenesis%253A%2520exploiting%2520cellular%2520adherence%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2003%26volume%3D15%26spage%3D633%26epage%3D639%26doi%3D10.1016%2FS0955-0674%2803%2900099-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chagnot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Listrat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astruc, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desvaux, M.</span><span> </span><span class="NLM_article-title">Bacterial adhesion to animal tissues: protein determinants for recognition of extracellular matrix components</span> <span class="citation_source-journal">Cell. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span><span class="refDoi"> DOI: 10.1111/cmi.12002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1111%2Fcmi.12002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=22882798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=1687-1696&author=C.+Chagnotauthor=A.+Listratauthor=T.+Astrucauthor=M.+Desvaux&title=Bacterial+adhesion+to+animal+tissues%3A+protein+determinants+for+recognition+of+extracellular+matrix+components&doi=10.1111%2Fcmi.12002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial adhesion to animal tissues: protein determinants for recognition of extracellular matrix components</span></div><div class="casAuthors">Chagnot, Caroline; Listrat, Anne; Astruc, Thierry; Desvaux, Mickael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1687-1696</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The extracellular matrix (ECM) is present within all animal tissues and organs.  Actually, it surrounds the eukaryotic cells composing the four basic tissue types, i.e. epithelial, muscle, nerve and connective.  ECM does not solely refer to connective tissue but composes all tissues where its compn., structure and organization vary from one tissue to another.  Constituted of the four main fibrous proteins, i.e., collagen, fibronectin, laminin and elastin, ECM components form a highly structured and functional network via specific interactions.  From the basement membrane to interstitial matrix, further heterogeneity exists in the organization of the ECM in various tissues and organs also depending on their physiol. state.  Back to a mol. level, bacterial proteins represent the most significant part of the microbial surface components recognizing adhesive matrix mols. (MSCRAMM).  These cell surface proteins are secreted and localized differently in monoderm and diderm-LPS bacteria.  While one collagen-binding domain (CBD) and different fibronectin-binding domains (FBD1 to 8) have been registered in databases, much remains to be learned on specific binding to other ECM proteins via single or supramol. protein structures.  Besides theinteraction of bacterial proteins with individual ECM components, this review aims at stressing the importance of fully considering the ECM at supramol., cellular, tissue and organ levels.  This conceptual view should not be overlooked to rigorously comprehend the physiol. of bacterial interaction from commensal to pathogenic species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMpLccx2OGVLVg90H21EOLACvtfcHk0livCEHo__SsAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWisbfK&md5=934c2aee39c53330b0ff906c15fb7478</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fcmi.12002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcmi.12002%26sid%3Dliteratum%253Aachs%26aulast%3DChagnot%26aufirst%3DC.%26aulast%3DListrat%26aufirst%3DA.%26aulast%3DAstruc%26aufirst%3DT.%26aulast%3DDesvaux%26aufirst%3DM.%26atitle%3DBacterial%2520adhesion%2520to%2520animal%2520tissues%253A%2520protein%2520determinants%2520for%2520recognition%2520of%2520extracellular%2520matrix%2520components%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D1687%26epage%3D1696%26doi%3D10.1111%2Fcmi.12002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ofek, I.; Beachey, E. H.</span><span> </span><span class="NLM_article-title">General concepts and principles of bacterial adherence</span>. In  <span class="citation_source-book">Bacterial Adherence, Receptors and Recognition</span>, <span class="NLM_contrib-group">Beachey, E. H.</span>, Ed.; <span class="NLM_publisher-name">Chapman and Hall</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1980</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">6</span>, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1007%2F978-94-009-5863-0_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=1-29&author=I.+Ofek&author=E.+H.+Beacheyauthor=E.+H.+Beachey&title=Bacterial+Adherence%2C+Receptors+and+Recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2F978-94-009-5863-0_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-94-009-5863-0_1%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DI.%26atitle%3DGeneral%2520concepts%2520and%2520principles%2520of%2520bacterial%2520adherence%26btitle%3DBacterial%2520Adherence%252C%2520Receptors%2520and%2520Recognition%26aulast%3DBeachey%26aufirst%3DE.%2BH.%26pub%3DChapman%2520and%2520Hall%26date%3D1980%26volume%3D6%26spage%3D1%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ofek, I.; Doyle, R. J.</span><span> </span><span class="NLM_article-title">Common Themes in Bacterial Adhesion</span>. In  <span class="citation_source-book">Bacterial Adhesion to Cells and Tissues</span>; <span class="NLM_publisher-name">Chapman and Hall</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1994</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1007%2F978-1-4684-6435-1_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=513-561&author=I.+Ofek&author=R.+J.+Doyle&title=Bacterial+Adhesion+to+Cells+and+Tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4684-6435-1_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4684-6435-1_11%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DI.%26atitle%3DCommon%2520Themes%2520in%2520Bacterial%2520Adhesion%26btitle%3DBacterial%2520Adhesion%2520to%2520Cells%2520and%2520Tissues%26pub%3DChapman%2520and%2520Hall%26date%3D1994%26spage%3D513%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Aminov, R. I.</span><span> </span><span class="NLM_article-title">A brief history of the antibiotic era: lessons learned and challenges for the future</span> <span class="citation_source-journal">Front. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="refDoi"> DOI: 10.3389/fmicb.2010.00134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.3389%2Ffmicb.2010.00134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21687759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC3MnhvFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=134&author=R.+I.+Aminov&title=A+brief+history+of+the+antibiotic+era%3A+lessons+learned+and+challenges+for+the+future&doi=10.3389%2Ffmicb.2010.00134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A brief history of the antibiotic era: lessons learned and challenges for the future</span></div><div class="casAuthors">Aminov Rustam I</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article gives a very brief overview of the antibiotic era, beginning from the discovery of first antibiotics until the present day situation, which is marred by the emergence of hard-to-treat multiple antibiotic-resistant infections.  The ways of responding to the antibiotic resistance challenges such as the development of novel strategies in the search for new antimicrobials, designing more effective preventive measures and, importantly, better understanding the ecology of antibiotics and antibiotic resistance are discussed.  The expansion of conceptual frameworks based on recent developments in the field of antimicrobials, antibiotic resistance, and chemotherapy is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfn9PZkmJQCdhSDZx9hyjKfW6udTcc2eamPYucOvnQbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnhvFahtw%253D%253D&md5=dce335e0deb68eed8c865d861d8ce6c4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2010.00134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2010.00134%26sid%3Dliteratum%253Aachs%26aulast%3DAminov%26aufirst%3DR.%2BI.%26atitle%3DA%2520brief%2520history%2520of%2520the%2520antibiotic%2520era%253A%2520lessons%2520learned%2520and%2520challenges%2520for%2520the%2520future%26jtitle%3DFront.%2520Microbiol.%26date%3D2010%26volume%3D1%26spage%3D134%26doi%3D10.3389%2Ffmicb.2010.00134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Who will develop new antibacterial agents?</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">20130430</span><span class="refDoi"> DOI: 10.1098/rstb.2013.0430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1098%2Frstb.2013.0430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=24821916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC2cjit1OisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2014&pages=20130430&author=S.+T.+Cole&title=Who+will+develop+new+antibacterial+agents%3F&doi=10.1098%2Frstb.2013.0430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Who will develop new antibacterial agents?</span></div><div class="casAuthors">Cole Stewart T</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1645</span>),
    <span class="NLM_cas:pages">20130430</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The golden age of antimicrobial drug development is a distant memory, and the likelihood of there being another seems slim.  In part, this is because the pharmaceutical industry, which has now adopted an unsustainable business model, abandoned the anti-infective sector, and the pipeline is almost empty.  The contribution to this crisis of national governments, health agencies and funders also merits discussion.  Much of the basis for drug discovery is funded by the public sector, thereby generating intellectual property and leads for drug development that are often not pursued owing to funding gaps.  In particular, the cost of testing drug efficacy in clinical trials is beyond the means of most companies and organizations.  Lack of a concerted international effort to develop new antimicrobials is particularly alarming at a time when multidrug-resistant bacteria threaten all areas of human medicine globally.  Here, the steps that led to this situation are retraced, and some possible solutions to the dilemma are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfZ9O2ls1xU5I8NvIb08rbfW6udTcc2eamPYucOvnQbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjit1OisA%253D%253D&md5=2f42322da21ab17f301e103920b47e9b</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1098%2Frstb.2013.0430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2013.0430%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DWho%2520will%2520develop%2520new%2520antibacterial%2520agents%253F%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2014%26volume%3D369%26spage%3D20130430%26doi%3D10.1098%2Frstb.2013.0430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walsh, C.</span><span> </span><span class="NLM_article-title">Where will new antibiotics come from?</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1038/nrmicro727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnrmicro727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=15040181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFWlu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=65-70&author=C.+Walsh&title=Where+will+new+antibiotics+come+from%3F&doi=10.1038%2Fnrmicro727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Where will new antibiotics come from?</span></div><div class="casAuthors">Walsh, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-70</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a const. need for new antibacterial drugs owing to the inevitable development of resistance that follows the introduction of antibiotics to the clinic.  When a new class of antibiotic is introduced, it is effective at first, but will eventually select for survival of the small fraction of bacterial populations that have an intrinsic or acquired resistance mechanism.  Pathogens that are resistant to multiple drugs emerge around the globe, so how robust are antibiotic discovery processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWf-wNvjdudbVg90H21EOLACvtfcHk0lgJRwLhi_Wjig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFWlu7s%253D&md5=be8a897b57e796094c5b54652152d533</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro727%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DC.%26atitle%3DWhere%2520will%2520new%2520antibiotics%2520come%2520from%253F%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2003%26volume%3D1%26spage%3D65%26epage%3D70%26doi%3D10.1038%2Fnrmicro727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almqvist, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Targeting virulence for antimicrobial chemotherapy</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1016/j.coph.2003.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.coph.2003.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=14559097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVersLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=513-519&author=Y.+M.+Leeauthor=F.+Almqvistauthor=S.+J.+Hultgren&title=Targeting+virulence+for+antimicrobial+chemotherapy&doi=10.1016%2Fj.coph.2003.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting virulence for antimicrobial chemotherapy</span></div><div class="casAuthors">Lee, Yvonne M.; Almqvist, Fredrik; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Untreatable bacterial infections constitute a dark but valid threat, with nos. of antibiotic resistant pathogens, as well as newly emerging ones, rising quickly.  To combat this dangerous prospect, growing research into antimicrobials could be aimed at targeting the virulence of pathogens.  Virulence refers to an organism's ability to establish an infection and cause disease.  Many steps involved in the infection process can be targeted, including adherence, invasion and host defense evasion.  Identification and characterization of virulence factors that aid in bacterial pathogenicity will lead to new drugs that can be applied to a variety of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2tUTy7NyZG7Vg90H21EOLACvtfcHk0lhDyG-u_NKDsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVersLY%253D&md5=5446898f6e3e2caf8588fea1eb2736d9</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2003.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2003.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DAlmqvist%26aufirst%3DF.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DTargeting%2520virulence%2520for%2520antimicrobial%2520chemotherapy%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D513%26epage%3D519%26doi%3D10.1016%2Fj.coph.2003.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rasko, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, V.</span><span> </span><span class="NLM_article-title">Anti-virulence strategies to combat bacteria-mediated disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1038/nrd3013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnrd3013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=20081869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=117-128&author=D.+A.+Raskoauthor=V.+Sperandio&title=Anti-virulence+strategies+to+combat+bacteria-mediated+disease&doi=10.1038%2Fnrd3013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-virulence strategies to combat bacteria-mediated disease</span></div><div class="casAuthors">Rasko, David A.; Sperandio, Vanessa</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibiotic resistance is one of the greatest challenges of the twenty-first century.  However, the increasing understanding of bacterial pathogenesis and intercellular communication has revealed many potential strategies to develop novel drugs to treat bacteria-mediated disease.  Interference with bacterial virulence and/or cell-to-cell signaling pathways is an esp. compelling approach, as it is thought to apply less selective pressure for the development of bacterial resistance than traditional strategies, which are aimed at killing bacteria or preventing their growth.  Here, we discuss the mechanisms of bacterial virulence and present promising anti-virulence strategies and compds. for the future treatment of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_XHw8YsfL7Vg90H21EOLACvtfcHk0lhDyG-u_NKDsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D&md5=e46d5501a1a28a3deb2e3b2432dff66a</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrd3013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3013%26sid%3Dliteratum%253Aachs%26aulast%3DRasko%26aufirst%3DD.%2BA.%26aulast%3DSperandio%26aufirst%3DV.%26atitle%3DAnti-virulence%2520strategies%2520to%2520combat%2520bacteria-mediated%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D117%26epage%3D128%26doi%3D10.1038%2Fnrd3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasty, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Anti-adhesion therapy of bacterial diseases: prospects and problems</span> <span class="citation_source-journal">FEMS Immunol. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1016/S0928-8244(03)00228-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0928-8244%2803%2900228-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=14522453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns12mu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=181-191&author=I.+Ofekauthor=D.+L.+Hastyauthor=N.+Sharon&title=Anti-adhesion+therapy+of+bacterial+diseases%3A+prospects+and+problems&doi=10.1016%2FS0928-8244%2803%2900228-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-adhesion therapy of bacterial diseases: prospects and problems</span></div><div class="casAuthors">Ofek, Itzhak; Hasty, David L.; Sharon, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Immunology and Medical Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">FIMIEV</span>;
        ISSN:<span class="NLM_cas:issn">0928-8244</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The alarming increase in drug-resistant bacteria makes a search for novel means of fighting bacterial infections imperative.  An attractive approach is the use of agents that interfere with the ability of the bacteria to adhere to tissues of the host, since such adhesion is one of the initial stages of the infectious process.  The validity of this approach was unequivocally demonstrated in expts. performed in a wide variety of animals, from mice to monkeys, and recently also in humans.  Here the authors review various approaches to anti-adhesion therapy, including the use of receptor and adhesin analogs, dietary constituents, sublethal concns. of antibiotics and adhesin-based vaccines.  Because anti-adhesive agents are not bactericidal, the propagation and spread of resistant strains is much less likely to occur than as a result of exposure to bactericidal agents, such as antibiotics.  Anti-adhesive drugs, once developed, may, therefore, serve as a new means to fight infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreciCaROJQL7Vg90H21EOLACvtfcHk0lhDyG-u_NKDsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns12mu70%253D&md5=6effc02ae6bddbd23ac437b3b4918131</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2FS0928-8244%2803%2900228-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-8244%252803%252900228-1%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DHasty%26aufirst%3DD.%2BL.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DAnti-adhesion%2520therapy%2520of%2520bacterial%2520diseases%253A%2520prospects%2520and%2520problems%26jtitle%3DFEMS%2520Immunol.%2520Med.%2520Microbiol.%26date%3D2003%26volume%3D38%26spage%3D181%26epage%3D191%26doi%3D10.1016%2FS0928-8244%2803%2900228-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cozens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. C.</span><span> </span><span class="NLM_article-title">Anti-adhesion methods as novel therapeutics for bacterial infections</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1457</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span><span class="refDoi"> DOI: 10.1586/eri.12.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1586%2Feri.12.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=23253323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1457-1468&author=D.+Cozensauthor=R.+C.+Read&title=Anti-adhesion+methods+as+novel+therapeutics+for+bacterial+infections&doi=10.1586%2Feri.12.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-adhesion methods as novel therapeutics for bacterial infections</span></div><div class="casAuthors">Cozens, Daniel; Read, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1457-1468</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Anti-adhesion therapies for bacterial infections offer an alternative to antibiotics, with those therapies bacteria are not killed but are prevented from causing harm to a host by inhibiting adherence to host cells and tissues, a prerequisite for the majority of infectious diseases.  The mechanisms of these potential therapeutic agents include inhibition of adhesins and their host receptors, vaccination with adhesins or analogs, use of probiotics and dietary supplements that interfere with receptor-adhesin interactions, subminimal inhibitory concns. of antibiotics and manipulation of hydrophobic interactions.  Once developed, these drugs will contribute to the arsenal for fighting infectious disease in the future, potentially subverting antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw2Y4_UrjF8LVg90H21EOLACvtfcHk0lhDyG-u_NKDsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmtL7O&md5=52a245c93a8aec943bd6d1f70990de47</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1586%2Feri.12.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.12.145%26sid%3Dliteratum%253Aachs%26aulast%3DCozens%26aufirst%3DD.%26aulast%3DRead%26aufirst%3DR.%2BC.%26atitle%3DAnti-adhesion%2520methods%2520as%2520novel%2520therapeutics%2520for%2520bacterial%2520infections%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2012%26volume%3D10%26spage%3D1457%26epage%3D1468%26doi%3D10.1586%2Feri.12.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schembri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Genst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuhrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattegard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavialov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyns, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klemm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscarson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Greve, H.</span><span> </span><span class="NLM_article-title">Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span><span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04415.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1111%2Fj.1365-2958.2004.04415.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=15659162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=441-455&author=J.+Bouckaertauthor=J.+Berglundauthor=M.+Schembriauthor=E.+De+Genstauthor=L.+Coolsauthor=M.+Wuhrerauthor=C.+S.+Hungauthor=J.+Pinknerauthor=R.+Slattegardauthor=A.+Zavialovauthor=D.+Choudhuryauthor=S.+Langermannauthor=S.+J.+Hultgrenauthor=L.+Wynsauthor=P.+Klemmauthor=S.+Oscarsonauthor=S.+D.+Knightauthor=H.+De+Greve&title=Receptor+binding+studies+disclose+a+novel+class+of+high-affinity+inhibitors+of+the+Escherichia+coli+FimH+adhesin&doi=10.1111%2Fj.1365-2958.2004.04415.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin</span></div><div class="casAuthors">Bouckaert, Julie; Berglund, Jenny; Schembri, Mark; De Genst, Erwin; Cools, Lieve; Wuhrer, Manfred; Hung, Chia-Suei; Pinkner, Jerome; Slaettegard, Rikard; Zavialov, Anton; Choudhury, Devapriya; Langermann, Solomon; Hultgren, Scott J.; Wyns, Lode; Klemm, Per; Oscarson, Stefan; Knight, Stefan D.; De Greve, Henri</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-455</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Mannose-binding type 1 pili are important virulence factors for the establishment of Escherichia coli urinary tract infections (UTIs).  These infections are initiated by adhesion of uropathogenic E. coli to uroplakin receptors in the uroepithelium via the FimH adhesin located at the tips of type 1 pili.  Blocking of bacterial adhesion is able to prevent infection.  Here, the authors provide for the first time binding data of the mol. events underlying type 1 fimbrial adherence, by crystallog. analyses of the FimH receptor binding domains from a uropathogenic and a K-12 strain, and affinity measurements with mannose, common mono- and disaccharides, and a series of alkyl and aryl mannosides.  The results illustrate that the lectin domain of the FimH adhesin is a stable and functional entity and that an exogenous Bu α-D-mannoside, bound in the crystal structures, exhibits a significantly better affinity for FimH (Kd = 0.15 μM) than mannose (Kd = 2.3 μM).  Exploration of the binding affinities of α-D-mannosides with longer alkyl tails revealed affinities up to 5 nM.  Aryl mannosides and fructose can also bind with high affinities to the FimH lectin domain, with a 100-fold improvement and 15-fold redn. in affinity, resp., compared with mannose.  Taken together, these relative FimH affinities correlate exceptionally well with the relative concns. of the same glycans needed for the inhibition of adherence of type 1 piliated E. coli.  The authors foresee that the authors' findings will spark new ideas and initiatives for the development of UTI vaccines and anti-adhesive drugs to prevent anticipated and recurrent UTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkCuZSIXeshLVg90H21EOLACvtfcHk0liHY3iFBXy_mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWgt7c%253D&md5=9f70959aff94b04ce2926947b2b5519f</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04415.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04415.x%26sid%3Dliteratum%253Aachs%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DBerglund%26aufirst%3DJ.%26aulast%3DSchembri%26aufirst%3DM.%26aulast%3DDe%2BGenst%26aufirst%3DE.%26aulast%3DCools%26aufirst%3DL.%26aulast%3DWuhrer%26aufirst%3DM.%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DPinkner%26aufirst%3DJ.%26aulast%3DSlattegard%26aufirst%3DR.%26aulast%3DZavialov%26aufirst%3DA.%26aulast%3DChoudhury%26aufirst%3DD.%26aulast%3DLangermann%26aufirst%3DS.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DWyns%26aufirst%3DL.%26aulast%3DKlemm%26aufirst%3DP.%26aulast%3DOscarson%26aufirst%3DS.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DDe%2BGreve%26aufirst%3DH.%26atitle%3DReceptor%2520binding%2520studies%2520disclose%2520a%2520novel%2520class%2520of%2520high-affinity%2520inhibitors%2520of%2520the%2520Escherichia%2520coli%2520FimH%2520adhesin%26jtitle%3DMol.%2520Microbiol.%26date%3D2005%26volume%3D55%26spage%3D441%26epage%3D455%26doi%3D10.1111%2Fj.1365-2958.2004.04415.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Jones, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholes, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2085</span><span class="refDoi"> DOI: 10.1073/pnas.92.6.2081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1073%2Fpnas.92.6.2081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=2081-2085&author=C.+H.+Jonesauthor=J.+S.+Pinknerauthor=R.+Rothauthor=J.+Heuserauthor=A.+V.+Nicholesauthor=S.+N.+Abrahamauthor=S.+J.+Hultgren&title=FimH+adhesin+of+type+1+pili+is+assembled+into+a+fibrillar+tip+structure+in+the+Enterobacteriaceae&doi=10.1073%2Fpnas.92.6.2081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.6.2081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.6.2081%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BH.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DR.%26aulast%3DHeuser%26aufirst%3DJ.%26aulast%3DNicholes%26aufirst%3DA.%2BV.%26aulast%3DAbraham%26aufirst%3DS.%2BN.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DFimH%2520adhesin%2520of%2520type%25201%2520pili%2520is%2520assembled%2520into%2520a%2520fibrillar%2520tip%2520structure%2520in%2520the%2520Enterobacteriaceae%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D2081%26epage%3D2085%26doi%3D10.1073%2Fpnas.92.6.2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auguste, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strouse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02915.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1046%2Fj.1365-2958.2002.02915.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=12010488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2002&pages=903-915&author=C.+S.+Hungauthor=J.+Bouckaertauthor=D.+Hungauthor=J.+Pinknerauthor=C.+Widbergauthor=A.+DeFuscoauthor=C.+G.+Augusteauthor=R.+Strouseauthor=S.+Langermannauthor=G.+Waksmanauthor=S.+J.+Hultgren&title=Structural+basis+of+tropism+of+Escherichia+coli+to+the+bladder+during+urinary+tract+infection&doi=10.1046%2Fj.1365-2958.2002.02915.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span></div><div class="casAuthors">Hung, Chia-Suei; Bouckaert, Julie; Hung, Danielle; Pinkner, Jerome; Widberg, Charlotte; DeFusco, Anthony; Auguste, C. Gale; Strouse, Robert; Langermann, Solomon; Waksman, Gabriel; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">903-915</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The first step in the colonization of the human urinary tract by pathogenic Escherichia coli is the mannose-sensitive binding of FimH, the adhesin present at the tip of type 1 pili, to the bladder epithelium.  We elucidated crystallog. the interactions of FimH with D-mannose.  The unique site binding pocket occupied by D-mannose was probed using site-directed mutagenesis.  All but one of the mutants examd. had greatly diminished mannose-binding activity and had also lost the ability to bind human bladder cells.  The binding activity of the monosaccharide D-mannose was delineated from this of mannotriose (Man(α1-3)[Man(α1-6)]Man) by generating mutants that abolished D-mannose binding but retained mannotriose binding activity.  Our structure/function anal. demonstrated that the binding of the monosaccharide α-D-mannose is the primary bladder cell receptor for uropathogenic E. coli and that this event requires a highly conserved FimH binding pocket.  The residues in the FimH mannose-binding pocket were sequenced and found to be invariant in over 200 uropathogenic strains of E. coli.  Only enterohemorrhagic E. coli (EHEC) possess a sequence variation within the mannose-binding pocket of FimH, suggesting a naturally occurring mechanism of attenuation in EHEC bacteria that would prevent them from being targeted to the urinary tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoljy6DS5GA8bVg90H21EOLACvtfcHk0liHY3iFBXy_mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D&md5=b2d31ffbc2540d4be1bfff9d4036f5eb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02915.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02915.x%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DHung%26aufirst%3DD.%26aulast%3DPinkner%26aufirst%3DJ.%26aulast%3DWidberg%26aufirst%3DC.%26aulast%3DDeFusco%26aufirst%3DA.%26aulast%3DAuguste%26aufirst%3DC.%2BG.%26aulast%3DStrouse%26aufirst%3DR.%26aulast%3DLangermann%26aufirst%3DS.%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520tropism%2520of%2520Escherichia%2520coli%2520to%2520the%2520bladder%2520during%2520urinary%2520tract%2520infection%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D44%26spage%3D903%26epage%3D915%26doi%3D10.1046%2Fj.1365-2958.2002.02915.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Puorger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wider, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glockshuber, R.</span><span> </span><span class="NLM_article-title">Structure, folding and stability of FimA, the main structural subunit of type 1 pili from uropathogenic Escherichia coli strains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/j.jmb.2011.07.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.jmb.2011.07.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2011&pages=520-535&author=C.+Puorgerauthor=M.+Vetschauthor=G.+Widerauthor=R.+Glockshuber&title=Structure%2C+folding+and+stability+of+FimA%2C+the+main+structural+subunit+of+type+1+pili+from+uropathogenic+Escherichia+coli+strains&doi=10.1016%2Fj.jmb.2011.07.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.07.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.07.044%26sid%3Dliteratum%253Aachs%26aulast%3DPuorger%26aufirst%3DC.%26aulast%3DVetsch%26aufirst%3DM.%26aulast%3DWider%26aufirst%3DG.%26aulast%3DGlockshuber%26aufirst%3DR.%26atitle%3DStructure%252C%2520folding%2520and%2520stability%2520of%2520FimA%252C%2520the%2520main%2520structural%2520subunit%2520of%2520type%25201%2520pili%2520from%2520uropathogenic%2520Escherichia%2520coli%2520strains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D412%26spage%3D520%26epage%3D535%26doi%3D10.1016%2Fj.jmb.2011.07.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebbel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glockshuber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X. P.</span><span> </span><span class="NLM_article-title">Uroplakin Ia is the urothelial receptor for uropathogenic <i>Escherichia coli</i>: evidence from in vitro FimH binding</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11739641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVKls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2001&pages=4095-4103&author=G.+Zhouauthor=W.+J.+Moauthor=P.+Sebbelauthor=G.+Minauthor=T.+A.+Neubertauthor=R.+Glockshuberauthor=X.+R.+Wuauthor=T.+T.+Sunauthor=X.+P.+Kong&title=Uroplakin+Ia+is+the+urothelial+receptor+for+uropathogenic+Escherichia+coli%3A+evidence+from+in+vitro+FimH+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding</span></div><div class="casAuthors">Zhou, Ge; Mo, Wen-Jun; Sebbel, Peter; Min, Guangwei; Neubert, Thomas A.; Glockshuber, Rudi; Wu, Xue-Ru; Sun, Tung-Tien; Kong, Xiang-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4095-4103</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The binding of uropathogenic Escherichia coli to the urothelial surface is a crucial initial event for establishing urinary tract infection because it allows the bacteria to gain a foothold on the urothelial surface, thus preventing them from being removed by micturition.  In addn., it triggers bacterial invasion as well as host urothelial defense.  This binding is mediated by the FimH adhesin located at the tip of the bacterial type 1-fimbrium, a filamentous attachment app., and its urothelial receptor.  We have prepd. a biotinylated, recombinant FimH-FimC adhesin:chaperone complex and used it to identify its mouse urothelial receptor.  The FimH-FimC complex binds specifically to a single 24 kDa major mouse urothelial plaque protein, which we identified as uroplakin Ia by mass spectrometry, cDNA cloning and immunoreactivity.  The terminal mannosyl moieties on Asn-169 of uroplakin Ia are responsible for FimH as well as Con A binding.  Although FimH binds to uroplakin Ia with only moderate strength (Kd ∼100 nM between pH 4 and 9), the binding between multiple fimbriae of a bacterium and the cryst. array of polymd. uroplakin receptors should achieve high avidity and stable bacterial attachment.  The FimH-FimC complex binds preferentially to the mouse urothelial umbrella cells in a pattern similar to uroplakin staining.  Our results indicate that the structurally related uroplakins Ia and Ib are glycosylated differently, that uroplakin Ia serves as the urothelial receptor for the type 1-fimbriated E. coli, and that the binding of uropathogenic bacteria to uroplakin Ia may play a key role in mediating the urothelial responses to bacterial attachment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHR7X2E8llv7Vg90H21EOLACvtfcHk0li4JUA_zEy7dQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVKls7c%253D&md5=e5eaf72956e8ca3a562b0cffbb8a3e96</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DMo%26aufirst%3DW.%2BJ.%26aulast%3DSebbel%26aufirst%3DP.%26aulast%3DMin%26aufirst%3DG.%26aulast%3DNeubert%26aufirst%3DT.%2BA.%26aulast%3DGlockshuber%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DX.%2BR.%26aulast%3DSun%26aufirst%3DT.%2BT.%26aulast%3DKong%26aufirst%3DX.%2BP.%26atitle%3DUroplakin%2520Ia%2520is%2520the%2520urothelial%2520receptor%2520for%2520uropathogenic%2520Escherichia%2520coli%253A%2520evidence%2520from%2520in%2520vitro%2520FimH%2520binding%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2001%26volume%3D114%26spage%3D4095%26epage%3D4103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Eto, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundsbak, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, M. A.</span><span> </span><span class="NLM_article-title">Integrin-mediated host cell invasion by type 1-piliated uropathogenic <i>Escherichia coli</i></span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e100</span><span class="refDoi"> DOI: 10.1371/journal.ppat.0030100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.ppat.0030100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=e100&author=D.+S.+Etoauthor=T.+A.+Jonesauthor=J.+L.+Sundsbakauthor=M.+A.+Mulvey&title=Integrin-mediated+host+cell+invasion+by+type+1-piliated+uropathogenic+Escherichia+coli&doi=10.1371%2Fjournal.ppat.0030100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.0030100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.0030100%26sid%3Dliteratum%253Aachs%26aulast%3DEto%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DT.%2BA.%26aulast%3DSundsbak%26aufirst%3DJ.%2BL.%26aulast%3DMulvey%26aufirst%3DM.%2BA.%26atitle%3DIntegrin-mediated%2520host%2520cell%2520invasion%2520by%2520type%25201-piliated%2520uropathogenic%2520Escherichia%2520coli%26jtitle%3DPLoS%2520Pathog.%26date%3D2007%26volume%3D3%26spage%3De100%26doi%3D10.1371%2Fjournal.ppat.0030100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Anderson, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Intracellular bacterial biofilm-like pods in urinary tract infections</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1126/science.1084550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1126%2Fscience.1084550" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=105-107&author=G.+G.+Andersonauthor=J.+J.+Palermoauthor=J.+D.+Schillingauthor=R.+Rothauthor=J.+Heuserauthor=S.+J.+Hultgren&title=Intracellular+bacterial+biofilm-like+pods+in+urinary+tract+infections&doi=10.1126%2Fscience.1084550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1084550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1084550%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DG.%2BG.%26aulast%3DPalermo%26aufirst%3DJ.%2BJ.%26aulast%3DSchilling%26aufirst%3DJ.%2BD.%26aulast%3DRoth%26aufirst%3DR.%26aulast%3DHeuser%26aufirst%3DJ.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DIntracellular%2520bacterial%2520biofilm-like%2520pods%2520in%2520urinary%2520tract%2520infections%26jtitle%3DScience%26date%3D2003%26volume%3D301%26spage%3D105%26epage%3D107%26doi%3D10.1126%2Fscience.1084550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Griebling, T. L.</span><span> </span><span class="NLM_article-title">Urinary tract infection in women</span>. In Urologic Diseases in America; <span class="NLM_contrib-group">Litwin, M.S.; Saigal, C.S.</span>, Eds.; <span class="NLM_publisher-name">U.S. Government Printing Office</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+L.+Grieblingauthor=M.S.+Litwin&author=C.S.+Saigal&title=Urinary+tract+infection+in+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26aulast%3DGriebling%26aufirst%3DT.%2BL.%26atitle%3DUrinary%2520tract%2520infection%2520in%2520women%26jtitle%3DUrologic%2520Diseases%2520in%2520America%26aulast%3DLitwin%26aufirst%3DM.S.%26pub%3DU.S.%2520Government%2520Printing%2520Office%26date%3D2007%26spage%3D587%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Foxman, B.</span><span> </span><span class="NLM_article-title">Epidemiology of urinary tract infections: incidence, morbidity, and economic costs</span> <span class="citation_source-journal">DM, Dis.-Mon.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1067/mda.2003.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1067%2Fmda.2003.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=12601337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FovFagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2003&pages=53-70&author=B.+Foxman&title=Epidemiology+of+urinary+tract+infections%3A+incidence%2C+morbidity%2C+and+economic+costs&doi=10.1067%2Fmda.2003.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of urinary tract infections: incidence, morbidity, and economic costs</span></div><div class="casAuthors">Foxman Betsy</div><div class="citationInfo"><span class="NLM_cas:title">Disease-a-month : DM</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">53-70</span>
        ISSN:<span class="NLM_cas:issn">0011-5029</span>.
    </div><div class="casAbstract">Urinary tract infections (UTIs) are considered to be the most common bacterial infection.  According to the 1997 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, UTI accounted for nearly 7 million office visits and 1 million emergency department visits, resulting in 100,000 hospitalizations.  Nevertheless, it is difficult to accurately assess the incidence of UTIs, because they are not reportable diseases in the United States.  This situation is further complicated by the fact that accurate diagnosis depends on both the presence of symptoms and a positive urine culture, although in most outpatient settings this diagnosis is made without the benefit of culture.  Women are significantly more likely to experience UTI than men.  Nearly 1 in 3 women will have had at least 1 episode of UTI requiring antimicrobial therapy by the age of 24 years.  Almost half of all women will experience 1 UTI during their lifetime.  Specific subpopulations at increased risk of UTI include infants, pregnant women, the elderly, patients with spinal cord injuries and/or catheters, patients with diabetes or multiple sclerosis, patients with acquired immunodeficiency disease syndrome/human immunodeficiency virus, and patients with underlying urologic abnormalities.  Catheter-associated UTI is the most common nosocomial infection, accounting for >1 million cases in hospitals and nursing homes.  The risk of UTI increases with increasing duration of catheterization.  In noninstitutionalized elderly populations, UTIs are the second most common form of infection, accounting for nearly 25% of all infections.  There are important medical and financial implications associated with UTIs.  In the nonobstructed, nonpregnant female adult, acute uncomplicated UTI is believed to be a benign illness with no long-term medical consequences.  However, UTI elevates the risk of pyelonephritis, premature delivery, and fetal mortality among pregnant women, and is associated with impaired renal function and end-stage renal disease among pediatric patients.  Financially, the estimated annual cost of community-acquired UTI is significant, at approximately $1.6 billion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQ38Fbr8nVBDDnmmyUf5qOfW6udTcc2eb9UVe_A3pUaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FovFagtw%253D%253D&md5=eadd54209396955108dbbbb63fb2cc6e</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1067%2Fmda.2003.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmda.2003.7%26sid%3Dliteratum%253Aachs%26aulast%3DFoxman%26aufirst%3DB.%26atitle%3DEpidemiology%2520of%2520urinary%2520tract%2520infections%253A%2520incidence%252C%2520morbidity%252C%2520and%2520economic%2520costs%26jtitle%3DDM%252C%2520Dis.-Mon.%26date%3D2003%26volume%3D49%26spage%3D53%26epage%3D70%26doi%3D10.1067%2Fmda.2003.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kärkkäinen, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikäheimo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katila, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siitonen, A.</span><span> </span><span class="NLM_article-title">Recurrence of urinary tract infections in adult patients with community- acquired pyelonephritis caused by E. coli: a 1-year follow-up</span> <span class="citation_source-journal">Scand. J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1080/003655400458767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1080%2F003655400458767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11055653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BD3crgsV2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2000&pages=495-499&author=U.+M.+K%C3%A4rkk%C3%A4inenauthor=R.+Ik%C3%A4heimoauthor=M.+L.+Katilaauthor=A.+Siitonen&title=Recurrence+of+urinary+tract+infections+in+adult+patients+with+community-+acquired+pyelonephritis+caused+by+E.+coli%3A+a+1-year+follow-up&doi=10.1080%2F003655400458767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up</span></div><div class="casAuthors">Karkkainen U M; Ikaheimo R; Katila M L; Siitonen A</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian journal of infectious diseases</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">495-9</span>
        ISSN:<span class="NLM_cas:issn">0036-5548</span>.
    </div><div class="casAbstract">In a prospective study, 42 women were followed for recurrence of urinary tract infections (UTIs) for 1 y after an index episode of community-acquired pyelonephritis caused by Escherichia coli.  Altogether, 26 repeat episodes were detected.  Of these, 20 occurred at least 1 month after the index episode and were regarded as recurrences.  In all, 40%, (17 of 42) of the women had recurrences.  An earlier history of UTI increased the risk of recurrence: 52%, of the 29 women with previous UTI had at least 1 recurrence, compared with 15%, of the 13 patients without previous UTI.  E. coli caused the majority (73%) of the recurrences.  Genotype comparisons by RAPD-PCR analysis between E. coli isolates from a patient showed that 75%. of the original and recurrent strains were genetically non-identical.  Of the 54 E. coli strains, 42 were carrying genes coding for G adhesins of P fimbriae: 40 isolates carried class II, I class III and 1 carried both class II and III G adhesin genes.  Each of the virulence-associated factors (genes for G adhesins, MRHA, haemolysin, type 1C fimbriae, and O and K antigens) was evenly distributed among E. coli isolates of index episodes, independent of the recurrences.  The index isolates, however, had more virulence-associated factors than did the isolates from the recurrences which were mainly due to lower UTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjpF21U4dOBuqrn-c4Of3KfW6udTcc2eb9UVe_A3pUaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3crgsV2ksA%253D%253D&md5=233e348778c2591fa974b05a7ce079d1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1080%2F003655400458767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F003655400458767%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A4rkk%25C3%25A4inen%26aufirst%3DU.%2BM.%26aulast%3DIk%25C3%25A4heimo%26aufirst%3DR.%26aulast%3DKatila%26aufirst%3DM.%2BL.%26aulast%3DSiitonen%26aufirst%3DA.%26atitle%3DRecurrence%2520of%2520urinary%2520tract%2520infections%2520in%2520adult%2520patients%2520with%2520community-%2520acquired%2520pyelonephritis%2520caused%2520by%2520E.%2520coli%253A%2520a%25201-year%2520follow-up%26jtitle%3DScand.%2520J.%2520Infect.%2520Dis.%26date%3D2000%26volume%3D32%26spage%3D495%26epage%3D499%26doi%3D10.1080%2F003655400458767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ikähelmo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siitonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiskanen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kärkkäinen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuosmanen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipponen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäkelä, P. H.</span><span> </span><span class="NLM_article-title">Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1093/clinids/22.1.91</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1093%2Fclinids%2F22.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=8824972" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1996&pages=91-99&author=R.+Ik%C3%A4helmoauthor=A.+Siitonenauthor=T.+Heiskanenauthor=U.+K%C3%A4rkk%C3%A4inenauthor=P.+Kuosmanenauthor=P.+Lipponenauthor=P.+H.+M%C3%A4kel%C3%A4&title=Recurrence+of+urinary+tract+infection+in+a+primary+care+setting%3A+analysis+of+a+1-year+follow-up+of+179+women&doi=10.1093%2Fclinids%2F22.1.91"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F22.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F22.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DIk%25C3%25A4helmo%26aufirst%3DR.%26aulast%3DSiitonen%26aufirst%3DA.%26aulast%3DHeiskanen%26aufirst%3DT.%26aulast%3DK%25C3%25A4rkk%25C3%25A4inen%26aufirst%3DU.%26aulast%3DKuosmanen%26aufirst%3DP.%26aulast%3DLipponen%26aufirst%3DP.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DP.%2BH.%26atitle%3DRecurrence%2520of%2520urinary%2520tract%2520infection%2520in%2520a%2520primary%2520care%2520setting%253A%2520analysis%2520of%2520a%25201-year%2520follow-up%2520of%2520179%2520women%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1996%26volume%3D22%26spage%3D91%26epage%3D99%26doi%3D10.1093%2Fclinids%2F22.1.91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Foxman, B.</span><span> </span><span class="NLM_article-title">Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden</span> <span class="citation_source-journal">Infect. Dis. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.idc.2013.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.idc.2013.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=24484571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC2crjsF2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1-13&author=B.+Foxman&title=Urinary+tract+infection+syndromes%3A+occurrence%2C+recurrence%2C+bacteriology%2C+risk+factors%2C+and+disease+burden&doi=10.1016%2Fj.idc.2013.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden</span></div><div class="casAuthors">Foxman Betsy</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Urinary tract infection (UTI) is one of the most common bacterial infections, accounting for 0.9% of all ambulatory visits in the United States.  This review defines the major UTI syndromes, their occurrence and recurrence, bacteriology, risk factors, and disease burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNGmy0Ym3J9XWEEzDrymxmfW6udTcc2eaFNJgeRxuOwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crjsF2ltw%253D%253D&md5=8700ffd4e117ea98258fdfd4d15b1c12</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2013.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2013.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DFoxman%26aufirst%3DB.%26atitle%3DUrinary%2520tract%2520infection%2520syndromes%253A%2520occurrence%252C%2520recurrence%252C%2520bacteriology%252C%2520risk%2520factors%252C%2520and%2520disease%2520burden%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2014%26volume%3D28%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.idc.2013.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ronald, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolle, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naber, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooton, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriole, V.</span><span> </span><span class="NLM_article-title">Urinary tract infection in adults: research priorities and strategies</span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1016/S0924-8579(01)00303-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0924-8579%2801%2900303-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11295419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisValsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=343-348&author=A.+R.+Ronaldauthor=L.+E.+Nicolleauthor=E.+Stammauthor=J.+Kriegerauthor=J.+Warrenauthor=A.+Schaefferauthor=K.+G.+Naberauthor=T.+M.+Hootonauthor=J.+Johnsonauthor=S.+Chambersauthor=V.+Andriole&title=Urinary+tract+infection+in+adults%3A+research+priorities+and+strategies&doi=10.1016%2FS0924-8579%2801%2900303-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary tract infection in adults: research priorities and strategies</span></div><div class="casAuthors">Ronald, A. R.; Nicolle, L. E.; Stamm, E.; Krieger, J.; Warren, J.; Schaeffer, A.; Naber, K. G.; Hooton, T. M.; Johnson, J.; Chambers, S.; Andriole, V.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-348</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Waning interest in urinary tract infection (UTI) research has limited clin. advances during the past two decades.  Although care has improved for some specific UTI syndromes, there is limited evidence for most of the decisions made each day in the management of these infections.  Addnl. clin. research is necessary to improve UTI prevention and care strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRyMRRahpEy7Vg90H21EOLACvtfcHk0lific6YlKkJ7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisValsLs%253D&md5=d942e3b6dbbd6a9b1f0e82468e4d6f2c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0924-8579%2801%2900303-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-8579%252801%252900303-X%26sid%3Dliteratum%253Aachs%26aulast%3DRonald%26aufirst%3DA.%2BR.%26aulast%3DNicolle%26aufirst%3DL.%2BE.%26aulast%3DStamm%26aufirst%3DE.%26aulast%3DKrieger%26aufirst%3DJ.%26aulast%3DWarren%26aufirst%3DJ.%26aulast%3DSchaeffer%26aufirst%3DA.%26aulast%3DNaber%26aufirst%3DK.%2BG.%26aulast%3DHooton%26aufirst%3DT.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DChambers%26aufirst%3DS.%26aulast%3DAndriole%26aufirst%3DV.%26atitle%3DUrinary%2520tract%2520infection%2520in%2520adults%253A%2520research%2520priorities%2520and%2520strategies%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2001%26volume%3D17%26spage%3D343%26epage%3D348%26doi%3D10.1016%2FS0924-8579%2801%2900303-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karlowsky, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decorby, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laing, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhanel, G. G.</span><span> </span><span class="NLM_article-title">Fluoroquinolone-resistant urinary isolates of <i>Escherichia coli</i> from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2251</span><span class="NLM_x">–</span> <span class="NLM_lpage">2254</span><span class="refDoi"> DOI: 10.1128/AAC.00123-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1128%2FAAC.00123-06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=2251-2254&author=J.+A.+Karlowskyauthor=D.+J.+Hobanauthor=M.+R.+Decorbyauthor=N.+M.+Laingauthor=G.+G.+Zhanel&title=Fluoroquinolone-resistant+urinary+isolates+of+Escherichia+coli+from+outpatients+are+frequently+multidrug+resistant%3A+results+from+the+North+American+Urinary+Tract+Infection+Collaborative+Alliance-Quinolone+Resistance+study&doi=10.1128%2FAAC.00123-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00123-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00123-06%26sid%3Dliteratum%253Aachs%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DDecorby%26aufirst%3DM.%2BR.%26aulast%3DLaing%26aufirst%3DN.%2BM.%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26atitle%3DFluoroquinolone-resistant%2520urinary%2520isolates%2520of%2520Escherichia%2520coli%2520from%2520outpatients%2520are%2520frequently%2520multidrug%2520resistant%253A%2520results%2520from%2520the%2520North%2520American%2520Urinary%2520Tract%2520Infection%2520Collaborative%2520Alliance-Quinolone%2520Resistance%2520study%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D2251%26epage%3D2254%26doi%3D10.1128%2FAAC.00123-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">National Disease and Therapeutic Index</span>; <span class="NLM_publisher-name">IMS Health, Inc.</span>: <span class="NLM_publisher-loc">Plymouth Meeting, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Disease+and+Therapeutic+Index%3B+IMS+Health%2C+Inc.%3A+Plymouth+Meeting%2C+PA%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DNational%2520Disease%2520and%2520Therapeutic%2520Index%26pub%3DIMS%2520Health%252C%2520Inc%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Blango, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, M. A.</span><span> </span><span class="NLM_article-title">Persistence of uropathogenic <i>Escherichia coli</i> in the face of multiple antibiotics</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span><span class="refDoi"> DOI: 10.1128/AAC.00014-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1128%2FAAC.00014-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1855-1863&author=M.+G.+Blangoauthor=M.+A.+Mulvey&title=Persistence+of+uropathogenic+Escherichia+coli+in+the+face+of+multiple+antibiotics&doi=10.1128%2FAAC.00014-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.00014-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00014-10%26sid%3Dliteratum%253Aachs%26aulast%3DBlango%26aufirst%3DM.%2BG.%26aulast%3DMulvey%26aufirst%3DM.%2BA.%26atitle%3DPersistence%2520of%2520uropathogenic%2520Escherichia%2520coli%2520in%2520the%2520face%2520of%2520multiple%2520antibiotics%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1855%26epage%3D1863%26doi%3D10.1128%2FAAC.00014-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mydock-McGrane, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn’s disease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1517/13543776.2016.1131266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1517%2F13543776.2016.1131266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=26651364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=175-197&author=L.+K.+Mydock-McGraneauthor=Z.+T.+Cusumanoauthor=J.+W.+Janetka&title=Mannose-derived+FimH+antagonists%3A+a+promising+anti-virulence+therapeutic+strategy+for+urinary+tract+infections+and+Crohn%E2%80%99s+disease&doi=10.1517%2F13543776.2016.1131266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease</span></div><div class="casAuthors">Mydock-McGrane, Laurel K.; Cusumano, Zachary T.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-197</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Type 1 pili are utilized by Gram-neg. bacteria to adhere to host tissue and thus are a key virulence factor in urinary tract infections (UTIs) and Crohn's disease (CD).  This adhesion is mediated through specific binding of the terminal adhesin, FimH, to mannosylated host glycoproteins.  FimH is essential for UTI pathogenesis and thus is a promising therapeutic target.: Herein, we review the structural frameworks of FimH antagonists disclosed in the patent literature.  X-ray crystallog. binding studies of D-mannose and early FimH antagonists have uncovered key mol. interactions.  Exploiting this knowledge, mannosides with extraordinarily high binding affinities have been designed.  Structure-activity relationships (SAR) and structure-property relationship (SPR) studies have resulted in the rapid development of orally bioavailable FimH antagonists with promising therapeutic potential for UTI and CD.: It is our opinion that biaryl or 'two-ring' mannosides, which represent the largest and most thoroughly tested class of FimH antagonists, also hold the most promise as a novel treatment for UTIs.  These antagonists have also been shown to have efficacy in treating CD.  Judging from the strong preclin. data, we predict that one or more FimH antagonists will be entering the clinic within the next 1-2 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_i0DZwcMRbVg90H21EOLACvtfcHk0li7xK4h--TaHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D&md5=a28cd9875e0f5bf0c91f716c3d7b7653</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1131266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1131266%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%2BT.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DMannose-derived%2520FimH%2520antagonists%253A%2520a%2520promising%2520anti-virulence%2520therapeutic%2520strategy%2520for%2520urinary%2520tract%2520infections%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D175%26epage%3D197%26doi%3D10.1517%2F13543776.2016.1131266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martinez-Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Gil, L. J.</span><span> </span><span class="NLM_article-title"><i>Escherichia coli</i> in chronic inflammatory bowel diseases: An update on adherent invasive <i>Escherichia coli</i> pathogenicity</span> <span class="citation_source-journal">World J. Gastrointest. Pathophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.4291/wjgp.v5.i3.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.4291%2Fwjgp.v5.i3.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=25133024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FivVCgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=213-227&author=M.+Martinez-Medinaauthor=L.+J.+Garcia-Gil&title=Escherichia+coli+in+chronic+inflammatory+bowel+diseases%3A+An+update+on+adherent+invasive+Escherichia+coli+pathogenicity&doi=10.4291%2Fwjgp.v5.i3.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity</span></div><div class="casAuthors">Martinez-Medina Margarita; Garcia-Gil Librado Jesus</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal pathophysiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-27</span>
        ISSN:<span class="NLM_cas:issn">2150-5330</span>.
    </div><div class="casAbstract">Escherichia coli (E. coli), and particularly the adherent invasive E. coli (AIEC) pathotype, has been increasingly implicated in the ethiopathogenesis of Crohn's disease (CD).  E. coli strains with similar pathogenic features to AIEC have been associated with other intestinal disorders such as ulcerative colitis, colorectal cancer, and coeliac disease, but AIEC prevalence in these diseases remains largely unexplored.  Since AIEC was described one decade ago, substantial progress has been made in deciphering its mechanisms of pathogenicity.  However, the molecular bases that characterize the phenotypic properties of this pathotype are still not well resolved.  A review of studies focused on E. coli populations in inflammatory bowel disease (IBD) is presented here and we discuss about the putative role of this species on each IBD subtype.  Given the relevance of AIEC in CD pathogenesis, we present the latest research findings concerning AIEC host-microbe interactions and pathogenicity.  We also review the existing data regarding the prevalence and abundance of AIEC in CD and its association with other intestinal diseases from humans and animals, in order to discuss the AIEC disease- and host-specificity.  Finally, we highlight the fact that dietary components frequently found in industrialized countries may enhance AIEC colonization in the gut, which merits further investigation and the implementation of preventative measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLaqWjAreWhjAyhZbj3lKdfW6udTcc2eaQ6fzv0Mqn8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FivVCgtA%253D%253D&md5=41a27d8217945e67fef677a8b338fab3</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.4291%2Fwjgp.v5.i3.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4291%252Fwjgp.v5.i3.213%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Medina%26aufirst%3DM.%26aulast%3DGarcia-Gil%26aufirst%3DL.%2BJ.%26atitle%3DEscherichia%2520coli%2520in%2520chronic%2520inflammatory%2520bowel%2520diseases%253A%2520An%2520update%2520on%2520adherent%2520invasive%2520Escherichia%2520coli%2520pathogenicity%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Pathophysiol.%26date%3D2014%26volume%3D5%26spage%3D213%26epage%3D227%26doi%3D10.4291%2Fwjgp.v5.i3.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Boudeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darfeuille-Michaud, A.</span><span> </span><span class="NLM_article-title">Type 1 pili-mediated adherence of <i>Escherichia coli</i> strain LF82 isolated from Crohn’s disease is involved in bacterial invasion of intestinal epithelial cells</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.1111/j.1365-2958.2001.02315.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1111%2Fj.1365-2958.2001.02315.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11251843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Ogurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2001&pages=1272-1284&author=J.+Boudeauauthor=N.+Barnichauthor=A.+Darfeuille-Michaud&title=Type+1+pili-mediated+adherence+of+Escherichia+coli+strain+LF82+isolated+from+Crohn%E2%80%99s+disease+is+involved+in+bacterial+invasion+of+intestinal+epithelial+cells&doi=10.1111%2Fj.1365-2958.2001.02315.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells</span></div><div class="casAuthors">Boudeau, Jerome; Barnich, Nicolas; Darfeuille-Michaud, Arlette</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1272-1284</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The invasive ability of E. coli strain LF82, isolated from an ileal biopsy of a patient with Crohn's disease, was previously characterized.  In the present study, we performed TnphoA insertion mutagenesis to identify genes involved in LF82 invasion of intestinal epithelial cells.  Most of the non-invasive mutants had an insertion mutation within the type 1 pili-encoding operon.  Two non-invasive fim mutants, which harbored an insertion within the fimI and fimF genes, still adhered but had lost the ability to induce host cell membrane elongations at the sites of contact with the epithelial cells.  Transcomplementation expts. with a fim operon cloned from E. coli K-12 restored both invasive ability and the ability to induce host cell membrane elongations.  Expression of the cloned LF82 or K-12 fim operon into the non-invasive lab. strain JM109 did not confer invasive properties.  Thus, these findings showed that: (i) type 1 pili-mediated adherence is involved in LF82-induced perturbation of host cell signalling responsible for membrane elongations; (ii) native shafts are required for type 1 pilus-mediated induction of membrane elongations; (iii) this active phenomenon is a key step in the establishment of the invasive process; and (iv) type 1 pili alone are not sufficient to trigger bacterial internalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKJVsViY7-ULVg90H21EOLACvtfcHk0li7xK4h--TaHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Ogurk%253D&md5=9f378073ccf52a608bdf95847e5bde98</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2001.02315.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2001.02315.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoudeau%26aufirst%3DJ.%26aulast%3DBarnich%26aufirst%3DN.%26aulast%3DDarfeuille-Michaud%26aufirst%3DA.%26atitle%3DType%25201%2520pili-mediated%2520adherence%2520of%2520Escherichia%2520coli%2520strain%2520LF82%2520isolated%2520from%2520Crohn%25E2%2580%2599s%2520disease%2520is%2520involved%2520in%2520bacterial%2520invasion%2520of%2520intestinal%2520epithelial%2520cells%26jtitle%3DMol.%2520Microbiol.%26date%3D2001%26volume%3D39%26spage%3D1272%26epage%3D1284%26doi%3D10.1111%2Fj.1365-2958.2001.02315.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">109ra115</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1126%2Fscitranslmed.3003021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=22089451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=109ra115&author=C.+K.+Cusumanoauthor=J.+S.+Pinknerauthor=Z.+Hanauthor=S.+E.+Greeneauthor=B.+A.+Fordauthor=J.+R.+Crowleyauthor=J.+P.+Hendersonauthor=J.+W.+Janetkaauthor=S.+J.+Hultgren&title=Treatment+and+prevention+of+urinary+tract+infection+with+orally+active+FimH+inhibitors&doi=10.1126%2Fscitranslmed.3003021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span></div><div class="casAuthors">Cusumano Corinne K; Pinkner Jerome S; Han Zhenfu; Greene Sarah E; Ford Bradley A; Crowley Jan R; Henderson Jeffrey P; Janetka James W; Hultgren Scott J</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">109</span>),
    <span class="NLM_cas:pages">109ra115</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic and recurrent urinary tract infections pose a serious medical problem because there are few effective treatment options.  Patients with chronic urinary tract infections are commonly treated with long-term prophylactic antibiotics that promote the development of antibiotic-resistant forms of uropathogenic Escherichia coli (UPEC), further complicating treatment.  We developed small-molecular weight compounds termed mannosides that specifically inhibit the FimH type 1 pilus lectin of UPEC, which mediates bacterial colonization, invasion, and formation of recalcitrant intracellular bacterial communities in the bladder epithelium.  Here, we optimized these compounds for oral bioavailability and demonstrated their fast-acting efficacy in treating chronic urinary tract infections in a preclinical murine model.  These compounds also prevented infection in vivo when given prophylactically and strongly potentiated the activity of the current standard of care therapy, trimethoprim-sulfamethoxazole, against clinically resistant PBC-1 UPEC bacteria.  These compounds have therapeutic efficacy after oral administration for the treatment of established urinary tract infections in vivo.  Their unique mechanism of action-targeting the pilus tip adhesin FimH-circumvents the conventional requirement for drug penetration of the outer membrane, minimizing the potential for the development of resistance.  The small-molecular weight compounds described herein promise to provide substantial benefit to women suffering from chronic and recurrent urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJjBsZZFqz29j_Vg2vObihfW6udTcc2eabVjv5Ky4uzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D&md5=253b506b7485c2cf042cb5665c518277</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003021%26sid%3Dliteratum%253Aachs%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DGreene%26aufirst%3DS.%2BE.%26aulast%3DFord%26aufirst%3DB.%2BA.%26aulast%3DCrowley%26aufirst%3DJ.%2BR.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DTreatment%2520and%2520prevention%2520of%2520urinary%2520tract%2520infection%2520with%2520orally%2520active%2520FimH%2520inhibitors%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D109ra115%26doi%3D10.1126%2Fscitranslmed.3003021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3945</span><span class="NLM_x">–</span> <span class="NLM_lpage">3959</span><span class="refDoi"> DOI: 10.1021/jm300165m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300165m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3945-3959&author=Z.+Hanauthor=J.+S.+Pinknerauthor=B.+Fordauthor=E.+Chorellauthor=J.+M.+Crowleyauthor=C.+K.+Cusumanoauthor=S.+Campbellauthor=J.+P.+Hendersonauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Lead+optimization+studies+on+FimH+antagonists%3A+discovery+of+potent+and+orally+bioavailable+ortho-substituted+biphenyl+mannosides&doi=10.1021%2Fjm300165m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization Studies on FimH Antagonists: Discovery of Potent and Orally Bioavailable Ortho-Substituted Biphenyl Mannosides</span></div><div class="casAuthors">Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Chorell, Erik; Crowley, Jan M.; Cusumano, Corinne K.; Campbell, Scott; Henderson, Jeffrey P.; Hultgren, Scott J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3945-3959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we describe the X-ray structure-based design and optimization of biaryl mannoside FimH inhibitors.  Diverse modifications to the biaryl ring to improve druglike phys. and pharmacokinetic properties of mannosides were assessed for FimH binding affinity based on their effects on hemagglutination and biofilm formation along with direct FimH binding assays.  Substitution on the mannoside Ph ring ortho to the glycosidic bond results in large potency enhancements several-fold higher than those of corresponding unsubstituted matched pairs and can be rationalized from increased hydrophobic interactions with the FimH hydrophobic ridge (Ile13) or "tyrosine gate" (Tyr137 and Tyr48) also lined by Ile52.  The lead mannosides have increased metabolic stability and oral bioavailability as detd. from in vitro PAMPA predictive model of cellular permeability and in vivo pharmacokinetic studies in mice, thereby representing advanced preclin. candidates with promising potential as novel therapeutics for the clin. treatment and prevention of recurring urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBCwLuNdyjLVg90H21EOLACvtfcHk0lgMQjBM7z5mcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D&md5=2a9b4e564162f8c3292802826fa33974</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm300165m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300165m%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DChorell%26aufirst%3DE.%26aulast%3DCrowley%26aufirst%3DJ.%2BM.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DLead%2520optimization%2520studies%2520on%2520FimH%2520antagonists%253A%2520discovery%2520of%2520potent%2520and%2520orally%2520bioavailable%2520ortho-substituted%2520biphenyl%2520mannosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3945%26epage%3D3959%26doi%3D10.1021%2Fjm300165m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellenberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Structure-based drug design and optimization of mannoside bacterial FimH antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4779</span><span class="NLM_x">–</span> <span class="NLM_lpage">4792</span><span class="refDoi"> DOI: 10.1021/jm100438s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100438s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4779-4792&author=Z.+Hanauthor=J.+S.+Pinknerauthor=B.+Fordauthor=R.+Obermannauthor=W.+Nolanauthor=S.+A.+Wildmanauthor=D.+Hobbsauthor=T.+Ellenbergerauthor=C.+K.+Cusumanoauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Structure-based+drug+design+and+optimization+of+mannoside+bacterial+FimH+antagonists&doi=10.1021%2Fjm100438s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH Antagonists</span></div><div class="casAuthors">Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Obermann, Robert; Nolan, William; Wildman, Scott A.; Hobbs, Doug; Ellenberger, Tom; Cusumano, Corinne K.; Hultgren, Scott J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4779-4792</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FimH-mediated cellular adhesion to mannosylated proteins is crit. in the ability of uropathogenic E. coli (UPEC) to colonize and invade the bladder epithelium during urinary tract infection.  We describe the discovery and optimization of potent small-mol. FimH bacterial adhesion antagonists based on α-D-mannose 1-position anomeric glycosides using X-ray structure-guided drug design.  Optimized biarylmannosides display low nanomolar binding affinity for FimH in a fluorescence polarization assay and submicromolar cellular activity in a hemagglutination (HA) functional cell assay of bacterial adhesion.  X-ray crystallog. demonstrates that the biphenyl moiety makes several key interactions with the outer surface of FimH including π-π interactions with Tyr-48 and an H-bonding electrostatic interaction with the Arg-98/Glu-50 salt bridge.  Dimeric analogs linked through the biaryl ring show an impressive 8-fold increase in potency relative to monomeric matched pairs and represent the most potent FimH antagonists identified to date.  The FimH antagonists described herein hold great potential for development as novel therapeutics for the effective treatment of urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJR-ZxMIVWzbVg90H21EOLACvtfcHk0lgyGyM6UPA_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFOkt7s%253D&md5=61cd971d5c0e95acb77a6b2ae75d902f</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjm100438s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100438s%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DObermann%26aufirst%3DR.%26aulast%3DNolan%26aufirst%3DW.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DHobbs%26aufirst%3DD.%26aulast%3DEllenberger%26aufirst%3DT.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DStructure-based%2520drug%2520design%2520and%2520optimization%2520of%2520mannoside%2520bacterial%2520FimH%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4779%26epage%3D4792%26doi%3D10.1021%2Fjm100438s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Firon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashkenazi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirelman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated <i>Escherichia coli</i> to yeast and intestinal epithelial cells</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=3542836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADyaL2sXhtlGitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1987&pages=472-476&author=N.+Fironauthor=S.+Ashkenaziauthor=D.+Mirelmanauthor=I.+Ofekauthor=N.+Sharon&title=Aromatic+alpha-glycosides+of+mannose+are+powerful+inhibitors+of+the+adherence+of+type+1+fimbriated+Escherichia+coli+to+yeast+and+intestinal+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells</span></div><div class="casAuthors">Firon, Nurit; Ashkenazi, Shai; Mirelman, David; Ofek, Itzhak; Sharon, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">472-6</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Adherence of bacteria via their surface lectins to host epithelial cells is considered an important initial event in bacterial pathogenesis.  Mannose-specific (type 1) fimbriae are among the most commonly found lectins in enterobacteria.  The effect of arom. α-glycosides of mannose was studied on the agglutination of mannan-contg. yeasts by different strains of E. coli and on the adherence of the bacteria to guinea pig ileal epithelial cells.  In both systems, these compds. were considerably more effective inhibitors than Me α-mannoside, with 4-methylumbelliferyl α-mannoside and p-nitro-o-chlorophenyl α-mannoside being the strongest inhibitors.  Both compds. were approx. 400-times stronger inhibitors of yeast agglutination by E. coli O128 than was Me α-mannoside and 1000- and 470-fold stronger, resp., than was Me α-mannoside in inhibiting the adherence of the bacteria to ileal epithelial cells.  4-Methylumbelliferyl α-mannoside was 540-1000 times more effective in inhibiting yeast agglutination by 4 addnl. strains of mannose-specific E. coli.  It was also more efficient than Me α-mannoside in removing adherent E. coli O128 from ileal epithelial cells.  The results provide further evidence that type 1 fimbriae of E. coli possess a hydrophobic region next to the mannose-binding site.  The results suggest that 4-methyllumbelliferyl α-mannoside and p-nitro-o-chlorophenyl α-mannoside are good candidates for the design of therapeutic agents that may prevent adherence in vivo and infection by E. coli strains that express type 1 fimbriae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq04bolSK5gJ7Vg90H21EOLACvtfcHk0lgyGyM6UPA_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtlGitrw%253D&md5=552429e6e5bf2731439a24762a7d30a0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiron%26aufirst%3DN.%26aulast%3DAshkenazi%26aufirst%3DS.%26aulast%3DMirelman%26aufirst%3DD.%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DAromatic%2520alpha-glycosides%2520of%2520mannose%2520are%2520powerful%2520inhibitors%2520of%2520the%2520adherence%2520of%2520type%25201%2520fimbriated%2520Escherichia%2520coli%2520to%2520yeast%2520and%2520intestinal%2520epithelial%2520cells%26jtitle%3DInfect.%2520Immun.%26date%3D1987%26volume%3D55%26spage%3D472%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Firon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Carbohydrate-binding sites of the mannose-specific fimbrial lectins of Enterobacteria</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1128%2FIAI.43.3.1088-1090.1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=6142000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADyaL2cXhtF2itLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1984&pages=1088-1090&author=N.+Fironauthor=I.+Ofekauthor=N.+Sharon&title=Carbohydrate-binding+sites+of+the+mannose-specific+fimbrial+lectins+of+Enterobacteria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria</span></div><div class="casAuthors">Firon, Nurit; Ofek, Itzhak; Sharon, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1088-90</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The combining sites of type 1 fimbrial lectins of various species of enterobacteria were studied by measuring the inhibitory activity of linear and branched oligosaccharides and several glycosides of D-mannose on the agglutination of yeast cells by the organisms.  All 5 strains of Escherichia coli possessed an elongated combining site best fitting a trisaccharide and including a hydrophobic region.  Similar results were obtained with Klebsiella pneumoniae.  Within the Salmonella genus, the combining sites of the 6 species were similar, but all differed from those of the E. coli strains.  The combining sites of Enterobacteer cloacae and Enterobacter agglomerans were different from each other and from those of Salmonella species and E. coli.  Thus, although they are classified under the general term mannose-specific, bacterial lectins in the form of type 1 fimbriae on different genera apparently exhibit differences in sugar specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80HxUnevGcLVg90H21EOLACvtfcHk0lgyGyM6UPA_Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtF2itLw%253D&md5=f3b606bd5040e8eef227b8a47c1952ea</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1128%2FIAI.43.3.1088-1090.1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.43.3.1088-1090.1984%26sid%3Dliteratum%253Aachs%26aulast%3DFiron%26aufirst%3DN.%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DCarbohydrate-binding%2520sites%2520of%2520the%2520mannose-specific%2520fimbrial%2520lectins%2520of%2520Enterobacteria%26jtitle%3DInfect.%2520Immun.%26date%3D1984%26volume%3D43%26spage%3D1088%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Firon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Eshcerichia coli</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1426</span><span class="NLM_x">–</span> <span class="NLM_lpage">1432</span><span class="refDoi"> DOI: 10.1016/0006-291X(82)90947-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2F0006-291X%2882%2990947-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1982&pages=1426-1432&author=N.+Fironauthor=I.+Ofekauthor=N.+Sharon&title=Interaction+of+mannose-containing+oligosaccharides+with+the+fimbrial+lectin+of+Eshcerichia+coli&doi=10.1016%2F0006-291X%2882%2990947-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2882%2990947-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252882%252990947-0%26sid%3Dliteratum%253Aachs%26aulast%3DFiron%26aufirst%3DN.%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DInteraction%2520of%2520mannose-containing%2520oligosaccharides%2520with%2520the%2520fimbrial%2520lectin%2520of%2520Eshcerichia%2520coli%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1982%26volume%3D105%26spage%3D1426%26epage%3D1432%26doi%3D10.1016%2F0006-291X%2882%2990947-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Klein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüthi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezençon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiesko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8627</span><span class="NLM_x">–</span> <span class="NLM_lpage">8641</span><span class="refDoi"> DOI: 10.1021/jm101011y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101011y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8627-8641&author=T.+Kleinauthor=D.+Abgottsponauthor=M.+Wittwerauthor=S.+Rabbaniauthor=J.+Heroldauthor=X.+Jiangauthor=S.+Kleebauthor=C.+L%C3%BCthiauthor=M.+Scharenbergauthor=J.+Bezen%C3%A7onauthor=E.+Gublerauthor=L.+Pangauthor=M.+Smieskoauthor=B.+Cuttingauthor=O.+Schwardtauthor=B.+Ernst&title=FimH+antagonists+for+the+oral+treatment+of+urinary+tract+infections%3A+from+design+and+synthesis+to+in+vitro+and+in+vivo+evaluation&doi=10.1021%2Fjm101011y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">FimH Antagonists for the Oral Treatment of Urinary Tract Infections: From Design and Synthesis to in Vitro and in Vivo Evaluation</span></div><div class="casAuthors">Klein, Tobias; Abgottspon, Daniela; Wittwer, Matthias; Rabbani, Said; Herold, Janno; Jiang, Xiao-Hua; Kleeb, Simon; Luthi, Christine; Scharenberg, Meike; Bezencon, Jacqueline; Gubler, Erich; Pang, Li-Juan; Smiesko, Martin; Cutting, Brian; Schwardt, Oliver; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8627-8641</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urinary tract infection (UTI) by uropathogenic Escherichia coli (UPEC) is one of the most common infections, particularly affecting women.  The interaction of FimH, a lectin located at the tip of bacterial pili, with high mannose structures is crit. for the ability of UPEC to colonize and invade the bladder epithelium.  We describe the synthesis and the in vitro/in vivo evaluation of α-D-mannosides with the ability to block the bacteria/host cell interaction.  According to the pharmacokinetic properties, a prodrug approach for their evaluation in the UTI mouse model was explored.  As a result, an orally available, low mol. wt. FimH antagonist was identified with the potential to reduce the colony forming units (CFU) in the urine by 2 orders of magnitude and in the bladder by 4 orders of magnitude.  With FimH antagonist I, the great potential for the effective treatment of urinary tract infections with a new class of orally available anti-infectives could be demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_u1FpN_VK97Vg90H21EOLACvtfcHk0ljIDbqGzw0m1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7bO&md5=7caa417c8f4235cbbd780558adeab411</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm101011y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101011y%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DHerold%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DL%25C3%25BCthi%26aufirst%3DC.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DBezen%25C3%25A7on%26aufirst%3DJ.%26aulast%3DGubler%26aufirst%3DE.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%2520for%2520the%2520oral%2520treatment%2520of%2520urinary%2520tract%2520infections%253A%2520from%2520design%2520and%2520synthesis%2520to%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8627%26epage%3D8641%26doi%3D10.1021%2Fjm101011y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zihlmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiesko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezencon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2221</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span><span class="refDoi"> DOI: 10.1021/jm501524q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501524q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2221-2239&author=S.+Kleebauthor=L.+Pangauthor=K.+Mayerauthor=D.+Erisauthor=A.+Siglauthor=R.+C.+Prestonauthor=P.+Zihlmannauthor=T.+Sharpeauthor=R.+P.+Jakobauthor=D.+Abgottsponauthor=A.+S.+Hutterauthor=M.+Scharenbergauthor=X.+Jiangauthor=G.+Navarraauthor=S.+Rabbaniauthor=M.+Smieskoauthor=N.+Ludinauthor=J.+Bezenconauthor=O.+Schwardtauthor=T.+Maierauthor=B.+Ernst&title=FimH+antagonists%3A+bioisosteres+to+improve+the+in+vitro+and+in+vivo+PK%2FPD+profile&doi=10.1021%2Fjm501524q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjm501524q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501524q%26sid%3Dliteratum%253Aachs%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DMayer%26aufirst%3DK.%26aulast%3DEris%26aufirst%3DD.%26aulast%3DSigl%26aufirst%3DA.%26aulast%3DPreston%26aufirst%3DR.%2BC.%26aulast%3DZihlmann%26aufirst%3DP.%26aulast%3DSharpe%26aufirst%3DT.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DHutter%26aufirst%3DA.%2BS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DNavarra%26aufirst%3DG.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DLudin%26aufirst%3DN.%26aulast%3DBezencon%26aufirst%3DJ.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%253A%2520bioisosteres%2520to%2520improve%2520the%2520in%2520vitro%2520and%2520in%2520vivo%2520PK%252FPD%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2221%26epage%3D2239%26doi%3D10.1021%2Fjm501524q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sperling, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhorst, T. K.</span><span> </span><span class="NLM_article-title">Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: design, synthesis and binding properties of mannoside ligands</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3913</span><span class="NLM_x">–</span> <span class="NLM_lpage">3922</span><span class="refDoi"> DOI: 10.1039/b610745a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1039%2Fb610745a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=17047870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2hurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=3913-3922&author=O.+Sperlingauthor=A.+Fuchsauthor=T.+K.+Lindhorst&title=Evaluation+of+the+carbohydrate+recognition+domain+of+the+bacterial+adhesin+FimH%3A+design%2C+synthesis+and+binding+properties+of+mannoside+ligands&doi=10.1039%2Fb610745a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands</span></div><div class="casAuthors">Sperling, Oliver; Fuchs, Andreas; Lindhorst, Thisbe K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3913-3922</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Fimbriae are proteinogeneous appendages on the surface of bacteria, which mediate bacterial adhesion to the host cell glycocalyx.  The so-called type 1 fimbriae exhibit specificity for α-d-mannosides and, therefore, they are assumed to mediate bacterial adhesion via the interaction of a fimbrial lectin and α-d-mannosyl residues exposed on the host cell surface.  This carbohydrate-specific adhesive protein subunit of type 1 fimbriae has been identified as a protein called FimH.  The crystal structure of this lectin is known and, based on this information, the mol. details of the interaction of mannoside ligands and FimH are addressed in this paper.  Computer-based docking methods were used to evaluate known ligands as well as to design new ones.  Then, a series of new mannosides with extended aglycon was synthesized and tested as inhibitors of type 1 fimbriae-mediated bacterial adhesion in an ELISA.  The results obtained were compared to the predictions and findings as delivered by mol. modeling.  This study led to an improved understanding of the ligand-receptor interactions under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3PgYI7XkA4LVg90H21EOLACvtfcHk0ljIDbqGzw0m1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2hurfL&md5=4066e179bc6e4a12e1a04eff9ff2cf4b</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1039%2Fb610745a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb610745a%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DO.%26aulast%3DFuchs%26aufirst%3DA.%26aulast%3DLindhorst%26aufirst%3DT.%2BK.%26atitle%3DEvaluation%2520of%2520the%2520carbohydrate%2520recognition%2520domain%2520of%2520the%2520bacterial%2520adhesin%2520FimH%253A%2520design%252C%2520synthesis%2520and%2520binding%2520properties%2520of%2520mannoside%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D3913%26epage%3D3922%26doi%3D10.1039%2Fb610745a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chalopin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez Dorta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caudan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumych, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilyy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deniaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn’s disease</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3913</span><span class="NLM_x">–</span> <span class="NLM_lpage">3925</span><span class="refDoi"> DOI: 10.1039/C6OB00424E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1039%2FC6OB00424E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=27043998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFOhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=3913-3925&author=T.+Chalopinauthor=D.+Alvarez+Dortaauthor=A.+Sivignonauthor=M.+Caudanauthor=T.+I.+Dumychauthor=R.+O.+Bilyyauthor=D.+Deniaudauthor=N.+Barnichauthor=J.+Bouckaertauthor=S.+G.+Gouin&title=Second+generation+of+thiazolylmannosides%2C+FimH+antagonists+for+E.+coli-induced+Crohn%E2%80%99s+disease&doi=10.1039%2FC6OB00424E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease</span></div><div class="casAuthors">Chalopin, T.; Alvarez Dorta, D.; Sivignon, A.; Caudan, M.; Dumych, T. I.; Bilyy, R. O.; Deniaud, D.; Barnich, N.; Bouckaert, J.; Gouin, S. G.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3913-3925</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The anti-adhesive strategy, consisting of disrupting bacterial attachment to the host cells, is widely explored as an alternative to antibiotic therapies.  Recently, thiazolylmannosides (TazMans) have been identified as strong anti-adhesives of E. coli strains implied in the gut inflammation of patients with Crohn's disease.  In this work, we developed a second generation of TazMans with improved chem. stability.  The anomeric nitrogen was substituted by short linkers and the compds. were assessed against the bacterial adhesion FimH and the clin. isolated LF82 E. coli strain in four in vitro assays.  The results obtained on the FimH adhesion alone and the whole bacteria enabled the identification of a candidate for further in vivo evaluations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkKdlFrE3oQ7Vg90H21EOLACvtfcHk0lg3Cbu-kPJqbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFOhtrY%253D&md5=6afd4a3eb9cb6e17c11f007cfb1ff44c</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1039%2FC6OB00424E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB00424E%26sid%3Dliteratum%253Aachs%26aulast%3DChalopin%26aufirst%3DT.%26aulast%3DAlvarez%2BDorta%26aufirst%3DD.%26aulast%3DSivignon%26aufirst%3DA.%26aulast%3DCaudan%26aufirst%3DM.%26aulast%3DDumych%26aufirst%3DT.%2BI.%26aulast%3DBilyy%26aufirst%3DR.%2BO.%26aulast%3DDeniaud%26aufirst%3DD.%26aulast%3DBarnich%26aufirst%3DN.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DSecond%2520generation%2520of%2520thiazolylmannosides%252C%2520FimH%2520antagonists%2520for%2520E.%2520coli-induced%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D3913%26epage%3D3925%26doi%3D10.1039%2FC6OB00424E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Alvarez Dorta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalopin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumych, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilyy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deniaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krammer, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ruyck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensink, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">The Antiadhesive Strategy in Crohn′s Disease: Orally Active Mannosides to Decolonize Pathogenic <i>Escherichia coli</i> from the Gut</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">952</span><span class="refDoi"> DOI: 10.1002/cbic.201600018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcbic.201600018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=936-952&author=D.+Alvarez+Dortaauthor=A.+Sivignonauthor=T.+Chalopinauthor=T.+I.+Dumychauthor=G.+Roosauthor=R.+O.+Bilyyauthor=D.+Deniaudauthor=E.-M.+Krammerauthor=J.+de+Ruyckauthor=M.+F.+Lensinkauthor=J.+Bouckaertauthor=N.+Barnichauthor=S.+G.+Gouin&title=The+Antiadhesive+Strategy+in+Crohn%E2%80%B2s+Disease%3A+Orally+Active+Mannosides+to+Decolonize+Pathogenic+Escherichia+coli+from+the+Gut&doi=10.1002%2Fcbic.201600018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600018%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%2BDorta%26aufirst%3DD.%26aulast%3DSivignon%26aufirst%3DA.%26aulast%3DChalopin%26aufirst%3DT.%26aulast%3DDumych%26aufirst%3DT.%2BI.%26aulast%3DRoos%26aufirst%3DG.%26aulast%3DBilyy%26aufirst%3DR.%2BO.%26aulast%3DDeniaud%26aufirst%3DD.%26aulast%3DKrammer%26aufirst%3DE.-M.%26aulast%3Dde%2BRuyck%26aufirst%3DJ.%26aulast%3DLensink%26aufirst%3DM.%2BF.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DBarnich%26aufirst%3DN.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Antiadhesive%2520Strategy%2520in%2520Crohn%25E2%2580%25B2s%2520Disease%253A%2520Orally%2520Active%2520Mannosides%2520to%2520Decolonize%2520Pathogenic%2520Escherichia%2520coli%2520from%2520the%2520Gut%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D936%26epage%3D952%26doi%3D10.1002%2Fcbic.201600018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Brument, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumych, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerardel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalopin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deniaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilyy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darfeuille-Michaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">Thiazolylaminomannosides as potent antiadhesives of type 1 piliated <i>Escherichia coli</i> isolated from Crohn’s disease patients</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5395</span><span class="NLM_x">–</span> <span class="NLM_lpage">5406</span><span class="refDoi"> DOI: 10.1021/jm400723n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400723n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFKju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5395-5406&author=S.+Brumentauthor=A.+Sivignonauthor=T.+I.+Dumychauthor=N.+Moreauauthor=G.+Roosauthor=Y.+Guerardelauthor=T.+Chalopinauthor=D.+Deniaudauthor=R.+O.+Bilyyauthor=A.+Darfeuille-Michaudauthor=J.+Bouckaertauthor=S.+G.+Gouin&title=Thiazolylaminomannosides+as+potent+antiadhesives+of+type+1+piliated+Escherichia+coli+isolated+from+Crohn%E2%80%99s+disease+patients&doi=10.1021%2Fjm400723n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23eR"><div class="casContent"><span class="casTitleNuber">23e</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolylaminomannosides As Potent Antiadhesives of Type 1 Piliated Escherichia coli Isolated from Crohn's Disease Patients</span></div><div class="casAuthors">Brument, Sami; Sivignon, Adeline; Dumych, Tetiana I.; Moreau, Nicolas; Roos, Goedele; Guerardel, Yann; Chalopin, Thibaut; Deniaud, David; Bilyy, Rostyslav O.; Darfeuille-Michaud, Arlette; Bouckaert, Julie; Gouin, Sebastien G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5395-5406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adherent-invasive Escherichia coli (AIEC) have previously been shown to induce gut inflammation in patients with Crohn's disease (CD).  We developed a set of mannosides to prevent AIEC attachment to the gut by blocking the FimH bacterial adhesin.  The crystal structure of the FimH lectin domain in complex with a lead thiazolylaminomannoside highlighted the preferential position for pharmacomodulations.  A small library of analogs showing nanomolar affinity for FimH was then developed.  Notably, AIEC attachment to intestinal cells was efficiently prevented by the most active compd. and at around 10000-fold and 100-fold lower concns. than mannose and the potent FimH inhibitor heptylmannoside, resp.  An ex vivo assay performed on the colonic tissue of a transgenic mouse model of CD confirmed this antiadhesive potential.  Given the key role of AIEC in the chronic intestinal inflammation of CD patients, these results suggest a potential antiadhesive treatment with the FimH inhibitors developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquOL1t8Q_PF7Vg90H21EOLACvtfcHk0lg3Cbu-kPJqbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFKju7w%253D&md5=659bfc5d2a53ba328a48d7298af8cf72</span></div><a href="/servlet/linkout?suffix=cit23e&amp;dbid=16384&amp;doi=10.1021%2Fjm400723n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400723n%26sid%3Dliteratum%253Aachs%26aulast%3DBrument%26aufirst%3DS.%26aulast%3DSivignon%26aufirst%3DA.%26aulast%3DDumych%26aufirst%3DT.%2BI.%26aulast%3DMoreau%26aufirst%3DN.%26aulast%3DRoos%26aufirst%3DG.%26aulast%3DGuerardel%26aufirst%3DY.%26aulast%3DChalopin%26aufirst%3DT.%26aulast%3DDeniaud%26aufirst%3DD.%26aulast%3DBilyy%26aufirst%3DR.%2BO.%26aulast%3DDarfeuille-Michaud%26aufirst%3DA.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DThiazolylaminomannosides%2520as%2520potent%2520antiadhesives%2520of%2520type%25201%2520piliated%2520Escherichia%2520coli%2520isolated%2520from%2520Crohn%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5395%26epage%3D5406%26doi%3D10.1021%2Fjm400723n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH antagonists: structure-activity and structure-property relationships for biphenyl alpha-D-mannopyranosides</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1404</span><span class="NLM_x">–</span> <span class="NLM_lpage">1422</span><span class="refDoi"> DOI: 10.1002/cmdc.201200125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.201200125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1404-1422&author=L.+Pangauthor=S.+Kleebauthor=K.+Lemmeauthor=S.+Rabbaniauthor=M.+Scharenbergauthor=A.+Zalewskiauthor=F.+Schadlerauthor=O.+Schwardtauthor=B.+Ernst&title=FimH+antagonists%3A+structure-activity+and+structure-property+relationships+for+biphenyl+alpha-D-mannopyranosides&doi=10.1002%2Fcmdc.201200125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23f&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200125%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DL.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DLemme%26aufirst%3DK.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DZalewski%26aufirst%3DA.%26aulast%3DSchadler%26aufirst%3DF.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%253A%2520structure-activity%2520and%2520structure-property%2520relationships%2520for%2520biphenyl%2520alpha-D-mannopyranosides%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1404%26epage%3D1422%26doi%3D10.1002%2Fcmdc.201200125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">Antiadhesion therapy for urinary tract infections—A balanced PK/PD profile proved to be key for success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4700</span><span class="NLM_x">–</span> <span class="NLM_lpage">4713</span><span class="refDoi"> DOI: 10.1021/jm300192x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300192x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4700-4713&author=X.+Jiangauthor=D.+Abgottsponauthor=S.+Kleebauthor=S.+Rabbaniauthor=M.+Scharenbergauthor=M.+Wittwerauthor=M.+Haugauthor=O.+Schwardtauthor=B.+Ernst&title=Antiadhesion+therapy+for+urinary+tract+infections%E2%80%94A+balanced+PK%2FPD+profile+proved+to+be+key+for+success&doi=10.1021%2Fjm300192x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23g&amp;dbid=16384&amp;doi=10.1021%2Fjm300192x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300192x%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DHaug%26aufirst%3DM.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DAntiadhesion%2520therapy%2520for%2520urinary%2520tract%2520infections%25E2%2580%2594A%2520balanced%2520PK%252FPD%2520profile%2520proved%2520to%2520be%2520key%2520for%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4700%26epage%3D4713%26doi%3D10.1021%2Fjm300192x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caveliers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahoutte, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovensky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">Heptyl alpha-D-mannosides grafted on a beta-cyclodextrin core to interfere with <i>Escherichia coli</i> adhesion: an in vivo multivalent effect</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7847</span><span class="NLM_x">–</span> <span class="NLM_lpage">7855</span><span class="refDoi"> DOI: 10.1002/chem.201204015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fchem.201204015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=23595913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvFaju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=7847-7855&author=J.+Bouckaertauthor=Z.+Liauthor=C.+Xavierauthor=M.+Almantauthor=V.+Caveliersauthor=T.+Lahoutteauthor=S.+D.+Weeksauthor=J.+Kovenskyauthor=S.+G.+Gouin&title=Heptyl+alpha-D-mannosides+grafted+on+a+beta-cyclodextrin+core+to+interfere+with+Escherichia+coli+adhesion%3A+an+in+vivo+multivalent+effect&doi=10.1002%2Fchem.201204015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Heptyl α-D-Mannosides Grafted on a β-Cyclodextrin Core to Interfere with Escherichia coli Adhesion: An In Vivo Multivalent Effect</span></div><div class="casAuthors">Bouckaert, Julie; Li, Zhaoli; Xavier, Catarina; Almant, Mehdi; Caveliers, Vicky; Lahoutte, Tony; Weeks, Stephen D.; Kovensky, Jose; Gouin, Sebastien G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7847-7855</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Heptyl α-D-mannoside (HM) has previously been identified as a nano-molar FimH antagonist able to prevent Escherichia coli adhesion.  We have designed mono- and heptavalent glycoconjugates in which HM is tethered to β-cyclodextrin (β-CD) through short and long spacers.  One-pot click or co-clicking procedures were developed to directly obtain the glycoconjugates from unprotected HM and β-CD precursors.  These FimH antagonists were examd. biophys. and in vivo.  Reverse titrns. by isothermal calorimetry led to trapping of the short-tethered heptavalent β-CD in a complex with three FimH lectins.  Combined dynamic light scattering and small-angle X-ray soln. scattering data allowed the construction of a model of the FimH trimer.  The heptavalent β-CDs were shown to capture and aggregate living bacteria in soln. and are therefore also able to aggregate FimH when attached to different bacteria pili.  The first in vivo evaluation of multivalent FimH inhibitors has been performed.  The heptavalent β-CDs proved to be much more effective anti-adhesive agents than monovalent refs. with doses of around 2 μg instilled in the mouse bladder leading to a significantly decreased E. coli load.  I.v. injected radiolabeled glycoconjugates can rapidly reach the mouse bladder and > 2 μg concns. can easily be retained over 24 h to prevent fluxing bacteria from re-binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowPgL08GrccLVg90H21EOLACvtfcHk0liHiSX6Bfaxqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvFaju74%253D&md5=b0e67e2b8bd45d0a73bcfa69296c3f9b</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201204015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201204015%26sid%3Dliteratum%253Aachs%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXavier%26aufirst%3DC.%26aulast%3DAlmant%26aufirst%3DM.%26aulast%3DCaveliers%26aufirst%3DV.%26aulast%3DLahoutte%26aufirst%3DT.%26aulast%3DWeeks%26aufirst%3DS.%2BD.%26aulast%3DKovensky%26aufirst%3DJ.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DHeptyl%2520alpha-D-mannosides%2520grafted%2520on%2520a%2520beta-cyclodextrin%2520core%2520to%2520interfere%2520with%2520Escherichia%2520coli%2520adhesion%253A%2520an%2520in%2520vivo%2520multivalent%2520effect%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2013%26volume%3D19%26spage%3D7847%26epage%3D7855%26doi%3D10.1002%2Fchem.201204015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gouin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovensky, J.</span><span> </span><span class="NLM_article-title">Synthetic Multimeric Heptyl Mannosides as Potent Antiadhesives of Uropathogenic <i>Escherichia coli</i></span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.1002/cmdc.200900034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.200900034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Kgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=749-755&author=S.+G.+Gouinauthor=A.+Wellensauthor=J.+Bouckaertauthor=J.+Kovensky&title=Synthetic+Multimeric+Heptyl+Mannosides+as+Potent+Antiadhesives+of+Uropathogenic+Escherichia+coli&doi=10.1002%2Fcmdc.200900034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Multimeric Heptyl Mannosides as Potent Antiadhesives of Uropathogenic Escherichia coli</span></div><div class="casAuthors">Gouin, Sebastien G.; Wellens, Adinda; Bouckaert, Julie; Kovensky, Jose</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sweet medicine: Multimeric glycoconjugates with valencies ranging from one to four were synthesized by click chem.  Unprecedented adhesion inhibitions of piliated E. coli to human bladder cells were recorded with the multimers; a tetravalent deriv. showed inhibitory concns. 6000- and 64-fold lower than mannose and heptyl α-D-mannoside, resp.  Urinary tract infections caused by uropathogenic Escherichia coli presents a serious communal and nosocomial health problem initiated by bacterial adhesion to the bladder cells.  E. coli expresses fimbriae with a mannose-binding adhesin, FimH, at the tip.  Heptyl α-D-mannoside (HM) is a nanomolar inhibitor of this lectin, preventing adhesion of type 1-piliated E. coli and reducing bacteria levels in a murine cystitis model.  Herein, we described the synthesis of multimeric heptyl-mannosides with valencies ranging from one to four by copper-catalyzed azide alkyne cycloaddn. (CuAAC).  Biol. evaluation of the multivalent compds. revealed an increase in potency compared to HM.  Inhibition of bladder cell binding highlighted a promising tetravalent deriv. with inhibitory concns. 6000- and 64-fold lower than mannose and HM resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqshcLleD-6LVg90H21EOLACvtfcHk0liHiSX6Bfaxqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Kgsbc%253D&md5=b2b4bcd93a34ac9fae0baca586924117</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900034%26sid%3Dliteratum%253Aachs%26aulast%3DGouin%26aufirst%3DS.%2BG.%26aulast%3DWellens%26aufirst%3DA.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DKovensky%26aufirst%3DJ.%26atitle%3DSynthetic%2520Multimeric%2520Heptyl%2520Mannosides%2520as%2520Potent%2520Antiadhesives%2520of%2520Uropathogenic%2520Escherichia%2520coli%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D749%26epage%3D755%26doi%3D10.1002%2Fcmdc.200900034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Touaibia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R.</span><span> </span><span class="NLM_article-title">Mannosylated G(0) dendrimers with nanomolar affinities to <i>Escherichia coli</i> FimH</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1190</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span><span class="refDoi"> DOI: 10.1002/cmdc.200700063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.200700063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=17589887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1190-1201&author=M.+Touaibiaauthor=A.+Wellensauthor=T.+C.+Shiaoauthor=Q.+Wangauthor=S.+Siroisauthor=J.+Bouckaertauthor=R.+Roy&title=Mannosylated+G%280%29+dendrimers+with+nanomolar+affinities+to+Escherichia+coli+FimH&doi=10.1002%2Fcmdc.200700063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Mannosylated G(0) dendrimers with nano-molar affinities to Escherichia coli FimH</span></div><div class="casAuthors">Touaibia, Mohamed; Wellens, Adinda; Shiao, Tze Chieh; Wang, Qingan; Sirois, Suzanne; Bouckaert, Julie; Roy, Rene</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1190-1201</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Penta-erythritol and bis-penta-erythritol scaffolds were used for the prepn. of first generation glycodendrimers bearing aryl α-D-mannopyranoside residues assembled using single-step Sonogashira and click chem.  The carbohydrate precursors were built with either para-iodo-Ph, propargyl, or 2-azido-Et aglycons whereas the penta-erythritol moieties were built with terminal azide or propargyl groups, resp.  Crosslinking abilities of this series of glycodendrimers were first evaluated with the lectin from Canavalia ensiformis (Con A).  Surface plasmon resonance measurements showed these two families of mannosylated clusters as the best ligands known to date toward Escherichia coli K12 FimH with sub-nano-molar affinities (Kd of 0.45 nM).  These clusters were 1000 times more potent than mannose for their capacity to inhibit the binding of E. coli to erythrocytes in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf9VwIPJknlbVg90H21EOLACvtfcHk0lhYh93eVUXzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemt74%253D&md5=47bb60eb63194ed2aeccf387a6725ae8</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700063%26sid%3Dliteratum%253Aachs%26aulast%3DTouaibia%26aufirst%3DM.%26aulast%3DWellens%26aufirst%3DA.%26aulast%3DShiao%26aufirst%3DT.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSirois%26aufirst%3DS.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DRoy%26aufirst%3DR.%26atitle%3DMannosylated%2520G%25280%2529%2520dendrimers%2520with%2520nanomolar%2520affinities%2520to%2520Escherichia%2520coli%2520FimH%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1190%26epage%3D1201%26doi%3D10.1002%2Fcmdc.200700063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lindhorst, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krallmann-Wenzel, U.</span><span> </span><span class="NLM_article-title">Inhibition of the type 1 fimbriae-mediated adhesion of <i>Escherichia coli</i> to erythrocytes by multiantennary alpha-mannosyl clusters: the effect of multivalency</span> <span class="citation_source-journal">Glycoconjugate J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span><span class="refDoi"> DOI: 10.1023/A:1006920027641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1023%2FA%3A1006920027641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=9881767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=605-613&author=T.+K.+Lindhorstauthor=C.+Kieburgauthor=U.+Krallmann-Wenzel&title=Inhibition+of+the+type+1+fimbriae-mediated+adhesion+of+Escherichia+coli+to+erythrocytes+by+multiantennary+alpha-mannosyl+clusters%3A+the+effect+of+multivalency&doi=10.1023%2FA%3A1006920027641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24dR"><div class="casContent"><span class="casTitleNuber">24d</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the type 1 fimbriae-mediated adhesion of Escherichia coli to erythrocytes by multiantennary α-mannosyl clusters: the effect of multivalency</span></div><div class="casAuthors">Lindhorst, Thisbe K.; Kieburg, Christoffer; Krallmann-Wenzel, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">605-613</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">α-Mannosyl glycoclusters and glycodendrimers were tested as multivalent inhibitors of the type 1 (mannose-specific) fimbriae of a recombinant E. coli HB101 strain.  Inhibition of hemagglutination of guinea pig erythrocytes was detd. on microtiter plates.  The effect of multivalency is pronounced for up to three mannosyl residues in the mol., whereas larger derivs. do not have an appreciable effect on binding to the fimbrial carbohydrate binding domain.  The best glycoclusters tested reach the binding potency of the known potent inhibitor pNPMan (I).  The results support the idea of a monovalent recognition site at the adhesive protein FimH, which might best accommodate mols. with the size of a trisaccharide or those which expose up to three α-mannosyl residues, such as the glycocluster II.  The results obtained with the thiourea-bridged α-mannosyl clusters, possessing defined sugar valences, facilitate the development of high affinity inhibitors of the fimbrial lectin on type 1 fimbriae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGN8vdfHZ1JLVg90H21EOLACvtfcHk0lhYh93eVUXzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGku7w%253D&md5=03580f8b56f4c8c9d43e3a7e7dcc9b32</span></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006920027641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006920027641%26sid%3Dliteratum%253Aachs%26aulast%3DLindhorst%26aufirst%3DT.%2BK.%26aulast%3DKieburg%26aufirst%3DC.%26aulast%3DKrallmann-Wenzel%26aufirst%3DU.%26atitle%3DInhibition%2520of%2520the%2520type%25201%2520fimbriae-mediated%2520adhesion%2520of%2520Escherichia%2520coli%2520to%2520erythrocytes%2520by%2520multiantennary%2520alpha-mannosyl%2520clusters%253A%2520the%2520effect%2520of%2520multivalency%26jtitle%3DGlycoconjugate%2520J.%26date%3D1998%26volume%3D15%26spage%3D605%26epage%3D613%26doi%3D10.1023%2FA%3A1006920027641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Jarvis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mydock-McGrane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1002/cmdc.201600006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.201600006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=367-373&author=C.+Jarvisauthor=Z.+Hanauthor=V.+Kalasauthor=R.+Kleinauthor=J.+S.+Pinknerauthor=B.+Fordauthor=J.+Binkleyauthor=C.+K.+Cusumanoauthor=Z.+Cusumanoauthor=L.+Mydock-McGraneauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Antivirulence+Isoquinolone+Mannosides%3A+Optimization+of+the+Biaryl+Aglycone+for+FimH+Lectin+Binding+Affinity+and+Efficacy+in+the+Treatment+of+Chronic+UTI&doi=10.1002%2Fcmdc.201600006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600006%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DJ.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DAntivirulence%2520Isoquinolone%2520Mannosides%253A%2520Optimization%2520of%2520the%2520Biaryl%2520Aglycone%2520for%2520FimH%2520Lectin%2520Binding%2520Affinity%2520and%2520Efficacy%2520in%2520the%2520Treatment%2520of%2520Chronic%2520UTI%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D367%26epage%3D373%26doi%3D10.1002%2Fcmdc.201600006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Vicente, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Barbero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiara, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicent, C.</span><span> </span><span class="NLM_article-title">Hydrogen-bonding cooperativity: using an intramolecular hydrogen bond to design a carbohydrate derivative with a cooperative hydrogen-bond donor centre</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4240</span><span class="NLM_x">–</span> <span class="NLM_lpage">4251</span><span class="refDoi"> DOI: 10.1002/chem.200400042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fchem.200400042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=15352107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4240-4251&author=V.+Vicenteauthor=J.+Martinauthor=J.+Jimenez-Barberoauthor=J.+L.+Chiaraauthor=C.+Vicent&title=Hydrogen-bonding+cooperativity%3A+using+an+intramolecular+hydrogen+bond+to+design+a+carbohydrate+derivative+with+a+cooperative+hydrogen-bond+donor+centre&doi=10.1002%2Fchem.200400042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen-bonding cooperativity: Using an intramolecular hydrogen bond to design a carbohydrate derivative with a cooperative hydrogen-bond donor center</span></div><div class="casAuthors">Vicente, Virginie; Martin, Jason; Jimenez-Barbero, Jesus; Chiara, Jose Luis; Vicent, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry--A European Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4240-4251</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Neighboring groups can be strategically located to polarize HO···OH intramol. hydrogen bonds in an intended direction.  A group with a unique hydrogen-bond donor or acceptor character, located at hydrogen-bonding distance to a particular OH group, has been used to initiate the hydrogen-bond network and to polarize a HO···OH hydrogen bond in a predicted direction.  This enhanced the donor character of a particular OH group and made it a cooperative hydrogen-bond center.  We have proved that a five-membered-ring intramol. hydrogen bond established between an amide NH group and a hydroxy group, which is addnl. located in a 1,3-cis-diaxial relationship to a second hydroxy group, can be used to select a unique direction on the six-membered-ring intramol. hydrogen bond between the two axial OH groups, so that one of them behaves as an efficient cooperative donor.  The mannopyranoside derivs. (I) and (II) were used as models to demonstrate the presence in soln. of the 1,2-(e,a)/five-membered-ring intramol. hydrogen bond., where as the talose deriv. (III) was designed and synthesized to prove this hydrogen-bonding network by NMR spectroscopy.  Once a well-defined hydrogen-bond is formed between the OH and the amido groups of a pyranose ring, these hydrogen-bonding groups no longer act as independent hydrogen-bonding centers, but as hydrogen-bonding arrays.  This introduces a new perspective on the properties of carbohydrate OH groups and it is important for the de novo design of mol. recognition processes, at least in nonpolar media.  Carbohydrates I-III have shown to be efficient phosphate binders in nonpolar solvents owing to the presence of cooperative hydroxy centers in the mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtL1qtqYYSUrVg90H21EOLACvtfcHk0lhYh93eVUXzMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCkurk%253D&md5=1b2eb3abf6c7937ce85573ff8f7591e4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fchem.200400042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200400042%26sid%3Dliteratum%253Aachs%26aulast%3DVicente%26aufirst%3DV.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DJimenez-Barbero%26aufirst%3DJ.%26aulast%3DChiara%26aufirst%3DJ.%2BL.%26aulast%3DVicent%26aufirst%3DC.%26atitle%3DHydrogen-bonding%2520cooperativity%253A%2520using%2520an%2520intramolecular%2520hydrogen%2520bond%2520to%2520design%2520a%2520carbohydrate%2520derivative%2520with%2520a%2520cooperative%2520hydrogen-bond%2520donor%2520centre%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2004%26volume%3D10%26spage%3D4240%26epage%3D4251%26doi%3D10.1002%2Fchem.200400042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Janetka, J. W.; Han, Z.; Hultgren, S.; Pinkner, J. S.; Cusumano, C. K.</span><span> </span><span class="NLM_article-title">Compounds and methods for treating bacterial infections</span>. WO/2011/050323,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+W.+Janetka&author=Z.+Han&author=S.+Hultgren&author=J.+S.+Pinkner&author=C.+K.+Cusumano&title=Compounds+and+methods+for+treating+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DCompounds%2520and%2520methods%2520for%2520treating%2520bacterial%2520infections%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiesko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6454</span><span class="NLM_x">–</span> <span class="NLM_lpage">6473</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.08.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.bmc.2011.08.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21962988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlejsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6454-6473&author=O.+Schwardtauthor=S.+Rabbaniauthor=M.+Hartmannauthor=D.+Abgottsponauthor=M.+Wittwerauthor=S.+Kleebauthor=A.+Zalewskiauthor=M.+Smieskoauthor=B.+Cuttingauthor=B.+Ernst&title=Design%2C+synthesis+and+biological+evaluation+of+mannosyl+triazoles+as+FimH+antagonists&doi=10.1016%2Fj.bmc.2011.08.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists</span></div><div class="casAuthors">Schwardt, Oliver; Rabbani, Said; Hartmann, Margrit; Abgottspon, Daniela; Wittwer, Matthias; Kleeb, Simon; Zalewski, Adam; Smiesko, Martin; Cutting, Brian; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6454-6473</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Urinary tract infection (UTI) caused by uropathogenic Escherichia coli (UPEC) is one of the most prevalent infectious diseases.  Particularly affected are women, who have a 40-50% risk to experience at least one symptomatic UTI episode at some time during their life.  In the initial step of the infection, the lectin FimH, located at the tip of bacterial pili, interacts with the high-mannosylated uroplakin Ia glycoprotein on the urinary bladder mucosa.  This interaction is crit. for the ability of UPEC to colonize and invade the bladder epithelium.  X-ray structures of FimH co-crystd. with two different ligands, the physiol. binding epitope oligomannose-3 and the antagonist biphenyl α-D-mannoside I revealed different binding modes, an in-docking-mode and an out-docking-mode, resp.  To accomplish the in-docking-mode, that is the docking mode where the ligand is hosted by the so-called tyrosine gate, FimH antagonists with increased flexibility were designed and synthesized.  All mannoside derivs., e.g. II, showed nanomolar affinities, but only one representative, the 4-pyridiyl deriv. II, was as potent as the ref. compd. n-heptyl α-D-mannoside.  Furthermore, a loss of affinity was obsd. for C-glycosides and derivs. where the triazole aglycon is directly N-linked to the anomeric center.  A conformational anal. by NMR revealed that the triazolyl-methyl-C-mannosides adopt an unusual 1C4 chair conformation, explaining the comparably lower affinity of these compds.  Furthermore, to address the drug-likeness of this new class of FimH antagonists, selected pharmacokinetics parameters, which are crit. for oral bioavailability (lipophilicity, soly., and membrane permeation), were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYsFPRTmZcebVg90H21EOLACvtfcHk0ljIo1egoveFDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlejsLvM&md5=1b71d66a480861e4add04a19ddb9cc59</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.08.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.08.057%26sid%3Dliteratum%253Aachs%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DZalewski%26aufirst%3DA.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520mannosyl%2520triazoles%2520as%2520FimH%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6454%26epage%3D6473%26doi%3D10.1016%2Fj.bmc.2011.08.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Myers, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. C.</span><span> </span><span class="NLM_article-title">Improved preparations of some per-O-acetylated aldohexopyranosyl cyanides</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1016/S0008-6215(00)90029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0008-6215%2800%2990029-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1986&pages=145-163&author=R.+W.+Myersauthor=Y.+C.+Lee&title=Improved+preparations+of+some+per-O-acetylated+aldohexopyranosyl+cyanides&doi=10.1016%2FS0008-6215%2800%2990029-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2800%2990029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252800%252990029-6%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BC.%26atitle%3DImproved%2520preparations%2520of%2520some%2520per-O-acetylated%2520aldohexopyranosyl%2520cyanides%26jtitle%3DCarbohydr.%2520Res.%26date%3D1986%26volume%3D154%26spage%3D145%26epage%3D163%26doi%3D10.1016%2FS0008-6215%2800%2990029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Maity, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Mannose Analogs as Inhibitors of Alpha-Mannosidase</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6965</span><span class="NLM_x">–</span> <span class="NLM_lpage">6974</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)81349-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0040-4020%2801%2981349-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=6965-6974&author=S.+K.+Maityauthor=S.+K.+Duttaauthor=A.+K.+Banerjeeauthor=B.+Achariauthor=M.+Singh&title=Design+and+Synthesis+of+Mannose+Analogs+as+Inhibitors+of+Alpha-Mannosidase&doi=10.1016%2FS0040-4020%2801%2981349-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2981349-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252981349-1%26sid%3Dliteratum%253Aachs%26aulast%3DMaity%26aufirst%3DS.%2BK.%26aulast%3DDutta%26aufirst%3DS.%2BK.%26aulast%3DBanerjee%26aufirst%3DA.%2BK.%26aulast%3DAchari%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Mannose%2520Analogs%2520as%2520Inhibitors%2520of%2520Alpha-Mannosidase%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D6965%26epage%3D6974%26doi%3D10.1016%2FS0040-4020%2801%2981349-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezencon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamberger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH Antagonists: Phosphate Prodrugs Improve Oral Bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3163</span><span class="NLM_x">–</span> <span class="NLM_lpage">3182</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01923</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3163-3182&author=S.+Kleebauthor=X.+Jiangauthor=P.+Freiauthor=A.+Siglauthor=J.+Bezenconauthor=K.+Bambergerauthor=O.+Schwardtauthor=B.+Ernst&title=FimH+Antagonists%3A+Phosphate+Prodrugs+Improve+Oral+Bioavailability&doi=10.1021%2Facs.jmedchem.5b01923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01923%26sid%3Dliteratum%253Aachs%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DFrei%26aufirst%3DP.%26aulast%3DSigl%26aufirst%3DA.%26aulast%3DBezencon%26aufirst%3DJ.%26aulast%3DBamberger%26aufirst%3DK.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520Antagonists%253A%2520Phosphate%2520Prodrugs%2520Improve%2520Oral%2520Bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3163%26epage%3D3182%26doi%3D10.1021%2Facs.jmedchem.5b01923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Janetka, J. W.; Han, Z.; Hultgren, S.; Pinkner, J. S.; Cusumano, C. K.</span><span> </span><span class="NLM_article-title">Compounds and methods for treating bacterial infections</span>. WO/2014/194270,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+W.+Janetka&author=Z.+Han&author=S.+Hultgren&author=J.+S.+Pinkner&author=C.+K.+Cusumano&title=Compounds+and+methods+for+treating+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DCompounds%2520and%2520methods%2520for%2520treating%2520bacterial%2520infections%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Fiege, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zihlmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">The tyrosine gate of the bacterial lectin FimH: a conformational analysis by NMR spectroscopy and X-ray crystallography</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1002/cbic.201402714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcbic.201402714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=25940742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1235-1246&author=B.+Fiegeauthor=S.+Rabbaniauthor=R.+C.+Prestonauthor=R.+P.+Jakobauthor=P.+Zihlmannauthor=O.+Schwardtauthor=X.+Jiangauthor=T.+Maierauthor=B.+Ernst&title=The+tyrosine+gate+of+the+bacterial+lectin+FimH%3A+a+conformational+analysis+by+NMR+spectroscopy+and+X-ray+crystallography&doi=10.1002%2Fcbic.201402714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Tyrosine Gate of the Bacterial Lectin FimH: A Conformational Analysis by NMR Spectroscopy and X-ray Crystallography</span></div><div class="casAuthors">Fiege, Brigitte; Rabbani, Said; Preston, Roland C.; Jakob, Roman P.; Zihlmann, Pascal; Schwardt, Oliver; Jiang, Xiaohua; Maier, Timm; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1235-1246</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Urinary tract infections caused by uropathogenic E. coli are among the most prevalent infectious diseases.  The mannose-specific lectin FimH mediates the adhesion of the bacteria to the urothelium, thus enabling host cell invasion and recurrent infections.  An attractive alternative to antibiotic treatment is the development of FimH antagonists that mimic the physiol. ligand.  A large variety of candidate drugs have been developed and characterized by means of in vitro studies and animal models.  Here we present the X-ray co-crystal structures of FimH with members of four antagonist classes.  In three of these cases no structural data had previously been available.  We used NMR spectroscopy to characterize FimH-antagonist interactions further by chem. shift perturbation.  The anal. allowed a clear detn. of the conformation of the tyrosine gate motif that is crucial for the interaction with aglycon moieties and was not obvious from X-ray structural data alone.  Finally, ITC expts. provided insight into the thermodn. of antagonist binding.  In conjunction with the structural information from X-ray and NMR expts. the results provide a mechanism for the often-obsd. enthalpy-entropy compensation of FimH antagonists that plays a role in fine-tuning of the interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ZlLJ0nu7AbVg90H21EOLACvtfcHk0li5xEQUnPOtkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOitrs%253D&md5=a92e50330b554009a72fee92fd573dd0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402714%26sid%3Dliteratum%253Aachs%26aulast%3DFiege%26aufirst%3DB.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DPreston%26aufirst%3DR.%2BC.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DZihlmann%26aufirst%3DP.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DThe%2520tyrosine%2520gate%2520of%2520the%2520bacterial%2520lectin%2520FimH%253A%2520a%2520conformational%2520analysis%2520by%2520NMR%2520spectroscopy%2520and%2520X-ray%2520crystallography%26jtitle%3DChemBioChem%26date%3D2015%26volume%3D16%26spage%3D1235%26epage%3D1246%26doi%3D10.1002%2Fcbic.201402714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">de Ruyck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensink, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span> </span><span class="NLM_article-title">Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin</span> <span class="citation_source-journal">IUCrJ</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1107/S2052252516002487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1107%2FS2052252516002487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=27158502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28Xntlyhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=163-167&author=J.+de+Ruyckauthor=M.+F.+Lensinkauthor=J.+Bouckaert&title=Structures+of+C-mannosylated+anti-adhesives+bound+to+the+type+1+fimbrial+FimH+adhesin&doi=10.1107%2FS2052252516002487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin</span></div><div class="casAuthors">de Ruyck, Jerome; Lensink, Marc F.; Bouckaert, Julie</div><div class="citationInfo"><span class="NLM_cas:title">IUCrJ</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">163-167</span>CODEN:
                <span class="NLM_cas:coden">IUCRAJ</span>;
        ISSN:<span class="NLM_cas:issn">2052-2525</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Selective inhibitors of the type 1 fimbrial adhesin FimH are recognized as attractive alternatives for antibiotic therapies and prophylaxes against Escherichia coli infections such as urinary-tract infections.  To construct these inhibitors, the α-D-mannopyranoside of high-mannose N-glycans, recognized with exclusive specificity on glycoprotein receptors by FimH, forms the basal structure.  A hydrophobic aglycon is then linked to the mannose by the O1 oxygen inherently present in the α-anomeric configuration.  Substitution of this O atom by a carbon introduces a C-glycosidic bond, which may enhance the therapeutic potential of such compds. owing to the inability of enzymes to degrade C-glycosidic bonds.  Here, the first crystal structures of the E. coli FimH adhesin in complex with C-glycosidically linked mannopyranosides are presented.  These findings explain the role of the spacer in positioning biphenyl ligands for interactions by means of arom. stacking in the tyrosine gate of FimH and how the normally hydrated C-glycosidic link is tolerated.  As these new compds. can bind FimH, it can be assumed that they have the potential to serve as potent new antagonists of FimH, paving the way for the design of a new family of anti-adhesive compds. against urinary-tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3oBGrQGwKLVg90H21EOLACvtfcHk0li5xEQUnPOtkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xntlyhtrs%253D&md5=514c8b09a5674f62eec9b580650dfb81</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS2052252516002487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052252516002487%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRuyck%26aufirst%3DJ.%26aulast%3DLensink%26aufirst%3DM.%2BF.%26aulast%3DBouckaert%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520C-mannosylated%2520anti-adhesives%2520bound%2520to%2520the%2520type%25201%2520fimbrial%2520FimH%2520adhesin%26jtitle%3DIUCrJ%26date%3D2016%26volume%3D3%26spage%3D163%26epage%3D167%26doi%3D10.1107%2FS2052252516002487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Tiwari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, A. K.</span><span> </span><span class="NLM_article-title">Cyclodextrins in delivery systems: Applications</span> <span class="citation_source-journal">J. Pharm. BioAllied Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.4103/0975-7406.67003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.4103%2F0975-7406.67003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=72-79&author=G.+Tiwariauthor=R.+Tiwariauthor=A.+K.+Rai&title=Cyclodextrins+in+delivery+systems%3A+Applications&doi=10.4103%2F0975-7406.67003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4103%2F0975-7406.67003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0975-7406.67003%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DG.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DRai%26aufirst%3DA.%2BK.%26atitle%3DCyclodextrins%2520in%2520delivery%2520systems%253A%2520Applications%26jtitle%3DJ.%2520Pharm.%2520BioAllied%2520Sci.%26date%3D2010%26volume%3D2%26spage%3D72%26epage%3D79%26doi%3D10.4103%2F0975-7406.67003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Elisia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cederberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cait, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adomat, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guns, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNagny, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samudio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, G.</span><span> </span><span class="NLM_article-title">DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0152538</span><span class="refDoi"> DOI: 10.1371/journal.pone.0152538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.pone.0152538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0152538&author=I.+Elisiaauthor=H.+Nakamuraauthor=V.+Lamauthor=E.+Hofsauthor=R.+Cederbergauthor=J.+Caitauthor=M.+R.+Hughesauthor=L.+Leeauthor=W.+Jiaauthor=H.+H.+Adomatauthor=E.+S.+Gunsauthor=K.+M.+McNagnyauthor=I.+Samudioauthor=G.+Krystal&title=DMSO+Represses+Inflammatory+Cytokine+Production+from+Human+Blood+Cells+and+Reduces+Autoimmune+Arthritis&doi=10.1371%2Fjournal.pone.0152538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152538%26sid%3Dliteratum%253Aachs%26aulast%3DElisia%26aufirst%3DI.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DV.%26aulast%3DHofs%26aufirst%3DE.%26aulast%3DCederberg%26aufirst%3DR.%26aulast%3DCait%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DM.%2BR.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DAdomat%26aufirst%3DH.%2BH.%26aulast%3DGuns%26aufirst%3DE.%2BS.%26aulast%3DMcNagny%26aufirst%3DK.%2BM.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DKrystal%26aufirst%3DG.%26atitle%3DDMSO%2520Represses%2520Inflammatory%2520Cytokine%2520Production%2520from%2520Human%2520Blood%2520Cells%2520and%2520Reduces%2520Autoimmune%2520Arthritis%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0152538%26doi%3D10.1371%2Fjournal.pone.0152538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tewari, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Te, A. E.</span><span> </span><span class="NLM_article-title">Role of inflammation in bladder function and interstitial cystitis</span> <span class="citation_source-journal">Ther. Adv. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1177/1756287211398255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1177%2F1756287211398255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21789096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVWktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=19-33&author=S.+Groverauthor=A.+Srivastavaauthor=R.+Leeauthor=A.+K.+Tewariauthor=A.+E.+Te&title=Role+of+inflammation+in+bladder+function+and+interstitial+cystitis&doi=10.1177%2F1756287211398255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inflammation in bladder function and interstitial cystitis</span></div><div class="casAuthors">Grover, Sonal; Srivastava, Abhishek; Lee, Richard; Tewari, Ashutosh K.; Te, Alexis E.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Urology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">TAUHAQ</span>;
        ISSN:<span class="NLM_cas:issn">1756-2872</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Cystitis, or inflammation of the bladder, has a direct effect on bladder function.  Interstitial cystitis is a syndrome characterized by urinary bladder pain and irritative symptoms of more than 6 mo duration.  It commonly occurs in young to middle-aged women with no known cause and in fact represents a diagnosis of exclusion.  Many factors have been suggested, including chronic or subclin. infection, autoimmunity and genetic susceptibility, which could be responsible for initiating the inflammatory response.  However, a central role of inflammation has been confirmed in the pathogenesis of interstitial cystitis.  Patients with interstitial cystitis are usually managed with multimodal therapy to break the vicious cycle of chronic inflammation at every step.  Patients who develop irreversible pathologies such as fibrosis are managed surgically, which is usually reserved for refractory cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxt8LInpW3BbVg90H21EOLACvtfcHk0lgDPGWkWmIjKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVWktLo%253D&md5=5b682c8f1558aa24b859e65e0ea3b635</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1177%2F1756287211398255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1756287211398255%26sid%3Dliteratum%253Aachs%26aulast%3DGrover%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DTewari%26aufirst%3DA.%2BK.%26aulast%3DTe%26aufirst%3DA.%2BE.%26atitle%3DRole%2520of%2520inflammation%2520in%2520bladder%2520function%2520and%2520interstitial%2520cystitis%26jtitle%3DTher.%2520Adv.%2520Urol.%26date%3D2011%26volume%3D3%26spage%3D19%26epage%3D33%26doi%3D10.1177%2F1756287211398255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">A murine model of urinary tract infection</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span><span class="refDoi"> DOI: 10.1038/nprot.2009.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnprot.2009.116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1230-1243&author=C.+S.+Hungauthor=K.+W.+Dodsonauthor=S.+J.+Hultgren&title=A+murine+model+of+urinary+tract+infection&doi=10.1038%2Fnprot.2009.116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2009.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2009.116%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DDodson%26aufirst%3DK.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DA%2520murine%2520model%2520of%2520urinary%2520tract%2520infection%26jtitle%3DNat.%2520Protoc.%26date%3D2009%26volume%3D4%26spage%3D1230%26epage%3D1243%26doi%3D10.1038%2Fnprot.2009.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schwartz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conover, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Uropathogenic <i>Escherichia coli</i> superinfection enhances the severity of mouse bladder infection</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1004599</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1004599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.ppat.1004599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004599&author=D.+J.+Schwartzauthor=M.+S.+Conoverauthor=T.+J.+Hannanauthor=S.+J.+Hultgren&title=Uropathogenic+Escherichia+coli+superinfection+enhances+the+severity+of+mouse+bladder+infection&doi=10.1371%2Fjournal.ppat.1004599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004599%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BJ.%26aulast%3DConover%26aufirst%3DM.%2BS.%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DUropathogenic%2520Escherichia%2520coli%2520superinfection%2520enhances%2520the%2520severity%2520of%2520mouse%2520bladder%2520infection%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26spage%3De1004599%26doi%3D10.1371%2Fjournal.ppat.1004599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hannan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mysorekar, I. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson-Schmid, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Early severe inflammatory responses to uropathogenic <i>E. coli</i> predispose to chronic and recurrent urinary tract infection</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001042</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1001042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.ppat.1001042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=e1001042&author=T.+J.+Hannanauthor=I.+U.+Mysorekarauthor=C.+S.+Hungauthor=M.+L.+Isaacson-Schmidauthor=S.+J.+Hultgren&title=Early+severe+inflammatory+responses+to+uropathogenic+E.+coli+predispose+to+chronic+and+recurrent+urinary+tract+infection&doi=10.1371%2Fjournal.ppat.1001042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1001042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1001042%26sid%3Dliteratum%253Aachs%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DMysorekar%26aufirst%3DI.%2BU.%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DIsaacson-Schmid%26aufirst%3DM.%2BL.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DEarly%2520severe%2520inflammatory%2520responses%2520to%2520uropathogenic%2520E.%2520coli%2520predispose%2520to%2520chronic%2520and%2520recurrent%2520urinary%2520tract%2520infection%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26spage%3De1001042%26doi%3D10.1371%2Fjournal.ppat.1001042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosen, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooton, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Detection of intracellular bacterial communities in human urinary tract infection</span> <span class="citation_source-journal">PLoS Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e329</span><span class="refDoi"> DOI: 10.1371/journal.pmed.0040329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.pmed.0040329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=18092884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BD2sjmslOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=e329&author=D.+A.+Rosenauthor=T.+M.+Hootonauthor=W.+E.+Stammauthor=P.+A.+Humphreyauthor=S.+J.+Hultgren&title=Detection+of+intracellular+bacterial+communities+in+human+urinary+tract+infection&doi=10.1371%2Fjournal.pmed.0040329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of intracellular bacterial communities in human urinary tract infection</span></div><div class="casAuthors">Rosen David A; Hooton Thomas M; Stamm Walter E; Humphrey Peter A; Hultgren Scott J</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e329</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Urinary tract infections (UTIs) are one of the most common bacterial infections and are predominantly caused by uropathogenic Escherichia coli (UPEC).  While UTIs are typically considered extracellular infections, it has been recently demonstrated that UPEC bind to, invade, and replicate within the murine bladder urothelium to form intracellular bacterial communities (IBCs).  These IBCs dissociate and bacteria flux out of bladder facet cells, some with filamentous morphology, and ultimately establish quiescent intracellular reservoirs that can seed recurrent infection.  This IBC pathogenic cycle has not yet been investigated in humans.  In this study we sought to determine whether evidence of an IBC pathway could be found in urine specimens from women with acute UTI.  METHODS AND FINDINGS:  We collected midstream, clean-catch urine specimens from 80 young healthy women with acute uncomplicated cystitis and 20 asymptomatic women with a history of UTI.  Investigators were blinded to culture results and clinical history.  Samples were analyzed by light microscopy, immunofluorescence, and electron microscopy for evidence of exfoliated IBCs and filamentous bacteria.  Evidence of IBCs was found in 14 of 80 (18%) urines from women with UTI.  Filamentous bacteria were found in 33 of 80 (41%) urines from women with UTI.  None of the 20 urines from the asymptomatic comparative group showed evidence of IBCs or filaments.  Filamentous bacteria were present in all 14 of the urines with IBCs compared to 19 (29%) of 66 samples with no evidence of IBCs (p < 0.001).  Of 65 urines from patients with E. coli infections, 14 (22%) had evidence of IBCs and 29 (45%) had filamentous bacteria, while none of the gram-positive infections had IBCs or filamentous bacteria.  CONCLUSIONS:  The presence of exfoliated IBCs and filamentous bacteria in the urines of women with acute cystitis suggests that the IBC pathogenic pathway characterized in the murine model may occur in humans.  The findings support the occurrence of an intracellular bacterial niche in some women with cystitis that may have important implications for UTI recurrence and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwOO8ErfpuaGHOrQ6qeX-mfW6udTcc2eZtl5biVr6PXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjmslOlsQ%253D%253D&md5=6a15b375b4614deff9610c6272cabfd6</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0040329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0040329%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DD.%2BA.%26aulast%3DHooton%26aufirst%3DT.%2BM.%26aulast%3DStamm%26aufirst%3DW.%2BE.%26aulast%3DHumphrey%26aufirst%3DP.%2BA.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DDetection%2520of%2520intracellular%2520bacterial%2520communities%2520in%2520human%2520urinary%2520tract%2520infection%26jtitle%3DPLoS%2520Med.%26date%3D2007%26volume%3D4%26spage%3De329%26doi%3D10.1371%2Fjournal.pmed.0040329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schlager, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeGallo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendley, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C. A.</span><span> </span><span class="NLM_article-title">B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2364</span><span class="refDoi"> DOI: 10.1016/j.juro.2011.07.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.juro.2011.07.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=22019034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC3MbovV2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=2359-2364&author=T.+A.+Schlagerauthor=R.+LeGalloauthor=D.+Innesauthor=J.+O.+Hendleyauthor=C.+A.+Peters&title=B+cell+infiltration+and+lymphonodular+hyperplasia+in+bladder+submucosa+of+patients+with+persistent+bacteriuria+and+recurrent+urinary+tract+infections&doi=10.1016%2Fj.juro.2011.07.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37bR"><div class="casContent"><span class="casTitleNuber">37b</span><div class="casTitle"><span class="NLM_cas:atitle">B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections</span></div><div class="casAuthors">Schlager T A; LeGallo Robin; Innes D; Hendley J O; Peters C A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2359-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We defined chronic inflammatory cell types in bladder submucosa and the presence of umbrella cells on the surface of bladder epithelium in patients 5 to 21 years old with persistent bacteriuria due to neurogenic bladder and recurrent urinary tract infections associated with vesicoureteral reflux.  MATERIALS AND METHODS:  Bladder mucosa biopsies from 12 patients and 6 controls were fixed in Carnoy's solution and examined for T cells (CD3, CD4, CD8), B cells (CD79) and plasma cells (CD138).  The number of cells in a defined area of submucosa was determined by counting all nuclei in the area.  A contiguous section was also stained for uroplakin expression with a monoclonal antibody against uroplakin III to ascertain the integrity of bladder umbrella cells.  RESULTS:  B cells, plasma cells and lymphoid nodules were found only in patient biopsies.  T cell expression was evident in patient and control biopsies.  Uroplakin staining of surface epithelium was uniform from control biopsies but spotty or entirely absent from patient biopsies.  CONCLUSIONS:  Patients with persistent bacteriuria or recurrent urinary tract infections had significant B cell infiltration in the submucosa, including lymphoid nodules.  These inflammatory changes are likely due to antigenic stimulation from repeated exposure to bacteria.  These changes are associated with frequent absence of uroplakin on surface epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCj6nuL_eJZ8ScOqQTSkOffW6udTcc2eZtl5biVr6PXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbovV2htw%253D%253D&md5=c5040ae2d160ff1a761adf38238d1c6b</span></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2011.07.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2011.07.114%26sid%3Dliteratum%253Aachs%26aulast%3DSchlager%26aufirst%3DT.%2BA.%26aulast%3DLeGallo%26aufirst%3DR.%26aulast%3DInnes%26aufirst%3DD.%26aulast%3DHendley%26aufirst%3DJ.%2BO.%26aulast%3DPeters%26aufirst%3DC.%2BA.%26atitle%3DB%2520cell%2520infiltration%2520and%2520lymphonodular%2520hyperplasia%2520in%2520bladder%2520submucosa%2520of%2520patients%2520with%2520persistent%2520bacteriuria%2520and%2520recurrent%2520urinary%2520tract%2520infections%26jtitle%3DJ.%2520Urol.%26date%3D2011%26volume%3D186%26spage%3D2359%26epage%3D2364%26doi%3D10.1016%2Fj.juro.2011.07.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hansson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjalmas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultengren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jodal, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svanborg-Eden, C.</span><span> </span><span class="NLM_article-title">Follicular cystitis in girls with untreated asymptomatic or covert bacteriuria</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0022-5347%2817%2939950-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=2405189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADyaK3c7jsVSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1990&pages=330-332&author=S.+Hanssonauthor=E.+Hansonauthor=K.+Hjalmasauthor=M.+Hultengrenauthor=U.+Jodalauthor=S.+Ollingauthor=C.+Svanborg-Eden&title=Follicular+cystitis+in+girls+with+untreated+asymptomatic+or+covert+bacteriuria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37cR"><div class="casContent"><span class="casTitleNuber">37c</span><div class="casTitle"><span class="NLM_cas:atitle">Follicular cystitis in girls with untreated asymptomatic or covert bacteriuria</span></div><div class="casAuthors">Hansson S; Hanson E; Hjalmas K; Hultengren M; Jodal U; Olling S; Svanborg-Eden C</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">330-2</span>
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    </div><div class="casAbstract">Nodular changes of the bladder mucosa, that is cystitis follicularis or cystitis cystica, are found in 2 to 9% of all children with urinary tract infections.  The nodules are composed of lymphoid aggregates, resembling Peyer's patches in the intestine.  Children with this finding are considered to have a poor short-term prognosis with a marked tendency for recurrent infections.  Screening programs for bacteriuria have revealed that a few per cent of the female population are bacteriuric without symptoms of overt disease.  Of 59 girls followed with untreated asymptomatic bacteriuria 52 had nodular changes of the bladder mucosa at cystoscopy.  Biopsy was performed in 22 girls, and revealed lymphocytic infiltration in 19 and follicular formation in 11.  The nodular changes persisted when bacteriuria continued but disappeared in patients who became abacteriuric.  This finding demonstrates the reversibility of the changes, and supports the assumption that they are secondary to the presence of bacteria and not a primary lesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkZbg0ZdhBtevW160gIxP_fW6udTcc2eZtl5biVr6PXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7jsVSqtQ%253D%253D&md5=88c51794106407ba66ff8d7ab23bb297</span></div><a href="/servlet/linkout?suffix=cit37c&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2817%2939950-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252817%252939950-0%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DS.%26aulast%3DHanson%26aufirst%3DE.%26aulast%3DHjalmas%26aufirst%3DK.%26aulast%3DHultengren%26aufirst%3DM.%26aulast%3DJodal%26aufirst%3DU.%26aulast%3DOlling%26aufirst%3DS.%26aulast%3DSvanborg-Eden%26aufirst%3DC.%26atitle%3DFollicular%2520cystitis%2520in%2520girls%2520with%2520untreated%2520asymptomatic%2520or%2520covert%2520bacteriuria%26jtitle%3DJ.%2520Urol.%26date%3D1990%26volume%3D143%26spage%3D330%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hannan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riehl, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Post, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwendener, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooton, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stappenbeck, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenson, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis</span> <span class="citation_source-journal">EBioMedicine.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/j.ebiom.2014.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.ebiom.2014.10.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=46-57&author=T.+J.+Hannanauthor=P.+L.+Robertsauthor=T.+E.+Riehlauthor=S.+van+der+Postauthor=J.+M.+Binkleyauthor=D.+J.+Schwartzauthor=H.+Miyoshiauthor=M.+Mackauthor=R.+A.+Schwendenerauthor=T.+M.+Hootonauthor=T.+S.+Stappenbeckauthor=G.+C.+Hanssonauthor=W.+F.+Stensonauthor=M.+Colonnaauthor=A.+E.+Stapletonauthor=S.+J.+Hultgren&title=Inhibition+of+Cyclooxygenase-2+Prevents+Chronic+and+Recurrent+Cystitis&doi=10.1016%2Fj.ebiom.2014.10.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37d&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2014.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2014.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DRoberts%26aufirst%3DP.%2BL.%26aulast%3DRiehl%26aufirst%3DT.%2BE.%26aulast%3Dvan%2Bder%2BPost%26aufirst%3DS.%26aulast%3DBinkley%26aufirst%3DJ.%2BM.%26aulast%3DSchwartz%26aufirst%3DD.%2BJ.%26aulast%3DMiyoshi%26aufirst%3DH.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DSchwendener%26aufirst%3DR.%2BA.%26aulast%3DHooton%26aufirst%3DT.%2BM.%26aulast%3DStappenbeck%26aufirst%3DT.%2BS.%26aulast%3DHansson%26aufirst%3DG.%2BC.%26aulast%3DStenson%26aufirst%3DW.%2BF.%26aulast%3DColonna%26aufirst%3DM.%26aulast%3DStapleton%26aufirst%3DA.%2BE.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DInhibition%2520of%2520Cyclooxygenase-2%2520Prevents%2520Chronic%2520and%2520Recurrent%2520Cystitis%26jtitle%3DEBioMedicine.%26date%3D2014%26volume%3D1%26spage%3D46%26epage%3D57%26doi%3D10.1016%2Fj.ebiom.2014.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sattin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, A.</span><span> </span><span class="NLM_article-title">Glycoconjugates and Glycomimetics as Microbial Anti-Adhesives</span> <span class="citation_source-journal">Trends Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1016/j.tibtech.2016.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.tibtech.2016.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=26875976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=483-495&author=S.+Sattinauthor=A.+Bernardi&title=Glycoconjugates+and+Glycomimetics+as+Microbial+Anti-Adhesives&doi=10.1016%2Fj.tibtech.2016.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Glycoconjugates and Glycomimetics as Microbial Anti-Adhesives</span></div><div class="casAuthors">Sattin, Sara; Bernardi, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">483-495</span>CODEN:
                <span class="NLM_cas:coden">TRBIDM</span>;
        ISSN:<span class="NLM_cas:issn">0167-7799</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Microbial adhesion is an essential step in infection and is mediated primarily by protein-carbohydrate interactions.  Antagonists of such interactions have become a promising target for anti-adhesive therapy in several infective diseases.  Monovalent protein-sugar interactions are often weak, and most successful anti-adhesive materials consist of multivalent glycoconjugates.  Although often very effective in hampering microbial adhesion, natural epitopes often show limited resistance to enzymic degrdn.  The use of carbohydrate mimics (glycomimetics) as a replacement for natural sugars potentially allows higher metabolic stability and also higher selectivity towards the desired protein target.  In this review we describe the state of the art in the design and synthesis of glycoconjugates and glycomimetics employed for the construction of anti-adhesive biomaterials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6YxCBQhH0Z7Vg90H21EOLACvtfcHk0lhXtP1Ah4_Nnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCltLw%253D&md5=335ad2bd9d327257ea5b363a9bd5d1c2</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.tibtech.2016.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibtech.2016.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DSattin%26aufirst%3DS.%26aulast%3DBernardi%26aufirst%3DA.%26atitle%3DGlycoconjugates%2520and%2520Glycomimetics%2520as%2520Microbial%2520Anti-Adhesives%26jtitle%3DTrends%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D483%26epage%3D495%26doi%3D10.1016%2Fj.tibtech.2016.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cecioni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imberty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, S.</span><span> </span><span class="NLM_article-title">Glycomimetics versus multivalent glycoconjugates for the design of high affinity lectin ligands</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1021/cr500303t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500303t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFans7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=525-561&author=S.+Cecioniauthor=A.+Imbertyauthor=S.+Vidal&title=Glycomimetics+versus+multivalent+glycoconjugates+for+the+design+of+high+affinity+lectin+ligands&doi=10.1021%2Fcr500303t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Glycomimetics versus Multivalent Glycoconjugates for the Design of High Affinity Lectin Ligands</span></div><div class="casAuthors">Cecioni, Samy; Imberty, Anne; Vidal, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">525-561</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review is aimed at giving an overview of the numerous synthetic approaches for building glycomimetics and glycoclusters designed for high affinity binding by lectins of interest in human health.  Selected examples related to neurol. diseases,cancer, and infection are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMeUedZ6R-o7Vg90H21EOLACvtfcHk0lhXtP1Ah4_Nnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFans7bM&md5=261b50560ae13f3072b0d11919000a16</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1021%2Fcr500303t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500303t%26sid%3Dliteratum%253Aachs%26aulast%3DCecioni%26aufirst%3DS.%26aulast%3DImberty%26aufirst%3DA.%26aulast%3DVidal%26aufirst%3DS.%26atitle%3DGlycomimetics%2520versus%2520multivalent%2520glycoconjugates%2520for%2520the%2520design%2520of%2520high%2520affinity%2520lectin%2520ligands%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D525%26epage%3D561%26doi%3D10.1021%2Fcr500303t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sutkeviciute, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thepaut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeagh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grudinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reina, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clerici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieschi, F.</span><span> </span><span class="NLM_article-title">Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span><span class="refDoi"> DOI: 10.1021/cb500054h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500054h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1377-1385&author=I.+Sutkeviciuteauthor=M.+Thepautauthor=S.+Sattinauthor=A.+Berziauthor=J.+McGeaghauthor=S.+Grudininauthor=J.+Weiserauthor=A.+Le+Royauthor=J.+J.+Reinaauthor=J.+Rojoauthor=M.+Clericiauthor=A.+Bernardiauthor=C.+Ebelauthor=F.+Fieschi&title=Unique+DC-SIGN+clustering+activity+of+a+small+glycomimetic%3A+A+lesson+for+ligand+design&doi=10.1021%2Fcb500054h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38cR"><div class="casContent"><span class="casTitleNuber">38c</span><div class="casTitle"><span class="NLM_cas:atitle">Unique DC-SIGN Clustering Activity of a Small Glycomimetic: A Lesson for Ligand Design</span></div><div class="casAuthors">Sutkeviciute, Ieva; Thepaut, Michel; Sattin, Sara; Berzi, Angela; McGeagh, John; Grudinin, Sergei; Weiser, Jorg; Le Roy, Aline; Reina, Jose J.; Rojo, Javier; Clerici, Mario; Bernardi, Anna; Ebel, Christine; Fieschi, Franck</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1377-1385</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DC-SIGN is a dendritic cell-specific C-type lectin receptor that recognizes highly glycosylated ligands expressed on the surface of various pathogens.  This receptor plays an important role in the early stages of many viral infections, including HIV, which makes it an interesting therapeutic target.  Glycomimetic compds. are good drug candidates for DC-SIGN inhibition due to their high soly., resistance to glycosidases, and nontoxicity.  We studied the structural properties of the interaction of the tetrameric DC-SIGN extracellular domain (ECD), with two glycomimetic antagonists, a pseudomannobioside and a linear pseudomannotrioside .  Though the inhibitory potency of pseudomannotrioside, as measured by SPR competition expts., was pseudomannobioside order of magnitude higher than that of pseudomannobioside, crystal structures of the complexes within the DC-SIGN carbohydrate recognition domain showed the same binding mode for both compds.  Moreover, when conjugated to multivalent scaffolds, the inhibitory potencies of these compds. became uniform.  Combining isothermal titrn. microcalorimetry, anal. ultracentrifugation, and dynamic light scattering techniques to study DC-SIGN ECD interaction with these glycomimetics revealed that pseudomannotrioside is able, without any multivalent presentation, to cluster DC-SIGN tetramers leading to an artificially overestimated inhibitory potency.  The use of multivalent scaffolds presenting pseudomannobioside or pseudomannotrioside in HIV trans-infection inhibition assay confirms the loss of potency of pseudomannotrioside upon conjugation and the equal efficacy of chem. simpler compd. pseudomannobioside.  This study documents a unique case where, among two active compds. chem. derived, the compd. with the lower apparent activity is the optimal lead for further drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSsL4oxpJD7Vg90H21EOLACvtfcHk0lhXtP1Ah4_Nnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtLc%253D&md5=89af8431ef89595c2a76e6fbab25a98a</span></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=10.1021%2Fcb500054h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500054h%26sid%3Dliteratum%253Aachs%26aulast%3DSutkeviciute%26aufirst%3DI.%26aulast%3DThepaut%26aufirst%3DM.%26aulast%3DSattin%26aufirst%3DS.%26aulast%3DBerzi%26aufirst%3DA.%26aulast%3DMcGeagh%26aufirst%3DJ.%26aulast%3DGrudinin%26aufirst%3DS.%26aulast%3DWeiser%26aufirst%3DJ.%26aulast%3DLe%2BRoy%26aufirst%3DA.%26aulast%3DReina%26aufirst%3DJ.%2BJ.%26aulast%3DRojo%26aufirst%3DJ.%26aulast%3DClerici%26aufirst%3DM.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DEbel%26aufirst%3DC.%26aulast%3DFieschi%26aufirst%3DF.%26atitle%3DUnique%2520DC-SIGN%2520clustering%2520activity%2520of%2520a%2520small%2520glycomimetic%253A%2520A%2520lesson%2520for%2520ligand%2520design%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1377%26epage%3D1385%26doi%3D10.1021%2Fcb500054h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Thepaut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutkeviciute, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-Viana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabrol, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieschi, F.</span><span> </span><span class="NLM_article-title">Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">2518</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span><span class="refDoi"> DOI: 10.1021/ja3053305</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3053305" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=2518-2529&author=M.+Thepautauthor=C.+Guzziauthor=I.+Sutkeviciuteauthor=S.+Sattinauthor=R.+Ribeiro-Vianaauthor=N.+Vargaauthor=E.+Chabrolauthor=J.+Rojoauthor=A.+Bernardiauthor=J.+Anguloauthor=P.+M.+Nietoauthor=F.+Fieschi&title=Structure+of+a+glycomimetic+ligand+in+the+carbohydrate+recognition+domain+of+C-type+lectin+DC-SIGN.+Structural+requirements+for+selectivity+and+ligand+design&doi=10.1021%2Fja3053305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38d&amp;dbid=16384&amp;doi=10.1021%2Fja3053305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3053305%26sid%3Dliteratum%253Aachs%26aulast%3DThepaut%26aufirst%3DM.%26aulast%3DGuzzi%26aufirst%3DC.%26aulast%3DSutkeviciute%26aufirst%3DI.%26aulast%3DSattin%26aufirst%3DS.%26aulast%3DRibeiro-Viana%26aufirst%3DR.%26aulast%3DVarga%26aufirst%3DN.%26aulast%3DChabrol%26aufirst%3DE.%26aulast%3DRojo%26aufirst%3DJ.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DAngulo%26aufirst%3DJ.%26aulast%3DNieto%26aufirst%3DP.%2BM.%26aulast%3DFieschi%26aufirst%3DF.%26atitle%3DStructure%2520of%2520a%2520glycomimetic%2520ligand%2520in%2520the%2520carbohydrate%2520recognition%2520domain%2520of%2520C-type%2520lectin%2520DC-SIGN.%2520Structural%2520requirements%2520for%2520selectivity%2520and%2520ligand%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D2518%26epage%3D2529%26doi%3D10.1021%2Fja3053305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hauck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommeyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varrot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imberty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titz, A.</span><span> </span><span class="NLM_article-title">Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1784</span><span class="refDoi"> DOI: 10.1021/cb400371r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400371r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotlensrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1775-1784&author=D.+Hauckauthor=I.+Joachimauthor=B.+Frommeyerauthor=A.+Varrotauthor=B.+Philippauthor=H.+M.+M%C3%B6llerauthor=A.+Imbertyauthor=T.+E.+Exnerauthor=A.+Titz&title=Discovery+of+two+classes+of+potent+glycomimetic+inhibitors+of+Pseudomonas+aeruginosa+LecB+with+distinct+binding+modes&doi=10.1021%2Fcb400371r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38eR"><div class="casContent"><span class="casTitleNuber">38e</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Two Classes of Potent Glycomimetic Inhibitors of Pseudomonas aeruginosa LecB with Distinct Binding Modes</span></div><div class="casAuthors">Hauck, Dirk; Joachim, Ines; Frommeyer, Benjamin; Varrot, Annabelle; Philipp, Bodo; Moeller, Heiko M.; Imberty, Anne; Exner, Thomas E.; Titz, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1775-1784</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The treatment of infections due to the opportunistic pathogen Pseudomonas aeruginosa is often difficult, as a consequence of bacterial biofilm formation.  Such a protective environment shields the bacterium from host defense and antibiotic treatment and secures its survival.  One crucial factor for maintenance of the biofilm architecture is the carbohydrate-binding lectin LecB.  Here, we report the identification of potent mannose-based LecB inhibitors from a screening of four series of mannosides in a novel competitive binding assay for LecB.  Cinnamide and sulfonamide derivs., e.g. I, are inhibitors of bacterial adhesion with up to a 20-fold increase in affinity to LecB compared to the natural ligand Me mannoside.  Because many lectins of the host require terminal saccharides (e.g., fucosides), such capped structures as reported here may offer a beneficial selectivity profile for the pathogenic lectin.  Both classes of compds. show distinct binding modes at the protein, offering the advantage of a simultaneous development of two new lead structures as anti-pseudomonadal drugs with an anti-virulence mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5a8of6XtObVg90H21EOLACvtfcHk0ljWw0r-JN0ekA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotlensrw%253D&md5=e194c1845e7aa25b04e366281a4a5c0a</span></div><a href="/servlet/linkout?suffix=cit38e&amp;dbid=16384&amp;doi=10.1021%2Fcb400371r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400371r%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DD.%26aulast%3DJoachim%26aufirst%3DI.%26aulast%3DFrommeyer%26aufirst%3DB.%26aulast%3DVarrot%26aufirst%3DA.%26aulast%3DPhilipp%26aufirst%3DB.%26aulast%3DM%25C3%25B6ller%26aufirst%3DH.%2BM.%26aulast%3DImberty%26aufirst%3DA.%26aulast%3DExner%26aufirst%3DT.%2BE.%26aulast%3DTitz%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520two%2520classes%2520of%2520potent%2520glycomimetic%2520inhibitors%2520of%2520Pseudomonas%2520aeruginosa%2520LecB%2520with%2520distinct%2520binding%2520modes%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1775%26epage%3D1784%26doi%3D10.1021%2Fcb400371r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Chabre, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giguere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocheleau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauthu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imberty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R.</span><span> </span><span class="NLM_article-title">Combining glycomimetic and multivalent strategies toward designing potent bacterial lectin inhibitors</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6545</span><span class="NLM_x">–</span> <span class="NLM_lpage">6562</span><span class="refDoi"> DOI: 10.1002/chem.201003402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fchem.201003402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21523837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6545-6562&author=Y.+M.+Chabreauthor=D.+Giguereauthor=B.+Blanchardauthor=J.+Rodrigueauthor=S.+Rocheleauauthor=M.+Neaultauthor=S.+Rauthuauthor=A.+Papadopoulosauthor=A.+A.+Arnoldauthor=A.+Imbertyauthor=R.+Roy&title=Combining+glycomimetic+and+multivalent+strategies+toward+designing+potent+bacterial+lectin+inhibitors&doi=10.1002%2Fchem.201003402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38fR"><div class="casContent"><span class="casTitleNuber">38f</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Glycomimetic and Multivalent Strategies toward Designing Potent Bacterial Lectin Inhibitors</span></div><div class="casAuthors">Chabre, Yoann M.; Giguere, Denis; Blanchard, Bertrand; Rodrigue, Jacques; Rocheleau, Sylvain; Neault, Mathieu; Rauthu, Subhash; Papadopoulos, Alex; Arnold, Alexandre A.; Imberty, Anne; Roy, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6545-6562, S6545/1-S6545/134</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">As part of ongoing activities toward the design of potent and selective ligands against galactoside-binding proteins from animal, bacterial, and plant lectins, a systematic investigation involving the synthesis and binding evaluations of a series of original β-C-galactopyranoside mimetics is described.  The multivalent presentation of partly optimized candidates on various dendritic scaffolds through CuI-catalyzed azide-alkyne cycloaddn. (CuAAc) has also been achieved.  Biophys. investigations based on isothermal titrn. calorimetry (ITC) have indicated a dissocn. const. in the low micromolar range for the best optimized monovalent conjugate (Kd=37 μM).  The results thus confirmed that stable C-galactosides could represent efficient synthetic glycomimetics of natural α-linked oligosaccharidic inhibitors of PA-IL lectin (Lec A) from the pathogenic Pseudomonas aeruginosa.  Striking enhancements in the avidity of the glycoconjugates were also obsd. for tri-, hexa-, and nonavalent derivs., among which the most potent exhibited dissocn. consts. below 500 nM, corresponding to a 400-fold increase in affinity compared with the β-D-Gal-O-Me used as ref.  To deepen the understanding of the binding mode of the best glycomimetics involved in the recognition process, mol. modeling studies, docking calcns., and NMR diffusion measurements have been performed.  Although favorable complementary interactions induced by the addn. of the hydrophobic aglycon might explain the affinity enhancement, exptl. detn. of the size and the topol. of the multivalent conjugates further supported the formation of aggregative complexes as a major multivalent binding mode.  This work represents a systematic and comprehensive study towards a thorough understanding of the protein-carbohydrate interactions involved in Pseudomonas aeruginosa infection, and as such should prove useful for the development of stable and optimized anti-adhesive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnLGu6DhR6rVg90H21EOLACvtfcHk0ljWw0r-JN0ekA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsb4%253D&md5=c4018853d3340f828e864bbc1ae0704b</span></div><a href="/servlet/linkout?suffix=cit38f&amp;dbid=16384&amp;doi=10.1002%2Fchem.201003402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201003402%26sid%3Dliteratum%253Aachs%26aulast%3DChabre%26aufirst%3DY.%2BM.%26aulast%3DGiguere%26aufirst%3DD.%26aulast%3DBlanchard%26aufirst%3DB.%26aulast%3DRodrigue%26aufirst%3DJ.%26aulast%3DRocheleau%26aufirst%3DS.%26aulast%3DNeault%26aufirst%3DM.%26aulast%3DRauthu%26aufirst%3DS.%26aulast%3DPapadopoulos%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DA.%2BA.%26aulast%3DImberty%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DR.%26atitle%3DCombining%2520glycomimetic%2520and%2520multivalent%2520strategies%2520toward%2520designing%2520potent%2520bacterial%2520lectin%2520inhibitors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D6545%26epage%3D6562%26doi%3D10.1002%2Fchem.201003402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Magnani, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">Glycomimetic drugs—a new source of therapeutic opportunities</span> <span class="citation_source-journal">Discovery Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=247-252&author=J.+L.+Magnaniauthor=B.+Ernst&title=Glycomimetic+drugs%E2%80%94a+new+source+of+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMagnani%26aufirst%3DJ.%2BL.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DGlycomimetic%2520drugs%25E2%2580%2594a%2520new%2520source%2520of%2520therapeutic%2520opportunities%26jtitle%3DDiscovery%2520Med.%26date%3D2009%26volume%3D8%26spage%3D247%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ernst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnani, J. L.</span><span> </span><span class="NLM_article-title">From carbohydrate leads to glycomimetic drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1038/nrd2852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnrd2852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=19629075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFymtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=661-677&author=B.+Ernstauthor=J.+L.+Magnani&title=From+carbohydrate+leads+to+glycomimetic+drugs&doi=10.1038%2Fnrd2852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38hR"><div class="casContent"><span class="casTitleNuber">38h</span><div class="casTitle"><span class="NLM_cas:atitle">From carbohydrate leads to glycomimetic drugs</span></div><div class="casAuthors">Ernst, Beat; Magnani, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">661-677</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Carbohydrates are the most abundant natural products.  Besides their role in metab. and as structural building blocks, they are fundamental constituents of every cell surface, where they are involved in vital cellular recognition processes.  Carbohydrates are a relatively untapped source of new drugs and therefore offer exciting new therapeutic opportunities.  Advances in the functional understanding of carbohydrate-protein interactions have enabled the development of a new class of small-mol. drugs, known as glycomimetics.  These compds. mimic the bioactive function of carbohydrates and address the drawbacks of carbohydrate leads, namely their low activity and insufficient drug-like properties.  Here, we examine examples of approved carbohydrate-derived drugs, discuss the potential of carbohydrate-binding proteins as new drug targets (focusing on the lectin families) and consider ways to overcome the challenges of developing this unique class of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6PJbzb53pf7Vg90H21EOLACvtfcHk0lhLqpBu1BVlKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFymtLk%253D&md5=e9de5f51c13bfa145fca68ec38d542ac</span></div><a href="/servlet/linkout?suffix=cit38h&amp;dbid=16384&amp;doi=10.1038%2Fnrd2852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2852%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DB.%26aulast%3DMagnani%26aufirst%3DJ.%2BL.%26atitle%3DFrom%2520carbohydrate%2520leads%2520to%2520glycomimetic%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D661%26epage%3D677%26doi%3D10.1038%2Fnrd2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sipos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablonkai, I.</span><span> </span><span class="NLM_article-title">Preparation of 1-C-glycosyl aldehydes by reductive hydrolysis</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">1503</span><span class="NLM_x">–</span> <span class="NLM_lpage">1510</span><span class="refDoi"> DOI: 10.1016/j.carres.2011.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.carres.2011.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21575933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFSqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2011&pages=1503-1510&author=S.+Siposauthor=I.+Jablonkai&title=Preparation+of+1-C-glycosyl+aldehydes+by+reductive+hydrolysis&doi=10.1016%2Fj.carres.2011.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 1-C-glycosyl aldehydes by reductive hydrolysis</span></div><div class="casAuthors">Sipos, Szabolcs; Jablonkai, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1503-1510</span>CODEN:
                <span class="NLM_cas:coden">CRBRAT</span>;
        ISSN:<span class="NLM_cas:issn">0008-6215</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Reductive hydrolysis of various protected glycosyl cyanides was carried out using DIBAL-H to form aldimine intermediates which were then hydrolyzed under mildly acidic condition to provide the corresponding aldehyde derivs.  While 1-C-formyl glycal and 2-deoxy glycosyl derivs. were stable during isolation and storage 1-C-glycosyl formaldehydes in the gluco, galacto and manno series were sensitive and decompn. occurred by 2-alkyloxy elimination.  A one-pot method using N,N'-diphenylethylenediamine to trap these aldehydes in stable form was developed.  Reductive hydrolysis of glycosyl cyanides offers valuable aldehyde building blocks in a convenient way which can be applied in the synthesis of complex C-glycosides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEbXOJZogtJbVg90H21EOLACvtfcHk0lhLqpBu1BVlKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFSqsL8%253D&md5=631fce2d4f548b71c5fdda57b6d31884</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.carres.2011.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.carres.2011.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DSipos%26aufirst%3DS.%26aulast%3DJablonkai%26aufirst%3DI.%26atitle%3DPreparation%2520of%25201-C-glycosyl%2520aldehydes%2520by%2520reductive%2520hydrolysis%26jtitle%3DCarbohydr.%2520Res.%26date%3D2011%26volume%3D346%26spage%3D1503%26epage%3D1510%26doi%3D10.1016%2Fj.carres.2011.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Lin, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W. C.</span><span> </span><span class="NLM_article-title">Synthesis of novel polyhydroxylated pyrrolidine-triazole/-isoxazole hybrid molecules</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2107</span><span class="refDoi"> DOI: 10.1039/C4OB01934B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1039%2FC4OB01934B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=2100-2107&author=C.+K.+Linauthor=L.+W.+Chengauthor=H.+Y.+Liauthor=W.+Y.+Yunauthor=W.+C.+Cheng&title=Synthesis+of+novel+polyhydroxylated+pyrrolidine-triazole%2F-isoxazole+hybrid+molecules&doi=10.1039%2FC4OB01934B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FC4OB01934B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01934B%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BK.%26aulast%3DCheng%26aufirst%3DL.%2BW.%26aulast%3DLi%26aufirst%3DH.%2BY.%26aulast%3DYun%26aufirst%3DW.%2BY.%26aulast%3DCheng%26aufirst%3DW.%2BC.%26atitle%3DSynthesis%2520of%2520novel%2520polyhydroxylated%2520pyrrolidine-triazole%252F-isoxazole%2520hybrid%2520molecules%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D2100%26epage%3D2107%26doi%3D10.1039%2FC4OB01934B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b','cit20c'],'ref21':['cit21a','cit21b','cit21c'],'ref22':['cit22'],'ref23':['cit23a','cit23b','cit23c','cit23d','cit23e','cit23f','cit23g'],'ref24':['cit24a','cit24b','cit24c','cit24d'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36a','cit36b','cit36c'],'ref37':['cit37a','cit37b','cit37c','cit37d'],'ref38':['cit38a','cit38b','cit38c','cit38d','cit38e','cit38f','cit38g','cit38h'],'ref39':['cit39'],'ref40':['cit40']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Amarendar
Reddy Maddirala, Roger Klein, Jerome S. Pinkner, Vasilios Kalas, Scott J. Hultgren, <span class="NLM_string-name hlFld-ContribAuthor">James W. Janetka</span>. </span><span class="cited-content_cbyCitation_article-title">Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 467-479. <a href="https://doi.org/10.1021/acs.jmedchem.8b01561" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01561%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiphenyl%252BGal%252Band%252BGalNAc%252BFmlH%252BLectin%252BAntagonists%252Bof%252BUropathogenic%252BE.%252Bcoli%252B%252528UPEC%252529%25253A%252BOptimization%252Bthrough%252BIterative%252BRational%252BDrug%252BDesign%26aulast%3DMaddirala%26aufirst%3DAmarendar%2BReddy%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D07102018%26date%3D02012019%26date%3D12122018%26volume%3D62%26issue%3D2%26spage%3D467%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Feng Zhu, Jacob Rodriguez, Sloane O’Neill, <span class="NLM_string-name hlFld-ContribAuthor">Maciej A. Walczak</span>. </span><span class="cited-content_cbyCitation_article-title">Acyl Glycosides through Stereospecific Glycosyl Cross-Coupling: Rapid Access to C(sp3)-Linked Glycomimetics. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2018,</strong> <em>4 </em>
                                    (12)
                                     , 1652-1662. <a href="https://doi.org/10.1021/acscentsci.8b00628" title="DOI URL">https://doi.org/10.1021/acscentsci.8b00628</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.8b00628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.8b00628%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DAcyl%252BGlycosides%252Bthrough%252BStereospecific%252BGlycosyl%252BCross-Coupling%25253A%252BRapid%252BAccess%252Bto%252BC%252528sp3%252529-Linked%252BGlycomimetics%26aulast%3DZhu%26aufirst%3DFeng%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06092018%26date%3D04122018%26volume%3D4%26issue%3D12%26spage%3D1652%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Leila Mousavifar, Mohamed Touaibia, <span class="NLM_string-name hlFld-ContribAuthor">René Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2018,</strong> <em>51 </em>
                                    (11)
                                     , 2937-2948. <a href="https://doi.org/10.1021/acs.accounts.8b00397" title="DOI URL">https://doi.org/10.1021/acs.accounts.8b00397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.8b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.8b00397%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DDevelopment%252Bof%252BMannopyranoside%252BTherapeutics%252Bagainst%252BAdherent-Invasive%252BEscherichia%252Bcoli%252BInfections%26aulast%3DMousavifar%26aufirst%3DLeila%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06082018%26date%3D05102018%26volume%3D51%26issue%3D11%26spage%3D2937%26epage%3D2948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hussein  Al-Mughaid</span>, <span class="hlFld-ContribAuthor ">Maha  Khazaaleh</span>. </span><span class="cited-content_cbyCitation_article-title">α-d-Mannoside ligands with a valency ranging from one to three: Synthesis and hemagglutination inhibitory properties. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2021,</strong> <em>508 </em>, 108396. <a href="https://doi.org/10.1016/j.carres.2021.108396" title="DOI URL">https://doi.org/10.1016/j.carres.2021.108396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2021.108396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2021.108396%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3D%2525CE%2525B1-d-Mannoside%252Bligands%252Bwith%252Ba%252Bvalency%252Branging%252Bfrom%252Bone%252Bto%252Bthree%25253A%252BSynthesis%252Band%252Bhemagglutination%252Binhibitory%252Bproperties%26aulast%3DAl-Mughaid%26aufirst%3DHussein%26date%3D2021%26volume%3D508%26spage%3D108396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernadette  Jones-Freeman</span>, <span class="hlFld-ContribAuthor ">Michelle  Chonwerawong</span>, <span class="hlFld-ContribAuthor ">Vanessa R.  Marcelino</span>, <span class="hlFld-ContribAuthor ">Aniruddh V.  Deshpande</span>, <span class="hlFld-ContribAuthor ">Samuel C.  Forster</span>, <span class="hlFld-ContribAuthor ">Malcolm R.  Starkey</span>. </span><span class="cited-content_cbyCitation_article-title">The microbiome and host mucosal interactions in urinary tract diseases. </span><span class="cited-content_cbyCitation_journal-name">Mucosal Immunology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (4)
                                     , 779-792. <a href="https://doi.org/10.1038/s41385-020-00372-5" title="DOI URL">https://doi.org/10.1038/s41385-020-00372-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41385-020-00372-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41385-020-00372-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMucosal%2520Immunology%26atitle%3DThe%252Bmicrobiome%252Band%252Bhost%252Bmucosal%252Binteractions%252Bin%252Burinary%252Btract%252Bdiseases%26aulast%3DJones-Freeman%26aufirst%3DBernadette%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D4%26spage%3D779%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Li</span>, <span class="hlFld-ContribAuthor ">Kaichen  Zhou</span>, <span class="hlFld-ContribAuthor ">Jingyu  Wang</span>, <span class="hlFld-ContribAuthor ">Jiahe  Guo</span>, <span class="hlFld-ContribAuthor ">Yang  Cao</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Tao  Guan</span>, <span class="hlFld-ContribAuthor ">Wenchao  Sheng</span>, <span class="hlFld-ContribAuthor ">Mingyao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi  Yao</span>, <span class="hlFld-ContribAuthor ">Quan  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Diagnostic Value of the Fimbriae Distribution Pattern in Localization of Urinary Tract Infection. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Medicine</span><span> <strong>2021,</strong> <em>8 </em><a href="https://doi.org/10.3389/fmed.2021.602691" title="DOI URL">https://doi.org/10.3389/fmed.2021.602691</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmed.2021.602691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmed.2021.602691%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Medicine%26atitle%3DDiagnostic%252BValue%252Bof%252Bthe%252BFimbriae%252BDistribution%252BPattern%252Bin%252BLocalization%252Bof%252BUrinary%252BTract%252BInfection%26aulast%3DLi%26aufirst%3DXiao%26date%3D2021%26date%3D2021%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishnu C.  Damalanka</span>, <span class="hlFld-ContribAuthor ">Amarendar Reddy  Maddirala</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approaches to glycomimetic design: development of small molecular weight lectin antagonists. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 513-536. <a href="https://doi.org/10.1080/17460441.2021.1857721" title="DOI URL">https://doi.org/10.1080/17460441.2021.1857721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1857721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1857721%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bapproaches%252Bto%252Bglycomimetic%252Bdesign%25253A%252Bdevelopment%252Bof%252Bsmall%252Bmolecular%252Bweight%252Blectin%252Bantagonists%26aulast%3DDamalanka%26aufirst%3DVishnu%2BC.%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D5%26spage%3D513%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roland E.  Dolle</span>, <span class="hlFld-ContribAuthor ">Laurel K.  McGrane</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>, <span class="hlFld-ContribAuthor ">Jared T.  Hammill</span>, <span class="hlFld-ContribAuthor ">Rodney Kiplin  Guy</span>, <span class="hlFld-ContribAuthor ">Anjan  Debnath</span>, <span class="hlFld-ContribAuthor ">Peter M.  Cheuka</span>, <span class="hlFld-ContribAuthor ">Claire Le  Manach</span>, <span class="hlFld-ContribAuthor ">Kelly  Chibale</span>, <span class="hlFld-ContribAuthor ">Ake  Elhammer</span>, <span class="hlFld-ContribAuthor ">Martin  Handfield</span>, <span class="hlFld-ContribAuthor ">Michael J.  Dawson</span>, <span class="hlFld-ContribAuthor ">Stefano  Donadio</span>, <span class="hlFld-ContribAuthor ">Jae H.  Park</span>, <span class="hlFld-ContribAuthor ">Alan  Joslyn</span>. </span><span class="cited-content_cbyCitation_article-title">Anti‐Infective Case Histories. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-95. <a href="https://doi.org/10.1002/0471266949.bmc288" title="DOI URL">https://doi.org/10.1002/0471266949.bmc288</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc288%26sid%3Dliteratum%253Aachs%26atitle%3DAnti%2525E2%252580%252590Infective%252BCase%252BHistories%26aulast%3DDolle%26aufirst%3DRoland%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D95%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leila  Mousavifar</span>, <span class="hlFld-ContribAuthor ">René  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development in the design of small ‘drug-like’ and nanoscale glycomimetics against Escherichia coli infections. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>55 </em><a href="https://doi.org/10.1016/j.drudis.2021.02.025" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.02.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.02.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.02.025%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRecent%252Bdevelopment%252Bin%252Bthe%252Bdesign%252Bof%252Bsmall%252B%2525E2%252580%252598drug-like%2525E2%252580%252599%252Band%252Bnanoscale%252Bglycomimetics%252Bagainst%252BEscherichia%252Bcoli%252Binfections%26aulast%3DMousavifar%26aufirst%3DLeila%26date%3D2021%26volume%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Day</span>, <span class="hlFld-ContribAuthor ">Alvin W.  Lo</span>, <span class="hlFld-ContribAuthor ">Lauren E.  Hartley-Tassell</span>, <span class="hlFld-ContribAuthor ">M. Pilar  Argente</span>, <span class="hlFld-ContribAuthor ">Jessica  Poole</span>, <span class="hlFld-ContribAuthor ">Nathan P.  King</span>, <span class="hlFld-ContribAuthor ">Joe  Tiralongo</span>, <span class="hlFld-ContribAuthor ">Michael P.  Jennings</span>, <span class="hlFld-ContribAuthor ">Mark A.  Schembri</span>, . </span><span class="cited-content_cbyCitation_article-title">Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression. </span><span class="cited-content_cbyCitation_journal-name">mBio</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/mBio.03664-20" title="DOI URL">https://doi.org/10.1128/mBio.03664-20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/mBio.03664-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FmBio.03664-20%26sid%3Dliteratum%253Aachs%26jtitle%3DmBio%26atitle%3DDiscovery%252Bof%252BBacterial%252BFimbria%2525E2%252580%252593Glycan%252BInteractions%252BUsing%252BWhole-Cell%252BRecombinant%252BEscherichia%252Bcoli%252BExpression%26aulast%3DDay%26aufirst%3DChristopher%2BJ.%26date%3D2021%26volume%3D12%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tihomir  Tomašič</span>, <span class="hlFld-ContribAuthor ">Said  Rabbani</span>, <span class="hlFld-ContribAuthor ">Roman P.  Jakob</span>, <span class="hlFld-ContribAuthor ">Andreas  Reisner</span>, <span class="hlFld-ContribAuthor ">Žiga  Jakopin</span>, <span class="hlFld-ContribAuthor ">Timm  Maier</span>, <span class="hlFld-ContribAuthor ">Beat  Ernst</span>, <span class="hlFld-ContribAuthor ">Marko  Anderluh</span>. </span><span class="cited-content_cbyCitation_article-title">Does targeting Arg98 of FimH lead to high affinity antagonists?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113093. <a href="https://doi.org/10.1016/j.ejmech.2020.113093" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113093%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDoes%252Btargeting%252BArg98%252Bof%252BFimH%252Blead%252Bto%252Bhigh%252Baffinity%252Bantagonists%25253F%26aulast%3DToma%25C5%25A1i%25C4%258D%26aufirst%3DTihomir%26date%3D2021%26volume%3D211%26spage%3D113093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisa K.  McLellan</span>, <span class="hlFld-ContribAuthor ">Michael R.  McAllaster</span>, <span class="hlFld-ContribAuthor ">Arthur S.  Kim</span>, <span class="hlFld-ContribAuthor ">Ľubomíra  Tóthová</span>, <span class="hlFld-ContribAuthor ">Patrick D.  Olson</span>, <span class="hlFld-ContribAuthor ">Jerome S.  Pinkner</span>, <span class="hlFld-ContribAuthor ">Allyssa L.  Daugherty</span>, <span class="hlFld-ContribAuthor ">Teri N.  Hreha</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>, <span class="hlFld-ContribAuthor ">Daved H.  Fremont</span>, <span class="hlFld-ContribAuthor ">Scott J.  Hultgren</span>, <span class="hlFld-ContribAuthor ">Herbert W.  Virgin</span>, <span class="hlFld-ContribAuthor ">David A.  Hunstad</span>, . </span><span class="cited-content_cbyCitation_article-title">A host receptor enables type 1 pilus-mediated pathogenesis of Escherichia coli pyelonephritis. </span><span class="cited-content_cbyCitation_journal-name">PLOS Pathogens</span><span> <strong>2021,</strong> <em>17 </em>
                                    (1)
                                     , e1009314. <a href="https://doi.org/10.1371/journal.ppat.1009314" title="DOI URL">https://doi.org/10.1371/journal.ppat.1009314</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1009314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1009314%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Pathogens%26atitle%3DA%252Bhost%252Breceptor%252Benables%252Btype%252B1%252Bpilus-mediated%252Bpathogenesis%252Bof%252BEscherichia%252Bcoli%252Bpyelonephritis%26aulast%3DMcLellan%26aufirst%3DLisa%2BK.%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D1%26spage%3De1009314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Jiang</span>, <span class="hlFld-ContribAuthor ">Mengxin  Geng</span>, <span class="hlFld-ContribAuthor ">Liping  Bai</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Biofilms Therapy: Current Research Strategies and Development Hurdles. </span><span class="cited-content_cbyCitation_journal-name">Microorganisms</span><span> <strong>2020,</strong> <em>8 </em>
                                    (8)
                                     , 1222. <a href="https://doi.org/10.3390/microorganisms8081222" title="DOI URL">https://doi.org/10.3390/microorganisms8081222</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/microorganisms8081222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmicroorganisms8081222%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroorganisms%26atitle%3DTargeting%252BBiofilms%252BTherapy%25253A%252BCurrent%252BResearch%252BStrategies%252Band%252BDevelopment%252BHurdles%26aulast%3DJiang%26aufirst%3DYu%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D8%26spage%3D1222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meysam  Sarshar</span>, <span class="hlFld-ContribAuthor ">Payam  Behzadi</span>, <span class="hlFld-ContribAuthor ">Cecilia  Ambrosi</span>, <span class="hlFld-ContribAuthor ">Carlo  Zagaglia</span>, <span class="hlFld-ContribAuthor ">Anna Teresa  Palamara</span>, <span class="hlFld-ContribAuthor ">Daniela  Scribano</span>. </span><span class="cited-content_cbyCitation_article-title">FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against Uropathogens. </span><span class="cited-content_cbyCitation_journal-name">Antibiotics</span><span> <strong>2020,</strong> <em>9 </em>
                                    (7)
                                     , 397. <a href="https://doi.org/10.3390/antibiotics9070397" title="DOI URL">https://doi.org/10.3390/antibiotics9070397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antibiotics9070397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantibiotics9070397%26sid%3Dliteratum%253Aachs%26jtitle%3DAntibiotics%26atitle%3DFimH%252Band%252BAnti-Adhesive%252BTherapeutics%25253A%252BA%252BDisarming%252BStrategy%252BAgainst%252BUropathogens%26aulast%3DSarshar%26aufirst%3DMeysam%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D7%26spage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pearl  Magala</span>, <span class="hlFld-ContribAuthor ">Rachel E.  Klevit</span>, <span class="hlFld-ContribAuthor ">Wendy E.  Thomas</span>, <span class="hlFld-ContribAuthor ">Evgeni V.  Sokurenko</span>, <span class="hlFld-ContribAuthor ">Ronald E.  Stenkamp</span>. </span><span class="cited-content_cbyCitation_article-title">RMSD analysis of structures of the bacterial protein FimH identifies five conformations of its lectin domain. </span><span class="cited-content_cbyCitation_journal-name">Proteins: Structure, Function, and Bioinformatics</span><span> <strong>2020,</strong> <em>88 </em>
                                    (4)
                                     , 593-603. <a href="https://doi.org/10.1002/prot.25840" title="DOI URL">https://doi.org/10.1002/prot.25840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prot.25840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprot.25840%26sid%3Dliteratum%253Aachs%26jtitle%3DProteins%253A%2520Structure%252C%2520Function%252C%2520and%2520Bioinformatics%26atitle%3DRMSD%252Banalysis%252Bof%252Bstructures%252Bof%252Bthe%252Bbacterial%252Bprotein%252BFimH%252Bidentifies%252Bfive%252Bconformations%252Bof%252Bits%252Blectin%252Bdomain%26aulast%3DMagala%26aufirst%3DPearl%26date%3D2020%26date%3D2019%26volume%3D88%26issue%3D4%26spage%3D593%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger D.  Klein</span>, <span class="hlFld-ContribAuthor ">Scott J.  Hultgren</span>. </span><span class="cited-content_cbyCitation_article-title">Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2020,</strong> <em>18 </em>
                                    (4)
                                     , 211-226. <a href="https://doi.org/10.1038/s41579-020-0324-0" title="DOI URL">https://doi.org/10.1038/s41579-020-0324-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41579-020-0324-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41579-020-0324-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DUrinary%252Btract%252Binfections%25253A%252Bmicrobial%252Bpathogenesis%25252C%252Bhost%2525E2%252580%252593pathogen%252Binteractions%252Band%252Bnew%252Btreatment%252Bstrategies%26aulast%3DKlein%26aufirst%3DRoger%2BD.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D211%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin O.  Tamadonfar</span>, <span class="hlFld-ContribAuthor ">Natalie S.  Omattage</span>, <span class="hlFld-ContribAuthor ">Caitlin N.  Spaulding</span>, <span class="hlFld-ContribAuthor ">Scott J.  Hultgren</span>. </span><span class="cited-content_cbyCitation_article-title">Reaching the End of the Line. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 83-99. <a href="https://doi.org/10.1128/9781683670261.ch6" title="DOI URL">https://doi.org/10.1128/9781683670261.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/9781683670261.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2F9781683670261.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DReaching%252Bthe%252BEnd%252Bof%252Bthe%252BLine%26aulast%3DTamadonfar%26aufirst%3DKevin%2BO.%26date%3D2020%26date%3D2020%26spage%3D83%26epage%3D99%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DBacteria%252Band%252BIntracellularity%26aulast%3DCossart%26aufirst%3DPascale%26date%3D2019%26volume%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vivek  Vinod</span>, <span class="hlFld-ContribAuthor ">Sukhithasri  Vijayrajratnam</span>, <span class="hlFld-ContribAuthor ">Anil Kumar  Vasudevan</span>, <span class="hlFld-ContribAuthor ">Raja  Biswas</span>. </span><span class="cited-content_cbyCitation_article-title">The cell surface adhesins of Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Microbiological Research</span><span> <strong>2020,</strong> <em>232 </em>, 126392. <a href="https://doi.org/10.1016/j.micres.2019.126392" title="DOI URL">https://doi.org/10.1016/j.micres.2019.126392</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.micres.2019.126392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.micres.2019.126392%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiological%2520Research%26atitle%3DThe%252Bcell%252Bsurface%252Badhesins%252Bof%252BMycobacterium%252Btuberculosis%26aulast%3DVinod%26aufirst%3DVivek%26date%3D2020%26volume%3D232%26spage%3D126392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joscha  Meiers</span>, <span class="hlFld-ContribAuthor ">Eike  Siebs</span>, <span class="hlFld-ContribAuthor ">Eva  Zahorska</span>, <span class="hlFld-ContribAuthor ">Alexander  Titz</span>. </span><span class="cited-content_cbyCitation_article-title">Lectin antagonists in infection, immunity, and inflammation. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2019,</strong> <em>53 </em>, 51-67. <a href="https://doi.org/10.1016/j.cbpa.2019.07.005" title="DOI URL">https://doi.org/10.1016/j.cbpa.2019.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2019.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DLectin%252Bantagonists%252Bin%252Binfection%25252C%252Bimmunity%25252C%252Band%252Binflammation%26aulast%3DMeiers%26aufirst%3DJoscha%26date%3D2019%26volume%3D53%26spage%3D51%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Victor  Tetz</span>, <span class="hlFld-ContribAuthor ">George  Tetz</span>. </span><span class="cited-content_cbyCitation_article-title">Bacterial DNA induces the formation of heat-resistant disease-associated proteins in human plasma. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-54618-9" title="DOI URL">https://doi.org/10.1038/s41598-019-54618-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-54618-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-54618-9%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DBacterial%252BDNA%252Binduces%252Bthe%252Bformation%252Bof%252Bheat-resistant%252Bdisease-associated%252Bproteins%252Bin%252Bhuman%252Bplasma%26aulast%3DTetz%26aufirst%3DVictor%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathleen  O’Connor</span>, <span class="hlFld-ContribAuthor ">Madeleine  Morrissette</span>, <span class="hlFld-ContribAuthor ">Philip  Strandwitz</span>, <span class="hlFld-ContribAuthor ">Meghan  Ghiglieri</span>, <span class="hlFld-ContribAuthor ">Mariaelena  Caboni</span>, <span class="hlFld-ContribAuthor ">Haiyan  Liu</span>, <span class="hlFld-ContribAuthor ">Christina  Khoo</span>, <span class="hlFld-ContribAuthor ">Anthony  D’Onofrio</span>, <span class="hlFld-ContribAuthor ">Kim  Lewis</span>, . </span><span class="cited-content_cbyCitation_article-title">Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2019,</strong> <em>14 </em>
                                    (11)
                                     , e0224836. <a href="https://doi.org/10.1371/journal.pone.0224836" title="DOI URL">https://doi.org/10.1371/journal.pone.0224836</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0224836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0224836%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DCranberry%252Bextracts%252Bpromote%252Bgrowth%252Bof%252BBacteroidaceae%252Band%252Bdecrease%252Babundance%252Bof%252BEnterobacteriaceae%252Bin%252Ba%252Bhuman%252Bgut%252Bsimulator%252Bmodel%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DKathleen%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D11%26spage%3De0224836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leila  Mousavifar</span>, <span class="hlFld-ContribAuthor ">Gérard  Vergoten</span>, <span class="hlFld-ContribAuthor ">Guillaume  Charron</span>, <span class="hlFld-ContribAuthor ">René  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative Study of Aryl O-, C-, and S-Mannopyranosides as Potential Adhesion Inhibitors toward Uropathogenic E. coli FimH. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (19)
                                     , 3566. <a href="https://doi.org/10.3390/molecules24193566" title="DOI URL">https://doi.org/10.3390/molecules24193566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24193566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24193566%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComparative%252BStudy%252Bof%252BAryl%252BO-%25252C%252BC-%25252C%252Band%252BS-Mannopyranosides%252Bas%252BPotential%252BAdhesion%252BInhibitors%252Btoward%252BUropathogenic%252BE.%252Bcoli%252BFimH%26aulast%3DMousavifar%26aufirst%3DLeila%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D19%26spage%3D3566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel  Hevey</span>. </span><span class="cited-content_cbyCitation_article-title">Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design. </span><span class="cited-content_cbyCitation_journal-name">Biomimetics</span><span> <strong>2019,</strong> <em>4 </em>
                                    (3)
                                     , 53. <a href="https://doi.org/10.3390/biomimetics4030053" title="DOI URL">https://doi.org/10.3390/biomimetics4030053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomimetics4030053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomimetics4030053%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomimetics%26atitle%3DBioisosteres%252Bof%252BCarbohydrate%252BFunctional%252BGroups%252Bin%252BGlycomimetic%252BDesign%26aulast%3DHevey%26aufirst%3DRachel%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D3%26spage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madeleine  Cauwel</span>, <span class="hlFld-ContribAuthor ">Adeline  Sivignon</span>, <span class="hlFld-ContribAuthor ">Clarisse  Bridot</span>, <span class="hlFld-ContribAuthor ">Medy C.  Nongbe</span>, <span class="hlFld-ContribAuthor ">David  Deniaud</span>, <span class="hlFld-ContribAuthor ">Benoit  Roubinet</span>, <span class="hlFld-ContribAuthor ">Ludovic  Landemarre</span>, <span class="hlFld-ContribAuthor ">François-Xavier  Felpin</span>, <span class="hlFld-ContribAuthor ">Julie  Bouckaert</span>, <span class="hlFld-ContribAuthor ">Nicolas  Barnich</span>, <span class="hlFld-ContribAuthor ">Sébastien G.  Gouin</span>. </span><span class="cited-content_cbyCitation_article-title">Heptylmannose-functionalized cellulose for the binding and specific detection of pathogenic
              E. coli. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (68)
                                     , 10158-10161. <a href="https://doi.org/10.1039/C9CC05545B" title="DOI URL">https://doi.org/10.1039/C9CC05545B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC05545B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC05545B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DHeptylmannose-functionalized%252Bcellulose%252Bfor%252Bthe%252Bbinding%252Band%252Bspecific%252Bdetection%252Bof%252Bpathogenic%252BE.%252Bcoli%26aulast%3DCauwel%26aufirst%3DMadeleine%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D68%26spage%3D10158%26epage%3D10161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel  Hevey</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for the Development of Glycomimetic Drug Candidates. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (2)
                                     , 55. <a href="https://doi.org/10.3390/ph12020055" title="DOI URL">https://doi.org/10.3390/ph12020055</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12020055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12020055%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DStrategies%252Bfor%252Bthe%252BDevelopment%252Bof%252BGlycomimetic%252BDrug%252BCandidates%26aulast%3DHevey%26aufirst%3DRachel%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D2%26spage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin O.  Tamadonfar</span>, <span class="hlFld-ContribAuthor ">Natalie S.  Omattage</span>, <span class="hlFld-ContribAuthor ">Caitlin N.  Spaulding</span>, <span class="hlFld-ContribAuthor ">Scott J.  Hultgren</span>, , , . </span><span class="cited-content_cbyCitation_article-title">Reaching the End of the Line: Urinary Tract Infections. </span><span class="cited-content_cbyCitation_journal-name">Microbiology Spectrum</span><span> <strong>2019,</strong> <em>7 </em>
                                    (3)
                                     <a href="https://doi.org/10.1128/microbiolspec.BAI-0014-2019" title="DOI URL">https://doi.org/10.1128/microbiolspec.BAI-0014-2019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/microbiolspec.BAI-0014-2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2Fmicrobiolspec.BAI-0014-2019%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%2520Spectrum%26atitle%3DReaching%252Bthe%252BEnd%252Bof%252Bthe%252BLine%25253A%252BUrinary%252BTract%252BInfections%26aulast%3DTamadonfar%26aufirst%3DKevin%2BO.%26date%3D2019%26volume%3D7%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harlei  Martin</span>, <span class="hlFld-ContribAuthor ">Mairead Mc  Govern</span>, <span class="hlFld-ContribAuthor ">Lorna  Abbey</span>, <span class="hlFld-ContribAuthor ">Aisling  Gilroy</span>, <span class="hlFld-ContribAuthor ">Stephanie  Mullins</span>, <span class="hlFld-ContribAuthor ">Sarah  Howell</span>, <span class="hlFld-ContribAuthor ">Kevin  Kavanagh</span>, <span class="hlFld-ContribAuthor ">Trinidad  Velasco-Torrijos</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of adherence of the yeast Candida albicans to buccal epithelial cells by synthetic aromatic glycoconjugates. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>160 </em>, 82-93. <a href="https://doi.org/10.1016/j.ejmech.2018.10.011" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.011%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibition%252Bof%252Badherence%252Bof%252Bthe%252Byeast%252BCandida%252Balbicans%252Bto%252Bbuccal%252Bepithelial%252Bcells%252Bby%252Bsynthetic%252Baromatic%252Bglycoconjugates%26aulast%3DMartin%26aufirst%3DHarlei%26date%3D2018%26volume%3D160%26spage%3D82%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Hooton</span>, <span class="hlFld-ContribAuthor ">Mariacristina  Vecchio</span>, <span class="hlFld-ContribAuthor ">Alison  Iroz</span>, <span class="hlFld-ContribAuthor ">Ivan  Tack</span>, <span class="hlFld-ContribAuthor ">Quentin  Dornic</span>, <span class="hlFld-ContribAuthor ">Isabelle  Seksek</span>, <span class="hlFld-ContribAuthor ">Yair  Lotan</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections. </span><span class="cited-content_cbyCitation_journal-name">JAMA Internal Medicine</span><span> <strong>2018,</strong> <em>178 </em>
                                    (11)
                                     , 1509. <a href="https://doi.org/10.1001/jamainternmed.2018.4204" title="DOI URL">https://doi.org/10.1001/jamainternmed.2018.4204</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1001/jamainternmed.2018.4204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1001%2Fjamainternmed.2018.4204%26sid%3Dliteratum%253Aachs%26jtitle%3DJAMA%2520Internal%2520Medicine%26atitle%3DEffect%252Bof%252BIncreased%252BDaily%252BWater%252BIntake%252Bin%252BPremenopausal%252BWomen%252BWith%252BRecurrent%252BUrinary%252BTract%252BInfections%26aulast%3DHooton%26aufirst%3DThomas%2BM.%26date%3D2018%26volume%3D178%26issue%3D11%26spage%3D1509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jitendra A.  Sattigeri</span>, <span class="hlFld-ContribAuthor ">Malvika  Garg</span>, <span class="hlFld-ContribAuthor ">Pragya  Bhateja</span>, <span class="hlFld-ContribAuthor ">Ajay  Soni</span>, <span class="hlFld-ContribAuthor ">Abdul Rehman Abdul  Rauf</span>, <span class="hlFld-ContribAuthor ">Mahendrakumar  Gupta</span>, <span class="hlFld-ContribAuthor ">Mahesh S.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Tarun  Jain</span>, <span class="hlFld-ContribAuthor ">Nidhi  Alekar</span>, <span class="hlFld-ContribAuthor ">Tarani Kanta  Barman</span>, <span class="hlFld-ContribAuthor ">Paras  Jha</span>, <span class="hlFld-ContribAuthor ">Tridib  Chaira</span>, <span class="hlFld-ContribAuthor ">Ramesh B.  Bambal</span>, <span class="hlFld-ContribAuthor ">Dilip J.  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Takahide  Nishi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of thiomannosides, potent and orally active FimH inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (17)
                                     , 2993-2997. <a href="https://doi.org/10.1016/j.bmcl.2018.06.017" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.06.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.06.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bthiomannosides%25252C%252Bpotent%252Band%252Borally%252Bactive%252BFimH%252Binhibitors%26aulast%3DSattigeri%26aufirst%3DJitendra%2BA.%26date%3D2018%26volume%3D28%26issue%3D17%26spage%3D2993%26epage%3D2997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eva-Maria  Krammer</span>, <span class="hlFld-ContribAuthor ">Jerome  de Ruyck</span>, <span class="hlFld-ContribAuthor ">Goedele  Roos</span>, <span class="hlFld-ContribAuthor ">Julie  Bouckaert</span>, <span class="hlFld-ContribAuthor ">Marc  Lensink</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Dynamical Binding Processes in the Design of Non-Antibiotic Anti-Adhesives by Molecular Simulation—The Example of FimH. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (7)
                                     , 1641. <a href="https://doi.org/10.3390/molecules23071641" title="DOI URL">https://doi.org/10.3390/molecules23071641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23071641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23071641%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTargeting%252BDynamical%252BBinding%252BProcesses%252Bin%252Bthe%252BDesign%252Bof%252BNon-Antibiotic%252BAnti-Adhesives%252Bby%252BMolecular%252BSimulation%2525E2%252580%252594The%252BExample%252Bof%252BFimH%26aulast%3DKrammer%26aufirst%3DEva-Maria%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D7%26spage%3D1641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasilios  Kalas</span>, <span class="hlFld-ContribAuthor ">Michael E.  Hibbing</span>, <span class="hlFld-ContribAuthor ">Amarendar Reddy  Maddirala</span>, <span class="hlFld-ContribAuthor ">Ryan  Chugani</span>, <span class="hlFld-ContribAuthor ">Jerome S.  Pinkner</span>, <span class="hlFld-ContribAuthor ">Laurel K.  Mydock-McGrane</span>, <span class="hlFld-ContribAuthor ">Matt S.  Conover</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>, <span class="hlFld-ContribAuthor ">Scott J.  Hultgren</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of glycomimetic FmlH ligands as inhibitors of bacterial adhesion during urinary tract infection. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2018,</strong> <em>115 </em>
                                    (12)
                                     , E2819-E2828. <a href="https://doi.org/10.1073/pnas.1720140115" title="DOI URL">https://doi.org/10.1073/pnas.1720140115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1720140115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1720140115%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bglycomimetic%252BFmlH%252Bligands%252Bas%252Binhibitors%252Bof%252Bbacterial%252Badhesion%252Bduring%252Burinary%252Btract%252Binfection%26aulast%3DKalas%26aufirst%3DVasilios%26date%3D2018%26date%3D2018%26volume%3D115%26issue%3D12%26spage%3DE2819%26epage%3DE2828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine A  Mowbray</span>, <span class="hlFld-ContribAuthor ">Syema  Shams</span>, <span class="hlFld-ContribAuthor ">Git  Chung</span>, <span class="hlFld-ContribAuthor ">Anna  Stanton</span>, <span class="hlFld-ContribAuthor ">Phillip  Aldridge</span>, <span class="hlFld-ContribAuthor ">Andrejus  Suchenko</span>, <span class="hlFld-ContribAuthor ">Robert S  Pickard</span>, <span class="hlFld-ContribAuthor ">Ased SM  Ali</span>, <span class="hlFld-ContribAuthor ">Judith  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">High molecular weight hyaluronic acid: a two-pronged protectant against infection of the urogenital tract?. </span><span class="cited-content_cbyCitation_journal-name">Clinical & Translational Immunology</span><span> <strong>2018,</strong> <em>7 </em>
                                    (6)
                                     , e1021. <a href="https://doi.org/10.1002/cti2.1021" title="DOI URL">https://doi.org/10.1002/cti2.1021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cti2.1021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcti2.1021%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520%2526%2520Translational%2520Immunology%26atitle%3DHigh%252Bmolecular%252Bweight%252Bhyaluronic%252Bacid%25253A%252Ba%252Btwo-pronged%252Bprotectant%252Bagainst%252Binfection%252Bof%252Bthe%252Burogenital%252Btract%25253F%26aulast%3DMowbray%26aufirst%3DCatherine%2BA%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D6%26spage%3De1021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G.  Cutolo</span>, <span class="hlFld-ContribAuthor ">F.  Reise</span>, <span class="hlFld-ContribAuthor ">M.  Schuler</span>, <span class="hlFld-ContribAuthor ">R.  Nehmé</span>, <span class="hlFld-ContribAuthor ">G.  Despras</span>, <span class="hlFld-ContribAuthor ">J.  Brekalo</span>, <span class="hlFld-ContribAuthor ">P.  Morin</span>, <span class="hlFld-ContribAuthor ">P.-Y.  Renard</span>, <span class="hlFld-ContribAuthor ">T. K.  Lindhorst</span>, <span class="hlFld-ContribAuthor ">A.  Tatibouët</span>. </span><span class="cited-content_cbyCitation_article-title">Bifunctional mannoside–glucosinolate glycoconjugates as enzymatically triggered isothiocyanates and FimH ligands. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (26)
                                     , 4900-4913. <a href="https://doi.org/10.1039/C8OB01128A" title="DOI URL">https://doi.org/10.1039/C8OB01128A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB01128A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB01128A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DBifunctional%252Bmannoside%2525E2%252580%252593glucosinolate%252Bglycoconjugates%252Bas%252Benzymatically%252Btriggered%252Bisothiocyanates%252Band%252BFimH%252Bligands%26aulast%3DCutolo%26aufirst%3DG.%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D26%26spage%3D4900%26epage%3D4913" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew B  Calvert</span>, <span class="hlFld-ContribAuthor ">Varsha R  Jumde</span>, <span class="hlFld-ContribAuthor ">Alexander  Titz</span>. </span><span class="cited-content_cbyCitation_article-title">Pathoblockers or antivirulence drugs as a new option for the treatment of bacterial infections. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>14 </em>, 2607-2617. <a href="https://doi.org/10.3762/bjoc.14.239" title="DOI URL">https://doi.org/10.3762/bjoc.14.239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.14.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.14.239%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPathoblockers%252Bor%252Bantivirulence%252Bdrugs%252Bas%252Ba%252Bnew%252Boption%252Bfor%252Bthe%252Btreatment%252Bof%252Bbacterial%252Binfections%26aulast%3DCalvert%26aufirst%3DMatthew%2BB%26date%3D2018%26date%3D2018%26volume%3D14%26spage%3D2607%26epage%3D2617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyun  Koo</span>, <span class="hlFld-ContribAuthor ">Raymond N.  Allan</span>, <span class="hlFld-ContribAuthor ">Robert P.  Howlin</span>, <span class="hlFld-ContribAuthor ">Paul  Stoodley</span>, <span class="hlFld-ContribAuthor ">Luanne  Hall-Stoodley</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting microbial biofilms: current and prospective therapeutic strategies. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Microbiology</span><span> <strong>2017,</strong> <em>15 </em>
                                    (12)
                                     , 740-755. <a href="https://doi.org/10.1038/nrmicro.2017.99" title="DOI URL">https://doi.org/10.1038/nrmicro.2017.99</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrmicro.2017.99&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrmicro.2017.99%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Microbiology%26atitle%3DTargeting%252Bmicrobial%252Bbiofilms%25253A%252Bcurrent%252Band%252Bprospective%252Btherapeutic%252Bstrategies%26aulast%3DKoo%26aufirst%3DHyun%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D12%26spage%3D740%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ased S. M.  Ali</span>, <span class="hlFld-ContribAuthor ">Catherine  Mowbray</span>, <span class="hlFld-ContribAuthor ">Marcelo  Lanz</span>, <span class="hlFld-ContribAuthor ">Anna  Stanton</span>, <span class="hlFld-ContribAuthor ">Samantha  Bowen</span>, <span class="hlFld-ContribAuthor ">Claire L.  Varley</span>, <span class="hlFld-ContribAuthor ">Paul  Hilton</span>, <span class="hlFld-ContribAuthor ">Karen  Brown</span>, <span class="hlFld-ContribAuthor ">Wendy  Robson</span>, <span class="hlFld-ContribAuthor ">Jennifer  Southgate</span>, <span class="hlFld-ContribAuthor ">Phillip D.  Aldridge</span>, <span class="hlFld-ContribAuthor ">Alison  Tyson-Capper</span>, <span class="hlFld-ContribAuthor ">Soman  Abraham</span>, <span class="hlFld-ContribAuthor ">Robert S.  Pickard</span>, <span class="hlFld-ContribAuthor ">Judith  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Deficiencies in the TLR5 Mediated Vaginal Response to Treat Female Recurrent Urinary Tract Infection. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-10445-4" title="DOI URL">https://doi.org/10.1038/s41598-017-10445-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-10445-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-10445-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTargeting%252BDeficiencies%252Bin%252Bthe%252BTLR5%252BMediated%252BVaginal%252BResponse%252Bto%252BTreat%252BFemale%252BRecurrent%252BUrinary%252BTract%252BInfection%26aulast%3DAli%26aufirst%3DAsed%2BS.%2BM.%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adeline  Sivignon</span>, <span class="hlFld-ContribAuthor ">Julie  Bouckaert</span>, <span class="hlFld-ContribAuthor ">Julien  Bernard</span>, <span class="hlFld-ContribAuthor ">Sebastien G.  Gouin</span>, <span class="hlFld-ContribAuthor ">Nicolas  Barnich</span>. </span><span class="cited-content_cbyCitation_article-title">The potential of FimH as a novel therapeutic target for the treatment of Crohn’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2017,</strong> <em>21 </em>
                                    (9)
                                     , 837-847. <a href="https://doi.org/10.1080/14728222.2017.1363184" title="DOI URL">https://doi.org/10.1080/14728222.2017.1363184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2017.1363184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2017.1363184%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DThe%252Bpotential%252Bof%252BFimH%252Bas%252Ba%252Bnovel%252Btherapeutic%252Btarget%252Bfor%252Bthe%252Btreatment%252Bof%252BCrohn%2525E2%252580%252599s%252Bdisease%26aulast%3DSivignon%26aufirst%3DAdeline%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D9%26spage%3D837%26epage%3D847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laurel K.  Mydock-McGrane</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Hannan</span>, <span class="hlFld-ContribAuthor ">James W.  Janetka</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2017,</strong> <em>12 </em>
                                    (7)
                                     , 711-731. <a href="https://doi.org/10.1080/17460441.2017.1331216" title="DOI URL">https://doi.org/10.1080/17460441.2017.1331216</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2017.1331216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2017.1331216%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRational%252Bdesign%252Bstrategies%252Bfor%252BFimH%252Bantagonists%25253A%252Bnew%252Bdrugs%252Bon%252Bthe%252Bhorizon%252Bfor%252Burinary%252Btract%252Binfection%252Band%252BCrohn%2525E2%252580%252599s%252Bdisease%26aulast%3DMydock-McGrane%26aufirst%3DLaurel%2BK.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D7%26spage%3D711%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Touaibia</span>, <span class="hlFld-ContribAuthor ">Eva-Maria  Krammer</span>, <span class="hlFld-ContribAuthor ">Tze  Shiao</span>, <span class="hlFld-ContribAuthor ">Nao  Yamakawa</span>, <span class="hlFld-ContribAuthor ">Qingan  Wang</span>, <span class="hlFld-ContribAuthor ">Anja  Glinschert</span>, <span class="hlFld-ContribAuthor ">Alex  Papadopoulos</span>, <span class="hlFld-ContribAuthor ">Leila  Mousavifar</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Maes</span>, <span class="hlFld-ContribAuthor ">Stefan  Oscarson</span>, <span class="hlFld-ContribAuthor ">Gerard  Vergoten</span>, <span class="hlFld-ContribAuthor ">Marc  Lensink</span>, <span class="hlFld-ContribAuthor ">René  Roy</span>, <span class="hlFld-ContribAuthor ">Julie  Bouckaert</span>. </span><span class="cited-content_cbyCitation_article-title">Sites for Dynamic Protein-Carbohydrate Interactions of O- and C-Linked Mannosides on the E. coli FimH Adhesin. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (7)
                                     , 1101. <a href="https://doi.org/10.3390/molecules22071101" title="DOI URL">https://doi.org/10.3390/molecules22071101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22071101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22071101%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSites%252Bfor%252BDynamic%252BProtein-Carbohydrate%252BInteractions%252Bof%252BO-%252Band%252BC-Linked%252BMannosides%252Bon%252Bthe%252BE.%252Bcoli%252BFimH%252BAdhesin%26aulast%3DTouaibia%26aufirst%3DMohamed%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D7%26spage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dimitri  Alvarez Dorta</span>, <span class="hlFld-ContribAuthor ">Thibaut  Chalopin</span>, <span class="hlFld-ContribAuthor ">Adeline  Sivignon</span>, <span class="hlFld-ContribAuthor ">Jérôme  de Ruyck</span>, <span class="hlFld-ContribAuthor ">Tetiana I.  Dumych</span>, <span class="hlFld-ContribAuthor ">Rostyslav O.  Bilyy</span>, <span class="hlFld-ContribAuthor ">David  Deniaud</span>, <span class="hlFld-ContribAuthor ">Nicolas  Barnich</span>, <span class="hlFld-ContribAuthor ">Julie  Bouckaert</span>, <span class="hlFld-ContribAuthor ">Sébastien G.  Gouin</span>. </span><span class="cited-content_cbyCitation_article-title">Physiochemical Tuning of Potent
              Escherichia coli
              Anti-Adhesives by Microencapsulation and Methylene Homologation. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (12)
                                     , 986-998. <a href="https://doi.org/10.1002/cmdc.201700061" title="DOI URL">https://doi.org/10.1002/cmdc.201700061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201700061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201700061%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DPhysiochemical%252BTuning%252Bof%252BPotent%252BEscherichia%252Bcoli%252BAnti-Adhesives%252Bby%252BMicroencapsulation%252Band%252BMethylene%252BHomologation%26aulast%3DAlvarez%25E2%2580%2585Dorta%26aufirst%3DDimitri%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D12%26spage%3D986%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hussein  Al-Mughaid</span>, <span class="hlFld-ContribAuthor ">Raed M.  Al-Zoubi</span>, <span class="hlFld-ContribAuthor ">Maha  Khazaaleh</span>, <span class="hlFld-ContribAuthor ">T. Bruce  Grindley</span>. </span><span class="cited-content_cbyCitation_article-title">Assembly and inhibitory activity of monovalent mannosides terminated with aromatic methyl esters: The effect of naphthyl groups. </span><span class="cited-content_cbyCitation_journal-name">Carbohydrate Research</span><span> <strong>2017,</strong> <em>446-447 </em>, 76-84. <a href="https://doi.org/10.1016/j.carres.2017.03.020" title="DOI URL">https://doi.org/10.1016/j.carres.2017.03.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.carres.2017.03.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.carres.2017.03.020%26sid%3Dliteratum%253Aachs%26jtitle%3DCarbohydrate%2520Research%26atitle%3DAssembly%252Band%252Binhibitory%252Bactivity%252Bof%252Bmonovalent%252Bmannosides%252Bterminated%252Bwith%252Baromatic%252Bmethyl%252Besters%25253A%252BThe%252Beffect%252Bof%252Bnaphthyl%252Bgroups%26aulast%3DAl-Mughaid%26aufirst%3DHussein%26date%3D2017%26volume%3D446-447%26spage%3D76%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cinzia  Colombo</span>, <span class="hlFld-ContribAuthor ">Anna  Bernardi</span>. </span><span class="cited-content_cbyCitation_article-title">Glycomimetics and Glycoconjugates as Therapeutics in Infectious Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.13887-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13887-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13887-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13887-9%26sid%3Dliteratum%253Aachs%26atitle%3DGlycomimetics%252Band%252BGlycoconjugates%252Bas%252BTherapeutics%252Bin%252BInfectious%252BDiseases%26aulast%3DColombo%26aufirst%3DCinzia%26date%3D2017%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Amanda C.  Richards</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Mulvey</span>, , , . </span><span class="cited-content_cbyCitation_article-title">Invasion of Host Cells and Tissues by Uropathogenic Bacteria. </span><span class="cited-content_cbyCitation_journal-name">Microbiology Spectrum</span><span> <strong>2016,</strong> <em>4 </em>
                                    (6)
                                     <a href="https://doi.org/10.1128/microbiolspec.UTI-0026-2016" title="DOI URL">https://doi.org/10.1128/microbiolspec.UTI-0026-2016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/microbiolspec.UTI-0026-2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2Fmicrobiolspec.UTI-0026-2016%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrobiology%2520Spectrum%26atitle%3DInvasion%252Bof%252BHost%252BCells%252Band%252BTissues%252Bby%252BUropathogenic%252BBacteria%26aulast%3DLewis%26aufirst%3DAdam%2BJ.%26date%3D2016%26volume%3D4%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Amanda C.  Richards</span>, <span class="hlFld-ContribAuthor ">Matthew A.  Mulvey</span>. </span><span class="cited-content_cbyCitation_article-title">Invasion of Host Cells and Tissues by Uropathogenic Bacteria. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 359-381. <a href="https://doi.org/10.1128/9781555817404.ch16" title="DOI URL">https://doi.org/10.1128/9781555817404.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/9781555817404.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2F9781555817404.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DInvasion%252Bof%252BHost%252BCells%252Band%252BTissues%252Bby%252BUropathogenic%252BBacteria%26aulast%3DLewis%26aufirst%3DAdam%2BJ.%26date%3D2016%26date%3D2016%26spage%3D359%26epage%3D381%26pub%3DASM%2520Press%26atitle%3DUrinary%252BTract%252BInfections%26aulast%3DMulvey%26aufirst%3DMatthew%2BA.%26date%3D2017%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Examples of simple glycosidic bond replacement of early lead <i>O</i>-mannosides <b>1</b> and <b>4</b>, with alternate linkers to the biphenyl aglycone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <i>N</i>-, <i>S</i>-, and Triazole-Linked Biphenyl Mannosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) methyl 4′-aminobiphenyl-3-carboxylate, EtOH, 55 °C; (b) 4-bromobenzenethiol, BF<sub>3</sub>–OEt<sub>2</sub>, DCM, 0 °C to rt; (c) 3-methoxycarbonylphenyl boronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/water (5/1), 80 °C; (d) NaOMe/MeOH, 0 °C to rt; (e) phenylacetylene, CuSO<sub>4</sub>, Na ascorbate, EtOH/H<sub>2</sub>O (4/1), rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <i>C</i>-Linked Amide Mannosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 25% HCl aq, 50 °C; (b) HATU, DIPEA, 0 °C to rt, DMF; (c) 4-bromobenzoyl chloride, pyridine, rt; (d) Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/water(5/1), 80 °C.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>C</i>-Linked Methylene and Hydroxy-Methylene Mannosides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIBAL, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C; (b) diethyl ether, −78 °C to −20 °C; (c) Dess–Martin periodinane, pyridine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) Li(<sup>t</sup>OBu)<sub>3</sub>AlH, THF, −40 to 0 °C; (e) 3-(<i>N</i>-methyaminocarbonyl)phenylboronic acid pinacol ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/water (5/1), 80 °C; (f) 10% Pd/C, H<sub>2</sub>, MeOH, rt.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Direct comparison of the potencies of <i>C</i>-linked methylene mannosides <b>21R</b>, <b>21S</b>, and <b>22</b> to those of similar <i>O</i>-mannoside analogues <b>23</b>, <b>24</b>, and <b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. In vitro analysis of mannoside potency. The difference in the conformational stability of the FimH lectin domain in the presence of mannoside compared to that in the absence of mannoside, as determined by differential scanning fluorimetry, is presented on the left axis. Measurement of the melting temperature is described in the methods. The hemagglutination inhibition data is presented relative to <span class="smallcaps smallerCapital">d</span>-mannose on the right axis and is described in the methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Structures and Synthesis of Prodrug Analogues of <i>O</i>-Mannoside <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ac<sub>2</sub>O, pyridine, rt; (b) POCl<sub>3</sub> trimethylphosphate, H<sub>2</sub>O, 0 °C; (c) TMSCl, Et<sub>3</sub>N, DMF, 0 °C; (d) AcOH, acetone/MeOH, 0 °C to rt; (e) <i>N</i>,<i>N</i>-dimethylglycine hydrochloride, DMAP, DIC, CH<sub>2</sub>Cl<sub>2</sub>/DIPEA, rt; (f) TFA, CH<sub>3</sub>CN, 0 °C.</p></p></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) X-ray structure of <b>23</b> bound to FimH (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F3F">5F3F</a>). Water-mediated H-bond of amide carbonyl to Y48. (B) Overlay of <b>23</b> with <b>24</b> (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F2F">5F2F</a>) and <b>1</b> (PBD <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MCY">3MCY</a>). Altered biphenyl ring conformation and amide carbonyl orientation of ortho-substituted mannosides <b>23</b> and <b>24</b> compared to <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Computational docking models of isomeric <i>C</i>-mannosides: (A) <i>S</i>-hydroxy (<b>21S</b>) and (B) <i>R</i>-hydroxy (<b>21R</b>) bound to the FimH mannose-binding pocket. The accepted model of <b>21R</b> is bound to FimH through water-mediated H-bond to D140 and N135.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (A) Derivatization of key building block <b>19R</b> (precursor to <b>21R</b>). (B) Small molecule X-ray structure of acetylated intermediate <b>27</b>, confirming the <i>R</i>-stereochemistry of the <b>21R</b> benzylic hydroxyl group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Mannoside levels were quantified in the urines of mice over a period of 8 h following oral gavage of drug as described in the methods. Data is presented as the mean and standard deviation from at least three independent experiments. Differences in concentration at the 8 h time point were tested for significance using Mann–Whitney U test. (* <i>P</i> < 0.05). (B) Measurement of mannoside in the plasma of rats following either a 10 mg/kg oral dose (dashed lines) or a 3 mg/kg intravenous dose (solid lines). Details regarding the measurement of mannoside are described in the methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Prophylactic treatment of an acute UTI. Mannoside was dosed orally at 25 mg/kg in 10% cyclodextrin, 30 min prior to infection with 10<sup>7</sup> CFUs UPEC. Bladders were harvested 6 h postinfection and bacterial burdens enumerated. (B) Mannoside treatment of chronic UTI. Mice were treated orally with 50 mg/kg of mannoside in 10% cyclodextrin, after 14 days of chronic UPEC infection. Bladders were harvested 6 h following oral dosing and bacterial burdens enumerated. Data from at least two independent experiments are presented in each panel; bars indicate geometric means. Differences between treated groups and vehicle were tested for significance using Mann–Whitney U test (*** <i>P</i> = 0.0001, **** <i>P</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Pharmacodynamics of <i>O</i>-linked mannoside. Chronically infected mice were treated orally with 50 mg/kg of mannoside <b>24</b>. Bladders were harvested at the designated time points following oral dosing and bacterial burden enumerated. Bars indicate geometric means. Differences between the designated time point and the 0 h time point were tested for significance using Mann–Whitney U test (* <i>P</i> < 0.05, ** <i>P</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/medium/jm-2016-009486_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Improved efficacy of <i>C</i>-linked mannosides. (A) Chronically infected mice were treated orally with 25 mg/kg of mannoside. Bladders were harvested 12 hours following oral dosing and bacterial burdens enumerated. (B) Mice were treated orally with 25 mg/kg of mannoside 30 min prior to infection. Bladders were harvested 6 h following infection and bacterial burdens enumerated. Data from at least two independent experiments are presented; bars indicate geometric means. Differences between treated groups and vehicle were tested for significance using Mann–Whitney U test (**<i>P</i> < 0.01, *** <i>P</i> = 0.0001, **** <i>P</i> < 0.0001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-20/acs.jmedchem.6b00948/20170930/images/large/jm-2016-009486_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00948&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 40 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Boyle, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, B. B.</span><span> </span><span class="NLM_article-title">Bacterial pathogenesis: exploiting cellular adherence</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">633</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span><span class="refDoi"> DOI: 10.1016/S0955-0674(03)00099-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0955-0674%2803%2900099-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=14519399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnslSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=633-639&author=E.+C.+Boyleauthor=B.+B.+Finlay&title=Bacterial+pathogenesis%3A+exploiting+cellular+adherence&doi=10.1016%2FS0955-0674%2803%2900099-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial pathogenesis: exploiting cellular adherence</span></div><div class="casAuthors">Boyle, Erin C.; Finlay, B. Brett</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">633-639</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Cell adhesion mols., such as integrins, cadherins, the Ig superfamily of cell adhesion mols. and selectins, play important structural roles and are involved in various signal transduction processes.  As an initial step in the infectious process, many bacterial pathogens adhere to cell adhesion mols. as a means of exploiting the underlying signaling pathways, entering into host cells or establishing extracellular persistence.  Often, bacteria are able to bind to cell adhesion mols. by mimicking or acting in place of host cell receptors or their ligands.  Recent studies have contributed to the authors' understanding of bacterial adherence mechanisms and the consequences of receptor engagement; they have also highlighted alternative functions of cell adhesion mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_foAdj7ONorVg90H21EOLACvtfcHk0lhdjjm1kJpjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnslSqsbc%253D&md5=2c66a4bf7a0edf039bc1258b164d271a</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2803%2900099-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252803%252900099-1%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DE.%2BC.%26aulast%3DFinlay%26aufirst%3DB.%2BB.%26atitle%3DBacterial%2520pathogenesis%253A%2520exploiting%2520cellular%2520adherence%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2003%26volume%3D15%26spage%3D633%26epage%3D639%26doi%3D10.1016%2FS0955-0674%2803%2900099-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chagnot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Listrat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Astruc, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desvaux, M.</span><span> </span><span class="NLM_article-title">Bacterial adhesion to animal tissues: protein determinants for recognition of extracellular matrix components</span> <span class="citation_source-journal">Cell. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1696</span><span class="refDoi"> DOI: 10.1111/cmi.12002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1111%2Fcmi.12002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=22882798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFWisbfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=1687-1696&author=C.+Chagnotauthor=A.+Listratauthor=T.+Astrucauthor=M.+Desvaux&title=Bacterial+adhesion+to+animal+tissues%3A+protein+determinants+for+recognition+of+extracellular+matrix+components&doi=10.1111%2Fcmi.12002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Bacterial adhesion to animal tissues: protein determinants for recognition of extracellular matrix components</span></div><div class="casAuthors">Chagnot, Caroline; Listrat, Anne; Astruc, Thierry; Desvaux, Mickael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1687-1696</span>CODEN:
                <span class="NLM_cas:coden">CEMIF5</span>;
        ISSN:<span class="NLM_cas:issn">1462-5814</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The extracellular matrix (ECM) is present within all animal tissues and organs.  Actually, it surrounds the eukaryotic cells composing the four basic tissue types, i.e. epithelial, muscle, nerve and connective.  ECM does not solely refer to connective tissue but composes all tissues where its compn., structure and organization vary from one tissue to another.  Constituted of the four main fibrous proteins, i.e., collagen, fibronectin, laminin and elastin, ECM components form a highly structured and functional network via specific interactions.  From the basement membrane to interstitial matrix, further heterogeneity exists in the organization of the ECM in various tissues and organs also depending on their physiol. state.  Back to a mol. level, bacterial proteins represent the most significant part of the microbial surface components recognizing adhesive matrix mols. (MSCRAMM).  These cell surface proteins are secreted and localized differently in monoderm and diderm-LPS bacteria.  While one collagen-binding domain (CBD) and different fibronectin-binding domains (FBD1 to 8) have been registered in databases, much remains to be learned on specific binding to other ECM proteins via single or supramol. protein structures.  Besides theinteraction of bacterial proteins with individual ECM components, this review aims at stressing the importance of fully considering the ECM at supramol., cellular, tissue and organ levels.  This conceptual view should not be overlooked to rigorously comprehend the physiol. of bacterial interaction from commensal to pathogenic species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMpLccx2OGVLVg90H21EOLACvtfcHk0lg13EA0wx5B8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFWisbfK&md5=934c2aee39c53330b0ff906c15fb7478</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fcmi.12002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcmi.12002%26sid%3Dliteratum%253Aachs%26aulast%3DChagnot%26aufirst%3DC.%26aulast%3DListrat%26aufirst%3DA.%26aulast%3DAstruc%26aufirst%3DT.%26aulast%3DDesvaux%26aufirst%3DM.%26atitle%3DBacterial%2520adhesion%2520to%2520animal%2520tissues%253A%2520protein%2520determinants%2520for%2520recognition%2520of%2520extracellular%2520matrix%2520components%26jtitle%3DCell.%2520Microbiol.%26date%3D2012%26volume%3D14%26spage%3D1687%26epage%3D1696%26doi%3D10.1111%2Fcmi.12002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ofek, I.; Beachey, E. H.</span><span> </span><span class="NLM_article-title">General concepts and principles of bacterial adherence</span>. In  <span class="citation_source-book">Bacterial Adherence, Receptors and Recognition</span>, <span class="NLM_contrib-group">Beachey, E. H.</span>, Ed.; <span class="NLM_publisher-name">Chapman and Hall</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">1980</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">6</span>, pp  <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1007%2F978-94-009-5863-0_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=1-29&author=I.+Ofek&author=E.+H.+Beacheyauthor=E.+H.+Beachey&title=Bacterial+Adherence%2C+Receptors+and+Recognition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1007%2F978-94-009-5863-0_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-94-009-5863-0_1%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DI.%26atitle%3DGeneral%2520concepts%2520and%2520principles%2520of%2520bacterial%2520adherence%26btitle%3DBacterial%2520Adherence%252C%2520Receptors%2520and%2520Recognition%26aulast%3DBeachey%26aufirst%3DE.%2BH.%26pub%3DChapman%2520and%2520Hall%26date%3D1980%26volume%3D6%26spage%3D1%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ofek, I.; Doyle, R. J.</span><span> </span><span class="NLM_article-title">Common Themes in Bacterial Adhesion</span>. In  <span class="citation_source-book">Bacterial Adhesion to Cells and Tissues</span>; <span class="NLM_publisher-name">Chapman and Hall</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1994</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1007%2F978-1-4684-6435-1_11" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1994&pages=513-561&author=I.+Ofek&author=R.+J.+Doyle&title=Bacterial+Adhesion+to+Cells+and+Tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1007%2F978-1-4684-6435-1_11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4684-6435-1_11%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DI.%26atitle%3DCommon%2520Themes%2520in%2520Bacterial%2520Adhesion%26btitle%3DBacterial%2520Adhesion%2520to%2520Cells%2520and%2520Tissues%26pub%3DChapman%2520and%2520Hall%26date%3D1994%26spage%3D513%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Aminov, R. I.</span><span> </span><span class="NLM_article-title">A brief history of the antibiotic era: lessons learned and challenges for the future</span> <span class="citation_source-journal">Front. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="refDoi"> DOI: 10.3389/fmicb.2010.00134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.3389%2Ffmicb.2010.00134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21687759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC3MnhvFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=134&author=R.+I.+Aminov&title=A+brief+history+of+the+antibiotic+era%3A+lessons+learned+and+challenges+for+the+future&doi=10.3389%2Ffmicb.2010.00134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A brief history of the antibiotic era: lessons learned and challenges for the future</span></div><div class="casAuthors">Aminov Rustam I</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">134</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This article gives a very brief overview of the antibiotic era, beginning from the discovery of first antibiotics until the present day situation, which is marred by the emergence of hard-to-treat multiple antibiotic-resistant infections.  The ways of responding to the antibiotic resistance challenges such as the development of novel strategies in the search for new antimicrobials, designing more effective preventive measures and, importantly, better understanding the ecology of antibiotics and antibiotic resistance are discussed.  The expansion of conceptual frameworks based on recent developments in the field of antimicrobials, antibiotic resistance, and chemotherapy is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfn9PZkmJQCdhSDZx9hyjKfW6udTcc2eZgdweHYNpfnLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnhvFahtw%253D%253D&md5=dce335e0deb68eed8c865d861d8ce6c4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2010.00134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2010.00134%26sid%3Dliteratum%253Aachs%26aulast%3DAminov%26aufirst%3DR.%2BI.%26atitle%3DA%2520brief%2520history%2520of%2520the%2520antibiotic%2520era%253A%2520lessons%2520learned%2520and%2520challenges%2520for%2520the%2520future%26jtitle%3DFront.%2520Microbiol.%26date%3D2010%26volume%3D1%26spage%3D134%26doi%3D10.3389%2Ffmicb.2010.00134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Who will develop new antibacterial agents?</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">20130430</span><span class="refDoi"> DOI: 10.1098/rstb.2013.0430</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1098%2Frstb.2013.0430" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=24821916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC2cjit1OisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2014&pages=20130430&author=S.+T.+Cole&title=Who+will+develop+new+antibacterial+agents%3F&doi=10.1098%2Frstb.2013.0430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Who will develop new antibacterial agents?</span></div><div class="casAuthors">Cole Stewart T</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">1645</span>),
    <span class="NLM_cas:pages">20130430</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The golden age of antimicrobial drug development is a distant memory, and the likelihood of there being another seems slim.  In part, this is because the pharmaceutical industry, which has now adopted an unsustainable business model, abandoned the anti-infective sector, and the pipeline is almost empty.  The contribution to this crisis of national governments, health agencies and funders also merits discussion.  Much of the basis for drug discovery is funded by the public sector, thereby generating intellectual property and leads for drug development that are often not pursued owing to funding gaps.  In particular, the cost of testing drug efficacy in clinical trials is beyond the means of most companies and organizations.  Lack of a concerted international effort to develop new antimicrobials is particularly alarming at a time when multidrug-resistant bacteria threaten all areas of human medicine globally.  Here, the steps that led to this situation are retraced, and some possible solutions to the dilemma are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRfZ9O2ls1xU5I8NvIb08rbfW6udTcc2eaZRcJ-SXoKv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjit1OisA%253D%253D&md5=2f42322da21ab17f301e103920b47e9b</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1098%2Frstb.2013.0430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2013.0430%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DWho%2520will%2520develop%2520new%2520antibacterial%2520agents%253F%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2014%26volume%3D369%26spage%3D20130430%26doi%3D10.1098%2Frstb.2013.0430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walsh, C.</span><span> </span><span class="NLM_article-title">Where will new antibiotics come from?</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1038/nrmicro727</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnrmicro727" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=15040181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFWlu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=65-70&author=C.+Walsh&title=Where+will+new+antibiotics+come+from%3F&doi=10.1038%2Fnrmicro727"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Where will new antibiotics come from?</span></div><div class="casAuthors">Walsh, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-70</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  There is a const. need for new antibacterial drugs owing to the inevitable development of resistance that follows the introduction of antibiotics to the clinic.  When a new class of antibiotic is introduced, it is effective at first, but will eventually select for survival of the small fraction of bacterial populations that have an intrinsic or acquired resistance mechanism.  Pathogens that are resistant to multiple drugs emerge around the globe, so how robust are antibiotic discovery processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWf-wNvjdudbVg90H21EOLACvtfcHk0lhz7RKbQvwDlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFWlu7s%253D&md5=be8a897b57e796094c5b54652152d533</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro727%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DC.%26atitle%3DWhere%2520will%2520new%2520antibiotics%2520come%2520from%253F%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2003%26volume%3D1%26spage%3D65%26epage%3D70%26doi%3D10.1038%2Fnrmicro727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almqvist, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Targeting virulence for antimicrobial chemotherapy</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span><span class="refDoi"> DOI: 10.1016/j.coph.2003.04.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.coph.2003.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=14559097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXotVersLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=513-519&author=Y.+M.+Leeauthor=F.+Almqvistauthor=S.+J.+Hultgren&title=Targeting+virulence+for+antimicrobial+chemotherapy&doi=10.1016%2Fj.coph.2003.04.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting virulence for antimicrobial chemotherapy</span></div><div class="casAuthors">Lee, Yvonne M.; Almqvist, Fredrik; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Untreatable bacterial infections constitute a dark but valid threat, with nos. of antibiotic resistant pathogens, as well as newly emerging ones, rising quickly.  To combat this dangerous prospect, growing research into antimicrobials could be aimed at targeting the virulence of pathogens.  Virulence refers to an organism's ability to establish an infection and cause disease.  Many steps involved in the infection process can be targeted, including adherence, invasion and host defense evasion.  Identification and characterization of virulence factors that aid in bacterial pathogenicity will lead to new drugs that can be applied to a variety of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2tUTy7NyZG7Vg90H21EOLACvtfcHk0lj7cfLHhAbHgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXotVersLY%253D&md5=5446898f6e3e2caf8588fea1eb2736d9</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2003.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2003.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BM.%26aulast%3DAlmqvist%26aufirst%3DF.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DTargeting%2520virulence%2520for%2520antimicrobial%2520chemotherapy%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2003%26volume%3D3%26spage%3D513%26epage%3D519%26doi%3D10.1016%2Fj.coph.2003.04.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rasko, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, V.</span><span> </span><span class="NLM_article-title">Anti-virulence strategies to combat bacteria-mediated disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span><span class="refDoi"> DOI: 10.1038/nrd3013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnrd3013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=20081869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=117-128&author=D.+A.+Raskoauthor=V.+Sperandio&title=Anti-virulence+strategies+to+combat+bacteria-mediated+disease&doi=10.1038%2Fnrd3013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-virulence strategies to combat bacteria-mediated disease</span></div><div class="casAuthors">Rasko, David A.; Sperandio, Vanessa</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">117-128</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Antibiotic resistance is one of the greatest challenges of the twenty-first century.  However, the increasing understanding of bacterial pathogenesis and intercellular communication has revealed many potential strategies to develop novel drugs to treat bacteria-mediated disease.  Interference with bacterial virulence and/or cell-to-cell signaling pathways is an esp. compelling approach, as it is thought to apply less selective pressure for the development of bacterial resistance than traditional strategies, which are aimed at killing bacteria or preventing their growth.  Here, we discuss the mechanisms of bacterial virulence and present promising anti-virulence strategies and compds. for the future treatment of bacterial infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrc_XHw8YsfL7Vg90H21EOLACvtfcHk0lj7cfLHhAbHgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVCmsA%253D%253D&md5=e46d5501a1a28a3deb2e3b2432dff66a</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrd3013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3013%26sid%3Dliteratum%253Aachs%26aulast%3DRasko%26aufirst%3DD.%2BA.%26aulast%3DSperandio%26aufirst%3DV.%26atitle%3DAnti-virulence%2520strategies%2520to%2520combat%2520bacteria-mediated%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D117%26epage%3D128%26doi%3D10.1038%2Fnrd3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasty, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Anti-adhesion therapy of bacterial diseases: prospects and problems</span> <span class="citation_source-journal">FEMS Immunol. Med. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">191</span><span class="refDoi"> DOI: 10.1016/S0928-8244(03)00228-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0928-8244%2803%2900228-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=14522453" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3sXns12mu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2003&pages=181-191&author=I.+Ofekauthor=D.+L.+Hastyauthor=N.+Sharon&title=Anti-adhesion+therapy+of+bacterial+diseases%3A+prospects+and+problems&doi=10.1016%2FS0928-8244%2803%2900228-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-adhesion therapy of bacterial diseases: prospects and problems</span></div><div class="casAuthors">Ofek, Itzhak; Hasty, David L.; Sharon, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">FEMS Immunology and Medical Microbiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-191</span>CODEN:
                <span class="NLM_cas:coden">FIMIEV</span>;
        ISSN:<span class="NLM_cas:issn">0928-8244</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review.  The alarming increase in drug-resistant bacteria makes a search for novel means of fighting bacterial infections imperative.  An attractive approach is the use of agents that interfere with the ability of the bacteria to adhere to tissues of the host, since such adhesion is one of the initial stages of the infectious process.  The validity of this approach was unequivocally demonstrated in expts. performed in a wide variety of animals, from mice to monkeys, and recently also in humans.  Here the authors review various approaches to anti-adhesion therapy, including the use of receptor and adhesin analogs, dietary constituents, sublethal concns. of antibiotics and adhesin-based vaccines.  Because anti-adhesive agents are not bactericidal, the propagation and spread of resistant strains is much less likely to occur than as a result of exposure to bactericidal agents, such as antibiotics.  Anti-adhesive drugs, once developed, may, therefore, serve as a new means to fight infectious diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreciCaROJQL7Vg90H21EOLACvtfcHk0lgqgiukTaNu0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXns12mu70%253D&md5=6effc02ae6bddbd23ac437b3b4918131</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2FS0928-8244%2803%2900228-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0928-8244%252803%252900228-1%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DHasty%26aufirst%3DD.%2BL.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DAnti-adhesion%2520therapy%2520of%2520bacterial%2520diseases%253A%2520prospects%2520and%2520problems%26jtitle%3DFEMS%2520Immunol.%2520Med.%2520Microbiol.%26date%3D2003%26volume%3D38%26spage%3D181%26epage%3D191%26doi%3D10.1016%2FS0928-8244%2803%2900228-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cozens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. C.</span><span> </span><span class="NLM_article-title">Anti-adhesion methods as novel therapeutics for bacterial infections</span> <span class="citation_source-journal">Expert Rev. Anti-Infect. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1457</span><span class="NLM_x">–</span> <span class="NLM_lpage">1468</span><span class="refDoi"> DOI: 10.1586/eri.12.145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1586%2Feri.12.145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=23253323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=1457-1468&author=D.+Cozensauthor=R.+C.+Read&title=Anti-adhesion+methods+as+novel+therapeutics+for+bacterial+infections&doi=10.1586%2Feri.12.145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-adhesion methods as novel therapeutics for bacterial infections</span></div><div class="casAuthors">Cozens, Daniel; Read, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Anti-Infective Therapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1457-1468</span>CODEN:
                <span class="NLM_cas:coden">ERATCK</span>;
        ISSN:<span class="NLM_cas:issn">1478-7210</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  Anti-adhesion therapies for bacterial infections offer an alternative to antibiotics, with those therapies bacteria are not killed but are prevented from causing harm to a host by inhibiting adherence to host cells and tissues, a prerequisite for the majority of infectious diseases.  The mechanisms of these potential therapeutic agents include inhibition of adhesins and their host receptors, vaccination with adhesins or analogs, use of probiotics and dietary supplements that interfere with receptor-adhesin interactions, subminimal inhibitory concns. of antibiotics and manipulation of hydrophobic interactions.  Once developed, these drugs will contribute to the arsenal for fighting infectious disease in the future, potentially subverting antibiotic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrw2Y4_UrjF8LVg90H21EOLACvtfcHk0lgqgiukTaNu0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmtL7O&md5=52a245c93a8aec943bd6d1f70990de47</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1586%2Feri.12.145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Feri.12.145%26sid%3Dliteratum%253Aachs%26aulast%3DCozens%26aufirst%3DD.%26aulast%3DRead%26aufirst%3DR.%2BC.%26atitle%3DAnti-adhesion%2520methods%2520as%2520novel%2520therapeutics%2520for%2520bacterial%2520infections%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2012%26volume%3D10%26spage%3D1457%26epage%3D1468%26doi%3D10.1586%2Feri.12.145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berglund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schembri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Genst, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cools, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuhrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattegard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavialov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhury, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyns, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klemm, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oscarson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Greve, H.</span><span> </span><span class="NLM_article-title">Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">455</span><span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04415.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1111%2Fj.1365-2958.2004.04415.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=15659162" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWgt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2005&pages=441-455&author=J.+Bouckaertauthor=J.+Berglundauthor=M.+Schembriauthor=E.+De+Genstauthor=L.+Coolsauthor=M.+Wuhrerauthor=C.+S.+Hungauthor=J.+Pinknerauthor=R.+Slattegardauthor=A.+Zavialovauthor=D.+Choudhuryauthor=S.+Langermannauthor=S.+J.+Hultgrenauthor=L.+Wynsauthor=P.+Klemmauthor=S.+Oscarsonauthor=S.+D.+Knightauthor=H.+De+Greve&title=Receptor+binding+studies+disclose+a+novel+class+of+high-affinity+inhibitors+of+the+Escherichia+coli+FimH+adhesin&doi=10.1111%2Fj.1365-2958.2004.04415.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin</span></div><div class="casAuthors">Bouckaert, Julie; Berglund, Jenny; Schembri, Mark; De Genst, Erwin; Cools, Lieve; Wuhrer, Manfred; Hung, Chia-Suei; Pinkner, Jerome; Slaettegard, Rikard; Zavialov, Anton; Choudhury, Devapriya; Langermann, Solomon; Hultgren, Scott J.; Wyns, Lode; Klemm, Per; Oscarson, Stefan; Knight, Stefan D.; De Greve, Henri</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">441-455</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Mannose-binding type 1 pili are important virulence factors for the establishment of Escherichia coli urinary tract infections (UTIs).  These infections are initiated by adhesion of uropathogenic E. coli to uroplakin receptors in the uroepithelium via the FimH adhesin located at the tips of type 1 pili.  Blocking of bacterial adhesion is able to prevent infection.  Here, the authors provide for the first time binding data of the mol. events underlying type 1 fimbrial adherence, by crystallog. analyses of the FimH receptor binding domains from a uropathogenic and a K-12 strain, and affinity measurements with mannose, common mono- and disaccharides, and a series of alkyl and aryl mannosides.  The results illustrate that the lectin domain of the FimH adhesin is a stable and functional entity and that an exogenous Bu α-D-mannoside, bound in the crystal structures, exhibits a significantly better affinity for FimH (Kd = 0.15 μM) than mannose (Kd = 2.3 μM).  Exploration of the binding affinities of α-D-mannosides with longer alkyl tails revealed affinities up to 5 nM.  Aryl mannosides and fructose can also bind with high affinities to the FimH lectin domain, with a 100-fold improvement and 15-fold redn. in affinity, resp., compared with mannose.  Taken together, these relative FimH affinities correlate exceptionally well with the relative concns. of the same glycans needed for the inhibition of adherence of type 1 piliated E. coli.  The authors foresee that the authors' findings will spark new ideas and initiatives for the development of UTI vaccines and anti-adhesive drugs to prevent anticipated and recurrent UTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkCuZSIXeshLVg90H21EOLACvtfcHk0lgqgiukTaNu0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWgt7c%253D&md5=9f70959aff94b04ce2926947b2b5519f</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04415.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04415.x%26sid%3Dliteratum%253Aachs%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DBerglund%26aufirst%3DJ.%26aulast%3DSchembri%26aufirst%3DM.%26aulast%3DDe%2BGenst%26aufirst%3DE.%26aulast%3DCools%26aufirst%3DL.%26aulast%3DWuhrer%26aufirst%3DM.%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DPinkner%26aufirst%3DJ.%26aulast%3DSlattegard%26aufirst%3DR.%26aulast%3DZavialov%26aufirst%3DA.%26aulast%3DChoudhury%26aufirst%3DD.%26aulast%3DLangermann%26aufirst%3DS.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DWyns%26aufirst%3DL.%26aulast%3DKlemm%26aufirst%3DP.%26aulast%3DOscarson%26aufirst%3DS.%26aulast%3DKnight%26aufirst%3DS.%2BD.%26aulast%3DDe%2BGreve%26aufirst%3DH.%26atitle%3DReceptor%2520binding%2520studies%2520disclose%2520a%2520novel%2520class%2520of%2520high-affinity%2520inhibitors%2520of%2520the%2520Escherichia%2520coli%2520FimH%2520adhesin%26jtitle%3DMol.%2520Microbiol.%26date%3D2005%26volume%3D55%26spage%3D441%26epage%3D455%26doi%3D10.1111%2Fj.1365-2958.2004.04415.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Jones, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholes, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">2081</span><span class="NLM_x">–</span> <span class="NLM_lpage">2085</span><span class="refDoi"> DOI: 10.1073/pnas.92.6.2081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1073%2Fpnas.92.6.2081" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=2081-2085&author=C.+H.+Jonesauthor=J.+S.+Pinknerauthor=R.+Rothauthor=J.+Heuserauthor=A.+V.+Nicholesauthor=S.+N.+Abrahamauthor=S.+J.+Hultgren&title=FimH+adhesin+of+type+1+pili+is+assembled+into+a+fibrillar+tip+structure+in+the+Enterobacteriaceae&doi=10.1073%2Fpnas.92.6.2081"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.6.2081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.6.2081%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%2BH.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DRoth%26aufirst%3DR.%26aulast%3DHeuser%26aufirst%3DJ.%26aulast%3DNicholes%26aufirst%3DA.%2BV.%26aulast%3DAbraham%26aufirst%3DS.%2BN.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DFimH%2520adhesin%2520of%2520type%25201%2520pili%2520is%2520assembled%2520into%2520a%2520fibrillar%2520tip%2520structure%2520in%2520the%2520Enterobacteriaceae%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D2081%26epage%3D2085%26doi%3D10.1073%2Fpnas.92.6.2081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auguste, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strouse, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langermann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span><span class="refDoi"> DOI: 10.1046/j.1365-2958.2002.02915.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1046%2Fj.1365-2958.2002.02915.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=12010488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2002&pages=903-915&author=C.+S.+Hungauthor=J.+Bouckaertauthor=D.+Hungauthor=J.+Pinknerauthor=C.+Widbergauthor=A.+DeFuscoauthor=C.+G.+Augusteauthor=R.+Strouseauthor=S.+Langermannauthor=G.+Waksmanauthor=S.+J.+Hultgren&title=Structural+basis+of+tropism+of+Escherichia+coli+to+the+bladder+during+urinary+tract+infection&doi=10.1046%2Fj.1365-2958.2002.02915.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection</span></div><div class="casAuthors">Hung, Chia-Suei; Bouckaert, Julie; Hung, Danielle; Pinkner, Jerome; Widberg, Charlotte; DeFusco, Anthony; Auguste, C. Gale; Strouse, Robert; Langermann, Solomon; Waksman, Gabriel; Hultgren, Scott J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">903-915</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The first step in the colonization of the human urinary tract by pathogenic Escherichia coli is the mannose-sensitive binding of FimH, the adhesin present at the tip of type 1 pili, to the bladder epithelium.  We elucidated crystallog. the interactions of FimH with D-mannose.  The unique site binding pocket occupied by D-mannose was probed using site-directed mutagenesis.  All but one of the mutants examd. had greatly diminished mannose-binding activity and had also lost the ability to bind human bladder cells.  The binding activity of the monosaccharide D-mannose was delineated from this of mannotriose (Man(α1-3)[Man(α1-6)]Man) by generating mutants that abolished D-mannose binding but retained mannotriose binding activity.  Our structure/function anal. demonstrated that the binding of the monosaccharide α-D-mannose is the primary bladder cell receptor for uropathogenic E. coli and that this event requires a highly conserved FimH binding pocket.  The residues in the FimH mannose-binding pocket were sequenced and found to be invariant in over 200 uropathogenic strains of E. coli.  Only enterohemorrhagic E. coli (EHEC) possess a sequence variation within the mannose-binding pocket of FimH, suggesting a naturally occurring mechanism of attenuation in EHEC bacteria that would prevent them from being targeted to the urinary tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoljy6DS5GA8bVg90H21EOLACvtfcHk0lhkuncW1AkUYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XktlGgsrY%253D&md5=b2d31ffbc2540d4be1bfff9d4036f5eb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-2958.2002.02915.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-2958.2002.02915.x%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DHung%26aufirst%3DD.%26aulast%3DPinkner%26aufirst%3DJ.%26aulast%3DWidberg%26aufirst%3DC.%26aulast%3DDeFusco%26aufirst%3DA.%26aulast%3DAuguste%26aufirst%3DC.%2BG.%26aulast%3DStrouse%26aufirst%3DR.%26aulast%3DLangermann%26aufirst%3DS.%26aulast%3DWaksman%26aufirst%3DG.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DStructural%2520basis%2520of%2520tropism%2520of%2520Escherichia%2520coli%2520to%2520the%2520bladder%2520during%2520urinary%2520tract%2520infection%26jtitle%3DMol.%2520Microbiol.%26date%3D2002%26volume%3D44%26spage%3D903%26epage%3D915%26doi%3D10.1046%2Fj.1365-2958.2002.02915.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Puorger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vetsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wider, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glockshuber, R.</span><span> </span><span class="NLM_article-title">Structure, folding and stability of FimA, the main structural subunit of type 1 pili from uropathogenic Escherichia coli strains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">412</span><span class="NLM_x">, </span> <span class="NLM_fpage">520</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span><span class="refDoi"> DOI: 10.1016/j.jmb.2011.07.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.jmb.2011.07.044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=412&publication_year=2011&pages=520-535&author=C.+Puorgerauthor=M.+Vetschauthor=G.+Widerauthor=R.+Glockshuber&title=Structure%2C+folding+and+stability+of+FimA%2C+the+main+structural+subunit+of+type+1+pili+from+uropathogenic+Escherichia+coli+strains&doi=10.1016%2Fj.jmb.2011.07.044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2011.07.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2011.07.044%26sid%3Dliteratum%253Aachs%26aulast%3DPuorger%26aufirst%3DC.%26aulast%3DVetsch%26aufirst%3DM.%26aulast%3DWider%26aufirst%3DG.%26aulast%3DGlockshuber%26aufirst%3DR.%26atitle%3DStructure%252C%2520folding%2520and%2520stability%2520of%2520FimA%252C%2520the%2520main%2520structural%2520subunit%2520of%2520type%25201%2520pili%2520from%2520uropathogenic%2520Escherichia%2520coli%2520strains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2011%26volume%3D412%26spage%3D520%26epage%3D535%26doi%3D10.1016%2Fj.jmb.2011.07.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Zhou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebbel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Min, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubert, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glockshuber, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, X. P.</span><span> </span><span class="NLM_article-title">Uroplakin Ia is the urothelial receptor for uropathogenic <i>Escherichia coli</i>: evidence from in vitro FimH binding</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">4095</span><span class="NLM_x">–</span> <span class="NLM_lpage">4103</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11739641" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptVKls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2001&pages=4095-4103&author=G.+Zhouauthor=W.+J.+Moauthor=P.+Sebbelauthor=G.+Minauthor=T.+A.+Neubertauthor=R.+Glockshuberauthor=X.+R.+Wuauthor=T.+T.+Sunauthor=X.+P.+Kong&title=Uroplakin+Ia+is+the+urothelial+receptor+for+uropathogenic+Escherichia+coli%3A+evidence+from+in+vitro+FimH+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding</span></div><div class="casAuthors">Zhou, Ge; Mo, Wen-Jun; Sebbel, Peter; Min, Guangwei; Neubert, Thomas A.; Glockshuber, Rudi; Wu, Xue-Ru; Sun, Tung-Tien; Kong, Xiang-Peng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4095-4103</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">The binding of uropathogenic Escherichia coli to the urothelial surface is a crucial initial event for establishing urinary tract infection because it allows the bacteria to gain a foothold on the urothelial surface, thus preventing them from being removed by micturition.  In addn., it triggers bacterial invasion as well as host urothelial defense.  This binding is mediated by the FimH adhesin located at the tip of the bacterial type 1-fimbrium, a filamentous attachment app., and its urothelial receptor.  We have prepd. a biotinylated, recombinant FimH-FimC adhesin:chaperone complex and used it to identify its mouse urothelial receptor.  The FimH-FimC complex binds specifically to a single 24 kDa major mouse urothelial plaque protein, which we identified as uroplakin Ia by mass spectrometry, cDNA cloning and immunoreactivity.  The terminal mannosyl moieties on Asn-169 of uroplakin Ia are responsible for FimH as well as Con A binding.  Although FimH binds to uroplakin Ia with only moderate strength (Kd ∼100 nM between pH 4 and 9), the binding between multiple fimbriae of a bacterium and the cryst. array of polymd. uroplakin receptors should achieve high avidity and stable bacterial attachment.  The FimH-FimC complex binds preferentially to the mouse urothelial umbrella cells in a pattern similar to uroplakin staining.  Our results indicate that the structurally related uroplakins Ia and Ib are glycosylated differently, that uroplakin Ia serves as the urothelial receptor for the type 1-fimbriated E. coli, and that the binding of uropathogenic bacteria to uroplakin Ia may play a key role in mediating the urothelial responses to bacterial attachment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHR7X2E8llv7Vg90H21EOLACvtfcHk0lhkuncW1AkUYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptVKls7c%253D&md5=e5eaf72956e8ca3a562b0cffbb8a3e96</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DMo%26aufirst%3DW.%2BJ.%26aulast%3DSebbel%26aufirst%3DP.%26aulast%3DMin%26aufirst%3DG.%26aulast%3DNeubert%26aufirst%3DT.%2BA.%26aulast%3DGlockshuber%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DX.%2BR.%26aulast%3DSun%26aufirst%3DT.%2BT.%26aulast%3DKong%26aufirst%3DX.%2BP.%26atitle%3DUroplakin%2520Ia%2520is%2520the%2520urothelial%2520receptor%2520for%2520uropathogenic%2520Escherichia%2520coli%253A%2520evidence%2520from%2520in%2520vitro%2520FimH%2520binding%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2001%26volume%3D114%26spage%3D4095%26epage%3D4103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Eto, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundsbak, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, M. A.</span><span> </span><span class="NLM_article-title">Integrin-mediated host cell invasion by type 1-piliated uropathogenic <i>Escherichia coli</i></span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e100</span><span class="refDoi"> DOI: 10.1371/journal.ppat.0030100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.ppat.0030100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=e100&author=D.+S.+Etoauthor=T.+A.+Jonesauthor=J.+L.+Sundsbakauthor=M.+A.+Mulvey&title=Integrin-mediated+host+cell+invasion+by+type+1-piliated+uropathogenic+Escherichia+coli&doi=10.1371%2Fjournal.ppat.0030100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.0030100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.0030100%26sid%3Dliteratum%253Aachs%26aulast%3DEto%26aufirst%3DD.%2BS.%26aulast%3DJones%26aufirst%3DT.%2BA.%26aulast%3DSundsbak%26aufirst%3DJ.%2BL.%26aulast%3DMulvey%26aufirst%3DM.%2BA.%26atitle%3DIntegrin-mediated%2520host%2520cell%2520invasion%2520by%2520type%25201-piliated%2520uropathogenic%2520Escherichia%2520coli%26jtitle%3DPLoS%2520Pathog.%26date%3D2007%26volume%3D3%26spage%3De100%26doi%3D10.1371%2Fjournal.ppat.0030100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Anderson, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palermo, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Intracellular bacterial biofilm-like pods in urinary tract infections</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span><span class="refDoi"> DOI: 10.1126/science.1084550</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1126%2Fscience.1084550" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=2003&pages=105-107&author=G.+G.+Andersonauthor=J.+J.+Palermoauthor=J.+D.+Schillingauthor=R.+Rothauthor=J.+Heuserauthor=S.+J.+Hultgren&title=Intracellular+bacterial+biofilm-like+pods+in+urinary+tract+infections&doi=10.1126%2Fscience.1084550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1084550&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1084550%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DG.%2BG.%26aulast%3DPalermo%26aufirst%3DJ.%2BJ.%26aulast%3DSchilling%26aufirst%3DJ.%2BD.%26aulast%3DRoth%26aufirst%3DR.%26aulast%3DHeuser%26aufirst%3DJ.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DIntracellular%2520bacterial%2520biofilm-like%2520pods%2520in%2520urinary%2520tract%2520infections%26jtitle%3DScience%26date%3D2003%26volume%3D301%26spage%3D105%26epage%3D107%26doi%3D10.1126%2Fscience.1084550" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Griebling, T. L.</span><span> </span><span class="NLM_article-title">Urinary tract infection in women</span>. In Urologic Diseases in America; <span class="NLM_contrib-group">Litwin, M.S.; Saigal, C.S.</span>, Eds.; <span class="NLM_publisher-name">U.S. Government Printing Office</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2007</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">587</span><span class="NLM_x">–</span> <span class="NLM_lpage">620</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=T.+L.+Grieblingauthor=M.S.+Litwin&author=C.S.+Saigal&title=Urinary+tract+infection+in+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26aulast%3DGriebling%26aufirst%3DT.%2BL.%26atitle%3DUrinary%2520tract%2520infection%2520in%2520women%26jtitle%3DUrologic%2520Diseases%2520in%2520America%26aulast%3DLitwin%26aufirst%3DM.S.%26pub%3DU.S.%2520Government%2520Printing%2520Office%26date%3D2007%26spage%3D587%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Foxman, B.</span><span> </span><span class="NLM_article-title">Epidemiology of urinary tract infections: incidence, morbidity, and economic costs</span> <span class="citation_source-journal">DM, Dis.-Mon.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span><span class="refDoi"> DOI: 10.1067/mda.2003.7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1067%2Fmda.2003.7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=12601337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BD3s%252FovFagtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2003&pages=53-70&author=B.+Foxman&title=Epidemiology+of+urinary+tract+infections%3A+incidence%2C+morbidity%2C+and+economic+costs&doi=10.1067%2Fmda.2003.7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Epidemiology of urinary tract infections: incidence, morbidity, and economic costs</span></div><div class="casAuthors">Foxman Betsy</div><div class="citationInfo"><span class="NLM_cas:title">Disease-a-month : DM</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">53-70</span>
        ISSN:<span class="NLM_cas:issn">0011-5029</span>.
    </div><div class="casAbstract">Urinary tract infections (UTIs) are considered to be the most common bacterial infection.  According to the 1997 National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, UTI accounted for nearly 7 million office visits and 1 million emergency department visits, resulting in 100,000 hospitalizations.  Nevertheless, it is difficult to accurately assess the incidence of UTIs, because they are not reportable diseases in the United States.  This situation is further complicated by the fact that accurate diagnosis depends on both the presence of symptoms and a positive urine culture, although in most outpatient settings this diagnosis is made without the benefit of culture.  Women are significantly more likely to experience UTI than men.  Nearly 1 in 3 women will have had at least 1 episode of UTI requiring antimicrobial therapy by the age of 24 years.  Almost half of all women will experience 1 UTI during their lifetime.  Specific subpopulations at increased risk of UTI include infants, pregnant women, the elderly, patients with spinal cord injuries and/or catheters, patients with diabetes or multiple sclerosis, patients with acquired immunodeficiency disease syndrome/human immunodeficiency virus, and patients with underlying urologic abnormalities.  Catheter-associated UTI is the most common nosocomial infection, accounting for >1 million cases in hospitals and nursing homes.  The risk of UTI increases with increasing duration of catheterization.  In noninstitutionalized elderly populations, UTIs are the second most common form of infection, accounting for nearly 25% of all infections.  There are important medical and financial implications associated with UTIs.  In the nonobstructed, nonpregnant female adult, acute uncomplicated UTI is believed to be a benign illness with no long-term medical consequences.  However, UTI elevates the risk of pyelonephritis, premature delivery, and fetal mortality among pregnant women, and is associated with impaired renal function and end-stage renal disease among pediatric patients.  Financially, the estimated annual cost of community-acquired UTI is significant, at approximately $1.6 billion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQ38Fbr8nVBDDnmmyUf5qOfW6udTcc2eah9wBn8woL0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s%252FovFagtw%253D%253D&md5=eadd54209396955108dbbbb63fb2cc6e</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1067%2Fmda.2003.7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmda.2003.7%26sid%3Dliteratum%253Aachs%26aulast%3DFoxman%26aufirst%3DB.%26atitle%3DEpidemiology%2520of%2520urinary%2520tract%2520infections%253A%2520incidence%252C%2520morbidity%252C%2520and%2520economic%2520costs%26jtitle%3DDM%252C%2520Dis.-Mon.%26date%3D2003%26volume%3D49%26spage%3D53%26epage%3D70%26doi%3D10.1067%2Fmda.2003.7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kärkkäinen, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikäheimo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katila, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siitonen, A.</span><span> </span><span class="NLM_article-title">Recurrence of urinary tract infections in adult patients with community- acquired pyelonephritis caused by E. coli: a 1-year follow-up</span> <span class="citation_source-journal">Scand. J. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">499</span><span class="refDoi"> DOI: 10.1080/003655400458767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1080%2F003655400458767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11055653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BD3crgsV2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2000&pages=495-499&author=U.+M.+K%C3%A4rkk%C3%A4inenauthor=R.+Ik%C3%A4heimoauthor=M.+L.+Katilaauthor=A.+Siitonen&title=Recurrence+of+urinary+tract+infections+in+adult+patients+with+community-+acquired+pyelonephritis+caused+by+E.+coli%3A+a+1-year+follow-up&doi=10.1080%2F003655400458767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up</span></div><div class="casAuthors">Karkkainen U M; Ikaheimo R; Katila M L; Siitonen A</div><div class="citationInfo"><span class="NLM_cas:title">Scandinavian journal of infectious diseases</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">495-9</span>
        ISSN:<span class="NLM_cas:issn">0036-5548</span>.
    </div><div class="casAbstract">In a prospective study, 42 women were followed for recurrence of urinary tract infections (UTIs) for 1 y after an index episode of community-acquired pyelonephritis caused by Escherichia coli.  Altogether, 26 repeat episodes were detected.  Of these, 20 occurred at least 1 month after the index episode and were regarded as recurrences.  In all, 40%, (17 of 42) of the women had recurrences.  An earlier history of UTI increased the risk of recurrence: 52%, of the 29 women with previous UTI had at least 1 recurrence, compared with 15%, of the 13 patients without previous UTI.  E. coli caused the majority (73%) of the recurrences.  Genotype comparisons by RAPD-PCR analysis between E. coli isolates from a patient showed that 75%. of the original and recurrent strains were genetically non-identical.  Of the 54 E. coli strains, 42 were carrying genes coding for G adhesins of P fimbriae: 40 isolates carried class II, I class III and 1 carried both class II and III G adhesin genes.  Each of the virulence-associated factors (genes for G adhesins, MRHA, haemolysin, type 1C fimbriae, and O and K antigens) was evenly distributed among E. coli isolates of index episodes, independent of the recurrences.  The index isolates, however, had more virulence-associated factors than did the isolates from the recurrences which were mainly due to lower UTIs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjpF21U4dOBuqrn-c4Of3KfW6udTcc2eah9wBn8woL0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3crgsV2ksA%253D%253D&md5=233e348778c2591fa974b05a7ce079d1</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1080%2F003655400458767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F003655400458767%26sid%3Dliteratum%253Aachs%26aulast%3DK%25C3%25A4rkk%25C3%25A4inen%26aufirst%3DU.%2BM.%26aulast%3DIk%25C3%25A4heimo%26aufirst%3DR.%26aulast%3DKatila%26aufirst%3DM.%2BL.%26aulast%3DSiitonen%26aufirst%3DA.%26atitle%3DRecurrence%2520of%2520urinary%2520tract%2520infections%2520in%2520adult%2520patients%2520with%2520community-%2520acquired%2520pyelonephritis%2520caused%2520by%2520E.%2520coli%253A%2520a%25201-year%2520follow-up%26jtitle%3DScand.%2520J.%2520Infect.%2520Dis.%26date%3D2000%26volume%3D32%26spage%3D495%26epage%3D499%26doi%3D10.1080%2F003655400458767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ikähelmo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siitonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiskanen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kärkkäinen, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuosmanen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipponen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mäkelä, P. H.</span><span> </span><span class="NLM_article-title">Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1093/clinids/22.1.91</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1093%2Fclinids%2F22.1.91" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=8824972" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1996&pages=91-99&author=R.+Ik%C3%A4helmoauthor=A.+Siitonenauthor=T.+Heiskanenauthor=U.+K%C3%A4rkk%C3%A4inenauthor=P.+Kuosmanenauthor=P.+Lipponenauthor=P.+H.+M%C3%A4kel%C3%A4&title=Recurrence+of+urinary+tract+infection+in+a+primary+care+setting%3A+analysis+of+a+1-year+follow-up+of+179+women&doi=10.1093%2Fclinids%2F22.1.91"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1093%2Fclinids%2F22.1.91&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fclinids%252F22.1.91%26sid%3Dliteratum%253Aachs%26aulast%3DIk%25C3%25A4helmo%26aufirst%3DR.%26aulast%3DSiitonen%26aufirst%3DA.%26aulast%3DHeiskanen%26aufirst%3DT.%26aulast%3DK%25C3%25A4rkk%25C3%25A4inen%26aufirst%3DU.%26aulast%3DKuosmanen%26aufirst%3DP.%26aulast%3DLipponen%26aufirst%3DP.%26aulast%3DM%25C3%25A4kel%25C3%25A4%26aufirst%3DP.%2BH.%26atitle%3DRecurrence%2520of%2520urinary%2520tract%2520infection%2520in%2520a%2520primary%2520care%2520setting%253A%2520analysis%2520of%2520a%25201-year%2520follow-up%2520of%2520179%2520women%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D1996%26volume%3D22%26spage%3D91%26epage%3D99%26doi%3D10.1093%2Fclinids%2F22.1.91" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Foxman, B.</span><span> </span><span class="NLM_article-title">Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden</span> <span class="citation_source-journal">Infect. Dis. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span><span class="refDoi"> DOI: 10.1016/j.idc.2013.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.idc.2013.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=24484571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC2crjsF2ltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=1-13&author=B.+Foxman&title=Urinary+tract+infection+syndromes%3A+occurrence%2C+recurrence%2C+bacteriology%2C+risk+factors%2C+and+disease+burden&doi=10.1016%2Fj.idc.2013.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14dR"><div class="casContent"><span class="casTitleNuber">14d</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden</span></div><div class="casAuthors">Foxman Betsy</div><div class="citationInfo"><span class="NLM_cas:title">Infectious disease clinics of North America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Urinary tract infection (UTI) is one of the most common bacterial infections, accounting for 0.9% of all ambulatory visits in the United States.  This review defines the major UTI syndromes, their occurrence and recurrence, bacteriology, risk factors, and disease burden.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNGmy0Ym3J9XWEEzDrymxmfW6udTcc2eb14jHaeEh1dLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2crjsF2ltw%253D%253D&md5=8700ffd4e117ea98258fdfd4d15b1c12</span></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1016%2Fj.idc.2013.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.idc.2013.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DFoxman%26aufirst%3DB.%26atitle%3DUrinary%2520tract%2520infection%2520syndromes%253A%2520occurrence%252C%2520recurrence%252C%2520bacteriology%252C%2520risk%2520factors%252C%2520and%2520disease%2520burden%26jtitle%3DInfect.%2520Dis.%2520Clin.%2520North%2520Am.%26date%3D2014%26volume%3D28%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.idc.2013.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ronald, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolle, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaeffer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naber, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooton, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andriole, V.</span><span> </span><span class="NLM_article-title">Urinary tract infection in adults: research priorities and strategies</span> <span class="citation_source-journal">Int. J. Antimicrob. Agents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">343</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span><span class="refDoi"> DOI: 10.1016/S0924-8579(01)00303-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0924-8579%2801%2900303-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11295419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisValsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2001&pages=343-348&author=A.+R.+Ronaldauthor=L.+E.+Nicolleauthor=E.+Stammauthor=J.+Kriegerauthor=J.+Warrenauthor=A.+Schaefferauthor=K.+G.+Naberauthor=T.+M.+Hootonauthor=J.+Johnsonauthor=S.+Chambersauthor=V.+Andriole&title=Urinary+tract+infection+in+adults%3A+research+priorities+and+strategies&doi=10.1016%2FS0924-8579%2801%2900303-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary tract infection in adults: research priorities and strategies</span></div><div class="casAuthors">Ronald, A. R.; Nicolle, L. E.; Stamm, E.; Krieger, J.; Warren, J.; Schaeffer, A.; Naber, K. G.; Hooton, T. M.; Johnson, J.; Chambers, S.; Andriole, V.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Antimicrobial Agents</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-348</span>CODEN:
                <span class="NLM_cas:coden">IAAGEA</span>;
        ISSN:<span class="NLM_cas:issn">0924-8579</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Waning interest in urinary tract infection (UTI) research has limited clin. advances during the past two decades.  Although care has improved for some specific UTI syndromes, there is limited evidence for most of the decisions made each day in the management of these infections.  Addnl. clin. research is necessary to improve UTI prevention and care strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRyMRRahpEy7Vg90H21EOLACvtfcHk0lhVWUlavoSuzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisValsLs%253D&md5=d942e3b6dbbd6a9b1f0e82468e4d6f2c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS0924-8579%2801%2900303-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0924-8579%252801%252900303-X%26sid%3Dliteratum%253Aachs%26aulast%3DRonald%26aufirst%3DA.%2BR.%26aulast%3DNicolle%26aufirst%3DL.%2BE.%26aulast%3DStamm%26aufirst%3DE.%26aulast%3DKrieger%26aufirst%3DJ.%26aulast%3DWarren%26aufirst%3DJ.%26aulast%3DSchaeffer%26aufirst%3DA.%26aulast%3DNaber%26aufirst%3DK.%2BG.%26aulast%3DHooton%26aufirst%3DT.%2BM.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DChambers%26aufirst%3DS.%26aulast%3DAndriole%26aufirst%3DV.%26atitle%3DUrinary%2520tract%2520infection%2520in%2520adults%253A%2520research%2520priorities%2520and%2520strategies%26jtitle%3DInt.%2520J.%2520Antimicrob.%2520Agents%26date%3D2001%26volume%3D17%26spage%3D343%26epage%3D348%26doi%3D10.1016%2FS0924-8579%2801%2900303-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karlowsky, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoban, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decorby, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laing, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhanel, G. G.</span><span> </span><span class="NLM_article-title">Fluoroquinolone-resistant urinary isolates of <i>Escherichia coli</i> from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2251</span><span class="NLM_x">–</span> <span class="NLM_lpage">2254</span><span class="refDoi"> DOI: 10.1128/AAC.00123-06</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1128%2FAAC.00123-06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=2251-2254&author=J.+A.+Karlowskyauthor=D.+J.+Hobanauthor=M.+R.+Decorbyauthor=N.+M.+Laingauthor=G.+G.+Zhanel&title=Fluoroquinolone-resistant+urinary+isolates+of+Escherichia+coli+from+outpatients+are+frequently+multidrug+resistant%3A+results+from+the+North+American+Urinary+Tract+Infection+Collaborative+Alliance-Quinolone+Resistance+study&doi=10.1128%2FAAC.00123-06"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1128%2FAAC.00123-06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00123-06%26sid%3Dliteratum%253Aachs%26aulast%3DKarlowsky%26aufirst%3DJ.%2BA.%26aulast%3DHoban%26aufirst%3DD.%2BJ.%26aulast%3DDecorby%26aufirst%3DM.%2BR.%26aulast%3DLaing%26aufirst%3DN.%2BM.%26aulast%3DZhanel%26aufirst%3DG.%2BG.%26atitle%3DFluoroquinolone-resistant%2520urinary%2520isolates%2520of%2520Escherichia%2520coli%2520from%2520outpatients%2520are%2520frequently%2520multidrug%2520resistant%253A%2520results%2520from%2520the%2520North%2520American%2520Urinary%2520Tract%2520Infection%2520Collaborative%2520Alliance-Quinolone%2520Resistance%2520study%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D2251%26epage%3D2254%26doi%3D10.1128%2FAAC.00123-06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">National Disease and Therapeutic Index</span>; <span class="NLM_publisher-name">IMS Health, Inc.</span>: <span class="NLM_publisher-loc">Plymouth Meeting, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Disease+and+Therapeutic+Index%3B+IMS+Health%2C+Inc.%3A+Plymouth+Meeting%2C+PA%2C+2004."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DNational%2520Disease%2520and%2520Therapeutic%2520Index%26pub%3DIMS%2520Health%252C%2520Inc%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Blango, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvey, M. A.</span><span> </span><span class="NLM_article-title">Persistence of uropathogenic <i>Escherichia coli</i> in the face of multiple antibiotics</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1855</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span><span class="refDoi"> DOI: 10.1128/AAC.00014-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1128%2FAAC.00014-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=1855-1863&author=M.+G.+Blangoauthor=M.+A.+Mulvey&title=Persistence+of+uropathogenic+Escherichia+coli+in+the+face+of+multiple+antibiotics&doi=10.1128%2FAAC.00014-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1128%2FAAC.00014-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.00014-10%26sid%3Dliteratum%253Aachs%26aulast%3DBlango%26aufirst%3DM.%2BG.%26aulast%3DMulvey%26aufirst%3DM.%2BA.%26atitle%3DPersistence%2520of%2520uropathogenic%2520Escherichia%2520coli%2520in%2520the%2520face%2520of%2520multiple%2520antibiotics%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D1855%26epage%3D1863%26doi%3D10.1128%2FAAC.00014-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mydock-McGrane, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, Z. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn’s disease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">197</span><span class="refDoi"> DOI: 10.1517/13543776.2016.1131266</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1517%2F13543776.2016.1131266" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=26651364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=175-197&author=L.+K.+Mydock-McGraneauthor=Z.+T.+Cusumanoauthor=J.+W.+Janetka&title=Mannose-derived+FimH+antagonists%3A+a+promising+anti-virulence+therapeutic+strategy+for+urinary+tract+infections+and+Crohn%E2%80%99s+disease&doi=10.1517%2F13543776.2016.1131266"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Mannose-derived FimH antagonists: a promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease</span></div><div class="casAuthors">Mydock-McGrane, Laurel K.; Cusumano, Zachary T.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-197</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Type 1 pili are utilized by Gram-neg. bacteria to adhere to host tissue and thus are a key virulence factor in urinary tract infections (UTIs) and Crohn's disease (CD).  This adhesion is mediated through specific binding of the terminal adhesin, FimH, to mannosylated host glycoproteins.  FimH is essential for UTI pathogenesis and thus is a promising therapeutic target.: Herein, we review the structural frameworks of FimH antagonists disclosed in the patent literature.  X-ray crystallog. binding studies of D-mannose and early FimH antagonists have uncovered key mol. interactions.  Exploiting this knowledge, mannosides with extraordinarily high binding affinities have been designed.  Structure-activity relationships (SAR) and structure-property relationship (SPR) studies have resulted in the rapid development of orally bioavailable FimH antagonists with promising therapeutic potential for UTI and CD.: It is our opinion that biaryl or 'two-ring' mannosides, which represent the largest and most thoroughly tested class of FimH antagonists, also hold the most promise as a novel treatment for UTIs.  These antagonists have also been shown to have efficacy in treating CD.  Judging from the strong preclin. data, we predict that one or more FimH antagonists will be entering the clinic within the next 1-2 years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx_i0DZwcMRbVg90H21EOLACvtfcHk0lgyAqo__KHNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlSrs78%253D&md5=a28cd9875e0f5bf0c91f716c3d7b7653</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543776.2016.1131266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2016.1131266%26sid%3Dliteratum%253Aachs%26aulast%3DMydock-McGrane%26aufirst%3DL.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%2BT.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DMannose-derived%2520FimH%2520antagonists%253A%2520a%2520promising%2520anti-virulence%2520therapeutic%2520strategy%2520for%2520urinary%2520tract%2520infections%2520and%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2016%26volume%3D26%26spage%3D175%26epage%3D197%26doi%3D10.1517%2F13543776.2016.1131266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martinez-Medina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Gil, L. J.</span><span> </span><span class="NLM_article-title"><i>Escherichia coli</i> in chronic inflammatory bowel diseases: An update on adherent invasive <i>Escherichia coli</i> pathogenicity</span> <span class="citation_source-journal">World J. Gastrointest. Pathophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.4291/wjgp.v5.i3.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.4291%2Fwjgp.v5.i3.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=25133024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FivVCgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=213-227&author=M.+Martinez-Medinaauthor=L.+J.+Garcia-Gil&title=Escherichia+coli+in+chronic+inflammatory+bowel+diseases%3A+An+update+on+adherent+invasive+Escherichia+coli+pathogenicity&doi=10.4291%2Fwjgp.v5.i3.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicity</span></div><div class="casAuthors">Martinez-Medina Margarita; Garcia-Gil Librado Jesus</div><div class="citationInfo"><span class="NLM_cas:title">World journal of gastrointestinal pathophysiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">213-27</span>
        ISSN:<span class="NLM_cas:issn">2150-5330</span>.
    </div><div class="casAbstract">Escherichia coli (E. coli), and particularly the adherent invasive E. coli (AIEC) pathotype, has been increasingly implicated in the ethiopathogenesis of Crohn's disease (CD).  E. coli strains with similar pathogenic features to AIEC have been associated with other intestinal disorders such as ulcerative colitis, colorectal cancer, and coeliac disease, but AIEC prevalence in these diseases remains largely unexplored.  Since AIEC was described one decade ago, substantial progress has been made in deciphering its mechanisms of pathogenicity.  However, the molecular bases that characterize the phenotypic properties of this pathotype are still not well resolved.  A review of studies focused on E. coli populations in inflammatory bowel disease (IBD) is presented here and we discuss about the putative role of this species on each IBD subtype.  Given the relevance of AIEC in CD pathogenesis, we present the latest research findings concerning AIEC host-microbe interactions and pathogenicity.  We also review the existing data regarding the prevalence and abundance of AIEC in CD and its association with other intestinal diseases from humans and animals, in order to discuss the AIEC disease- and host-specificity.  Finally, we highlight the fact that dietary components frequently found in industrialized countries may enhance AIEC colonization in the gut, which merits further investigation and the implementation of preventative measures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLaqWjAreWhjAyhZbj3lKdfW6udTcc2eaql3lHU4Kqirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FivVCgtA%253D%253D&md5=41a27d8217945e67fef677a8b338fab3</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.4291%2Fwjgp.v5.i3.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4291%252Fwjgp.v5.i3.213%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez-Medina%26aufirst%3DM.%26aulast%3DGarcia-Gil%26aufirst%3DL.%2BJ.%26atitle%3DEscherichia%2520coli%2520in%2520chronic%2520inflammatory%2520bowel%2520diseases%253A%2520An%2520update%2520on%2520adherent%2520invasive%2520Escherichia%2520coli%2520pathogenicity%26jtitle%3DWorld%2520J.%2520Gastrointest.%2520Pathophysiol.%26date%3D2014%26volume%3D5%26spage%3D213%26epage%3D227%26doi%3D10.4291%2Fwjgp.v5.i3.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Boudeau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darfeuille-Michaud, A.</span><span> </span><span class="NLM_article-title">Type 1 pili-mediated adherence of <i>Escherichia coli</i> strain LF82 isolated from Crohn’s disease is involved in bacterial invasion of intestinal epithelial cells</span> <span class="citation_source-journal">Mol. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1272</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span><span class="refDoi"> DOI: 10.1111/j.1365-2958.2001.02315.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1111%2Fj.1365-2958.2001.02315.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=11251843" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD3MXit1Ogurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2001&pages=1272-1284&author=J.+Boudeauauthor=N.+Barnichauthor=A.+Darfeuille-Michaud&title=Type+1+pili-mediated+adherence+of+Escherichia+coli+strain+LF82+isolated+from+Crohn%E2%80%99s+disease+is+involved+in+bacterial+invasion+of+intestinal+epithelial+cells&doi=10.1111%2Fj.1365-2958.2001.02315.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells</span></div><div class="casAuthors">Boudeau, Jerome; Barnich, Nicolas; Darfeuille-Michaud, Arlette</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1272-1284</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The invasive ability of E. coli strain LF82, isolated from an ileal biopsy of a patient with Crohn's disease, was previously characterized.  In the present study, we performed TnphoA insertion mutagenesis to identify genes involved in LF82 invasion of intestinal epithelial cells.  Most of the non-invasive mutants had an insertion mutation within the type 1 pili-encoding operon.  Two non-invasive fim mutants, which harbored an insertion within the fimI and fimF genes, still adhered but had lost the ability to induce host cell membrane elongations at the sites of contact with the epithelial cells.  Transcomplementation expts. with a fim operon cloned from E. coli K-12 restored both invasive ability and the ability to induce host cell membrane elongations.  Expression of the cloned LF82 or K-12 fim operon into the non-invasive lab. strain JM109 did not confer invasive properties.  Thus, these findings showed that: (i) type 1 pili-mediated adherence is involved in LF82-induced perturbation of host cell signalling responsible for membrane elongations; (ii) native shafts are required for type 1 pilus-mediated induction of membrane elongations; (iii) this active phenomenon is a key step in the establishment of the invasive process; and (iv) type 1 pili alone are not sufficient to trigger bacterial internalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKJVsViY7-ULVg90H21EOLACvtfcHk0lgyAqo__KHNUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXit1Ogurk%253D&md5=9f378073ccf52a608bdf95847e5bde98</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2001.02315.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2001.02315.x%26sid%3Dliteratum%253Aachs%26aulast%3DBoudeau%26aufirst%3DJ.%26aulast%3DBarnich%26aufirst%3DN.%26aulast%3DDarfeuille-Michaud%26aufirst%3DA.%26atitle%3DType%25201%2520pili-mediated%2520adherence%2520of%2520Escherichia%2520coli%2520strain%2520LF82%2520isolated%2520from%2520Crohn%25E2%2580%2599s%2520disease%2520is%2520involved%2520in%2520bacterial%2520invasion%2520of%2520intestinal%2520epithelial%2520cells%26jtitle%3DMol.%2520Microbiol.%26date%3D2001%26volume%3D39%26spage%3D1272%26epage%3D1284%26doi%3D10.1111%2Fj.1365-2958.2001.02315.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span> <span class="citation_source-journal">Sci. Transl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">109ra115</span><span class="refDoi"> DOI: 10.1126/scitranslmed.3003021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1126%2Fscitranslmed.3003021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=22089451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=109ra115&author=C.+K.+Cusumanoauthor=J.+S.+Pinknerauthor=Z.+Hanauthor=S.+E.+Greeneauthor=B.+A.+Fordauthor=J.+R.+Crowleyauthor=J.+P.+Hendersonauthor=J.+W.+Janetkaauthor=S.+J.+Hultgren&title=Treatment+and+prevention+of+urinary+tract+infection+with+orally+active+FimH+inhibitors&doi=10.1126%2Fscitranslmed.3003021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment and prevention of urinary tract infection with orally active FimH inhibitors</span></div><div class="casAuthors">Cusumano Corinne K; Pinkner Jerome S; Han Zhenfu; Greene Sarah E; Ford Bradley A; Crowley Jan R; Henderson Jeffrey P; Janetka James W; Hultgren Scott J</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">109</span>),
    <span class="NLM_cas:pages">109ra115</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chronic and recurrent urinary tract infections pose a serious medical problem because there are few effective treatment options.  Patients with chronic urinary tract infections are commonly treated with long-term prophylactic antibiotics that promote the development of antibiotic-resistant forms of uropathogenic Escherichia coli (UPEC), further complicating treatment.  We developed small-molecular weight compounds termed mannosides that specifically inhibit the FimH type 1 pilus lectin of UPEC, which mediates bacterial colonization, invasion, and formation of recalcitrant intracellular bacterial communities in the bladder epithelium.  Here, we optimized these compounds for oral bioavailability and demonstrated their fast-acting efficacy in treating chronic urinary tract infections in a preclinical murine model.  These compounds also prevented infection in vivo when given prophylactically and strongly potentiated the activity of the current standard of care therapy, trimethoprim-sulfamethoxazole, against clinically resistant PBC-1 UPEC bacteria.  These compounds have therapeutic efficacy after oral administration for the treatment of established urinary tract infections in vivo.  Their unique mechanism of action-targeting the pilus tip adhesin FimH-circumvents the conventional requirement for drug penetration of the outer membrane, minimizing the potential for the development of resistance.  The small-molecular weight compounds described herein promise to provide substantial benefit to women suffering from chronic and recurrent urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJjBsZZFqz29j_Vg2vObihfW6udTcc2eaUfuWj80jgE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38%252FgsFChtw%253D%253D&md5=253b506b7485c2cf042cb5665c518277</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3003021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3003021%26sid%3Dliteratum%253Aachs%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DGreene%26aufirst%3DS.%2BE.%26aulast%3DFord%26aufirst%3DB.%2BA.%26aulast%3DCrowley%26aufirst%3DJ.%2BR.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DTreatment%2520and%2520prevention%2520of%2520urinary%2520tract%2520infection%2520with%2520orally%2520active%2520FimH%2520inhibitors%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2011%26volume%3D3%26spage%3D109ra115%26doi%3D10.1126%2Fscitranslmed.3003021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chorell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3945</span><span class="NLM_x">–</span> <span class="NLM_lpage">3959</span><span class="refDoi"> DOI: 10.1021/jm300165m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300165m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3945-3959&author=Z.+Hanauthor=J.+S.+Pinknerauthor=B.+Fordauthor=E.+Chorellauthor=J.+M.+Crowleyauthor=C.+K.+Cusumanoauthor=S.+Campbellauthor=J.+P.+Hendersonauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Lead+optimization+studies+on+FimH+antagonists%3A+discovery+of+potent+and+orally+bioavailable+ortho-substituted+biphenyl+mannosides&doi=10.1021%2Fjm300165m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Lead Optimization Studies on FimH Antagonists: Discovery of Potent and Orally Bioavailable Ortho-Substituted Biphenyl Mannosides</span></div><div class="casAuthors">Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Chorell, Erik; Crowley, Jan M.; Cusumano, Corinne K.; Campbell, Scott; Henderson, Jeffrey P.; Hultgren, Scott J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3945-3959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, we describe the X-ray structure-based design and optimization of biaryl mannoside FimH inhibitors.  Diverse modifications to the biaryl ring to improve druglike phys. and pharmacokinetic properties of mannosides were assessed for FimH binding affinity based on their effects on hemagglutination and biofilm formation along with direct FimH binding assays.  Substitution on the mannoside Ph ring ortho to the glycosidic bond results in large potency enhancements several-fold higher than those of corresponding unsubstituted matched pairs and can be rationalized from increased hydrophobic interactions with the FimH hydrophobic ridge (Ile13) or "tyrosine gate" (Tyr137 and Tyr48) also lined by Ile52.  The lead mannosides have increased metabolic stability and oral bioavailability as detd. from in vitro PAMPA predictive model of cellular permeability and in vivo pharmacokinetic studies in mice, thereby representing advanced preclin. candidates with promising potential as novel therapeutics for the clin. treatment and prevention of recurring urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowBCwLuNdyjLVg90H21EOLACvtfcHk0lioEHqkWHzLeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XksVyltro%253D&md5=2a9b4e564162f8c3292802826fa33974</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm300165m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300165m%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DChorell%26aufirst%3DE.%26aulast%3DCrowley%26aufirst%3DJ.%2BM.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHenderson%26aufirst%3DJ.%2BP.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DLead%2520optimization%2520studies%2520on%2520FimH%2520antagonists%253A%2520discovery%2520of%2520potent%2520and%2520orally%2520bioavailable%2520ortho-substituted%2520biphenyl%2520mannosides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3945%26epage%3D3959%26doi%3D10.1021%2Fjm300165m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obermann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wildman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellenberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Structure-based drug design and optimization of mannoside bacterial FimH antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4779</span><span class="NLM_x">–</span> <span class="NLM_lpage">4792</span><span class="refDoi"> DOI: 10.1021/jm100438s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100438s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4779-4792&author=Z.+Hanauthor=J.+S.+Pinknerauthor=B.+Fordauthor=R.+Obermannauthor=W.+Nolanauthor=S.+A.+Wildmanauthor=D.+Hobbsauthor=T.+Ellenbergerauthor=C.+K.+Cusumanoauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Structure-based+drug+design+and+optimization+of+mannoside+bacterial+FimH+antagonists&doi=10.1021%2Fjm100438s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20cR"><div class="casContent"><span class="casTitleNuber">20c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Drug Design and Optimization of Mannoside Bacterial FimH Antagonists</span></div><div class="casAuthors">Han, Zhenfu; Pinkner, Jerome S.; Ford, Bradley; Obermann, Robert; Nolan, William; Wildman, Scott A.; Hobbs, Doug; Ellenberger, Tom; Cusumano, Corinne K.; Hultgren, Scott J.; Janetka, James W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4779-4792</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">FimH-mediated cellular adhesion to mannosylated proteins is crit. in the ability of uropathogenic E. coli (UPEC) to colonize and invade the bladder epithelium during urinary tract infection.  We describe the discovery and optimization of potent small-mol. FimH bacterial adhesion antagonists based on α-D-mannose 1-position anomeric glycosides using X-ray structure-guided drug design.  Optimized biarylmannosides display low nanomolar binding affinity for FimH in a fluorescence polarization assay and submicromolar cellular activity in a hemagglutination (HA) functional cell assay of bacterial adhesion.  X-ray crystallog. demonstrates that the biphenyl moiety makes several key interactions with the outer surface of FimH including π-π interactions with Tyr-48 and an H-bonding electrostatic interaction with the Arg-98/Glu-50 salt bridge.  Dimeric analogs linked through the biaryl ring show an impressive 8-fold increase in potency relative to monomeric matched pairs and represent the most potent FimH antagonists identified to date.  The FimH antagonists described herein hold great potential for development as novel therapeutics for the effective treatment of urinary tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJR-ZxMIVWzbVg90H21EOLACvtfcHk0lg1QWFom0MgEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFOkt7s%253D&md5=61cd971d5c0e95acb77a6b2ae75d902f</span></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjm100438s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100438s%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DObermann%26aufirst%3DR.%26aulast%3DNolan%26aufirst%3DW.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DHobbs%26aufirst%3DD.%26aulast%3DEllenberger%26aufirst%3DT.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DStructure-based%2520drug%2520design%2520and%2520optimization%2520of%2520mannoside%2520bacterial%2520FimH%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4779%26epage%3D4792%26doi%3D10.1021%2Fjm100438s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Firon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashkenazi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirelman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated <i>Escherichia coli</i> to yeast and intestinal epithelial cells</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=3542836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADyaL2sXhtlGitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1987&pages=472-476&author=N.+Fironauthor=S.+Ashkenaziauthor=D.+Mirelmanauthor=I.+Ofekauthor=N.+Sharon&title=Aromatic+alpha-glycosides+of+mannose+are+powerful+inhibitors+of+the+adherence+of+type+1+fimbriated+Escherichia+coli+to+yeast+and+intestinal+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21aR"><div class="casContent"><span class="casTitleNuber">21a</span><div class="casTitle"><span class="NLM_cas:atitle">Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells</span></div><div class="casAuthors">Firon, Nurit; Ashkenazi, Shai; Mirelman, David; Ofek, Itzhak; Sharon, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">472-6</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">Adherence of bacteria via their surface lectins to host epithelial cells is considered an important initial event in bacterial pathogenesis.  Mannose-specific (type 1) fimbriae are among the most commonly found lectins in enterobacteria.  The effect of arom. α-glycosides of mannose was studied on the agglutination of mannan-contg. yeasts by different strains of E. coli and on the adherence of the bacteria to guinea pig ileal epithelial cells.  In both systems, these compds. were considerably more effective inhibitors than Me α-mannoside, with 4-methylumbelliferyl α-mannoside and p-nitro-o-chlorophenyl α-mannoside being the strongest inhibitors.  Both compds. were approx. 400-times stronger inhibitors of yeast agglutination by E. coli O128 than was Me α-mannoside and 1000- and 470-fold stronger, resp., than was Me α-mannoside in inhibiting the adherence of the bacteria to ileal epithelial cells.  4-Methylumbelliferyl α-mannoside was 540-1000 times more effective in inhibiting yeast agglutination by 4 addnl. strains of mannose-specific E. coli.  It was also more efficient than Me α-mannoside in removing adherent E. coli O128 from ileal epithelial cells.  The results provide further evidence that type 1 fimbriae of E. coli possess a hydrophobic region next to the mannose-binding site.  The results suggest that 4-methyllumbelliferyl α-mannoside and p-nitro-o-chlorophenyl α-mannoside are good candidates for the design of therapeutic agents that may prevent adherence in vivo and infection by E. coli strains that express type 1 fimbriae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq04bolSK5gJ7Vg90H21EOLACvtfcHk0lg1QWFom0MgEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtlGitrw%253D&md5=552429e6e5bf2731439a24762a7d30a0</span></div><a href="/servlet/linkout?suffix=cit21a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFiron%26aufirst%3DN.%26aulast%3DAshkenazi%26aufirst%3DS.%26aulast%3DMirelman%26aufirst%3DD.%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DAromatic%2520alpha-glycosides%2520of%2520mannose%2520are%2520powerful%2520inhibitors%2520of%2520the%2520adherence%2520of%2520type%25201%2520fimbriated%2520Escherichia%2520coli%2520to%2520yeast%2520and%2520intestinal%2520epithelial%2520cells%26jtitle%3DInfect.%2520Immun.%26date%3D1987%26volume%3D55%26spage%3D472%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Firon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Carbohydrate-binding sites of the mannose-specific fimbrial lectins of Enterobacteria</span> <span class="citation_source-journal">Infect. Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">–</span> <span class="NLM_lpage">1090</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1128%2FIAI.43.3.1088-1090.1984" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=6142000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADyaL2cXhtF2itLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1984&pages=1088-1090&author=N.+Fironauthor=I.+Ofekauthor=N.+Sharon&title=Carbohydrate-binding+sites+of+the+mannose-specific+fimbrial+lectins+of+Enterobacteria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21bR"><div class="casContent"><span class="casTitleNuber">21b</span><div class="casTitle"><span class="NLM_cas:atitle">Carbohydrate-binding sites of the mannose-specific fimbrial lectins of enterobacteria</span></div><div class="casAuthors">Firon, Nurit; Ofek, Itzhak; Sharon, Nathan</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1088-90</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    </div><div class="casAbstract">The combining sites of type 1 fimbrial lectins of various species of enterobacteria were studied by measuring the inhibitory activity of linear and branched oligosaccharides and several glycosides of D-mannose on the agglutination of yeast cells by the organisms.  All 5 strains of Escherichia coli possessed an elongated combining site best fitting a trisaccharide and including a hydrophobic region.  Similar results were obtained with Klebsiella pneumoniae.  Within the Salmonella genus, the combining sites of the 6 species were similar, but all differed from those of the E. coli strains.  The combining sites of Enterobacteer cloacae and Enterobacter agglomerans were different from each other and from those of Salmonella species and E. coli.  Thus, although they are classified under the general term mannose-specific, bacterial lectins in the form of type 1 fimbriae on different genera apparently exhibit differences in sugar specificities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr80HxUnevGcLVg90H21EOLACvtfcHk0lg1QWFom0MgEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhtF2itLw%253D&md5=f3b606bd5040e8eef227b8a47c1952ea</span></div><a href="/servlet/linkout?suffix=cit21b&amp;dbid=16384&amp;doi=10.1128%2FIAI.43.3.1088-1090.1984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.43.3.1088-1090.1984%26sid%3Dliteratum%253Aachs%26aulast%3DFiron%26aufirst%3DN.%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DCarbohydrate-binding%2520sites%2520of%2520the%2520mannose-specific%2520fimbrial%2520lectins%2520of%2520Enterobacteria%26jtitle%3DInfect.%2520Immun.%26date%3D1984%26volume%3D43%26spage%3D1088%26epage%3D1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit21c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Firon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ofek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharon, N.</span><span> </span><span class="NLM_article-title">Interaction of mannose-containing oligosaccharides with the fimbrial lectin of Eshcerichia coli</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1426</span><span class="NLM_x">–</span> <span class="NLM_lpage">1432</span><span class="refDoi"> DOI: 10.1016/0006-291X(82)90947-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2F0006-291X%2882%2990947-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=1982&pages=1426-1432&author=N.+Fironauthor=I.+Ofekauthor=N.+Sharon&title=Interaction+of+mannose-containing+oligosaccharides+with+the+fimbrial+lectin+of+Eshcerichia+coli&doi=10.1016%2F0006-291X%2882%2990947-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21c&amp;dbid=16384&amp;doi=10.1016%2F0006-291X%2882%2990947-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-291X%252882%252990947-0%26sid%3Dliteratum%253Aachs%26aulast%3DFiron%26aufirst%3DN.%26aulast%3DOfek%26aufirst%3DI.%26aulast%3DSharon%26aufirst%3DN.%26atitle%3DInteraction%2520of%2520mannose-containing%2520oligosaccharides%2520with%2520the%2520fimbrial%2520lectin%2520of%2520Eshcerichia%2520coli%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1982%26volume%3D105%26spage%3D1426%26epage%3D1432%26doi%3D10.1016%2F0006-291X%2882%2990947-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Klein, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lüthi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezençon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiesko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in vitro and in vivo evaluation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8627</span><span class="NLM_x">–</span> <span class="NLM_lpage">8641</span><span class="refDoi"> DOI: 10.1021/jm101011y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101011y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8627-8641&author=T.+Kleinauthor=D.+Abgottsponauthor=M.+Wittwerauthor=S.+Rabbaniauthor=J.+Heroldauthor=X.+Jiangauthor=S.+Kleebauthor=C.+L%C3%BCthiauthor=M.+Scharenbergauthor=J.+Bezen%C3%A7onauthor=E.+Gublerauthor=L.+Pangauthor=M.+Smieskoauthor=B.+Cuttingauthor=O.+Schwardtauthor=B.+Ernst&title=FimH+antagonists+for+the+oral+treatment+of+urinary+tract+infections%3A+from+design+and+synthesis+to+in+vitro+and+in+vivo+evaluation&doi=10.1021%2Fjm101011y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">FimH Antagonists for the Oral Treatment of Urinary Tract Infections: From Design and Synthesis to in Vitro and in Vivo Evaluation</span></div><div class="casAuthors">Klein, Tobias; Abgottspon, Daniela; Wittwer, Matthias; Rabbani, Said; Herold, Janno; Jiang, Xiao-Hua; Kleeb, Simon; Luthi, Christine; Scharenberg, Meike; Bezencon, Jacqueline; Gubler, Erich; Pang, Li-Juan; Smiesko, Martin; Cutting, Brian; Schwardt, Oliver; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8627-8641</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urinary tract infection (UTI) by uropathogenic Escherichia coli (UPEC) is one of the most common infections, particularly affecting women.  The interaction of FimH, a lectin located at the tip of bacterial pili, with high mannose structures is crit. for the ability of UPEC to colonize and invade the bladder epithelium.  We describe the synthesis and the in vitro/in vivo evaluation of α-D-mannosides with the ability to block the bacteria/host cell interaction.  According to the pharmacokinetic properties, a prodrug approach for their evaluation in the UTI mouse model was explored.  As a result, an orally available, low mol. wt. FimH antagonist was identified with the potential to reduce the colony forming units (CFU) in the urine by 2 orders of magnitude and in the bladder by 4 orders of magnitude.  With FimH antagonist I, the great potential for the effective treatment of urinary tract infections with a new class of orally available anti-infectives could be demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_u1FpN_VK97Vg90H21EOLACvtfcHk0lgqu4xraQNTYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7bO&md5=7caa417c8f4235cbbd780558adeab411</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm101011y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101011y%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DT.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DHerold%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DL%25C3%25BCthi%26aufirst%3DC.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DBezen%25C3%25A7on%26aufirst%3DJ.%26aulast%3DGubler%26aufirst%3DE.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%2520for%2520the%2520oral%2520treatment%2520of%2520urinary%2520tract%2520infections%253A%2520from%2520design%2520and%2520synthesis%2520to%2520in%2520vitro%2520and%2520in%2520vivo%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8627%26epage%3D8641%26doi%3D10.1021%2Fjm101011y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zihlmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutter, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiesko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezencon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH antagonists: bioisosteres to improve the in vitro and in vivo PK/PD profile</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2221</span><span class="NLM_x">–</span> <span class="NLM_lpage">2239</span><span class="refDoi"> DOI: 10.1021/jm501524q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501524q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2221-2239&author=S.+Kleebauthor=L.+Pangauthor=K.+Mayerauthor=D.+Erisauthor=A.+Siglauthor=R.+C.+Prestonauthor=P.+Zihlmannauthor=T.+Sharpeauthor=R.+P.+Jakobauthor=D.+Abgottsponauthor=A.+S.+Hutterauthor=M.+Scharenbergauthor=X.+Jiangauthor=G.+Navarraauthor=S.+Rabbaniauthor=M.+Smieskoauthor=N.+Ludinauthor=J.+Bezenconauthor=O.+Schwardtauthor=T.+Maierauthor=B.+Ernst&title=FimH+antagonists%3A+bioisosteres+to+improve+the+in+vitro+and+in+vivo+PK%2FPD+profile&doi=10.1021%2Fjm501524q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjm501524q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501524q%26sid%3Dliteratum%253Aachs%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DL.%26aulast%3DMayer%26aufirst%3DK.%26aulast%3DEris%26aufirst%3DD.%26aulast%3DSigl%26aufirst%3DA.%26aulast%3DPreston%26aufirst%3DR.%2BC.%26aulast%3DZihlmann%26aufirst%3DP.%26aulast%3DSharpe%26aufirst%3DT.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DHutter%26aufirst%3DA.%2BS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DNavarra%26aufirst%3DG.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DLudin%26aufirst%3DN.%26aulast%3DBezencon%26aufirst%3DJ.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%253A%2520bioisosteres%2520to%2520improve%2520the%2520in%2520vitro%2520and%2520in%2520vivo%2520PK%252FPD%2520profile%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2221%26epage%3D2239%26doi%3D10.1021%2Fjm501524q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Sperling, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhorst, T. K.</span><span> </span><span class="NLM_article-title">Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: design, synthesis and binding properties of mannoside ligands</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">3913</span><span class="NLM_x">–</span> <span class="NLM_lpage">3922</span><span class="refDoi"> DOI: 10.1039/b610745a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1039%2Fb610745a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=17047870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtV2hurfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2006&pages=3913-3922&author=O.+Sperlingauthor=A.+Fuchsauthor=T.+K.+Lindhorst&title=Evaluation+of+the+carbohydrate+recognition+domain+of+the+bacterial+adhesin+FimH%3A+design%2C+synthesis+and+binding+properties+of+mannoside+ligands&doi=10.1039%2Fb610745a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the carbohydrate recognition domain of the bacterial adhesin FimH: Design, synthesis and binding properties of mannoside ligands</span></div><div class="casAuthors">Sperling, Oliver; Fuchs, Andreas; Lindhorst, Thisbe K.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3913-3922</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Fimbriae are proteinogeneous appendages on the surface of bacteria, which mediate bacterial adhesion to the host cell glycocalyx.  The so-called type 1 fimbriae exhibit specificity for α-d-mannosides and, therefore, they are assumed to mediate bacterial adhesion via the interaction of a fimbrial lectin and α-d-mannosyl residues exposed on the host cell surface.  This carbohydrate-specific adhesive protein subunit of type 1 fimbriae has been identified as a protein called FimH.  The crystal structure of this lectin is known and, based on this information, the mol. details of the interaction of mannoside ligands and FimH are addressed in this paper.  Computer-based docking methods were used to evaluate known ligands as well as to design new ones.  Then, a series of new mannosides with extended aglycon was synthesized and tested as inhibitors of type 1 fimbriae-mediated bacterial adhesion in an ELISA.  The results obtained were compared to the predictions and findings as delivered by mol. modeling.  This study led to an improved understanding of the ligand-receptor interactions under investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3PgYI7XkA4LVg90H21EOLACvtfcHk0ljSGYzEY7SVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtV2hurfL&md5=4066e179bc6e4a12e1a04eff9ff2cf4b</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1039%2Fb610745a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb610745a%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DO.%26aulast%3DFuchs%26aufirst%3DA.%26aulast%3DLindhorst%26aufirst%3DT.%2BK.%26atitle%3DEvaluation%2520of%2520the%2520carbohydrate%2520recognition%2520domain%2520of%2520the%2520bacterial%2520adhesin%2520FimH%253A%2520design%252C%2520synthesis%2520and%2520binding%2520properties%2520of%2520mannoside%2520ligands%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2006%26volume%3D4%26spage%3D3913%26epage%3D3922%26doi%3D10.1039%2Fb610745a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chalopin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvarez Dorta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caudan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumych, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilyy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deniaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn’s disease</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3913</span><span class="NLM_x">–</span> <span class="NLM_lpage">3925</span><span class="refDoi"> DOI: 10.1039/C6OB00424E</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1039%2FC6OB00424E" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=27043998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28XksFOhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=3913-3925&author=T.+Chalopinauthor=D.+Alvarez+Dortaauthor=A.+Sivignonauthor=M.+Caudanauthor=T.+I.+Dumychauthor=R.+O.+Bilyyauthor=D.+Deniaudauthor=N.+Barnichauthor=J.+Bouckaertauthor=S.+G.+Gouin&title=Second+generation+of+thiazolylmannosides%2C+FimH+antagonists+for+E.+coli-induced+Crohn%E2%80%99s+disease&doi=10.1039%2FC6OB00424E"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Second generation of thiazolylmannosides, FimH antagonists for E. coli-induced Crohn's disease</span></div><div class="casAuthors">Chalopin, T.; Alvarez Dorta, D.; Sivignon, A.; Caudan, M.; Dumych, T. I.; Bilyy, R. O.; Deniaud, D.; Barnich, N.; Bouckaert, J.; Gouin, S. G.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3913-3925</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The anti-adhesive strategy, consisting of disrupting bacterial attachment to the host cells, is widely explored as an alternative to antibiotic therapies.  Recently, thiazolylmannosides (TazMans) have been identified as strong anti-adhesives of E. coli strains implied in the gut inflammation of patients with Crohn's disease.  In this work, we developed a second generation of TazMans with improved chem. stability.  The anomeric nitrogen was substituted by short linkers and the compds. were assessed against the bacterial adhesion FimH and the clin. isolated LF82 E. coli strain in four in vitro assays.  The results obtained on the FimH adhesion alone and the whole bacteria enabled the identification of a candidate for further in vivo evaluations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkKdlFrE3oQ7Vg90H21EOLACvtfcHk0ljSGYzEY7SVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksFOhtrY%253D&md5=6afd4a3eb9cb6e17c11f007cfb1ff44c</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1039%2FC6OB00424E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6OB00424E%26sid%3Dliteratum%253Aachs%26aulast%3DChalopin%26aufirst%3DT.%26aulast%3DAlvarez%2BDorta%26aufirst%3DD.%26aulast%3DSivignon%26aufirst%3DA.%26aulast%3DCaudan%26aufirst%3DM.%26aulast%3DDumych%26aufirst%3DT.%2BI.%26aulast%3DBilyy%26aufirst%3DR.%2BO.%26aulast%3DDeniaud%26aufirst%3DD.%26aulast%3DBarnich%26aufirst%3DN.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DSecond%2520generation%2520of%2520thiazolylmannosides%252C%2520FimH%2520antagonists%2520for%2520E.%2520coli-induced%2520Crohn%25E2%2580%2599s%2520disease%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2016%26volume%3D14%26spage%3D3913%26epage%3D3925%26doi%3D10.1039%2FC6OB00424E" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Alvarez Dorta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalopin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumych, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilyy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deniaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krammer, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Ruyck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensink, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnich, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">The Antiadhesive Strategy in Crohn′s Disease: Orally Active Mannosides to Decolonize Pathogenic <i>Escherichia coli</i> from the Gut</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">952</span><span class="refDoi"> DOI: 10.1002/cbic.201600018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcbic.201600018" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2016&pages=936-952&author=D.+Alvarez+Dortaauthor=A.+Sivignonauthor=T.+Chalopinauthor=T.+I.+Dumychauthor=G.+Roosauthor=R.+O.+Bilyyauthor=D.+Deniaudauthor=E.-M.+Krammerauthor=J.+de+Ruyckauthor=M.+F.+Lensinkauthor=J.+Bouckaertauthor=N.+Barnichauthor=S.+G.+Gouin&title=The+Antiadhesive+Strategy+in+Crohn%E2%80%B2s+Disease%3A+Orally+Active+Mannosides+to+Decolonize+Pathogenic+Escherichia+coli+from+the+Gut&doi=10.1002%2Fcbic.201600018"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201600018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201600018%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarez%2BDorta%26aufirst%3DD.%26aulast%3DSivignon%26aufirst%3DA.%26aulast%3DChalopin%26aufirst%3DT.%26aulast%3DDumych%26aufirst%3DT.%2BI.%26aulast%3DRoos%26aufirst%3DG.%26aulast%3DBilyy%26aufirst%3DR.%2BO.%26aulast%3DDeniaud%26aufirst%3DD.%26aulast%3DKrammer%26aufirst%3DE.-M.%26aulast%3Dde%2BRuyck%26aufirst%3DJ.%26aulast%3DLensink%26aufirst%3DM.%2BF.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DBarnich%26aufirst%3DN.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DThe%2520Antiadhesive%2520Strategy%2520in%2520Crohn%25E2%2580%25B2s%2520Disease%253A%2520Orally%2520Active%2520Mannosides%2520to%2520Decolonize%2520Pathogenic%2520Escherichia%2520coli%2520from%2520the%2520Gut%26jtitle%3DChemBioChem%26date%3D2016%26volume%3D17%26spage%3D936%26epage%3D952%26doi%3D10.1002%2Fcbic.201600018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Brument, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sivignon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumych, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roos, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerardel, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalopin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deniaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilyy, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darfeuille-Michaud, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">Thiazolylaminomannosides as potent antiadhesives of type 1 piliated <i>Escherichia coli</i> isolated from Crohn’s disease patients</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">5395</span><span class="NLM_x">–</span> <span class="NLM_lpage">5406</span><span class="refDoi"> DOI: 10.1021/jm400723n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400723n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3sXptFKju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=5395-5406&author=S.+Brumentauthor=A.+Sivignonauthor=T.+I.+Dumychauthor=N.+Moreauauthor=G.+Roosauthor=Y.+Guerardelauthor=T.+Chalopinauthor=D.+Deniaudauthor=R.+O.+Bilyyauthor=A.+Darfeuille-Michaudauthor=J.+Bouckaertauthor=S.+G.+Gouin&title=Thiazolylaminomannosides+as+potent+antiadhesives+of+type+1+piliated+Escherichia+coli+isolated+from+Crohn%E2%80%99s+disease+patients&doi=10.1021%2Fjm400723n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23eR"><div class="casContent"><span class="casTitleNuber">23e</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolylaminomannosides As Potent Antiadhesives of Type 1 Piliated Escherichia coli Isolated from Crohn's Disease Patients</span></div><div class="casAuthors">Brument, Sami; Sivignon, Adeline; Dumych, Tetiana I.; Moreau, Nicolas; Roos, Goedele; Guerardel, Yann; Chalopin, Thibaut; Deniaud, David; Bilyy, Rostyslav O.; Darfeuille-Michaud, Arlette; Bouckaert, Julie; Gouin, Sebastien G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5395-5406</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adherent-invasive Escherichia coli (AIEC) have previously been shown to induce gut inflammation in patients with Crohn's disease (CD).  We developed a set of mannosides to prevent AIEC attachment to the gut by blocking the FimH bacterial adhesin.  The crystal structure of the FimH lectin domain in complex with a lead thiazolylaminomannoside highlighted the preferential position for pharmacomodulations.  A small library of analogs showing nanomolar affinity for FimH was then developed.  Notably, AIEC attachment to intestinal cells was efficiently prevented by the most active compd. and at around 10000-fold and 100-fold lower concns. than mannose and the potent FimH inhibitor heptylmannoside, resp.  An ex vivo assay performed on the colonic tissue of a transgenic mouse model of CD confirmed this antiadhesive potential.  Given the key role of AIEC in the chronic intestinal inflammation of CD patients, these results suggest a potential antiadhesive treatment with the FimH inhibitors developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquOL1t8Q_PF7Vg90H21EOLACvtfcHk0ljSGYzEY7SVAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXptFKju7w%253D&md5=659bfc5d2a53ba328a48d7298af8cf72</span></div><a href="/servlet/linkout?suffix=cit23e&amp;dbid=16384&amp;doi=10.1021%2Fjm400723n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400723n%26sid%3Dliteratum%253Aachs%26aulast%3DBrument%26aufirst%3DS.%26aulast%3DSivignon%26aufirst%3DA.%26aulast%3DDumych%26aufirst%3DT.%2BI.%26aulast%3DMoreau%26aufirst%3DN.%26aulast%3DRoos%26aufirst%3DG.%26aulast%3DGuerardel%26aufirst%3DY.%26aulast%3DChalopin%26aufirst%3DT.%26aulast%3DDeniaud%26aufirst%3DD.%26aulast%3DBilyy%26aufirst%3DR.%2BO.%26aulast%3DDarfeuille-Michaud%26aufirst%3DA.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DThiazolylaminomannosides%2520as%2520potent%2520antiadhesives%2520of%2520type%25201%2520piliated%2520Escherichia%2520coli%2520isolated%2520from%2520Crohn%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D5395%26epage%3D5406%26doi%3D10.1021%2Fjm400723n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Pang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemme, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH antagonists: structure-activity and structure-property relationships for biphenyl alpha-D-mannopyranosides</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1404</span><span class="NLM_x">–</span> <span class="NLM_lpage">1422</span><span class="refDoi"> DOI: 10.1002/cmdc.201200125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.201200125" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1404-1422&author=L.+Pangauthor=S.+Kleebauthor=K.+Lemmeauthor=S.+Rabbaniauthor=M.+Scharenbergauthor=A.+Zalewskiauthor=F.+Schadlerauthor=O.+Schwardtauthor=B.+Ernst&title=FimH+antagonists%3A+structure-activity+and+structure-property+relationships+for+biphenyl+alpha-D-mannopyranosides&doi=10.1002%2Fcmdc.201200125"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23f&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201200125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201200125%26sid%3Dliteratum%253Aachs%26aulast%3DPang%26aufirst%3DL.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DLemme%26aufirst%3DK.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DZalewski%26aufirst%3DA.%26aulast%3DSchadler%26aufirst%3DF.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520antagonists%253A%2520structure-activity%2520and%2520structure-property%2520relationships%2520for%2520biphenyl%2520alpha-D-mannopyranosides%26jtitle%3DChemMedChem%26date%3D2012%26volume%3D7%26spage%3D1404%26epage%3D1422%26doi%3D10.1002%2Fcmdc.201200125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haug, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">Antiadhesion therapy for urinary tract infections—A balanced PK/PD profile proved to be key for success</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4700</span><span class="NLM_x">–</span> <span class="NLM_lpage">4713</span><span class="refDoi"> DOI: 10.1021/jm300192x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300192x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4700-4713&author=X.+Jiangauthor=D.+Abgottsponauthor=S.+Kleebauthor=S.+Rabbaniauthor=M.+Scharenbergauthor=M.+Wittwerauthor=M.+Haugauthor=O.+Schwardtauthor=B.+Ernst&title=Antiadhesion+therapy+for+urinary+tract+infections%E2%80%94A+balanced+PK%2FPD+profile+proved+to+be+key+for+success&doi=10.1021%2Fjm300192x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23g&amp;dbid=16384&amp;doi=10.1021%2Fjm300192x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300192x%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DScharenberg%26aufirst%3DM.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DHaug%26aufirst%3DM.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DAntiadhesion%2520therapy%2520for%2520urinary%2520tract%2520infections%25E2%2580%2594A%2520balanced%2520PK%252FPD%2520profile%2520proved%2520to%2520be%2520key%2520for%2520success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4700%26epage%3D4713%26doi%3D10.1021%2Fjm300192x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xavier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almant, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caveliers, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahoutte, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovensky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouin, S. G.</span><span> </span><span class="NLM_article-title">Heptyl alpha-D-mannosides grafted on a beta-cyclodextrin core to interfere with <i>Escherichia coli</i> adhesion: an in vivo multivalent effect</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">7847</span><span class="NLM_x">–</span> <span class="NLM_lpage">7855</span><span class="refDoi"> DOI: 10.1002/chem.201204015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fchem.201204015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=23595913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvFaju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=7847-7855&author=J.+Bouckaertauthor=Z.+Liauthor=C.+Xavierauthor=M.+Almantauthor=V.+Caveliersauthor=T.+Lahoutteauthor=S.+D.+Weeksauthor=J.+Kovenskyauthor=S.+G.+Gouin&title=Heptyl+alpha-D-mannosides+grafted+on+a+beta-cyclodextrin+core+to+interfere+with+Escherichia+coli+adhesion%3A+an+in+vivo+multivalent+effect&doi=10.1002%2Fchem.201204015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Heptyl α-D-Mannosides Grafted on a β-Cyclodextrin Core to Interfere with Escherichia coli Adhesion: An In Vivo Multivalent Effect</span></div><div class="casAuthors">Bouckaert, Julie; Li, Zhaoli; Xavier, Catarina; Almant, Mehdi; Caveliers, Vicky; Lahoutte, Tony; Weeks, Stephen D.; Kovensky, Jose; Gouin, Sebastien G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7847-7855</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Heptyl α-D-mannoside (HM) has previously been identified as a nano-molar FimH antagonist able to prevent Escherichia coli adhesion.  We have designed mono- and heptavalent glycoconjugates in which HM is tethered to β-cyclodextrin (β-CD) through short and long spacers.  One-pot click or co-clicking procedures were developed to directly obtain the glycoconjugates from unprotected HM and β-CD precursors.  These FimH antagonists were examd. biophys. and in vivo.  Reverse titrns. by isothermal calorimetry led to trapping of the short-tethered heptavalent β-CD in a complex with three FimH lectins.  Combined dynamic light scattering and small-angle X-ray soln. scattering data allowed the construction of a model of the FimH trimer.  The heptavalent β-CDs were shown to capture and aggregate living bacteria in soln. and are therefore also able to aggregate FimH when attached to different bacteria pili.  The first in vivo evaluation of multivalent FimH inhibitors has been performed.  The heptavalent β-CDs proved to be much more effective anti-adhesive agents than monovalent refs. with doses of around 2 μg instilled in the mouse bladder leading to a significantly decreased E. coli load.  I.v. injected radiolabeled glycoconjugates can rapidly reach the mouse bladder and > 2 μg concns. can easily be retained over 24 h to prevent fluxing bacteria from re-binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowPgL08GrccLVg90H21EOLACvtfcHk0lh5Gb3DzQQSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvFaju74%253D&md5=b0e67e2b8bd45d0a73bcfa69296c3f9b</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1002%2Fchem.201204015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201204015%26sid%3Dliteratum%253Aachs%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXavier%26aufirst%3DC.%26aulast%3DAlmant%26aufirst%3DM.%26aulast%3DCaveliers%26aufirst%3DV.%26aulast%3DLahoutte%26aufirst%3DT.%26aulast%3DWeeks%26aufirst%3DS.%2BD.%26aulast%3DKovensky%26aufirst%3DJ.%26aulast%3DGouin%26aufirst%3DS.%2BG.%26atitle%3DHeptyl%2520alpha-D-mannosides%2520grafted%2520on%2520a%2520beta-cyclodextrin%2520core%2520to%2520interfere%2520with%2520Escherichia%2520coli%2520adhesion%253A%2520an%2520in%2520vivo%2520multivalent%2520effect%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2013%26volume%3D19%26spage%3D7847%26epage%3D7855%26doi%3D10.1002%2Fchem.201204015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gouin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovensky, J.</span><span> </span><span class="NLM_article-title">Synthetic Multimeric Heptyl Mannosides as Potent Antiadhesives of Uropathogenic <i>Escherichia coli</i></span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span><span class="refDoi"> DOI: 10.1002/cmdc.200900034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.200900034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD1MXls1Kgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=749-755&author=S.+G.+Gouinauthor=A.+Wellensauthor=J.+Bouckaertauthor=J.+Kovensky&title=Synthetic+Multimeric+Heptyl+Mannosides+as+Potent+Antiadhesives+of+Uropathogenic+Escherichia+coli&doi=10.1002%2Fcmdc.200900034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24bR"><div class="casContent"><span class="casTitleNuber">24b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic Multimeric Heptyl Mannosides as Potent Antiadhesives of Uropathogenic Escherichia coli</span></div><div class="casAuthors">Gouin, Sebastien G.; Wellens, Adinda; Bouckaert, Julie; Kovensky, Jose</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Sweet medicine: Multimeric glycoconjugates with valencies ranging from one to four were synthesized by click chem.  Unprecedented adhesion inhibitions of piliated E. coli to human bladder cells were recorded with the multimers; a tetravalent deriv. showed inhibitory concns. 6000- and 64-fold lower than mannose and heptyl α-D-mannoside, resp.  Urinary tract infections caused by uropathogenic Escherichia coli presents a serious communal and nosocomial health problem initiated by bacterial adhesion to the bladder cells.  E. coli expresses fimbriae with a mannose-binding adhesin, FimH, at the tip.  Heptyl α-D-mannoside (HM) is a nanomolar inhibitor of this lectin, preventing adhesion of type 1-piliated E. coli and reducing bacteria levels in a murine cystitis model.  Herein, we described the synthesis of multimeric heptyl-mannosides with valencies ranging from one to four by copper-catalyzed azide alkyne cycloaddn. (CuAAC).  Biol. evaluation of the multivalent compds. revealed an increase in potency compared to HM.  Inhibition of bladder cell binding highlighted a promising tetravalent deriv. with inhibitory concns. 6000- and 64-fold lower than mannose and HM resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqshcLleD-6LVg90H21EOLACvtfcHk0lh5Gb3DzQQSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXls1Kgsbc%253D&md5=b2b4bcd93a34ac9fae0baca586924117</span></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200900034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200900034%26sid%3Dliteratum%253Aachs%26aulast%3DGouin%26aufirst%3DS.%2BG.%26aulast%3DWellens%26aufirst%3DA.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DKovensky%26aufirst%3DJ.%26atitle%3DSynthetic%2520Multimeric%2520Heptyl%2520Mannosides%2520as%2520Potent%2520Antiadhesives%2520of%2520Uropathogenic%2520Escherichia%2520coli%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D749%26epage%3D755%26doi%3D10.1002%2Fcmdc.200900034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Touaibia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wellens, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiao, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirois, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R.</span><span> </span><span class="NLM_article-title">Mannosylated G(0) dendrimers with nanomolar affinities to <i>Escherichia coli</i> FimH</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1190</span><span class="NLM_x">–</span> <span class="NLM_lpage">1201</span><span class="refDoi"> DOI: 10.1002/cmdc.200700063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.200700063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=17589887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1190-1201&author=M.+Touaibiaauthor=A.+Wellensauthor=T.+C.+Shiaoauthor=Q.+Wangauthor=S.+Siroisauthor=J.+Bouckaertauthor=R.+Roy&title=Mannosylated+G%280%29+dendrimers+with+nanomolar+affinities+to+Escherichia+coli+FimH&doi=10.1002%2Fcmdc.200700063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24cR"><div class="casContent"><span class="casTitleNuber">24c</span><div class="casTitle"><span class="NLM_cas:atitle">Mannosylated G(0) dendrimers with nano-molar affinities to Escherichia coli FimH</span></div><div class="casAuthors">Touaibia, Mohamed; Wellens, Adinda; Shiao, Tze Chieh; Wang, Qingan; Sirois, Suzanne; Bouckaert, Julie; Roy, Rene</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1190-1201</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Penta-erythritol and bis-penta-erythritol scaffolds were used for the prepn. of first generation glycodendrimers bearing aryl α-D-mannopyranoside residues assembled using single-step Sonogashira and click chem.  The carbohydrate precursors were built with either para-iodo-Ph, propargyl, or 2-azido-Et aglycons whereas the penta-erythritol moieties were built with terminal azide or propargyl groups, resp.  Crosslinking abilities of this series of glycodendrimers were first evaluated with the lectin from Canavalia ensiformis (Con A).  Surface plasmon resonance measurements showed these two families of mannosylated clusters as the best ligands known to date toward Escherichia coli K12 FimH with sub-nano-molar affinities (Kd of 0.45 nM).  These clusters were 1000 times more potent than mannose for their capacity to inhibit the binding of E. coli to erythrocytes in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpf9VwIPJknlbVg90H21EOLACvtfcHk0ljQhaehrXIbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemt74%253D&md5=47bb60eb63194ed2aeccf387a6725ae8</span></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700063%26sid%3Dliteratum%253Aachs%26aulast%3DTouaibia%26aufirst%3DM.%26aulast%3DWellens%26aufirst%3DA.%26aulast%3DShiao%26aufirst%3DT.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSirois%26aufirst%3DS.%26aulast%3DBouckaert%26aufirst%3DJ.%26aulast%3DRoy%26aufirst%3DR.%26atitle%3DMannosylated%2520G%25280%2529%2520dendrimers%2520with%2520nanomolar%2520affinities%2520to%2520Escherichia%2520coli%2520FimH%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1190%26epage%3D1201%26doi%3D10.1002%2Fcmdc.200700063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lindhorst, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krallmann-Wenzel, U.</span><span> </span><span class="NLM_article-title">Inhibition of the type 1 fimbriae-mediated adhesion of <i>Escherichia coli</i> to erythrocytes by multiantennary alpha-mannosyl clusters: the effect of multivalency</span> <span class="citation_source-journal">Glycoconjugate J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">613</span><span class="refDoi"> DOI: 10.1023/A:1006920027641</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1023%2FA%3A1006920027641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=9881767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADyaK1cXltFGku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=605-613&author=T.+K.+Lindhorstauthor=C.+Kieburgauthor=U.+Krallmann-Wenzel&title=Inhibition+of+the+type+1+fimbriae-mediated+adhesion+of+Escherichia+coli+to+erythrocytes+by+multiantennary+alpha-mannosyl+clusters%3A+the+effect+of+multivalency&doi=10.1023%2FA%3A1006920027641"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24dR"><div class="casContent"><span class="casTitleNuber">24d</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the type 1 fimbriae-mediated adhesion of Escherichia coli to erythrocytes by multiantennary α-mannosyl clusters: the effect of multivalency</span></div><div class="casAuthors">Lindhorst, Thisbe K.; Kieburg, Christoffer; Krallmann-Wenzel, Ulrike</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">605-613</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">α-Mannosyl glycoclusters and glycodendrimers were tested as multivalent inhibitors of the type 1 (mannose-specific) fimbriae of a recombinant E. coli HB101 strain.  Inhibition of hemagglutination of guinea pig erythrocytes was detd. on microtiter plates.  The effect of multivalency is pronounced for up to three mannosyl residues in the mol., whereas larger derivs. do not have an appreciable effect on binding to the fimbrial carbohydrate binding domain.  The best glycoclusters tested reach the binding potency of the known potent inhibitor pNPMan (I).  The results support the idea of a monovalent recognition site at the adhesive protein FimH, which might best accommodate mols. with the size of a trisaccharide or those which expose up to three α-mannosyl residues, such as the glycocluster II.  The results obtained with the thiourea-bridged α-mannosyl clusters, possessing defined sugar valences, facilitate the development of high affinity inhibitors of the fimbrial lectin on type 1 fimbriae.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGN8vdfHZ1JLVg90H21EOLACvtfcHk0ljQhaehrXIbpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltFGku7w%253D&md5=03580f8b56f4c8c9d43e3a7e7dcc9b32</span></div><a href="/servlet/linkout?suffix=cit24d&amp;dbid=16384&amp;doi=10.1023%2FA%3A1006920027641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1006920027641%26sid%3Dliteratum%253Aachs%26aulast%3DLindhorst%26aufirst%3DT.%2BK.%26aulast%3DKieburg%26aufirst%3DC.%26aulast%3DKrallmann-Wenzel%26aufirst%3DU.%26atitle%3DInhibition%2520of%2520the%2520type%25201%2520fimbriae-mediated%2520adhesion%2520of%2520Escherichia%2520coli%2520to%2520erythrocytes%2520by%2520multiantennary%2520alpha-mannosyl%2520clusters%253A%2520the%2520effect%2520of%2520multivalency%26jtitle%3DGlycoconjugate%2520J.%26date%3D1998%26volume%3D15%26spage%3D605%26epage%3D613%26doi%3D10.1023%2FA%3A1006920027641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Jarvis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkner, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cusumano, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mydock-McGrane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span> </span><span class="NLM_article-title">Antivirulence Isoquinolone Mannosides: Optimization of the Biaryl Aglycone for FimH Lectin Binding Affinity and Efficacy in the Treatment of Chronic UTI</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">373</span><span class="refDoi"> DOI: 10.1002/cmdc.201600006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcmdc.201600006" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=367-373&author=C.+Jarvisauthor=Z.+Hanauthor=V.+Kalasauthor=R.+Kleinauthor=J.+S.+Pinknerauthor=B.+Fordauthor=J.+Binkleyauthor=C.+K.+Cusumanoauthor=Z.+Cusumanoauthor=L.+Mydock-McGraneauthor=S.+J.+Hultgrenauthor=J.+W.+Janetka&title=Antivirulence+Isoquinolone+Mannosides%3A+Optimization+of+the+Biaryl+Aglycone+for+FimH+Lectin+Binding+Affinity+and+Efficacy+in+the+Treatment+of+Chronic+UTI&doi=10.1002%2Fcmdc.201600006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600006%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DKalas%26aufirst%3DV.%26aulast%3DKlein%26aufirst%3DR.%26aulast%3DPinkner%26aufirst%3DJ.%2BS.%26aulast%3DFord%26aufirst%3DB.%26aulast%3DBinkley%26aufirst%3DJ.%26aulast%3DCusumano%26aufirst%3DC.%2BK.%26aulast%3DCusumano%26aufirst%3DZ.%26aulast%3DMydock-McGrane%26aufirst%3DL.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DAntivirulence%2520Isoquinolone%2520Mannosides%253A%2520Optimization%2520of%2520the%2520Biaryl%2520Aglycone%2520for%2520FimH%2520Lectin%2520Binding%2520Affinity%2520and%2520Efficacy%2520in%2520the%2520Treatment%2520of%2520Chronic%2520UTI%26jtitle%3DChemMedChem%26date%3D2016%26volume%3D11%26spage%3D367%26epage%3D373%26doi%3D10.1002%2Fcmdc.201600006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Vicente, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Barbero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiara, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicent, C.</span><span> </span><span class="NLM_article-title">Hydrogen-bonding cooperativity: using an intramolecular hydrogen bond to design a carbohydrate derivative with a cooperative hydrogen-bond donor centre</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4240</span><span class="NLM_x">–</span> <span class="NLM_lpage">4251</span><span class="refDoi"> DOI: 10.1002/chem.200400042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fchem.200400042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=15352107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslCkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=4240-4251&author=V.+Vicenteauthor=J.+Martinauthor=J.+Jimenez-Barberoauthor=J.+L.+Chiaraauthor=C.+Vicent&title=Hydrogen-bonding+cooperativity%3A+using+an+intramolecular+hydrogen+bond+to+design+a+carbohydrate+derivative+with+a+cooperative+hydrogen-bond+donor+centre&doi=10.1002%2Fchem.200400042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen-bonding cooperativity: Using an intramolecular hydrogen bond to design a carbohydrate derivative with a cooperative hydrogen-bond donor center</span></div><div class="casAuthors">Vicente, Virginie; Martin, Jason; Jimenez-Barbero, Jesus; Chiara, Jose Luis; Vicent, Cristina</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry--A European Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4240-4251</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Neighboring groups can be strategically located to polarize HO···OH intramol. hydrogen bonds in an intended direction.  A group with a unique hydrogen-bond donor or acceptor character, located at hydrogen-bonding distance to a particular OH group, has been used to initiate the hydrogen-bond network and to polarize a HO···OH hydrogen bond in a predicted direction.  This enhanced the donor character of a particular OH group and made it a cooperative hydrogen-bond center.  We have proved that a five-membered-ring intramol. hydrogen bond established between an amide NH group and a hydroxy group, which is addnl. located in a 1,3-cis-diaxial relationship to a second hydroxy group, can be used to select a unique direction on the six-membered-ring intramol. hydrogen bond between the two axial OH groups, so that one of them behaves as an efficient cooperative donor.  The mannopyranoside derivs. (I) and (II) were used as models to demonstrate the presence in soln. of the 1,2-(e,a)/five-membered-ring intramol. hydrogen bond., where as the talose deriv. (III) was designed and synthesized to prove this hydrogen-bonding network by NMR spectroscopy.  Once a well-defined hydrogen-bond is formed between the OH and the amido groups of a pyranose ring, these hydrogen-bonding groups no longer act as independent hydrogen-bonding centers, but as hydrogen-bonding arrays.  This introduces a new perspective on the properties of carbohydrate OH groups and it is important for the de novo design of mol. recognition processes, at least in nonpolar media.  Carbohydrates I-III have shown to be efficient phosphate binders in nonpolar solvents owing to the presence of cooperative hydroxy centers in the mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtL1qtqYYSUrVg90H21EOLACvtfcHk0lgOWS01F-NnaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslCkurk%253D&md5=1b2eb3abf6c7937ce85573ff8f7591e4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fchem.200400042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200400042%26sid%3Dliteratum%253Aachs%26aulast%3DVicente%26aufirst%3DV.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DJimenez-Barbero%26aufirst%3DJ.%26aulast%3DChiara%26aufirst%3DJ.%2BL.%26aulast%3DVicent%26aufirst%3DC.%26atitle%3DHydrogen-bonding%2520cooperativity%253A%2520using%2520an%2520intramolecular%2520hydrogen%2520bond%2520to%2520design%2520a%2520carbohydrate%2520derivative%2520with%2520a%2520cooperative%2520hydrogen-bond%2520donor%2520centre%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2004%26volume%3D10%26spage%3D4240%26epage%3D4251%26doi%3D10.1002%2Fchem.200400042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Janetka, J. W.; Han, Z.; Hultgren, S.; Pinkner, J. S.; Cusumano, C. K.</span><span> </span><span class="NLM_article-title">Compounds and methods for treating bacterial infections</span>. WO/2011/050323,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+W.+Janetka&author=Z.+Han&author=S.+Hultgren&author=J.+S.+Pinkner&author=C.+K.+Cusumano&title=Compounds+and+methods+for+treating+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DCompounds%2520and%2520methods%2520for%2520treating%2520bacterial%2520infections%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abgottspon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittwer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiesko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutting, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6454</span><span class="NLM_x">–</span> <span class="NLM_lpage">6473</span><span class="refDoi"> DOI: 10.1016/j.bmc.2011.08.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.bmc.2011.08.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21962988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlejsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=6454-6473&author=O.+Schwardtauthor=S.+Rabbaniauthor=M.+Hartmannauthor=D.+Abgottsponauthor=M.+Wittwerauthor=S.+Kleebauthor=A.+Zalewskiauthor=M.+Smieskoauthor=B.+Cuttingauthor=B.+Ernst&title=Design%2C+synthesis+and+biological+evaluation+of+mannosyl+triazoles+as+FimH+antagonists&doi=10.1016%2Fj.bmc.2011.08.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists</span></div><div class="casAuthors">Schwardt, Oliver; Rabbani, Said; Hartmann, Margrit; Abgottspon, Daniela; Wittwer, Matthias; Kleeb, Simon; Zalewski, Adam; Smiesko, Martin; Cutting, Brian; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6454-6473</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Urinary tract infection (UTI) caused by uropathogenic Escherichia coli (UPEC) is one of the most prevalent infectious diseases.  Particularly affected are women, who have a 40-50% risk to experience at least one symptomatic UTI episode at some time during their life.  In the initial step of the infection, the lectin FimH, located at the tip of bacterial pili, interacts with the high-mannosylated uroplakin Ia glycoprotein on the urinary bladder mucosa.  This interaction is crit. for the ability of UPEC to colonize and invade the bladder epithelium.  X-ray structures of FimH co-crystd. with two different ligands, the physiol. binding epitope oligomannose-3 and the antagonist biphenyl α-D-mannoside I revealed different binding modes, an in-docking-mode and an out-docking-mode, resp.  To accomplish the in-docking-mode, that is the docking mode where the ligand is hosted by the so-called tyrosine gate, FimH antagonists with increased flexibility were designed and synthesized.  All mannoside derivs., e.g. II, showed nanomolar affinities, but only one representative, the 4-pyridiyl deriv. II, was as potent as the ref. compd. n-heptyl α-D-mannoside.  Furthermore, a loss of affinity was obsd. for C-glycosides and derivs. where the triazole aglycon is directly N-linked to the anomeric center.  A conformational anal. by NMR revealed that the triazolyl-methyl-C-mannosides adopt an unusual 1C4 chair conformation, explaining the comparably lower affinity of these compds.  Furthermore, to address the drug-likeness of this new class of FimH antagonists, selected pharmacokinetics parameters, which are crit. for oral bioavailability (lipophilicity, soly., and membrane permeation), were detd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYsFPRTmZcebVg90H21EOLACvtfcHk0lgOWS01F-NnaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlejsLvM&md5=1b71d66a480861e4add04a19ddb9cc59</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.08.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.08.057%26sid%3Dliteratum%253Aachs%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DAbgottspon%26aufirst%3DD.%26aulast%3DWittwer%26aufirst%3DM.%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DZalewski%26aufirst%3DA.%26aulast%3DSmiesko%26aufirst%3DM.%26aulast%3DCutting%26aufirst%3DB.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520mannosyl%2520triazoles%2520as%2520FimH%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D6454%26epage%3D6473%26doi%3D10.1016%2Fj.bmc.2011.08.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Myers, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y. C.</span><span> </span><span class="NLM_article-title">Improved preparations of some per-O-acetylated aldohexopyranosyl cyanides</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span><span class="refDoi"> DOI: 10.1016/S0008-6215(00)90029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0008-6215%2800%2990029-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=1986&pages=145-163&author=R.+W.+Myersauthor=Y.+C.+Lee&title=Improved+preparations+of+some+per-O-acetylated+aldohexopyranosyl+cyanides&doi=10.1016%2FS0008-6215%2800%2990029-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FS0008-6215%2800%2990029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0008-6215%252800%252990029-6%26sid%3Dliteratum%253Aachs%26aulast%3DMyers%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DY.%2BC.%26atitle%3DImproved%2520preparations%2520of%2520some%2520per-O-acetylated%2520aldohexopyranosyl%2520cyanides%26jtitle%3DCarbohydr.%2520Res.%26date%3D1986%26volume%3D154%26spage%3D145%26epage%3D163%26doi%3D10.1016%2FS0008-6215%2800%2990029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Maity, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, M.</span><span> </span><span class="NLM_article-title">Design and Synthesis of Mannose Analogs as Inhibitors of Alpha-Mannosidase</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">6965</span><span class="NLM_x">–</span> <span class="NLM_lpage">6974</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)81349-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0040-4020%2801%2981349-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=6965-6974&author=S.+K.+Maityauthor=S.+K.+Duttaauthor=A.+K.+Banerjeeauthor=B.+Achariauthor=M.+Singh&title=Design+and+Synthesis+of+Mannose+Analogs+as+Inhibitors+of+Alpha-Mannosidase&doi=10.1016%2FS0040-4020%2801%2981349-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2981349-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252981349-1%26sid%3Dliteratum%253Aachs%26aulast%3DMaity%26aufirst%3DS.%2BK.%26aulast%3DDutta%26aufirst%3DS.%2BK.%26aulast%3DBanerjee%26aufirst%3DA.%2BK.%26aulast%3DAchari%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DM.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Mannose%2520Analogs%2520as%2520Inhibitors%2520of%2520Alpha-Mannosidase%26jtitle%3DTetrahedron%26date%3D1994%26volume%3D50%26spage%3D6965%26epage%3D6974%26doi%3D10.1016%2FS0040-4020%2801%2981349-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kleeb, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sigl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezencon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamberger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">FimH Antagonists: Phosphate Prodrugs Improve Oral Bioavailability</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">3163</span><span class="NLM_x">–</span> <span class="NLM_lpage">3182</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01923</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01923" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3163-3182&author=S.+Kleebauthor=X.+Jiangauthor=P.+Freiauthor=A.+Siglauthor=J.+Bezenconauthor=K.+Bambergerauthor=O.+Schwardtauthor=B.+Ernst&title=FimH+Antagonists%3A+Phosphate+Prodrugs+Improve+Oral+Bioavailability&doi=10.1021%2Facs.jmedchem.5b01923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01923%26sid%3Dliteratum%253Aachs%26aulast%3DKleeb%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DFrei%26aufirst%3DP.%26aulast%3DSigl%26aufirst%3DA.%26aulast%3DBezencon%26aufirst%3DJ.%26aulast%3DBamberger%26aufirst%3DK.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DFimH%2520Antagonists%253A%2520Phosphate%2520Prodrugs%2520Improve%2520Oral%2520Bioavailability%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3163%26epage%3D3182%26doi%3D10.1021%2Facs.jmedchem.5b01923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Janetka, J. W.; Han, Z.; Hultgren, S.; Pinkner, J. S.; Cusumano, C. K.</span><span> </span><span class="NLM_article-title">Compounds and methods for treating bacterial infections</span>. WO/2014/194270,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=J.+W.+Janetka&author=Z.+Han&author=S.+Hultgren&author=J.+S.+Pinkner&author=C.+K.+Cusumano&title=Compounds+and+methods+for+treating+bacterial+infections"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26atitle%3DCompounds%2520and%2520methods%2520for%2520treating%2520bacterial%2520infections%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Fiege, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabbani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preston, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zihlmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwardt, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">The tyrosine gate of the bacterial lectin FimH: a conformational analysis by NMR spectroscopy and X-ray crystallography</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1235</span><span class="NLM_x">–</span> <span class="NLM_lpage">1246</span><span class="refDoi"> DOI: 10.1002/cbic.201402714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fcbic.201402714" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=25940742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=1235-1246&author=B.+Fiegeauthor=S.+Rabbaniauthor=R.+C.+Prestonauthor=R.+P.+Jakobauthor=P.+Zihlmannauthor=O.+Schwardtauthor=X.+Jiangauthor=T.+Maierauthor=B.+Ernst&title=The+tyrosine+gate+of+the+bacterial+lectin+FimH%3A+a+conformational+analysis+by+NMR+spectroscopy+and+X-ray+crystallography&doi=10.1002%2Fcbic.201402714"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The Tyrosine Gate of the Bacterial Lectin FimH: A Conformational Analysis by NMR Spectroscopy and X-ray Crystallography</span></div><div class="casAuthors">Fiege, Brigitte; Rabbani, Said; Preston, Roland C.; Jakob, Roman P.; Zihlmann, Pascal; Schwardt, Oliver; Jiang, Xiaohua; Maier, Timm; Ernst, Beat</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1235-1246</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Urinary tract infections caused by uropathogenic E. coli are among the most prevalent infectious diseases.  The mannose-specific lectin FimH mediates the adhesion of the bacteria to the urothelium, thus enabling host cell invasion and recurrent infections.  An attractive alternative to antibiotic treatment is the development of FimH antagonists that mimic the physiol. ligand.  A large variety of candidate drugs have been developed and characterized by means of in vitro studies and animal models.  Here we present the X-ray co-crystal structures of FimH with members of four antagonist classes.  In three of these cases no structural data had previously been available.  We used NMR spectroscopy to characterize FimH-antagonist interactions further by chem. shift perturbation.  The anal. allowed a clear detn. of the conformation of the tyrosine gate motif that is crucial for the interaction with aglycon moieties and was not obvious from X-ray structural data alone.  Finally, ITC expts. provided insight into the thermodn. of antagonist binding.  In conjunction with the structural information from X-ray and NMR expts. the results provide a mechanism for the often-obsd. enthalpy-entropy compensation of FimH antagonists that plays a role in fine-tuning of the interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9ZlLJ0nu7AbVg90H21EOLACvtfcHk0ljPtRvz7VhAYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOitrs%253D&md5=a92e50330b554009a72fee92fd573dd0</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201402714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201402714%26sid%3Dliteratum%253Aachs%26aulast%3DFiege%26aufirst%3DB.%26aulast%3DRabbani%26aufirst%3DS.%26aulast%3DPreston%26aufirst%3DR.%2BC.%26aulast%3DJakob%26aufirst%3DR.%2BP.%26aulast%3DZihlmann%26aufirst%3DP.%26aulast%3DSchwardt%26aufirst%3DO.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DThe%2520tyrosine%2520gate%2520of%2520the%2520bacterial%2520lectin%2520FimH%253A%2520a%2520conformational%2520analysis%2520by%2520NMR%2520spectroscopy%2520and%2520X-ray%2520crystallography%26jtitle%3DChemBioChem%26date%3D2015%26volume%3D16%26spage%3D1235%26epage%3D1246%26doi%3D10.1002%2Fcbic.201402714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">de Ruyck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensink, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouckaert, J.</span><span> </span><span class="NLM_article-title">Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin</span> <span class="citation_source-journal">IUCrJ</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span><span class="refDoi"> DOI: 10.1107/S2052252516002487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1107%2FS2052252516002487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=27158502" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28Xntlyhtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2016&pages=163-167&author=J.+de+Ruyckauthor=M.+F.+Lensinkauthor=J.+Bouckaert&title=Structures+of+C-mannosylated+anti-adhesives+bound+to+the+type+1+fimbrial+FimH+adhesin&doi=10.1107%2FS2052252516002487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of C-mannosylated anti-adhesives bound to the type 1 fimbrial FimH adhesin</span></div><div class="casAuthors">de Ruyck, Jerome; Lensink, Marc F.; Bouckaert, Julie</div><div class="citationInfo"><span class="NLM_cas:title">IUCrJ</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">163-167</span>CODEN:
                <span class="NLM_cas:coden">IUCRAJ</span>;
        ISSN:<span class="NLM_cas:issn">2052-2525</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Selective inhibitors of the type 1 fimbrial adhesin FimH are recognized as attractive alternatives for antibiotic therapies and prophylaxes against Escherichia coli infections such as urinary-tract infections.  To construct these inhibitors, the α-D-mannopyranoside of high-mannose N-glycans, recognized with exclusive specificity on glycoprotein receptors by FimH, forms the basal structure.  A hydrophobic aglycon is then linked to the mannose by the O1 oxygen inherently present in the α-anomeric configuration.  Substitution of this O atom by a carbon introduces a C-glycosidic bond, which may enhance the therapeutic potential of such compds. owing to the inability of enzymes to degrade C-glycosidic bonds.  Here, the first crystal structures of the E. coli FimH adhesin in complex with C-glycosidically linked mannopyranosides are presented.  These findings explain the role of the spacer in positioning biphenyl ligands for interactions by means of arom. stacking in the tyrosine gate of FimH and how the normally hydrated C-glycosidic link is tolerated.  As these new compds. can bind FimH, it can be assumed that they have the potential to serve as potent new antagonists of FimH, paving the way for the design of a new family of anti-adhesive compds. against urinary-tract infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA3oBGrQGwKLVg90H21EOLACvtfcHk0ljPtRvz7VhAYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xntlyhtrs%253D&md5=514c8b09a5674f62eec9b580650dfb81</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1107%2FS2052252516002487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS2052252516002487%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRuyck%26aufirst%3DJ.%26aulast%3DLensink%26aufirst%3DM.%2BF.%26aulast%3DBouckaert%26aufirst%3DJ.%26atitle%3DStructures%2520of%2520C-mannosylated%2520anti-adhesives%2520bound%2520to%2520the%2520type%25201%2520fimbrial%2520FimH%2520adhesin%26jtitle%3DIUCrJ%26date%3D2016%26volume%3D3%26spage%3D163%26epage%3D167%26doi%3D10.1107%2FS2052252516002487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Tiwari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, A. K.</span><span> </span><span class="NLM_article-title">Cyclodextrins in delivery systems: Applications</span> <span class="citation_source-journal">J. Pharm. BioAllied Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">79</span><span class="refDoi"> DOI: 10.4103/0975-7406.67003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.4103%2F0975-7406.67003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=72-79&author=G.+Tiwariauthor=R.+Tiwariauthor=A.+K.+Rai&title=Cyclodextrins+in+delivery+systems%3A+Applications&doi=10.4103%2F0975-7406.67003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.4103%2F0975-7406.67003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F0975-7406.67003%26sid%3Dliteratum%253Aachs%26aulast%3DTiwari%26aufirst%3DG.%26aulast%3DTiwari%26aufirst%3DR.%26aulast%3DRai%26aufirst%3DA.%2BK.%26atitle%3DCyclodextrins%2520in%2520delivery%2520systems%253A%2520Applications%26jtitle%3DJ.%2520Pharm.%2520BioAllied%2520Sci.%26date%3D2010%26volume%3D2%26spage%3D72%26epage%3D79%26doi%3D10.4103%2F0975-7406.67003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Elisia, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofs, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cederberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cait, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adomat, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guns, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNagny, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samudio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krystal, G.</span><span> </span><span class="NLM_article-title">DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e0152538</span><span class="refDoi"> DOI: 10.1371/journal.pone.0152538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.pone.0152538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0152538&author=I.+Elisiaauthor=H.+Nakamuraauthor=V.+Lamauthor=E.+Hofsauthor=R.+Cederbergauthor=J.+Caitauthor=M.+R.+Hughesauthor=L.+Leeauthor=W.+Jiaauthor=H.+H.+Adomatauthor=E.+S.+Gunsauthor=K.+M.+McNagnyauthor=I.+Samudioauthor=G.+Krystal&title=DMSO+Represses+Inflammatory+Cytokine+Production+from+Human+Blood+Cells+and+Reduces+Autoimmune+Arthritis&doi=10.1371%2Fjournal.pone.0152538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0152538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0152538%26sid%3Dliteratum%253Aachs%26aulast%3DElisia%26aufirst%3DI.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DV.%26aulast%3DHofs%26aufirst%3DE.%26aulast%3DCederberg%26aufirst%3DR.%26aulast%3DCait%26aufirst%3DJ.%26aulast%3DHughes%26aufirst%3DM.%2BR.%26aulast%3DLee%26aufirst%3DL.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DAdomat%26aufirst%3DH.%2BH.%26aulast%3DGuns%26aufirst%3DE.%2BS.%26aulast%3DMcNagny%26aufirst%3DK.%2BM.%26aulast%3DSamudio%26aufirst%3DI.%26aulast%3DKrystal%26aufirst%3DG.%26atitle%3DDMSO%2520Represses%2520Inflammatory%2520Cytokine%2520Production%2520from%2520Human%2520Blood%2520Cells%2520and%2520Reduces%2520Autoimmune%2520Arthritis%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0152538%26doi%3D10.1371%2Fjournal.pone.0152538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tewari, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Te, A. E.</span><span> </span><span class="NLM_article-title">Role of inflammation in bladder function and interstitial cystitis</span> <span class="citation_source-journal">Ther. Adv. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1177/1756287211398255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1177%2F1756287211398255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21789096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVWktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=19-33&author=S.+Groverauthor=A.+Srivastavaauthor=R.+Leeauthor=A.+K.+Tewariauthor=A.+E.+Te&title=Role+of+inflammation+in+bladder+function+and+interstitial+cystitis&doi=10.1177%2F1756287211398255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35bR"><div class="casContent"><span class="casTitleNuber">35b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of inflammation in bladder function and interstitial cystitis</span></div><div class="casAuthors">Grover, Sonal; Srivastava, Abhishek; Lee, Richard; Tewari, Ashutosh K.; Te, Alexis E.</div><div class="citationInfo"><span class="NLM_cas:title">Therapeutic Advances in Urology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-33</span>CODEN:
                <span class="NLM_cas:coden">TAUHAQ</span>;
        ISSN:<span class="NLM_cas:issn">1756-2872</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Cystitis, or inflammation of the bladder, has a direct effect on bladder function.  Interstitial cystitis is a syndrome characterized by urinary bladder pain and irritative symptoms of more than 6 mo duration.  It commonly occurs in young to middle-aged women with no known cause and in fact represents a diagnosis of exclusion.  Many factors have been suggested, including chronic or subclin. infection, autoimmunity and genetic susceptibility, which could be responsible for initiating the inflammatory response.  However, a central role of inflammation has been confirmed in the pathogenesis of interstitial cystitis.  Patients with interstitial cystitis are usually managed with multimodal therapy to break the vicious cycle of chronic inflammation at every step.  Patients who develop irreversible pathologies such as fibrosis are managed surgically, which is usually reserved for refractory cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxt8LInpW3BbVg90H21EOLACvtfcHk0lidW4fiIfo7Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVWktLo%253D&md5=5b682c8f1558aa24b859e65e0ea3b635</span></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1177%2F1756287211398255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1756287211398255%26sid%3Dliteratum%253Aachs%26aulast%3DGrover%26aufirst%3DS.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DR.%26aulast%3DTewari%26aufirst%3DA.%2BK.%26aulast%3DTe%26aufirst%3DA.%2BE.%26atitle%3DRole%2520of%2520inflammation%2520in%2520bladder%2520function%2520and%2520interstitial%2520cystitis%26jtitle%3DTher.%2520Adv.%2520Urol.%26date%3D2011%26volume%3D3%26spage%3D19%26epage%3D33%26doi%3D10.1177%2F1756287211398255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">A murine model of urinary tract infection</span> <span class="citation_source-journal">Nat. Protoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1230</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span><span class="refDoi"> DOI: 10.1038/nprot.2009.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnprot.2009.116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1230-1243&author=C.+S.+Hungauthor=K.+W.+Dodsonauthor=S.+J.+Hultgren&title=A+murine+model+of+urinary+tract+infection&doi=10.1038%2Fnprot.2009.116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2009.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2009.116%26sid%3Dliteratum%253Aachs%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DDodson%26aufirst%3DK.%2BW.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DA%2520murine%2520model%2520of%2520urinary%2520tract%2520infection%26jtitle%3DNat.%2520Protoc.%26date%3D2009%26volume%3D4%26spage%3D1230%26epage%3D1243%26doi%3D10.1038%2Fnprot.2009.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schwartz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conover, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hannan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Uropathogenic <i>Escherichia coli</i> superinfection enhances the severity of mouse bladder infection</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1004599</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1004599</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.ppat.1004599" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1004599&author=D.+J.+Schwartzauthor=M.+S.+Conoverauthor=T.+J.+Hannanauthor=S.+J.+Hultgren&title=Uropathogenic+Escherichia+coli+superinfection+enhances+the+severity+of+mouse+bladder+infection&doi=10.1371%2Fjournal.ppat.1004599"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004599%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BJ.%26aulast%3DConover%26aufirst%3DM.%2BS.%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DUropathogenic%2520Escherichia%2520coli%2520superinfection%2520enhances%2520the%2520severity%2520of%2520mouse%2520bladder%2520infection%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26spage%3De1004599%26doi%3D10.1371%2Fjournal.ppat.1004599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hannan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mysorekar, I. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson-Schmid, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Early severe inflammatory responses to uropathogenic <i>E. coli</i> predispose to chronic and recurrent urinary tract infection</span> <span class="citation_source-journal">PLoS Pathog.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001042</span><span class="refDoi"> DOI: 10.1371/journal.ppat.1001042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.ppat.1001042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=e1001042&author=T.+J.+Hannanauthor=I.+U.+Mysorekarauthor=C.+S.+Hungauthor=M.+L.+Isaacson-Schmidauthor=S.+J.+Hultgren&title=Early+severe+inflammatory+responses+to+uropathogenic+E.+coli+predispose+to+chronic+and+recurrent+urinary+tract+infection&doi=10.1371%2Fjournal.ppat.1001042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36c&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1001042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1001042%26sid%3Dliteratum%253Aachs%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DMysorekar%26aufirst%3DI.%2BU.%26aulast%3DHung%26aufirst%3DC.%2BS.%26aulast%3DIsaacson-Schmid%26aufirst%3DM.%2BL.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DEarly%2520severe%2520inflammatory%2520responses%2520to%2520uropathogenic%2520E.%2520coli%2520predispose%2520to%2520chronic%2520and%2520recurrent%2520urinary%2520tract%2520infection%26jtitle%3DPLoS%2520Pathog.%26date%3D2010%26volume%3D6%26spage%3De1001042%26doi%3D10.1371%2Fjournal.ppat.1001042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Rosen, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooton, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Detection of intracellular bacterial communities in human urinary tract infection</span> <span class="citation_source-journal">PLoS Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">e329</span><span class="refDoi"> DOI: 10.1371/journal.pmed.0040329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1371%2Fjournal.pmed.0040329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=18092884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BD2sjmslOlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2007&pages=e329&author=D.+A.+Rosenauthor=T.+M.+Hootonauthor=W.+E.+Stammauthor=P.+A.+Humphreyauthor=S.+J.+Hultgren&title=Detection+of+intracellular+bacterial+communities+in+human+urinary+tract+infection&doi=10.1371%2Fjournal.pmed.0040329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">Detection of intracellular bacterial communities in human urinary tract infection</span></div><div class="casAuthors">Rosen David A; Hooton Thomas M; Stamm Walter E; Humphrey Peter A; Hultgren Scott J</div><div class="citationInfo"><span class="NLM_cas:title">PLoS medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e329</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Urinary tract infections (UTIs) are one of the most common bacterial infections and are predominantly caused by uropathogenic Escherichia coli (UPEC).  While UTIs are typically considered extracellular infections, it has been recently demonstrated that UPEC bind to, invade, and replicate within the murine bladder urothelium to form intracellular bacterial communities (IBCs).  These IBCs dissociate and bacteria flux out of bladder facet cells, some with filamentous morphology, and ultimately establish quiescent intracellular reservoirs that can seed recurrent infection.  This IBC pathogenic cycle has not yet been investigated in humans.  In this study we sought to determine whether evidence of an IBC pathway could be found in urine specimens from women with acute UTI.  METHODS AND FINDINGS:  We collected midstream, clean-catch urine specimens from 80 young healthy women with acute uncomplicated cystitis and 20 asymptomatic women with a history of UTI.  Investigators were blinded to culture results and clinical history.  Samples were analyzed by light microscopy, immunofluorescence, and electron microscopy for evidence of exfoliated IBCs and filamentous bacteria.  Evidence of IBCs was found in 14 of 80 (18%) urines from women with UTI.  Filamentous bacteria were found in 33 of 80 (41%) urines from women with UTI.  None of the 20 urines from the asymptomatic comparative group showed evidence of IBCs or filaments.  Filamentous bacteria were present in all 14 of the urines with IBCs compared to 19 (29%) of 66 samples with no evidence of IBCs (p < 0.001).  Of 65 urines from patients with E. coli infections, 14 (22%) had evidence of IBCs and 29 (45%) had filamentous bacteria, while none of the gram-positive infections had IBCs or filamentous bacteria.  CONCLUSIONS:  The presence of exfoliated IBCs and filamentous bacteria in the urines of women with acute cystitis suggests that the IBC pathogenic pathway characterized in the murine model may occur in humans.  The findings support the occurrence of an intracellular bacterial niche in some women with cystitis that may have important implications for UTI recurrence and treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQwOO8ErfpuaGHOrQ6qeX-mfW6udTcc2eaqg4CfBB8zu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjmslOlsQ%253D%253D&md5=6a15b375b4614deff9610c6272cabfd6</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pmed.0040329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pmed.0040329%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DD.%2BA.%26aulast%3DHooton%26aufirst%3DT.%2BM.%26aulast%3DStamm%26aufirst%3DW.%2BE.%26aulast%3DHumphrey%26aufirst%3DP.%2BA.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DDetection%2520of%2520intracellular%2520bacterial%2520communities%2520in%2520human%2520urinary%2520tract%2520infection%26jtitle%3DPLoS%2520Med.%26date%3D2007%26volume%3D4%26spage%3De329%26doi%3D10.1371%2Fjournal.pmed.0040329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schlager, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeGallo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendley, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C. A.</span><span> </span><span class="NLM_article-title">B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">2359</span><span class="NLM_x">–</span> <span class="NLM_lpage">2364</span><span class="refDoi"> DOI: 10.1016/j.juro.2011.07.114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.juro.2011.07.114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=22019034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADC%252BC3MbovV2htw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=2359-2364&author=T.+A.+Schlagerauthor=R.+LeGalloauthor=D.+Innesauthor=J.+O.+Hendleyauthor=C.+A.+Peters&title=B+cell+infiltration+and+lymphonodular+hyperplasia+in+bladder+submucosa+of+patients+with+persistent+bacteriuria+and+recurrent+urinary+tract+infections&doi=10.1016%2Fj.juro.2011.07.114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37bR"><div class="casContent"><span class="casTitleNuber">37b</span><div class="casTitle"><span class="NLM_cas:atitle">B cell infiltration and lymphonodular hyperplasia in bladder submucosa of patients with persistent bacteriuria and recurrent urinary tract infections</span></div><div class="casAuthors">Schlager T A; LeGallo Robin; Innes D; Hendley J O; Peters C A</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2359-64</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  We defined chronic inflammatory cell types in bladder submucosa and the presence of umbrella cells on the surface of bladder epithelium in patients 5 to 21 years old with persistent bacteriuria due to neurogenic bladder and recurrent urinary tract infections associated with vesicoureteral reflux.  MATERIALS AND METHODS:  Bladder mucosa biopsies from 12 patients and 6 controls were fixed in Carnoy's solution and examined for T cells (CD3, CD4, CD8), B cells (CD79) and plasma cells (CD138).  The number of cells in a defined area of submucosa was determined by counting all nuclei in the area.  A contiguous section was also stained for uroplakin expression with a monoclonal antibody against uroplakin III to ascertain the integrity of bladder umbrella cells.  RESULTS:  B cells, plasma cells and lymphoid nodules were found only in patient biopsies.  T cell expression was evident in patient and control biopsies.  Uroplakin staining of surface epithelium was uniform from control biopsies but spotty or entirely absent from patient biopsies.  CONCLUSIONS:  Patients with persistent bacteriuria or recurrent urinary tract infections had significant B cell infiltration in the submucosa, including lymphoid nodules.  These inflammatory changes are likely due to antigenic stimulation from repeated exposure to bacteria.  These changes are associated with frequent absence of uroplakin on surface epithelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCj6nuL_eJZ8ScOqQTSkOffW6udTcc2eZEg-q_HVFMtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbovV2htw%253D%253D&md5=c5040ae2d160ff1a761adf38238d1c6b</span></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2011.07.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2011.07.114%26sid%3Dliteratum%253Aachs%26aulast%3DSchlager%26aufirst%3DT.%2BA.%26aulast%3DLeGallo%26aufirst%3DR.%26aulast%3DInnes%26aufirst%3DD.%26aulast%3DHendley%26aufirst%3DJ.%2BO.%26aulast%3DPeters%26aufirst%3DC.%2BA.%26atitle%3DB%2520cell%2520infiltration%2520and%2520lymphonodular%2520hyperplasia%2520in%2520bladder%2520submucosa%2520of%2520patients%2520with%2520persistent%2520bacteriuria%2520and%2520recurrent%2520urinary%2520tract%2520infections%26jtitle%3DJ.%2520Urol.%26date%3D2011%26volume%3D186%26spage%3D2359%26epage%3D2364%26doi%3D10.1016%2Fj.juro.2011.07.114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hansson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hjalmas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultengren, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jodal, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svanborg-Eden, C.</span><span> </span><span class="NLM_article-title">Follicular cystitis in girls with untreated asymptomatic or covert bacteriuria</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">143</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2FS0022-5347%2817%2939950-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=2405189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A280%3ADyaK3c7jsVSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=1990&pages=330-332&author=S.+Hanssonauthor=E.+Hansonauthor=K.+Hjalmasauthor=M.+Hultengrenauthor=U.+Jodalauthor=S.+Ollingauthor=C.+Svanborg-Eden&title=Follicular+cystitis+in+girls+with+untreated+asymptomatic+or+covert+bacteriuria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37cR"><div class="casContent"><span class="casTitleNuber">37c</span><div class="casTitle"><span class="NLM_cas:atitle">Follicular cystitis in girls with untreated asymptomatic or covert bacteriuria</span></div><div class="casAuthors">Hansson S; Hanson E; Hjalmas K; Hultengren M; Jodal U; Olling S; Svanborg-Eden C</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">330-2</span>
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    </div><div class="casAbstract">Nodular changes of the bladder mucosa, that is cystitis follicularis or cystitis cystica, are found in 2 to 9% of all children with urinary tract infections.  The nodules are composed of lymphoid aggregates, resembling Peyer's patches in the intestine.  Children with this finding are considered to have a poor short-term prognosis with a marked tendency for recurrent infections.  Screening programs for bacteriuria have revealed that a few per cent of the female population are bacteriuric without symptoms of overt disease.  Of 59 girls followed with untreated asymptomatic bacteriuria 52 had nodular changes of the bladder mucosa at cystoscopy.  Biopsy was performed in 22 girls, and revealed lymphocytic infiltration in 19 and follicular formation in 11.  The nodular changes persisted when bacteriuria continued but disappeared in patients who became abacteriuric.  This finding demonstrates the reversibility of the changes, and supports the assumption that they are secondary to the presence of bacteria and not a primary lesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSkZbg0ZdhBtevW160gIxP_fW6udTcc2eZEg-q_HVFMtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3c7jsVSqtQ%253D%253D&md5=88c51794106407ba66ff8d7ab23bb297</span></div><a href="/servlet/linkout?suffix=cit37c&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2817%2939950-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252817%252939950-0%26sid%3Dliteratum%253Aachs%26aulast%3DHansson%26aufirst%3DS.%26aulast%3DHanson%26aufirst%3DE.%26aulast%3DHjalmas%26aufirst%3DK.%26aulast%3DHultengren%26aufirst%3DM.%26aulast%3DJodal%26aufirst%3DU.%26aulast%3DOlling%26aufirst%3DS.%26aulast%3DSvanborg-Eden%26aufirst%3DC.%26atitle%3DFollicular%2520cystitis%2520in%2520girls%2520with%2520untreated%2520asymptomatic%2520or%2520covert%2520bacteriuria%26jtitle%3DJ.%2520Urol.%26date%3D1990%26volume%3D143%26spage%3D330%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Hannan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riehl, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Post, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mack, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwendener, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooton, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stappenbeck, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenson, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stapleton, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultgren, S. J.</span><span> </span><span class="NLM_article-title">Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis</span> <span class="citation_source-journal">EBioMedicine.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span><span class="refDoi"> DOI: 10.1016/j.ebiom.2014.10.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.ebiom.2014.10.011" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2014&pages=46-57&author=T.+J.+Hannanauthor=P.+L.+Robertsauthor=T.+E.+Riehlauthor=S.+van+der+Postauthor=J.+M.+Binkleyauthor=D.+J.+Schwartzauthor=H.+Miyoshiauthor=M.+Mackauthor=R.+A.+Schwendenerauthor=T.+M.+Hootonauthor=T.+S.+Stappenbeckauthor=G.+C.+Hanssonauthor=W.+F.+Stensonauthor=M.+Colonnaauthor=A.+E.+Stapletonauthor=S.+J.+Hultgren&title=Inhibition+of+Cyclooxygenase-2+Prevents+Chronic+and+Recurrent+Cystitis&doi=10.1016%2Fj.ebiom.2014.10.011"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37d&amp;dbid=16384&amp;doi=10.1016%2Fj.ebiom.2014.10.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ebiom.2014.10.011%26sid%3Dliteratum%253Aachs%26aulast%3DHannan%26aufirst%3DT.%2BJ.%26aulast%3DRoberts%26aufirst%3DP.%2BL.%26aulast%3DRiehl%26aufirst%3DT.%2BE.%26aulast%3Dvan%2Bder%2BPost%26aufirst%3DS.%26aulast%3DBinkley%26aufirst%3DJ.%2BM.%26aulast%3DSchwartz%26aufirst%3DD.%2BJ.%26aulast%3DMiyoshi%26aufirst%3DH.%26aulast%3DMack%26aufirst%3DM.%26aulast%3DSchwendener%26aufirst%3DR.%2BA.%26aulast%3DHooton%26aufirst%3DT.%2BM.%26aulast%3DStappenbeck%26aufirst%3DT.%2BS.%26aulast%3DHansson%26aufirst%3DG.%2BC.%26aulast%3DStenson%26aufirst%3DW.%2BF.%26aulast%3DColonna%26aufirst%3DM.%26aulast%3DStapleton%26aufirst%3DA.%2BE.%26aulast%3DHultgren%26aufirst%3DS.%2BJ.%26atitle%3DInhibition%2520of%2520Cyclooxygenase-2%2520Prevents%2520Chronic%2520and%2520Recurrent%2520Cystitis%26jtitle%3DEBioMedicine.%26date%3D2014%26volume%3D1%26spage%3D46%26epage%3D57%26doi%3D10.1016%2Fj.ebiom.2014.10.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sattin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, A.</span><span> </span><span class="NLM_article-title">Glycoconjugates and Glycomimetics as Microbial Anti-Adhesives</span> <span class="citation_source-journal">Trends Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">483</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span><span class="refDoi"> DOI: 10.1016/j.tibtech.2016.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.tibtech.2016.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=26875976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFCltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=483-495&author=S.+Sattinauthor=A.+Bernardi&title=Glycoconjugates+and+Glycomimetics+as+Microbial+Anti-Adhesives&doi=10.1016%2Fj.tibtech.2016.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38aR"><div class="casContent"><span class="casTitleNuber">38a</span><div class="casTitle"><span class="NLM_cas:atitle">Glycoconjugates and Glycomimetics as Microbial Anti-Adhesives</span></div><div class="casAuthors">Sattin, Sara; Bernardi, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biotechnology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">483-495</span>CODEN:
                <span class="NLM_cas:coden">TRBIDM</span>;
        ISSN:<span class="NLM_cas:issn">0167-7799</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Microbial adhesion is an essential step in infection and is mediated primarily by protein-carbohydrate interactions.  Antagonists of such interactions have become a promising target for anti-adhesive therapy in several infective diseases.  Monovalent protein-sugar interactions are often weak, and most successful anti-adhesive materials consist of multivalent glycoconjugates.  Although often very effective in hampering microbial adhesion, natural epitopes often show limited resistance to enzymic degrdn.  The use of carbohydrate mimics (glycomimetics) as a replacement for natural sugars potentially allows higher metabolic stability and also higher selectivity towards the desired protein target.  In this review we describe the state of the art in the design and synthesis of glycoconjugates and glycomimetics employed for the construction of anti-adhesive biomaterials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6YxCBQhH0Z7Vg90H21EOLACvtfcHk0lh-hirSRtbqkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFCltLw%253D&md5=335ad2bd9d327257ea5b363a9bd5d1c2</span></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=10.1016%2Fj.tibtech.2016.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibtech.2016.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DSattin%26aufirst%3DS.%26aulast%3DBernardi%26aufirst%3DA.%26atitle%3DGlycoconjugates%2520and%2520Glycomimetics%2520as%2520Microbial%2520Anti-Adhesives%26jtitle%3DTrends%2520Biotechnol.%26date%3D2016%26volume%3D34%26spage%3D483%26epage%3D495%26doi%3D10.1016%2Fj.tibtech.2016.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cecioni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imberty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, S.</span><span> </span><span class="NLM_article-title">Glycomimetics versus multivalent glycoconjugates for the design of high affinity lectin ligands</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">525</span><span class="NLM_x">–</span> <span class="NLM_lpage">561</span><span class="refDoi"> DOI: 10.1021/cr500303t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr500303t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFans7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2015&pages=525-561&author=S.+Cecioniauthor=A.+Imbertyauthor=S.+Vidal&title=Glycomimetics+versus+multivalent+glycoconjugates+for+the+design+of+high+affinity+lectin+ligands&doi=10.1021%2Fcr500303t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Glycomimetics versus Multivalent Glycoconjugates for the Design of High Affinity Lectin Ligands</span></div><div class="casAuthors">Cecioni, Samy; Imberty, Anne; Vidal, Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">525-561</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review is aimed at giving an overview of the numerous synthetic approaches for building glycomimetics and glycoclusters designed for high affinity binding by lectins of interest in human health.  Selected examples related to neurol. diseases,cancer, and infection are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMeUedZ6R-o7Vg90H21EOLACvtfcHk0lhiryxBU7ecNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFans7bM&md5=261b50560ae13f3072b0d11919000a16</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1021%2Fcr500303t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr500303t%26sid%3Dliteratum%253Aachs%26aulast%3DCecioni%26aufirst%3DS.%26aulast%3DImberty%26aufirst%3DA.%26aulast%3DVidal%26aufirst%3DS.%26atitle%3DGlycomimetics%2520versus%2520multivalent%2520glycoconjugates%2520for%2520the%2520design%2520of%2520high%2520affinity%2520lectin%2520ligands%26jtitle%3DChem.%2520Rev.%26date%3D2015%26volume%3D115%26spage%3D525%26epage%3D561%26doi%3D10.1021%2Fcr500303t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sutkeviciute, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thepaut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeagh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grudinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Roy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reina, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clerici, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieschi, F.</span><span> </span><span class="NLM_article-title">Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span><span class="refDoi"> DOI: 10.1021/cb500054h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb500054h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1377-1385&author=I.+Sutkeviciuteauthor=M.+Thepautauthor=S.+Sattinauthor=A.+Berziauthor=J.+McGeaghauthor=S.+Grudininauthor=J.+Weiserauthor=A.+Le+Royauthor=J.+J.+Reinaauthor=J.+Rojoauthor=M.+Clericiauthor=A.+Bernardiauthor=C.+Ebelauthor=F.+Fieschi&title=Unique+DC-SIGN+clustering+activity+of+a+small+glycomimetic%3A+A+lesson+for+ligand+design&doi=10.1021%2Fcb500054h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38cR"><div class="casContent"><span class="casTitleNuber">38c</span><div class="casTitle"><span class="NLM_cas:atitle">Unique DC-SIGN Clustering Activity of a Small Glycomimetic: A Lesson for Ligand Design</span></div><div class="casAuthors">Sutkeviciute, Ieva; Thepaut, Michel; Sattin, Sara; Berzi, Angela; McGeagh, John; Grudinin, Sergei; Weiser, Jorg; Le Roy, Aline; Reina, Jose J.; Rojo, Javier; Clerici, Mario; Bernardi, Anna; Ebel, Christine; Fieschi, Franck</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1377-1385</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DC-SIGN is a dendritic cell-specific C-type lectin receptor that recognizes highly glycosylated ligands expressed on the surface of various pathogens.  This receptor plays an important role in the early stages of many viral infections, including HIV, which makes it an interesting therapeutic target.  Glycomimetic compds. are good drug candidates for DC-SIGN inhibition due to their high soly., resistance to glycosidases, and nontoxicity.  We studied the structural properties of the interaction of the tetrameric DC-SIGN extracellular domain (ECD), with two glycomimetic antagonists, a pseudomannobioside and a linear pseudomannotrioside .  Though the inhibitory potency of pseudomannotrioside, as measured by SPR competition expts., was pseudomannobioside order of magnitude higher than that of pseudomannobioside, crystal structures of the complexes within the DC-SIGN carbohydrate recognition domain showed the same binding mode for both compds.  Moreover, when conjugated to multivalent scaffolds, the inhibitory potencies of these compds. became uniform.  Combining isothermal titrn. microcalorimetry, anal. ultracentrifugation, and dynamic light scattering techniques to study DC-SIGN ECD interaction with these glycomimetics revealed that pseudomannotrioside is able, without any multivalent presentation, to cluster DC-SIGN tetramers leading to an artificially overestimated inhibitory potency.  The use of multivalent scaffolds presenting pseudomannobioside or pseudomannotrioside in HIV trans-infection inhibition assay confirms the loss of potency of pseudomannotrioside upon conjugation and the equal efficacy of chem. simpler compd. pseudomannobioside.  This study documents a unique case where, among two active compds. chem. derived, the compd. with the lower apparent activity is the optimal lead for further drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJSsL4oxpJD7Vg90H21EOLACvtfcHk0lhiryxBU7ecNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmsFWgtLc%253D&md5=89af8431ef89595c2a76e6fbab25a98a</span></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=10.1021%2Fcb500054h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb500054h%26sid%3Dliteratum%253Aachs%26aulast%3DSutkeviciute%26aufirst%3DI.%26aulast%3DThepaut%26aufirst%3DM.%26aulast%3DSattin%26aufirst%3DS.%26aulast%3DBerzi%26aufirst%3DA.%26aulast%3DMcGeagh%26aufirst%3DJ.%26aulast%3DGrudinin%26aufirst%3DS.%26aulast%3DWeiser%26aufirst%3DJ.%26aulast%3DLe%2BRoy%26aufirst%3DA.%26aulast%3DReina%26aufirst%3DJ.%2BJ.%26aulast%3DRojo%26aufirst%3DJ.%26aulast%3DClerici%26aufirst%3DM.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DEbel%26aufirst%3DC.%26aulast%3DFieschi%26aufirst%3DF.%26atitle%3DUnique%2520DC-SIGN%2520clustering%2520activity%2520of%2520a%2520small%2520glycomimetic%253A%2520A%2520lesson%2520for%2520ligand%2520design%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2014%26volume%3D9%26spage%3D1377%26epage%3D1385%26doi%3D10.1021%2Fcb500054h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Thepaut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutkeviciute, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sattin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro-Viana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabrol, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieto, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fieschi, F.</span><span> </span><span class="NLM_article-title">Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">2518</span><span class="NLM_x">–</span> <span class="NLM_lpage">2529</span><span class="refDoi"> DOI: 10.1021/ja3053305</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3053305" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=2518-2529&author=M.+Thepautauthor=C.+Guzziauthor=I.+Sutkeviciuteauthor=S.+Sattinauthor=R.+Ribeiro-Vianaauthor=N.+Vargaauthor=E.+Chabrolauthor=J.+Rojoauthor=A.+Bernardiauthor=J.+Anguloauthor=P.+M.+Nietoauthor=F.+Fieschi&title=Structure+of+a+glycomimetic+ligand+in+the+carbohydrate+recognition+domain+of+C-type+lectin+DC-SIGN.+Structural+requirements+for+selectivity+and+ligand+design&doi=10.1021%2Fja3053305"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38d&amp;dbid=16384&amp;doi=10.1021%2Fja3053305&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3053305%26sid%3Dliteratum%253Aachs%26aulast%3DThepaut%26aufirst%3DM.%26aulast%3DGuzzi%26aufirst%3DC.%26aulast%3DSutkeviciute%26aufirst%3DI.%26aulast%3DSattin%26aufirst%3DS.%26aulast%3DRibeiro-Viana%26aufirst%3DR.%26aulast%3DVarga%26aufirst%3DN.%26aulast%3DChabrol%26aufirst%3DE.%26aulast%3DRojo%26aufirst%3DJ.%26aulast%3DBernardi%26aufirst%3DA.%26aulast%3DAngulo%26aufirst%3DJ.%26aulast%3DNieto%26aufirst%3DP.%2BM.%26aulast%3DFieschi%26aufirst%3DF.%26atitle%3DStructure%2520of%2520a%2520glycomimetic%2520ligand%2520in%2520the%2520carbohydrate%2520recognition%2520domain%2520of%2520C-type%2520lectin%2520DC-SIGN.%2520Structural%2520requirements%2520for%2520selectivity%2520and%2520ligand%2520design%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D2518%26epage%3D2529%26doi%3D10.1021%2Fja3053305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hauck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachim, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommeyer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varrot, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Möller, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imberty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Exner, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Titz, A.</span><span> </span><span class="NLM_article-title">Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1784</span><span class="refDoi"> DOI: 10.1021/cb400371r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400371r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3sXotlensrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1775-1784&author=D.+Hauckauthor=I.+Joachimauthor=B.+Frommeyerauthor=A.+Varrotauthor=B.+Philippauthor=H.+M.+M%C3%B6llerauthor=A.+Imbertyauthor=T.+E.+Exnerauthor=A.+Titz&title=Discovery+of+two+classes+of+potent+glycomimetic+inhibitors+of+Pseudomonas+aeruginosa+LecB+with+distinct+binding+modes&doi=10.1021%2Fcb400371r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38eR"><div class="casContent"><span class="casTitleNuber">38e</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Two Classes of Potent Glycomimetic Inhibitors of Pseudomonas aeruginosa LecB with Distinct Binding Modes</span></div><div class="casAuthors">Hauck, Dirk; Joachim, Ines; Frommeyer, Benjamin; Varrot, Annabelle; Philipp, Bodo; Moeller, Heiko M.; Imberty, Anne; Exner, Thomas E.; Titz, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1775-1784</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The treatment of infections due to the opportunistic pathogen Pseudomonas aeruginosa is often difficult, as a consequence of bacterial biofilm formation.  Such a protective environment shields the bacterium from host defense and antibiotic treatment and secures its survival.  One crucial factor for maintenance of the biofilm architecture is the carbohydrate-binding lectin LecB.  Here, we report the identification of potent mannose-based LecB inhibitors from a screening of four series of mannosides in a novel competitive binding assay for LecB.  Cinnamide and sulfonamide derivs., e.g. I, are inhibitors of bacterial adhesion with up to a 20-fold increase in affinity to LecB compared to the natural ligand Me mannoside.  Because many lectins of the host require terminal saccharides (e.g., fucosides), such capped structures as reported here may offer a beneficial selectivity profile for the pathogenic lectin.  Both classes of compds. show distinct binding modes at the protein, offering the advantage of a simultaneous development of two new lead structures as anti-pseudomonadal drugs with an anti-virulence mode of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5a8of6XtObVg90H21EOLACvtfcHk0lhHifl66x3uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXotlensrw%253D&md5=e194c1845e7aa25b04e366281a4a5c0a</span></div><a href="/servlet/linkout?suffix=cit38e&amp;dbid=16384&amp;doi=10.1021%2Fcb400371r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400371r%26sid%3Dliteratum%253Aachs%26aulast%3DHauck%26aufirst%3DD.%26aulast%3DJoachim%26aufirst%3DI.%26aulast%3DFrommeyer%26aufirst%3DB.%26aulast%3DVarrot%26aufirst%3DA.%26aulast%3DPhilipp%26aufirst%3DB.%26aulast%3DM%25C3%25B6ller%26aufirst%3DH.%2BM.%26aulast%3DImberty%26aufirst%3DA.%26aulast%3DExner%26aufirst%3DT.%2BE.%26aulast%3DTitz%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520two%2520classes%2520of%2520potent%2520glycomimetic%2520inhibitors%2520of%2520Pseudomonas%2520aeruginosa%2520LecB%2520with%2520distinct%2520binding%2520modes%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D1775%26epage%3D1784%26doi%3D10.1021%2Fcb400371r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Chabre, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giguere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodrigue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocheleau, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauthu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papadopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imberty, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roy, R.</span><span> </span><span class="NLM_article-title">Combining glycomimetic and multivalent strategies toward designing potent bacterial lectin inhibitors</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6545</span><span class="NLM_x">–</span> <span class="NLM_lpage">6562</span><span class="refDoi"> DOI: 10.1002/chem.201003402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1002%2Fchem.201003402" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21523837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFylsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=6545-6562&author=Y.+M.+Chabreauthor=D.+Giguereauthor=B.+Blanchardauthor=J.+Rodrigueauthor=S.+Rocheleauauthor=M.+Neaultauthor=S.+Rauthuauthor=A.+Papadopoulosauthor=A.+A.+Arnoldauthor=A.+Imbertyauthor=R.+Roy&title=Combining+glycomimetic+and+multivalent+strategies+toward+designing+potent+bacterial+lectin+inhibitors&doi=10.1002%2Fchem.201003402"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38fR"><div class="casContent"><span class="casTitleNuber">38f</span><div class="casTitle"><span class="NLM_cas:atitle">Combining Glycomimetic and Multivalent Strategies toward Designing Potent Bacterial Lectin Inhibitors</span></div><div class="casAuthors">Chabre, Yoann M.; Giguere, Denis; Blanchard, Bertrand; Rodrigue, Jacques; Rocheleau, Sylvain; Neault, Mathieu; Rauthu, Subhash; Papadopoulos, Alex; Arnold, Alexandre A.; Imberty, Anne; Roy, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6545-6562, S6545/1-S6545/134</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">As part of ongoing activities toward the design of potent and selective ligands against galactoside-binding proteins from animal, bacterial, and plant lectins, a systematic investigation involving the synthesis and binding evaluations of a series of original β-C-galactopyranoside mimetics is described.  The multivalent presentation of partly optimized candidates on various dendritic scaffolds through CuI-catalyzed azide-alkyne cycloaddn. (CuAAc) has also been achieved.  Biophys. investigations based on isothermal titrn. calorimetry (ITC) have indicated a dissocn. const. in the low micromolar range for the best optimized monovalent conjugate (Kd=37 μM).  The results thus confirmed that stable C-galactosides could represent efficient synthetic glycomimetics of natural α-linked oligosaccharidic inhibitors of PA-IL lectin (Lec A) from the pathogenic Pseudomonas aeruginosa.  Striking enhancements in the avidity of the glycoconjugates were also obsd. for tri-, hexa-, and nonavalent derivs., among which the most potent exhibited dissocn. consts. below 500 nM, corresponding to a 400-fold increase in affinity compared with the β-D-Gal-O-Me used as ref.  To deepen the understanding of the binding mode of the best glycomimetics involved in the recognition process, mol. modeling studies, docking calcns., and NMR diffusion measurements have been performed.  Although favorable complementary interactions induced by the addn. of the hydrophobic aglycon might explain the affinity enhancement, exptl. detn. of the size and the topol. of the multivalent conjugates further supported the formation of aggregative complexes as a major multivalent binding mode.  This work represents a systematic and comprehensive study towards a thorough understanding of the protein-carbohydrate interactions involved in Pseudomonas aeruginosa infection, and as such should prove useful for the development of stable and optimized anti-adhesive agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxnLGu6DhR6rVg90H21EOLACvtfcHk0lhHifl66x3uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFylsb4%253D&md5=c4018853d3340f828e864bbc1ae0704b</span></div><a href="/servlet/linkout?suffix=cit38f&amp;dbid=16384&amp;doi=10.1002%2Fchem.201003402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201003402%26sid%3Dliteratum%253Aachs%26aulast%3DChabre%26aufirst%3DY.%2BM.%26aulast%3DGiguere%26aufirst%3DD.%26aulast%3DBlanchard%26aufirst%3DB.%26aulast%3DRodrigue%26aufirst%3DJ.%26aulast%3DRocheleau%26aufirst%3DS.%26aulast%3DNeault%26aufirst%3DM.%26aulast%3DRauthu%26aufirst%3DS.%26aulast%3DPapadopoulos%26aufirst%3DA.%26aulast%3DArnold%26aufirst%3DA.%2BA.%26aulast%3DImberty%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DR.%26atitle%3DCombining%2520glycomimetic%2520and%2520multivalent%2520strategies%2520toward%2520designing%2520potent%2520bacterial%2520lectin%2520inhibitors%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D6545%26epage%3D6562%26doi%3D10.1002%2Fchem.201003402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Magnani, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ernst, B.</span><span> </span><span class="NLM_article-title">Glycomimetic drugs—a new source of therapeutic opportunities</span> <span class="citation_source-journal">Discovery Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=247-252&author=J.+L.+Magnaniauthor=B.+Ernst&title=Glycomimetic+drugs%E2%80%94a+new+source+of+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMagnani%26aufirst%3DJ.%2BL.%26aulast%3DErnst%26aufirst%3DB.%26atitle%3DGlycomimetic%2520drugs%25E2%2580%2594a%2520new%2520source%2520of%2520therapeutic%2520opportunities%26jtitle%3DDiscovery%2520Med.%26date%3D2009%26volume%3D8%26spage%3D247%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ernst, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnani, J. L.</span><span> </span><span class="NLM_article-title">From carbohydrate leads to glycomimetic drugs</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">661</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span><span class="refDoi"> DOI: 10.1038/nrd2852</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1038%2Fnrd2852" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=19629075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovFymtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=661-677&author=B.+Ernstauthor=J.+L.+Magnani&title=From+carbohydrate+leads+to+glycomimetic+drugs&doi=10.1038%2Fnrd2852"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38hR"><div class="casContent"><span class="casTitleNuber">38h</span><div class="casTitle"><span class="NLM_cas:atitle">From carbohydrate leads to glycomimetic drugs</span></div><div class="casAuthors">Ernst, Beat; Magnani, John L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">661-677</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Carbohydrates are the most abundant natural products.  Besides their role in metab. and as structural building blocks, they are fundamental constituents of every cell surface, where they are involved in vital cellular recognition processes.  Carbohydrates are a relatively untapped source of new drugs and therefore offer exciting new therapeutic opportunities.  Advances in the functional understanding of carbohydrate-protein interactions have enabled the development of a new class of small-mol. drugs, known as glycomimetics.  These compds. mimic the bioactive function of carbohydrates and address the drawbacks of carbohydrate leads, namely their low activity and insufficient drug-like properties.  Here, we examine examples of approved carbohydrate-derived drugs, discuss the potential of carbohydrate-binding proteins as new drug targets (focusing on the lectin families) and consider ways to overcome the challenges of developing this unique class of novel therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6PJbzb53pf7Vg90H21EOLACvtfcHk0lhHifl66x3uTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovFymtLk%253D&md5=e9de5f51c13bfa145fca68ec38d542ac</span></div><a href="/servlet/linkout?suffix=cit38h&amp;dbid=16384&amp;doi=10.1038%2Fnrd2852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2852%26sid%3Dliteratum%253Aachs%26aulast%3DErnst%26aufirst%3DB.%26aulast%3DMagnani%26aufirst%3DJ.%2BL.%26atitle%3DFrom%2520carbohydrate%2520leads%2520to%2520glycomimetic%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D661%26epage%3D677%26doi%3D10.1038%2Fnrd2852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sipos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jablonkai, I.</span><span> </span><span class="NLM_article-title">Preparation of 1-C-glycosyl aldehydes by reductive hydrolysis</span> <span class="citation_source-journal">Carbohydr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">1503</span><span class="NLM_x">–</span> <span class="NLM_lpage">1510</span><span class="refDoi"> DOI: 10.1016/j.carres.2011.04.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1016%2Fj.carres.2011.04.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=21575933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFSqsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2011&pages=1503-1510&author=S.+Siposauthor=I.+Jablonkai&title=Preparation+of+1-C-glycosyl+aldehydes+by+reductive+hydrolysis&doi=10.1016%2Fj.carres.2011.04.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of 1-C-glycosyl aldehydes by reductive hydrolysis</span></div><div class="casAuthors">Sipos, Szabolcs; Jablonkai, Istvan</div><div class="citationInfo"><span class="NLM_cas:title">Carbohydrate Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1503-1510</span>CODEN:
                <span class="NLM_cas:coden">CRBRAT</span>;
        ISSN:<span class="NLM_cas:issn">0008-6215</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Reductive hydrolysis of various protected glycosyl cyanides was carried out using DIBAL-H to form aldimine intermediates which were then hydrolyzed under mildly acidic condition to provide the corresponding aldehyde derivs.  While 1-C-formyl glycal and 2-deoxy glycosyl derivs. were stable during isolation and storage 1-C-glycosyl formaldehydes in the gluco, galacto and manno series were sensitive and decompn. occurred by 2-alkyloxy elimination.  A one-pot method using N,N'-diphenylethylenediamine to trap these aldehydes in stable form was developed.  Reductive hydrolysis of glycosyl cyanides offers valuable aldehyde building blocks in a convenient way which can be applied in the synthesis of complex C-glycosides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEbXOJZogtJbVg90H21EOLACvtfcHk0lh0cStErhJlKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFSqsL8%253D&md5=631fce2d4f548b71c5fdda57b6d31884</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.carres.2011.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.carres.2011.04.019%26sid%3Dliteratum%253Aachs%26aulast%3DSipos%26aufirst%3DS.%26aulast%3DJablonkai%26aufirst%3DI.%26atitle%3DPreparation%2520of%25201-C-glycosyl%2520aldehydes%2520by%2520reductive%2520hydrolysis%26jtitle%3DCarbohydr.%2520Res.%26date%3D2011%26volume%3D346%26spage%3D1503%26epage%3D1510%26doi%3D10.1016%2Fj.carres.2011.04.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Lin, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yun, W. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, W. C.</span><span> </span><span class="NLM_article-title">Synthesis of novel polyhydroxylated pyrrolidine-triazole/-isoxazole hybrid molecules</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2100</span><span class="NLM_x">–</span> <span class="NLM_lpage">2107</span><span class="refDoi"> DOI: 10.1039/C4OB01934B</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;key=10.1039%2FC4OB01934B" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=2100-2107&author=C.+K.+Linauthor=L.+W.+Chengauthor=H.+Y.+Liauthor=W.+Y.+Yunauthor=W.+C.+Cheng&title=Synthesis+of+novel+polyhydroxylated+pyrrolidine-triazole%2F-isoxazole+hybrid+molecules&doi=10.1039%2FC4OB01934B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1039%2FC4OB01934B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC4OB01934B%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BK.%26aulast%3DCheng%26aufirst%3DL.%2BW.%26aulast%3DLi%26aufirst%3DH.%2BY.%26aulast%3DYun%26aufirst%3DW.%2BY.%26aulast%3DCheng%26aufirst%3DW.%2BC.%26atitle%3DSynthesis%2520of%2520novel%2520polyhydroxylated%2520pyrrolidine-triazole%252F-isoxazole%2520hybrid%2520molecules%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D2100%26epage%3D2107%26doi%3D10.1039%2FC4OB01934B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F2F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F2F','PDB','5F2F'); return false;">PDB: 5F2F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F3F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5F3F','PDB','5F3F'); return false;">PDB: 5F3F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MCY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MCY','PDB','3MCY'); return false;">PDB: 3MCY</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00948">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51347"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00948">10.1021/acs.jmedchem.6b00948</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline"><sup>1</sup>H and <sup>13</sup>C NMR, HPLC, and MS analytical data for new compounds and the details of the crystallography experiments, including the X-ray crystal determinants for both for the small molecule <b>27</b> and FimH co-crystal structure with <b>23</b>; details of the prophylactic acute UTI mouse model with <b>23</b> and prodrugs <b>23a</b>–<b>c</b>, as well as the rat pharmacokinetic study of <b>21R</b>, <b>23</b>, and <b>25</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_001.pdf">jm6b00948_si_001.pdf (4.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00948/suppl_file/jm6b00948_si_002.csv">jm6b00948_si_002.csv (3.62 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00948&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-20%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00948%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00948" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b6a53c393c94","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
